Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,mitochondrial translational termination (GO:0070126),0.7669174705873808,2.641340098529876,0.0,0.0,0.0,39/50,17.38%,MRPL42;CHCHD1;MRPL18;MRPS6;MRPL11;MRPL20;MRPL15;MRPL53;MRPL35;MRPS28;MRPS30;MRPL55;MRPS35;MRPL51;MRPL16;MRPL22;MRPS22;MRPL13;MRPL44;MRPL39;MRPS5;DAP3;MRPS31;MRPL40;MRPS10;MRPL45;MRPL49;MRPL37;MRPS12;MRPS18B;MRPL3;MRPL50;MRPS2;MRPL17;MRRF;GADD45GIP1;MRPL2;MRPS27;MRPS7
gsea,translational elongation (GO:0006414),0.7344379186317614,2.620287415913414,0.0,0.0,0.0,43/62,17.38%,EEF1A1;EEF1B2;MRPL42;CHCHD1;MRPL18;MRPS6;MRPL11;MRPL20;MRPL15;MRPL53;MRPL35;MRPS28;EEF1D;RACK1;MRPS30;MRPL55;MRPS35;MRPL51;MRPL16;MRPL22;MRPS22;MRPL13;MRPL44;MRPL39;MRPS5;TSFM;DAP3;MRPS31;MRPL40;MRPS10;MRPL45;MRPL49;MRPL37;MRPS12;MRPS18B;MRPL3;MRPL50;MRPS2;MRPL17;GADD45GIP1;MRPL2;MRPS27;MRPS7
gsea,translational termination (GO:0006415),0.7463175512251926,2.6194756956006717,0.0,0.0,0.0,40/55,17.38%,MRPL42;CHCHD1;MRPL18;MRPS6;MRPL11;MRPL20;MRPL15;MRPL53;MRPL35;MRPS28;MRPS30;MRPL55;MRPS35;MRPL51;MRPL16;MRPL22;MRPS22;MRPL13;MRPL44;MRPL39;MRPS5;DAP3;MRPS31;MRPL40;MRPS10;MRPL45;MRPL49;MRPL37;MRPS12;MRPS18B;MRPL3;MRPL50;MRPS2;MRPL17;N6AMT1;MRRF;GADD45GIP1;MRPL2;MRPS27;MRPS7
gsea,mitochondrial translational elongation (GO:0070125),0.7524697180006445,2.5988698649922317,0.0,0.0,0.0,39/52,17.38%,MRPL42;CHCHD1;MRPL18;MRPS6;MRPL11;MRPL20;MRPL15;MRPL53;MRPL35;MRPS28;MRPS30;MRPL55;MRPS35;MRPL51;MRPL16;MRPL22;MRPS22;MRPL13;MRPL44;MRPL39;MRPS5;TSFM;DAP3;MRPS31;MRPL40;MRPS10;MRPL45;MRPL49;MRPL37;MRPS12;MRPS18B;MRPL3;MRPL50;MRPS2;MRPL17;GADD45GIP1;MRPL2;MRPS27;MRPS7
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.8070291138182576,2.5639614067884438,0.0,0.0,0.0,17/27,10.78%,PPIA;RPLP0;CFL1;ANXA2;HNRNPF;MIF;HNRNPA2B1;PSME2;TCP1;SOD2;SNRPA1;LMNB1;GSTO1;IFNG;MTAP;RALA;HNRNPDL
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.7264044218549444,2.535177268086269,0.0,0.0,0.0,28/41,13.74%,UBB;PSMB2;RPS27A;ELOC;PSMA3;PSMA5;PSMA4;HIGD1A;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;CITED2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;EGLN1;PSMD1;PSMC5;PSME3
gsea,cellular response to hypoxia (GO:0071456),0.6486432282522695,2.5336079103908324,0.0,0.0,0.0,32/77,13.74%,UBB;PSMB2;RPS27A;ELOC;PSMA3;FAM162A;PSMA5;PGK1;PSMA4;HIGD1A;HILPDA;PSME2;PSMD6;PSMB5;RGCC;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;ZFP36L1;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;EGLN1;PSMD1;PSMC5;PSME3
gsea,cellular response to interleukin-12 (GO:0071349),0.8023914295643868,2.533171227900059,0.0,0.0,0.0,17/28,10.78%,PPIA;RPLP0;CFL1;ANXA2;HNRNPF;MIF;HNRNPA2B1;PSME2;TCP1;SOD2;SNRPA1;LMNB1;GSTO1;IFNG;MTAP;RALA;HNRNPDL
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.7138422422064213,2.52400417392445,0.0,0.0,0.0,29/48,18.34%,UBB;PSMB2;RPS27A;UBE2N;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA;RIPK2;PSMC1;MAP3K8
gsea,regulation of mRNA stability (GO:0043488),0.6413705486262277,2.520779196154921,0.0,0.0,0.0,45/94,13.74%,UBB;PSMB2;RPS27A;NPM1;PSMA3;PSMA5;ANP32A;PSMA4;VIM;YBX1;EXOSC3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;HNRNPD;EXOSC8;PSMD11;SERBP1;PSMB6;PSMA6;PSMC2;SET;PSMD12;RIDA;APEX1;EXOSC9;HSPA8;ZFP36L1;PSMB7;EXOSC5;EXOSC7;PSMC6;PSMD7;PSMD3;EXOSC1;PSMD2;AKT1;PSMD1;FUS;ZFP36;TENT5A;PSMC5;PSME3
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6806062405068274,2.518601484239244,0.0,0.0,0.0,29/53,15.16%,UBB;PSMB2;RPS27A;ELOC;PSMA3;PSMA5;PSMA4;HIGD1A;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;DNAJB1;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;EGLN1;PSMD1;PSMC5;PSME3;KLF2
gsea,regulation of mRNA catabolic process (GO:0061013),0.6575194126584419,2.5165470752500076,0.0,0.0,0.0,40/75,13.74%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;ANP32A;PSMA4;VIM;EXOSC3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;HNRNPD;EXOSC8;PSMD11;SERBP1;PSMB6;PSMA6;PSMC2;SET;PSMD12;APEX1;EXOSC9;HSPA8;ZFP36L1;PSMB7;EXOSC5;EXOSC7;PSMC6;PSMD7;PSMD3;EXOSC1;PSMD2;AKT1;PSMD1;ZFP36;PSMC5;PSME3
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.7048260423034416,2.5119799084128545,0.0,0.0,0.0,22/48,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,mitochondrial translation (GO:0032543),0.6919319743499832,2.497894694902701,0.0,0.0,0.0,40/63,17.38%,MRPL42;CHCHD1;MRPL18;MRPS6;MRPL11;MRPL20;MRPL15;MRPL53;MRPL35;MRPS28;MRPS30;MRPL55;MRPS35;MRPL51;MRPL16;MRPL22;MRPS22;MRPL13;MRPL44;MRPL39;MRPS5;TSFM;DAP3;MRPS31;MRPL40;MRPS10;MRPL45;MRPL49;MRPL37;MRPS12;MRPS18B;MRPL3;MRPL50;MRPS2;MRPL17;MRRF;GADD45GIP1;MRPL2;MRPS27;MRPS7
gsea,protein-DNA complex assembly (GO:0065004),0.6730291239253304,2.488273948203953,0.0,0.0,0.0,46/82,18.13%,UBB;PSMB2;RPS27A;RPA3;NPM1;PSMA3;PSMA5;PSMA4;ANP32B;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;ORC6;NAP1L1;PSMD11;PSMB6;RPA2;PSMA6;PSMC2;MCM4;HMGB2;MCM6;PSMD12;ASF1A;GMNN;PSMB7;PSMC6;PSMD7;RAD51;PSMD3;RAD23B;PSMD2;CENPV;PSMD1;PSMC5;GTF2H3;PSME3;ERCC3;CDK7;NAP1L4;ORC2;MCM7;CDT1;PSMC1
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.7005708279302286,2.483978918053663,0.0,0.0,0.0,23/42,13.74%,PFN1;PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7482032525663256,2.471833171430419,0.0,0.0,0.0,34/54,14.68%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;CDK1;AURKB;BUB3;MAD2L1;PSMD11;PSMB6;PSMA6;PSMC2;CDK2;UBE2C;PSMD12;PSMB7;ANAPC15;PSMC6;PSMD7;PSMD3;CDC20;PSMD2;PSMD1;PSMC5;PSME3;CCNB1
gsea,regulation of establishment of planar polarity (GO:0090175),0.7005635307642649,2.4713579488484942,0.0,0.0,0.0,23/42,13.74%,PFN1;PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.8177010624735596,2.464103791626832,0.0,0.0,0.0,24/29,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;ODC1;PSMB6;PSMA6;PSMC2;PSMD12;BCKDK;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,pre-replicative complex assembly (GO:0036388),0.7673928549669826,2.460843382708646,0.0,0.0,0.0,32/42,18.13%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;ORC6;PSMD11;PSMB6;PSMA6;PSMC2;MCM4;MCM6;PSMD12;GMNN;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;ORC2;MCM7;CDT1;PSMC1
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.6171486670395212,2.4517033673896984,0.0,0.0,0.0,24/59,13.74%,PFN1;PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;CTNNB1;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,cellular response to interleukin-1 (GO:0071347),0.6490275522077574,2.446805418163107,0.0,0.0,0.0,30/75,14.88%,UBB;PSMB2;RPS27A;UBE2N;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;CCL3;PSMD11;PSMB6;XCL1;PSMA6;PSMC2;PSMD12;CCL4;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;CCL1;RELA
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.6588487953266524,2.4465708277731575,0.0,0.0,0.0,27/55,13.74%,PSMB2;CDK4;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;RGCC;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;ZFP36L1;CDKN2C;PSMB7;PSMC6;PSMD7;CDKN2D;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.7566545141344134,2.4406783842176862,0.0,0.0,0.0,25/38,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PDIA3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;VAMP8;PSMD11;PSMB6;IFI30;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,mRNA metabolic process (GO:0016071),0.669871295242716,2.4278132100016503,0.0,0.0,0.0,27/59,14.04%,SNRPE;LSM2;SNRPF;SRSF2;HNRNPA2B1;LSM3;SNRPD3;SF3B4;U2AF1;SSB;NONO;SLBP;SRSF7;SNRPB;SRSF9;PTBP1;RIDA;CPSF3;CPSF6;HNRNPA0;U2AF2;SF3A3;SFPQ;HNRNPR;NCBP2;ZFP36;NCBP1
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.8689529345502132,2.4260759336460564,0.0,0.0,0.0,9/15,5.64%,NDUFA4;CYCS;NDUFAB1;SDHD;NDUFA12;UQCRC1;NDUFA5;CYC1;NDUFV1
gsea,aerobic electron transport chain (GO:0019646),0.8689529345502132,2.4260759336460564,0.0,0.0,0.0,9/15,5.64%,NDUFA4;CYCS;NDUFAB1;SDHD;NDUFA12;UQCRC1;NDUFA5;CYC1;NDUFV1
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.7721653419933505,2.420746584576324,0.0,0.0,0.0,24/32,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;ODC1;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PRKAG2;PSMD2;PSMD1;PSMC5;PSME3
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.771879339689362,2.407488122935073,0.0,0.0,0.0,24/35,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PDIA3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;VAMP8;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),0.6761602964570012,2.4017951356718625,0.0,0.0,0.0,23/34,25.60%,COX17;NDUFAB1;NDUFA12;NDUFA5;NDUFV1;COX18;CHCHD4;SDHAF3;NDUFAF5;IMMP2L;SAMM50;NDUFAF7;UQCC1;NDUFAF4;SLC25A33;SDHAF1;NDUFAF1;COX19;TIMM21;BCS1L;SCO2;TIMMDC1;FASTKD3
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.6398980300424248,2.400266754737552,0.0,0.0,0.0,33/67,18.13%,TMSB4X;PSMB2;EIF5A;PSMA3;PSMA5;PSMA4;TNFRSF4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;LTB;PSMA6;PSMC2;PSMD12;TNFRSF18;PSMB7;PSMC6;PSMD7;PSMD3;LTA;PSMD2;PSMD1;PSMC5;PSME3;TNFSF4;RELA;TNFSF12;TNFRSF1A;PSMC1
gsea,regulation of cellular amine metabolic process (GO:0033238),0.8173055625122607,2.3971148077969686,0.0,0.0,0.0,23/27,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;ODC1;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,cellular protein metabolic process (GO:0044267),0.5448043731240144,2.392119265214661,0.0,0.0,0.0,70/171,20.74%,RPL15;RPL10;RPS27A;RPLP0;RPS2;EEF1A1;MRPL42;MRPL18;MRPS6;ADPRH;MRPL11;CST3;STOML2;RPS25;LGALS1;UBE2S;RPS17;MRPL35;RSL24D1;UBE2M;RPS26;RPL23A;IGFBP7;RPL14;SERP1;RPN2;MRPL55;FARSB;PARL;RNF5;MRPL51;FDX1;DUSP12;RPL10A;MRPL13;PSEN2;MRPS5;PDIA6;SLC35A1;RPL3;RPL7A;RPS6;HTRA2;YARS2;MRPL37;RPL7;MRPS12;MRPS18B;MRPL3;MSRB2;UBE2L6;FDXR;ZDHHC2;ST3GAL6;ADORA2A;MRRF;COPS5;DHPS;RPL31;MRPS7;RPS18;PENK;HBS1L;APP;RABGGTB;RPL41;MEN1;RPL5;GSPT1;CSF2RA
gsea,RNA transport (GO:0050658),0.6725354384987982,2.383613760383711,0.0,0.0,0.0,27/53,16.66%,MAGOH;SRSF2;HNRNPA2B1;ALYREF;MAGOHB;YBX1;U2AF1;SRSF3;SARNP;HNRNPA1;SLBP;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;NUP62;THOC6;ZFP36L1;U2AF2;NCBP2;ZFP36;NCBP1;RNPS1;RAE1
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.7411831052665582,2.38177183911097,0.0,0.0,0.0,23/35,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;AURKB;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.6190837559738015,2.379673041679378,0.0,0.0,0.0,70/156,18.46%,SNRPE;LSM8;HNRNPF;MAGOH;PCBP1;LSM2;SNRPF;SNU13;SRSF2;SNRPD1;HNRNPA2B1;ALYREF;LSM3;HNRNPK;SNRPD3;SF3B4;HNRNPA3;MAGOHB;YBX1;U2AF1;SNRNP40;SRSF3;PHF5A;HNRNPA1;POLR2C;SMU1;PPIH;PPIL1;SNRPA;NONO;SNRPA1;PRPF38A;EIF4A3;SRSF7;RBM8A;HNRNPD;SNRPB;POLR2H;DDX39B;SRSF9;SRSF6;RBM17;PTBP1;PRPF19;CPSF3;HSPA8;HNRNPA0;PLRG1;U2AF2;DBR1;HNRNPC;SF3A3;POLR2L;SFPQ;HNRNPR;LSM7;NCBP2;FUS;POLR2E;GTF2F2;NCBP1;SNRNP25;RNPS1;HNRNPM;GEMIN6;PPIE;CSTF1;PRPF40A;CWC27;CPSF2
gsea,mitochondrial transport (GO:0006839),0.7279668428396346,2.3734560604962653,0.0,0.0,0.0,10/29,7.54%,SLC25A5;TOMM20;TIMM23;TOMM5;TIMM17A;PPIF;MTX2;TIMM8B;BAK1;COX18
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.7606493404083616,2.3608737905694683,0.0,0.0,0.0,22/31,13.74%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3
gsea,translation (GO:0006412),0.6392691873084486,2.3430246940888386,0.0,0.0,0.0,61/102,21.79%,RPL15;RPL10;RPS27A;RPLP0;RPS2;RPL22L1;EEF1A1;EEF1B2;EEF1E1;MRPL42;MRPL18;PPA1;MRPS6;MRPL11;RPS25;RPS17;MRPL35;RSL24D1;RPS26;RPL23A;MRPS28;EEF1D;RPL14;MRPL55;FARSB;MRPL51;DRG1;MRPL16;RPL10A;MRPL13;MRPS5;TSFM;RPL3;RPL7A;RPS6;YARS2;MRPL37;FARSA;RPL7;MRPS12;MRPS18B;MRPL3;MRPS2;N6AMT1;MRRF;PPA2;COPS5;AIMP2;DHPS;MRPL2;RPL31;MRPS7;RPS18;HBS1L;DRG2;RPL41;RPL5;GSPT1;EEF2;NOA1;TUFM
gsea,regulation of mitotic cell cycle (GO:0007346),0.6205120410175708,2.342550881829949,0.0,0.0,0.0,48/100,20.36%,PSMB2;CKS1B;PSMA3;PSMA5;CKS2;PSMA4;PSME2;PIN1;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;CDK1;BUB3;MAD2L1;PSMD11;PSMB6;EIF4E;PSMA6;PSMC2;UBE2C;PSMD12;PIM3;ASNS;PSMB7;ANAPC15;PSMC6;PSMD7;EIF4EBP1;PSMD3;CDC20;RCC1;PSMD2;PSMD1;PDXP;PSMC5;PSME3;CCNB1;ERCC3;DUSP3;CDC23;PRMT5;CDC16;PSMC1;APP;PLK1;FBXO5
gsea,nucleic acid metabolic process (GO:0090304),0.6785791887337674,2.342548572475788,0.0,0.0,0.0,24/49,15.58%,RAN;LSM8;HNRNPF;PCBP1;HNRNPA2B1;HNRNPK;HNRNPA3;HNRNPA1;POLR2C;HNRNPD;KPNA2;POLR2H;FEN1;PTBP1;HNRNPA0;HNRNPC;POLR2L;HNRNPR;NCBP2;POLR2E;GTF2F2;NCBP1;WDR74;HNRNPM
gsea,mRNA processing (GO:0006397),0.5859009038941078,2.340571650479915,0.0,0.0,0.0,80/181,19.83%,SNRPE;LSM8;HNRNPF;MAGOH;PCBP1;LSM2;SNRPF;SNU13;SRSF2;SNRPD1;HNRNPA2B1;ALYREF;LSM3;HNRNPK;SNRPD3;SF3B4;HNRNPA3;MAGOHB;YBX1;U2AF1;SNRNP40;SRSF3;SARNP;PHF5A;HNRNPA1;POLR2C;SMU1;PPIH;PPIL1;SNRPA;NONO;SNRPA1;PRPF38A;EIF4A3;SRSF7;RBM8A;HNRNPD;SNRPB;POLR2H;DDX39B;SRSF9;SRSF6;RBM17;PTBP1;PRPF19;THOC6;CPSF3;HSPA8;CPSF6;HNRNPA0;PLRG1;U2AF2;DBR1;HNRNPC;SF3A3;POLR2L;SFPQ;HNRNPR;LSM7;NCBP2;FUS;POLR2E;GTF2H3;GTF2F2;NCBP1;SNRNP25;RNPS1;HNRNPM;ERCC3;CDK7;GEMIN6;PPIE;CSTF1;PRPF40A;CWC27;CPSF2;THOC5;GEMIN2;THOC3;DDX41
gsea,cellular response to tumor necrosis factor (GO:0071356),0.5812381455627286,2.3320122004757167,0.0,0.0,0.0,42/104,18.13%,TMSB4X;PSMB2;EIF5A;PSMA3;PSMA5;PSMA4;TNFRSF4;YBX3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;CCL3;PSMD11;PSMB6;XCL1;LTB;PSMA6;PSMC2;PSMD12;CCL4;TNFRSF18;ZFP36L1;PSMB7;PSMC6;PSMD7;PSMD3;LTA;PSMD2;AKT1;PSMD1;ZFP36;PSMC5;PSME3;CCL1;TNFSF4;RELA;TNFSF12;GSDME;TNFRSF1A;PSMC1
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.541242322390595,2.3318218328833735,0.0,0.0,0.0,33/90,18.13%,PSMB2;UBE2N;PSMA3;PSMA5;CTLA4;PSMA4;PSME2;STOML2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;EIF2B1;PSMC2;LCP2;PSMD12;PSMB7;LAT2;PSMC6;PSMD7;PSMD3;NFKBIZ;PSMD2;PSMD1;PSMC5;PSME3;RELA;CD38;RIPK2;PSMC1
gsea,positive regulation of transferase activity (GO:0051347),0.611512801827494,2.3300233629053433,0.0,0.0,0.0,19/68,13.07%,UBE2N;RPS2;HNRNPA2B1;PTGES3;PIN1;TCP1;CCT4;RFC5;CCT2;AURKB;DBI;RFC4;HNRNPD;CHTF8;CTNNB1;DSCC1;DCUN1D1;HSP90AB1;RFC3
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.6008725378473548,2.3288341974560716,0.0,0.0,0.0,76/171,17.91%,SNRPE;LSM8;HNRNPF;MAGOH;PCBP1;LSM2;SNRPF;SNU13;SRSF2;SNRPD1;HNRNPA2B1;ALYREF;LSM3;HNRNPK;SNRPD3;SF3B4;HNRNPA3;MAGOHB;YBX1;U2AF1;SNRNP40;CLNS1A;SRSF3;PHF5A;HNRNPA1;POLR2C;SMU1;PPIH;PPIL1;STRAP;SNRPA;NONO;SMN1;SNRPA1;PRPF38A;EIF4A3;SRSF7;RBM8A;HNRNPD;SNRPB;POLR2H;DDX39B;SRSF9;SRSF6;RBM17;PTBP1;PRPF19;CPSF3;HSPA8;HNRNPA0;PLRG1;U2AF2;DBR1;HNRNPC;SF3A3;POLR2L;SFPQ;HNRNPR;LSM7;NCBP2;FUS;POLR2E;GTF2F2;NCBP1;SNRNP25;WDR77;RNPS1;HNRNPM;GEMIN6;PPIE;PRMT5;CSTF1;PRPF40A;SNUPN;DDX1;CWC27
gsea,negative regulation of programmed cell death (GO:0043069),0.4957464330591278,2.326279017365512,0.0,0.0,0.0,71/188,25.67%,RPL10;UBB;TPT1;RPS27A;CFL1;NME2;NPM1;MIF;VDAC1;PTMA;ARL6IP1;HNRNPK;HDAC1;PRDX3;HIGD1A;SERPINB9;PHB2;ANXA5;PRELID1;TNFAIP8;DNAJA1;BIRC5;PPIF;CDK1;MAD2L1;HDAC2;PA2G4;CITED2;CASP3;FHL2;PSEN2;NUP62;ANXA1;THOC6;PIM3;ASNS;APIP;HAX1;FXN;CTNNB1;HSPD1;HMGN5;AKT1;PSMC5;MYDGF;RELA;COPS5;BCL3;CD38;RIPK2;TAF9;FAS;HSPB1;AVEN;CRYAB;FIGNL1;PLK1;XBP1;TIGAR;MGMT;HSPA9;CBX4;CD40LG;PARK7;PLK2;CTSH;NUAK2;IL10;PIM2;BID;NFKBIA
gsea,peptidyl-proline modification (GO:0018208),0.7579448915892687,2.32255851091619,0.0,0.0,0.0,6/18,4.58%,PPIA;PIN1;PPIF;PPIH;PPIL1;FKBP4
gsea,gene expression (GO:0010467),0.5595803457622013,2.318455622213113,0.0,0.0,0.0,98/203,20.67%,RPL15;RPL10;RPS27A;RPLP0;RPS2;HNRNPF;EEF1A1;MAGOH;SRSF2;PTMA;HNRNPA2B1;ALYREF;HNRNPK;MRPL42;MAGOHB;MRPL18;U2AF1;SNRNP40;MRPS6;MRPL11;SRSF3;SARNP;RPS25;POLR2C;RPS17;MRPL35;RSL24D1;RPS26;RPL23A;NXT1;RPL14;SLBP;EIF4A3;SRSF7;RBM8A;HNRNPD;TAF1B;MRPL55;FARSB;EIF4E;POLR2H;DDX39B;MRPL51;SRSF9;DRG1;SRSF6;AAAS;RPL10A;MRPL13;MRPL44;MLF1;MRPS5;NUP62;TESC;THOC6;CPSF3;NUP43;HSPD1;DNAJB11;RPL3;RPL7A;NUP37;RPS6;NFKBIB;YARS2;U2AF2;POLR2L;MRPL37;RPL7;NCBP2;POLR2E;MRPS12;SEH1L;MRPS18B;MRPL3;NCBP1;PPP5C;MRRF;COPS5;BCL3;RNPS1;DHPS;E2F1;RPL31;RAE1;MRPS7;RPS18;CPSF2;NUP54;TSPAN5;THOC5;HBS1L;NUP35;THOC3;RPL41;RPL5;NR4A2;GSPT1
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6285643938402902,2.3167731638628832,0.0,0.0,0.0,12/38,11.57%,PPIA;TPT1;ENO1;YBX3;DNAJA1;PPIF;SOD2;SELENOS;CDKN2D;HERPUD1;HTRA2;AKT1
gsea,protein targeting to mitochondrion (GO:0006626),0.7252597017607801,2.3131105486316375,0.0,0.0,0.0,15/29,15.48%,DNAJC15;TOMM20;TIMM23;TOMM5;TIMM17A;GRPEL1;TIMM8B;PMPCB;CHCHD4;HSPD1;IMMP2L;SAMM50;TIMM10;TOMM40;PMPCA
gsea,positive regulation of catabolic process (GO:0009896),-0.6470556077094493,-2.311060393318006,0.0,0.005008148964388696,0.006,14/27,15.66%,HUWE1;IDE;VCP;NEDD4;AREL1;TNFAIP3;FOXO1;VSIR;BARD1;GSK3B;FZR1;HECW1;TIPARP;DDB1
gsea,T cell receptor signaling pathway (GO:0050852),0.5694421703778685,2.310029147398643,0.0,0.0,0.0,31/74,18.13%,PSMB2;UBE2N;PSMA3;PSMA5;CTLA4;PSMA4;PSME2;STOML2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;EIF2B1;PSMC2;LCP2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;NFKBIZ;PSMD2;PSMD1;PSMC5;PSME3;RELA;RIPK2;PSMC1
gsea,DNA-dependent DNA replication (GO:0006261),0.648642195954952,2.30231261388376,0.0,0.0,0.0,48/96,18.20%,UBB;PSMB2;RPS27A;RPA3;PSMA3;PSMA5;PSMA4;CDK2AP1;PSME2;PSMD6;PSMB5;PSMD14;RFC5;PSMC4;ORC6;HMGA1;RFC4;PSMD11;PSMB6;RPA2;GINS2;PSMA6;PSMC2;CDK2;MCM4;MCM6;CDC45;PSMD12;GMNN;PSMB7;PSMC6;PSMD7;POLD2;RAD51;PSMD3;WRNIP1;PSMD2;PSMD1;RFC3;PSMC5;PSME3;GINS4;ORC2;MCM7;POLE2;CDT1;PSMC1;PRIM2
gsea,ribosomal large subunit biogenesis (GO:0042273),0.729603847942641,2.29688887570595,0.0,0.0,0.0,26/43,15.15%,RPL10;RPLP0;NPM1;SNU13;MRPL20;NIP7;RSL24D1;EIF6;RPL23A;RPL14;NHP2;BRIX1;RRP15;RPL10A;EBNA1BP2;RPF2;RPL3;RPL7A;RPF1;WDR12;MRTO4;RPL7;NOP16;RSL1D1;WDR74;GTF3A
gsea,regulation of cell cycle phase transition (GO:1901987),0.6745805487625667,2.2941615134769,0.0,0.0,0.0,34/59,18.13%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;CDK1;BUB3;MAD2L1;PSMD11;PSMB6;PSMA6;PSMC2;UBE2C;PSMD12;PSMB7;ANAPC15;PSMC6;PSMD7;PSMD3;CDC20;PSMD2;PSMD1;PSMC5;PSME3;CCNB1;ERCC3;CDC23;CDC16;PSMC1
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.6654024560276813,2.286823465836068,0.0,0.0,0.0,23/42,14.83%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;OSM
gsea,negative regulation of BMP signaling pathway (GO:0030514),-0.7186069522065887,-2.2837433888270477,0.002717391304347826,0.003756111723291522,0.009,7/16,6.93%,SKIL;HTRA3;SKI;NOTCH1;SMAD7;LEMD3;TRIM33
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.5811773755982423,2.2760605807806913,0.0,0.0,0.0,98/183,23.89%,RPL15;RPL10;RPS27A;RPLP0;RPS2;RPA3;EEF1A1;DUT;EEF1B2;PTMA;MRPL42;MRPL18;MRPS6;MRPL11;RPS25;TIPIN;POLR2C;RPS17;PCLAF;MRPL35;RSL24D1;RFC5;CDK1;RPS26;ORC6;RPL23A;EEF1D;RPL14;NAP1L1;TYMS;RFC4;TAF1B;MRPL55;FARSB;RPA2;POLR2H;MRPL51;DRG1;CDK2;FEN1;MCM4;RPL10A;MRPL13;MCM6;MLF1;SET;CDC45;MRPS5;TSFM;RPL3;POLD2;RPL7A;RPS6;ST3GAL4;NFKBIB;YARS2;DONSON;POLR2L;TBRG1;MRPL37;RPL7;POLR2E;MRPS12;RFC3;MRPS18B;MRPL3;PPP5C;MRRF;COPS5;BCL3;RNPS1;DHPS;E2F1;ORC2;RPL31;ALAS1;RHNO1;MCM7;RAD1;MRPS7;RPS18;POLE2;EXO1;HBS1L;POLE3;RPL41;RPL5;NR4A2;GSPT1;EEF2;TUFM;TIMELESS;TOP1MT;RAD17;ORC5;MRPS18A;POLR2F;GRWD1
gsea,ribosome biogenesis (GO:0042254),0.608533921602834,2.263174046175847,0.0,0.0,0.0,73/134,25.04%,RPL15;RPL10;RAN;RPLP0;RPS2;NPM1;SNU13;EXOSC3;RPS25;RPS17;NIP7;EIF6;RPL23A;RPL14;EXOSC8;FCF1;UTP11;POP4;EMG1;MRPL22;RPL10A;EBNA1BP2;POP5;NOC4L;LTV1;EXOSC9;IMP4;EIF2A;RCL1;RPF2;LYAR;EXOSC5;EXOSC7;WDR75;RPL3;DDX47;RPL7A;EXOSC1;FBL;RPS6;DCAF13;RPF1;MPHOSPH6;UTP3;WDR12;MRTO4;RPL7;NOP58;NOP16;UTP4;WDR74;GTF3A;UTP18;RRP9;NAF1;RPL31;RIOK2;EXOSC4;GLUL;LAS1L;RPL41;RPL5;LSG1;PIH1D1;RRP12;NOL11;DDX27;DDX10;UTP6;WDR18;WDR55;RRP7A;PES1
gsea,NIK/NF-kappaB signaling (GO:0038061),0.6617738023686776,2.2588133054655897,0.0,0.0,0.0,24/42,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;AKT1;PSMD1;PSMC5;PSME3;RELA
gsea,positive regulation of DNA biosynthetic process (GO:2000573),0.6740061761604526,2.247760741030513,0.0,0.0,0.0,20/42,16.58%,PTGES3;CCT8;TCP1;HNRNPA1;RGCC;CCT4;RFC5;CCT2;AURKB;RFC4;CHTF8;CTNNB1;CCT5;CCT6A;DSCC1;HSP90AB1;CCT3;RFC3;CCT7;NAF1
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.7161310116779807,2.2456827400719135,0.0,0.0,0.0,13/25,14.47%,DNAJC15;TOMM20;TIMM23;TOMM5;TIMM17A;GRPEL1;TIMM8B;CHCHD4;HSPD1;RALA;AKT1;TIMM10;TOMM40
gsea,regulation of BMP signaling pathway (GO:0030510),-0.6123447761923607,-2.241776995526562,0.0,0.005564609960431884,0.019,12/26,20.44%,SKIL;HTRA3;SKI;NOTCH1;SMAD7;ITGA3;LEMD3;TRIM33;NUMA1;UBE2O;TWSG1;HIPK2
gsea,fatty acid oxidation (GO:0019395),0.6969112417428539,2.2401160695847104,0.0,0.0,0.0,13/26,14.59%,ADH5;SLC25A17;HADH;MTLN;ECI1;ACADL;BDH2;DECR1;PEX2;ACAT2;ADH4;MCAT;MECR
gsea,regulation of stem cell differentiation (GO:2000736),0.6333705848808846,2.2351731916683018,0.0,1.7634965153097872e-05,0.001,26/48,19.75%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;OSM;PSMC1;NSUN2;TCF3
gsea,postreplication repair (GO:0006301),0.682203481267117,2.2342640785160657,0.0,1.735941882258072e-05,0.001,13/35,13.36%,UBB;RPS27A;UBE2N;RPA3;PCLAF;RFC5;NSMCE1;RFC4;UBE2V2;RPA2;POLD2;RFC3;UBE2L6
gsea,gluconeogenesis (GO:0006094),0.7356205482597609,2.2331670298198865,0.0,1.709235084069486e-05,0.001,7/22,4.91%,PGAM1;MDH2;ALDOA;PGK1;ENO1;GAPDH;GOT1
gsea,RNA splicing (GO:0008380),0.6372677555044228,2.229610109678905,0.0,1.683337582795706e-05,0.001,27/60,15.50%,MAGOH;SNRPF;SRSF2;SNRPD1;SNRPD3;SF3B4;MAGOHB;U2AF1;SNRNP40;SMU1;NONO;SNRPA1;SRSF7;RBM8A;SNRPB;DDX39B;PTBP1;DDX47;DBR1;HNRNPC;SF3A3;SFPQ;NCBP2;FUS;NCBP1;SNRNP25;RNPS1
gsea,Fc receptor signaling pathway (GO:0038093),0.5686900107929306,2.2274158669809636,0.0,1.6582131412614417e-05,0.001,25/64,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;LCP2;PSMD12;PSMB7;LAT2;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.6600387954247098,2.226467484815437,0.0,1.63382765388995e-05,0.001,23/43,14.83%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;OSM
gsea,regulation of Ras protein signal transduction (GO:0046578),-0.5222607708494283,-2.2243190529011043,0.0,0.005008148964388696,0.021,22/45,22.60%,DENND4A;RAPGEF1;MYO9B;MADD;ERBIN;NOTCH1;BCR;ARHGDIA;RASGRP1;JAK2;DENND4B;FOXM1;IRS2;DENND4C;NOTCH2;ARHGEF18;SPRY2;ARHGEF28;KIF14;ARHGEF2;MFN2;DENND3
gsea,regulation of mitochondrial membrane potential (GO:0051881),0.6602049942275502,2.221238739778875,0.0,1.6101489922393707e-05,0.001,10/23,17.00%,UBB;PRDX3;BAX;PRELID1;STOML2;BAK1;MTLN;AKT1;PPA2;SLC25A33
gsea,fatty acid catabolic process (GO:0009062),0.644417407393215,2.207636471075692,0.0,1.5871468637788085e-05,0.001,13/31,14.59%,NUDT19;SLC25A17;HADH;MTLN;ECI1;ACADL;MCEE;BDH2;DECR1;PEX2;ACAT2;MCAT;MECR
gsea,proteasomal protein catabolic process (GO:0010498),0.5222620859769749,2.2068313068368575,0.0,1.5647926825988252e-05,0.001,36/102,18.66%,PSMB2;PSMA3;PSMA5;PSMA4;TBX21;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;IFI27;PSMD11;PSMB6;RNF5;PSMA6;NSFL1C;PSMC2;PRPF19;PSMD12;RNF126;PSMB7;CTNNB1;PSMC6;PSMD7;PSMD3;RAD23B;KCTD13;PSMD2;PSMD1;PLAA;PSMC5;PSME3;UBXN2B;MTA1;PSMC1;RAD23A
gsea,nucleobase-containing small molecule interconversion (GO:0015949),0.7986199943458159,2.2035585934961768,0.0,4.6291783526881906e-05,0.003,11/18,11.08%,NME2;DUT;NME1;DTYMK;RRM2;GLRX;AK6;TYMS;AK2;GSR;RRM1
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.5580680656893469,2.199417590682745,0.0,4.565764950596572e-05,0.003,25/64,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;LCP2;PSMD12;PSMB7;LAT2;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5941464884247672,2.198392321853328,0.0,4.385537386757234e-05,0.003,24/56,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;ICAM2;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5941464884247672,2.198392321853328,0.0,4.385537386757234e-05,0.003,24/56,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;ICAM2;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA
gsea,cellular response to lectin (GO:1990858),0.5941464884247672,2.198392321853328,0.0,4.385537386757234e-05,0.003,24/56,14.88%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;ICAM2;PSMD3;PSMD2;PSMD1;PSMC5;PSME3;RELA
gsea,hexose biosynthetic process (GO:0019319),0.7229019504527453,2.197653493237281,0.0,4.3285823557603864e-05,0.003,7/24,4.91%,PGAM1;MDH2;ALDOA;PGK1;ENO1;GAPDH;GOT1
gsea,peptide biosynthetic process (GO:0043043),0.6592643201422453,2.1881703136214443,0.0,8.546175420347429e-05,0.006,42/65,20.67%,RPL15;RPL10;RPS27A;RPLP0;RPS2;EEF1A1;MRPL42;MRPL18;MRPS6;MRPL11;RPS25;RPS17;MRPL35;RSL24D1;RPS26;RPL23A;RPL14;MRPL55;FARSB;MRPL51;RPL10A;MRPL13;MRPS5;RPL3;RPL7A;RPS6;YARS2;MRPL37;RPL7;MRPS12;MRPS18B;MRPL3;MRRF;COPS5;DHPS;RPL31;MRPS7;RPS18;HBS1L;RPL41;RPL5;GSPT1
gsea,wound healing (GO:0042060),-0.5541688426809634,-2.187278296996979,0.0,0.005342025562014609,0.027,8/30,14.88%,MYH9;MACF1;PLEC;ITGB3;NF1;MIA3;DCBLD2;SYT11
gsea,mitochondrion organization (GO:0007005),0.5287739021559533,2.1835424032562414,0.0,8.43799598464683e-05,0.006,47/102,30.56%,CYCS;TOMM20;TIMM23;PRDX3;TOMM5;TIMM17A;HIGD1A;BAX;PHB2;STOML2;MTX2;TIMM8B;TMEM70;THG1L;PHB;MTX1;CHCHD4;CHCHD10;HAX1;TFAM;HSPD1;GABPB1;MTFP1;IMMP2L;SAMM50;TIMM10;TOMM40;ALAS1;SLC25A33;PISD;TFB1M;MTFR1;BCS1L;TIMM50;ATP23;HSD17B10;PARK7;BID;MGME1;NIPSNAP2;SPG7;MGARP;SIRT4;NUBPL;TIMM9;FANCG;NRF1
gsea,rRNA metabolic process (GO:0016072),0.6033996464615801,2.182073717702841,0.0,8.332521034838744e-05,0.006,60/108,25.04%,RPL15;RPL10;RPLP0;RPS2;SNU13;EXOSC3;RPS25;RPS17;RPL23A;RPL14;EXOSC8;FCF1;UTP11;POP4;EMG1;RPL10A;EBNA1BP2;POP5;NOC4L;EXOSC9;IMP4;RCL1;LYAR;EXOSC5;EXOSC7;WDR75;RPL3;DDX47;RPL7A;EXOSC1;FBL;RPS6;DCAF13;RPF1;MPHOSPH6;UTP3;WDR12;MRTO4;RPL7;NOP58;UTP4;WDR74;NIFK;UTP18;RRP9;RPL31;EXOSC4;LAS1L;RPL41;RPL5;PIH1D1;RRP12;NOL11;DDX27;DDX10;UTP6;WDR18;WDR55;RRP7A;PES1
gsea,mRNA 3'-end processing (GO:0031124),0.6130101592421955,2.17581608190539,0.0,0.0001371608400796501,0.009,27/51,19.69%,MAGOH;SRSF2;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;SLBP;EIF4A3;SRSF7;RBM8A;DDX39B;SRSF9;SRSF6;THOC6;CPSF3;CPSF6;U2AF2;NCBP2;NCBP1;RNPS1;GRSF1;CSTF1;CPSF2;THOC5;THOC3;APP
gsea,negative regulation of apoptotic process (GO:0043066),0.4619098408894103,2.1727653349343123,0.0,0.00016258577628953648,0.011,77/228,25.67%,RPL10;UBB;TPT1;RPS27A;CFL1;NME2;NPM1;MIF;VDAC1;PTMA;ARL6IP1;HNRNPK;HDAC1;PRDX3;HIGD1A;SERPINB9;PHB2;ANXA5;PRELID1;TNFAIP8;DNAJA1;BIRC5;PPIF;CDK1;MAD2L1;SOD2;YWHAE;HDAC2;PA2G4;CITED2;CASP3;FHL2;SET;PSEN2;NUP62;GPX1;ANXA1;THOC6;PIM3;ASNS;APIP;HAX1;FXN;CTNNB1;HSPD1;CDKN2D;HMGN5;AKT1;SFPQ;PTRH2;MYDGF;RELA;COPS5;BCL3;CD38;RIPK2;TAF9;FAS;HSPB1;AVEN;CRYAB;FIGNL1;PLK1;XBP1;NR4A2;MGMT;HSPA9;CBX4;CD40LG;PARK7;PLK2;CTSH;NUAK2;IL10;PIM2;BID;NFKBIA
gsea,rRNA processing (GO:0006364),0.5895501917898384,2.1689299624072556,0.0,0.00017401248747454405,0.012,69/121,25.04%,RPL15;RPL10;RPLP0;RPS2;SNU13;EXOSC3;RPS25;RPS17;EIF6;RPL23A;RPL14;EXOSC8;NHP2;FCF1;RRP15;UTP11;POP4;EMG1;RPL10A;EBNA1BP2;POP5;NOC4L;EXOSC9;IMP4;RCL1;LYAR;EXOSC5;EXOSC7;WDR75;RPL3;DDX47;RPL7A;EXOSC1;FBL;RPS6;DCAF13;RPF1;MPHOSPH6;UTP3;WDR12;MRTO4;RPL7;NOP58;UTP4;RSL1D1;WDR74;SRFBP1;UTP18;RRP9;RPL31;RIOK2;EXOSC4;TFB1M;LAS1L;RPL41;RPL5;PIH1D1;RRP12;MAK16;NOL11;MRPL1;ERI1;DDX27;DDX10;UTP6;WDR18;WDR55;RRP7A;PES1
gsea,cytokine-mediated signaling pathway (GO:0019221),0.4889179043376672,2.1644150767962484,0.0,0.00018516713410752762,0.013,88/311,18.34%,PPIA;TMSB4X;UBB;PSMB2;RPS27A;RPLP0;UBE2N;CFL1;EIF5A;ANXA2;HNRNPF;MIF;PSMA3;PSMA5;HNRNPA2B1;PLP2;PSMA4;VIM;JUNB;TNFRSF4;PSME2;TCP1;PSMD6;PSMB5;BIRC5;PSMD14;PSMC4;SOD2;SOCS1;SNRPA1;CCL3;LMNB1;IFI27;PSMD11;PSMB6;BST2;XCL1;LTB;IFI30;GSTO1;PSMA6;PSMC2;IFNG;SAMHD1;CASP3;PSMD12;MTAP;CCL4;TNFRSF18;ANXA1;HSPA8;IRF5;PSMB7;PSMC6;PSMD7;PSMD3;RALA;LTA;IL7R;HNRNPDL;PSMD2;SP100;SOCS3;AKT1;PSMD1;IRF8;PSMC5;CD86;PSME3;ITGAX;CCL1;IL12RB2;IFNAR2;IRF9;TNFSF4;OSM;RELA;CASP1;ICAM1;TNFSF12;RIPK2;MAOA;TNFRSF1A;JAGN1;IL2RA;SLA;PSMC1;MAP3K8
gsea,RNA 3'-end processing (GO:0031123),0.6185012086293125,2.164144752540593,0.0,0.0001829886972356744,0.013,23/45,19.67%,MAGOH;SRSF2;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;EIF4A3;SRSF7;RBM8A;DDX39B;SRSF9;SRSF6;THOC6;CPSF3;U2AF2;NCBP2;NCBP1;RNPS1;CSTF1;CPSF2;THOC5;THOC3
gsea,activation of protein kinase B activity (GO:0032148),0.6581391135898016,2.160450347705078,0.0,0.0001937795589497382,0.014,1/16,0.02%,PPIA
gsea,positive regulation of neuron projection development (GO:0010976),-0.5901218031567834,-2.1517620772496273,0.0,0.007373108197572247,0.043,8/31,8.01%,RAPGEF1;EP300;SETX;PTK2B;RAPGEF2;KIDINS220;ARHGAP35;CAPRIN1
gsea,glucose metabolic process (GO:0006006),0.6431495252171379,2.1464067327848593,0.0,0.00022986264923693087,0.017,7/32,4.91%,PGAM1;MDH2;ALDOA;PGK1;ENO1;GAPDH;GOT1
gsea,nucleocytoplasmic transport (GO:0006913),0.6577493511599266,2.142470317895992,0.0,0.00027775070116129146,0.02,12/31,6.49%,SNRPE;NUTF2;NPM1;SNRPF;SNRPD1;SNRPD3;ANP32A;HNRNPA1;NXT1;SMN1;SNRPB;AAAS
gsea,regulation of exit from mitosis (GO:0007096),0.7048189157775456,2.1408389830857124,0.0,0.0002746299067662208,0.02,10/25,10.46%,UBB;RPS27A;PHB2;UBE2S;RGCC;BUB3;MAD2L1;UBE2C;ANAPC15;CDC20
gsea,protein transmembrane import into intracellular organelle (GO:0044743),0.7394779802642281,2.138707829567965,0.0,0.0002715784633577072,0.02,10/18,14.47%,DNAJC15;TOMM20;TIMM23;TIMM17A;GRPEL1;CHCHD4;PEX7;HSPD1;PEX2;TOMM40
gsea,neutrophil degranulation (GO:0043312),0.46728180815366654,2.1361931022240315,0.0,0.0002930117286976262,0.022,87/219,29.46%,PPIA;PGAM1;ANXA2;CD53;NME2;EEF1A1;S100A11;PLAC8;OSTF1;MIF;ALDOA;DDOST;PSMA5;APRT;CCT8;FABP5;CST3;PSMD6;TUBB4B;PSMD14;CCT2;IMPDH2;VAMP8;HMOX2;PSMD11;HMGB1;PA2G4;BST2;PSMC2;PGLYRP1;PSMD12;PRDX4;GUSB;HSPA8;PKM;GLIPR1;PSMB7;CTSS;AP1M1;PSMD7;BST1;CD14;PSMD3;VAMP7;ALAD;PGRMC1;LAMP1;CD68;PSMD2;NIT2;CYSTM1;RAB37;PSMD1;HSP90AB1;ITGAX;AGA;AGPAT2;ILF2;PPIE;CD63;TMBIM1;LGALS3;COMMD9;PTGES2;HGSNAT;EEF2;CPNE3;FCER1G;ANXA3;PGM1;CTSH;ATG7;ALDOC;ARSB;CD33;SELL;CTSZ;ADGRE5;SLC15A4;LAIR1;CYBB;PTAFR;HVCN1;PRG2;CD36;CD300A;GRN
gsea,cellular response to oxidative stress (GO:0034599),0.5137660531102993,2.1342055292049484,0.0,0.000301902936044882,0.023,12/70,11.57%,PPIA;PRDX1;CYCS;PRDX3;EIF2S1;SOD2;GPX1;SELENOS;GSR;HTRA2;PYCR2;AKT1
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.5477858411006373,2.131169698169926,0.0,0.0002986566679153671,0.023,51/129,18.13%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;PSMA4;PSME2;TUBA1A;ID2;PSMD6;TUBB4B;UBE2S;PSMB5;RGCC;PSMD14;PSMC4;CDK1;BUB3;MAD2L1;YWHAE;PSMD11;PSMB6;PSMA6;PSMC2;CDK2;UBE2C;TUBA4A;HAUS1;PSMD12;HAUS4;ZFP36L1;PSMB7;ANAPC15;PSMC6;PSMD7;PSMD3;CDC20;PSMD2;HAUS8;PSMD1;TM4SF5;PSMC5;PSME3;CCNB1;E2F1;ERCC3;CDC23;TPX2;RIOK2;CDC16;PSMC1
gsea,neutrophil mediated immunity (GO:0002446),0.46631359325714966,2.13094757997856,0.0,0.00029547946932052284,0.023,87/220,29.46%,PPIA;PGAM1;ANXA2;CD53;NME2;EEF1A1;S100A11;PLAC8;OSTF1;MIF;ALDOA;DDOST;PSMA5;APRT;CCT8;FABP5;CST3;PSMD6;TUBB4B;PSMD14;CCT2;IMPDH2;VAMP8;HMOX2;PSMD11;HMGB1;PA2G4;BST2;PSMC2;PGLYRP1;PSMD12;PRDX4;GUSB;HSPA8;PKM;GLIPR1;PSMB7;CTSS;AP1M1;PSMD7;BST1;CD14;PSMD3;VAMP7;ALAD;PGRMC1;LAMP1;CD68;PSMD2;NIT2;CYSTM1;RAB37;PSMD1;HSP90AB1;ITGAX;AGA;AGPAT2;ILF2;PPIE;CD63;TMBIM1;LGALS3;COMMD9;PTGES2;HGSNAT;EEF2;CPNE3;FCER1G;ANXA3;PGM1;CTSH;ATG7;ALDOC;ARSB;CD33;SELL;CTSZ;ADGRE5;SLC15A4;LAIR1;CYBB;PTAFR;HVCN1;PRG2;CD36;CD300A;GRN
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4890248250609248,2.130733694221487,0.0,0.00030406392548183486,0.024,55/168,20.69%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;PSMA4;TBX21;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;CDK1;AURKB;BUB3;MAD2L1;IFI27;PSMD11;PSMB6;RNF5;PSMA6;NSFL1C;PSMC2;CDK2;UBE2C;PSMD12;RNF126;PSMB7;CTNNB1;SELENOS;ANAPC15;PSMC6;PSMD7;PSMD3;HERPUD1;RAD23B;CDC20;DERL2;KCTD13;PSMD2;PSMD1;PLAA;PSMC5;PSME3;CCNB1;CDC23;UBXN2B;CDC16;MTA1;PSMC1;RAD23A;PLK1;FBXO5;FBXL14
gsea,maturation of LSU-rRNA (GO:0000470),0.714882300804669,2.129921983053031,0.0,0.0003008965929247324,0.024,19/24,25.04%,SNU13;EIF6;NHP2;RRP15;RPL10A;ZNHIT3;RPF2;RPL7L1;RPL7A;RPF1;WDR12;RPL7;RSL1D1;NIFK;DDX18;LAS1L;MAK16;MRPL1;PES1
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.5591926024245363,-2.1274561283587614,0.0,0.009300848076721864,0.059,12/31,21.96%,SKIL;HTRA3;NEDD4;SKI;NOTCH1;SMAD7;LEMD3;ATP2B4;TRIM33;SPRY2;HIPK2;HGS
gsea,error-prone translesion synthesis (GO:0042276),0.7409109766982871,2.1255826372754423,0.0,0.00034360911483871106,0.028,6/18,5.21%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2
gsea,epithelial cell differentiation (GO:0030855),0.5789645004263574,2.1240414612128466,0.0,0.0003401028993811732,0.028,17/44,21.57%,TAGLN2;VDAC1;PGK1;HDAC1;CDK1;E2F4;HDAC2;ANXA7;ANXA1;OVOL2;BDH2;AKT1;CNN3;DHRS9;LGALS3;DNPH1;PIH1D1
gsea,cellular respiration (GO:0045333),0.6886034803495774,2.1238877065267188,0.0,0.00033666751655914113,0.028,6/18,10.86%,CYCS;MDH2;UQCRC1;NDUFA5;MTLN;SDHA
gsea,neutrophil activation involved in immune response (GO:0002283),0.46600284338627107,2.1199285579991787,0.0,0.00037774095357935637,0.031,87/221,29.46%,PPIA;PGAM1;ANXA2;CD53;NME2;EEF1A1;S100A11;PLAC8;OSTF1;MIF;ALDOA;DDOST;PSMA5;APRT;CCT8;FABP5;CST3;PSMD6;TUBB4B;PSMD14;CCT2;IMPDH2;VAMP8;HMOX2;PSMD11;HMGB1;PA2G4;BST2;PSMC2;PGLYRP1;PSMD12;PRDX4;GUSB;HSPA8;PKM;GLIPR1;PSMB7;CTSS;AP1M1;PSMD7;BST1;CD14;PSMD3;VAMP7;ALAD;PGRMC1;LAMP1;CD68;PSMD2;NIT2;CYSTM1;RAB37;PSMD1;HSP90AB1;ITGAX;AGA;AGPAT2;ILF2;PPIE;CD63;TMBIM1;LGALS3;COMMD9;PTGES2;HGSNAT;EEF2;CPNE3;FCER1G;ANXA3;PGM1;CTSH;ATG7;ALDOC;ARSB;CD33;SELL;CTSZ;ADGRE5;SLC15A4;LAIR1;CYBB;PTAFR;HVCN1;PRG2;CD36;CD300A;GRN
gsea,ncRNA processing (GO:0034470),0.5448245078547624,2.1160538102061084,0.0,0.00038500097190674067,0.032,69/138,25.12%,RPL15;RPL10;RPLP0;RPS2;SNU13;HNRNPA2B1;EXOSC3;RPS25;RPS17;RPL23A;SSB;RPL14;EXOSC8;FCF1;UTP11;POP4;EMG1;THG1L;RPL10A;EBNA1BP2;MRPL44;POP5;NOC4L;EXOSC9;IMP4;RCL1;INTS11;LYAR;EXOSC5;RPP30;EXOSC7;WDR75;RPL3;DDX47;RPL7A;EXOSC1;FBL;RPS6;DCAF13;RPF1;MPHOSPH6;UTP3;WDR12;PRKRA;MRTO4;RPL7;NOP58;UTP4;WDR74;UTP18;RRP9;RPL31;EXOSC4;INTS4;LAS1L;RPL41;RPL5;PIH1D1;RRP12;NOL11;DDX27;DDX10;UTP6;WDR18;TARBP2;WDR55;RRP7A;PES1;INTS10
gsea,positive regulation of cell population proliferation (GO:0008284),0.4651239842864751,2.114387369854185,0.0,0.00039211863693358796,0.033,48/205,17.00%,SLC25A5;CNBP;NME2;CDK4;COX17;S100A6;NPM1;MIF;NME1;HDAC1;PRDX3;HILPDA;ID2;TSPAN31;TIPIN;BIRC5;PRMT1;NAP1L1;DNAJA2;HDAC2;BST2;CDK2;CDC123;IFNG;PHB;EZH2;FXN;BST1;RPS6;IL7R;DERL2;HMGN5;AKT1;CD86;LAMC2;ITGAX;CIAO1;IL12RB2;ASH2L;TNFSF4;WDR77;OSM;RELA;UFL1;DHPS;E2F1;PDGFA;SLC25A33
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.5348091592342948,2.1092142090223636,0.0,0.00040988452986909034,0.035,31/89,16.15%,PSMB2;PSMA3;PSMA5;HDAC1;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;RACK1;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;FRMD8;TAX1BP3;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;CBY1;PSMD1;PSMC5;TMEM64;PSME3;HIC1;AXIN2;DKKL1
gsea,regulation of axonogenesis (GO:0050770),-0.6911889953446448,-2.1071203901505347,0.0,0.010955325859600273,0.078,10/15,20.36%,KIF13B;SIPA1L1;ARHGDIA;ARHGAP35;PLXND1;METRN;GSK3B;EFNB3;PLXNA1;TIAM1
gsea,post-translational protein modification (GO:0043687),0.46534387775700514,2.1057561037277908,0.0,0.0004700396481191086,0.04,67/168,29.59%,PSMB2;ELOC;PSMA3;PSMA5;PSMA4;UCHL3;PSME2;CST3;PSMD6;LGALS1;RBBP7;PSMB5;PSMD14;UBE2M;PSMC4;IGFBP7;COPS4;PSMD11;PSMB6;PSMA6;PSMC2;COPS3;PSMD12;NAE1;PDIA6;PSMB7;PSMC6;PSMD7;PSMD3;COPS2;DSCC1;DCAF13;PSMD2;STT3A;SOCS3;PSMD1;DCUN1D1;LRR1;PSMC5;PSME3;COPS5;COPS7A;PENK;PSMC1;ESCO2;APP;RABGGTB;CISH;MEN1;DCAF4;FBXL14;NUB1;RAB13;RCN1;SERPIND1;LMO7;COPS7B;CUL5;SUMF2;GPS1;CUL4B;SENP8;KLHL3;P4HB;FBXL15;MFGE8;STC2
gsea,spliceosomal snRNP assembly (GO:0000387),0.6882028267417835,2.098998483448601,0.0,0.0005184679755010774,0.045,10/27,6.53%,SNRPE;LSM2;SNRPF;SNRPD1;SNRPD3;CLNS1A;STRAP;SMN1;SNRPB;PRPF19
gsea,nuclear export (GO:0051168),0.5839797762415921,2.0967263927685464,0.0,0.0005345390852538062,0.047,29/59,21.00%,RAN;NUTF2;MAGOH;SRSF2;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;HNRNPA1;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;NUP62;THOC6;DESI1;U2AF2;NCBP2;NCBP1;RNPS1;RAE1;THOC5;THOC3;STRADA;LSG1
gsea,regulation of apoptotic process (GO:0042981),0.4213816252067347,2.092308865434198,0.0,0.0005399265966499872,0.048,116/379,25.67%,PPIA;RPL10;UBB;TPT1;RPS27A;CFL1;NME2;NPM1;MIF;NME1;C1QBP;FAM162A;VDAC1;PTMA;ARL6IP1;EEF1E1;HNRNPK;CTLA4;ANP32A;HDAC1;PRDX3;MTCH2;HIGD1A;BAX;SERPINB9;PHB2;ANP32B;ANXA5;PRELID1;TNFAIP8;DNAJA1;LGALS1;BIRC5;PPIF;CDK1;PERP;ANP32E;MAD2L1;RACK1;HDAC2;HMGB1;PA2G4;UTP11;CITED2;BAK1;CASP3;FHL2;PHB;PSEN2;NUP62;NAE1;APEX1;ANXA1;IFT57;THOC6;IRF5;PIM3;ASNS;APIP;HAX1;FXN;CTNNB1;HSPD1;ACTN2;RPS6;HTRA2;LANCL1;MELK;HMGN5;AKT1;GADD45B;MYDGF;RSL1D1;ZBP1;RELA;COPS5;BCL3;RNPS1;CASP1;SGK1;E2F1;FADD;ERCC3;RTKN;DKKL1;CD38;RIPK2;TAF9;PHLDA1;FAS;HSPB1;AVEN;CRYAB;FIGNL1;PPID;RABGGTB;PLK1;XBP1;ITGB3BP;MGMT;HSPA9;SIGMAR1;CXCL10;CBX4;TFAP4;DUSP6;CD40LG;PARK7;PLK2;CTSH;NUAK2;ATG7;IL10;PIM2;BID;NFKBIA
gsea,dicarboxylic acid metabolic process (GO:0043648),0.5953236662257775,2.0922279312223844,0.0,0.0005349272763106354,0.048,13/35,19.12%,MDH2;ASS1;MTHFD2;GOT1;SHMT2;DHFR;SDHAF3;ME2;SDHA;NIT2;MTHFD2L;SHMT1;SLC19A1
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.5569501310868277,2.0888218540739047,0.0,0.0005402123729008605,0.049,27/72,16.15%,PSMB2;PSMA3;PSMA5;HDAC1;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;FRMD8;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;TMEM64;PSME3;AXIN2;DKKL1
gsea,RNA processing (GO:0006396),0.5379869087258025,2.088088070589544,0.0,0.0005454013768258087,0.049,37/108,15.50%,HNRNPF;MAGOH;SNRPF;SRSF2;SNRPD1;HNRNPA2B1;LSM3;HNRNPK;SNRPD3;SF3B4;MAGOHB;U2AF1;SNRNP40;SMU1;NONO;SNRPA1;SRSF7;RBM8A;HNRNPD;SNRPB;DDX39B;SRSF9;PTBP1;MRPL44;DDX47;CPSF6;HNRNPA0;U2AF2;HNRNPC;SF3A3;SFPQ;HNRNPR;NCBP2;FUS;NCBP1;SNRNP25;RNPS1
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.6540944672949128,2.0824749261257054,0.0,0.0005705149537367068,0.05,8/21,15.83%,UBB;RPS27A;RPA3;RPA2;RAD23B;GTF2H3;ERCC3;CDK7
gsea,protein modification by small protein removal (GO:0070646),0.4677894180319528,2.0795582027062394,0.0,0.0005852604060184357,0.052,48/152,19.81%,UBB;PSMB2;RPS27A;TOMM20;ACTB;PSMA3;PSMA5;PSMA4;UCHL3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;CDK1;UCHL5;COPS4;PSMD11;PSMB6;PSMA6;PSMC2;USP14;COPS3;PSMD12;CCNA2;DESI1;PSMB7;INO80C;ACTL6A;PSMC6;ADRM1;PSMD7;PSMD3;COPS2;RAD23B;CDC20;PSMD2;BRCC3;PSMD1;PSMC5;PSME3;COPS5;INO80E;COPS7A;ABRAXAS1;PSMC1;RAD23A;USP1
gsea,aggrephagy (GO:0035973),0.7221519234985865,2.07287405902468,0.0,0.0006587361762055409,0.059,4/15,1.66%,UBB;RPS27A;UBE2N;VIM
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.5727875894553068,2.071082052315408,0.0,0.000652957788694966,0.059,23/53,17.07%,UBB;RPS27A;RPA3;POLR2C;RFC5;RFC4;COPS4;HMGN1;RPA2;POLR2H;COPS3;PRPF19;POLD2;COPS2;POLR2L;POLR2E;RFC3;GTF2H3;COPS5;ERCC3;CDK7;COPS7A;PPIE
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),0.7058473266149731,2.0645461645546184,0.0,0.0007052452586008445,0.064,12/21,16.58%,CCT8;TCP1;HNRNPA1;CCT4;CCT2;AURKB;CTNNB1;CCT5;CCT6A;CCT3;CCT7;NAF1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.6371796481727164,2.062595635149427,0.0,0.0007470536100200254,0.065,15/28,15.53%,UBB;PSME2;PSMD14;UCHL5;PSMC2;USP14;GPX1;DESI1;PSMC6;ALAD;RAD23B;HSP90AB1;PSMC5;PSME3;UFL1
gsea,cytoplasmic microtubule organization (GO:0031122),-0.6079626081103917,-2.0583308833679386,0.0,0.017343034376679372,0.131,20/29,23.83%,CCDC88B;DYNC1H1;CLASP1;DCTN1;HOOK3;CLIP2;SLK;NUMA1;CCDC88C;TUBGCP4;KPNB1;TUBGCP6;CLIP1;CAMSAP1;PCM1;CAMSAP2;WDR73;TUBGCP3;PLK3;HOOK1
gsea,import into nucleus (GO:0051170),0.5779610280245563,2.057284857127174,0.0,0.0008166345401665322,0.068,13/54,7.30%,SNRPE;RAN;NUTF2;SNRPF;SNRPD1;HIKESHI;SNRPD3;PHB2;HNRNPA1;NXT1;SMN1;SNRPB;NUP62
gsea,ribosome assembly (GO:0042255),0.6747648877957725,2.0560505426547335,0.0,0.0008285444644811407,0.07,14/32,9.33%,RPL10;RPLP0;RPS27L;NPM1;C1QBP;MRPL20;RSL24D1;EIF6;RPL23A;BRIX1;MRPL22;EIF2A;RPF2;RPL3
gsea,pyruvate metabolic process (GO:0006090),0.6698765747148439,2.055557903595368,0.001953125,0.000821581905956089,0.07,12/30,14.07%,PGAM1;ALDOA;VDAC1;PGK1;ENO1;BSG;GAPDH;LDHA;PKM;ME2;ENO3;DLD
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.6994744755932626,2.054011138193544,0.0,0.0008425104601892508,0.073,8/16,16.70%,UBB;RPS27A;COPS4;COPS3;COPS2;RAD23B;COPS5;COPS7A
gsea,error-free translesion synthesis (GO:0070987),0.7281713424341612,2.0499044109970757,0.0,0.0009549115015132005,0.081,6/18,5.21%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2
gsea,selective autophagy (GO:0061912),0.6090661362209273,2.0485116397474927,0.0,0.0009561909384241181,0.082,5/29,2.13%,UBB;RPS27A;UBE2N;VIM;PHB2
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6896567166582361,2.0479984129882487,0.0,0.000957449571482826,0.083,13/23,16.58%,HNRNPA2B1;CCT8;TCP1;HNRNPA1;CCT4;CCT2;AURKB;CTNNB1;CCT5;CCT6A;CCT3;CCT7;NAF1
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),0.6154625612926052,2.0479931110316927,0.0,0.0009497282039708677,0.083,7/22,11.57%,FAM162A;BAX;PRELID1;PPIF;GPX1;FXN;AKT1
gsea,cellular response to chemical stress (GO:0062197),0.5146350208673706,2.0469571072302872,0.0,0.0009599064232134232,0.083,11/60,11.19%,PPIA;PRDX1;CYCS;PRDX3;EIF2S1;SOD2;GPX1;SELENOS;GSR;HTRA2;PYCR2
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),0.6571460976042025,2.0467305369502236,0.0019267822736030828,0.0009699230834203828,0.084,6/24,5.91%,PPIA;NOP10;PTGES3;GAR1;NHP2;CDK2
gsea,platelet degranulation (GO:0002576),0.5122530407575593,2.0464807445025026,0.0,0.0009622858937871515,0.084,17/57,23.41%,TMSB4X;TAGLN2;MANF;ALDOA;OLA1;ANXA5;CD9;TUBA4A;FAM3C;ACTN2;PLEK;PDGFA;CD63;APP;VEGFB;SELENOP;CYB5R1
gsea,carbohydrate catabolic process (GO:0016052),0.7325083552007103,2.0413882164093087,0.001941747572815534,0.0010242057105322624,0.088,7/20,8.12%,PGAM1;ALDOA;PGK1;ENO1;GAPDH;LDHA;PKM
gsea,intracellular protein transmembrane transport (GO:0065002),0.6701250640793819,2.0382199401996703,0.0,0.0010593282555919022,0.089,13/22,21.97%,DNAJC15;TOMM20;TIMM23;TIMM17A;GRPEL1;CHCHD4;PEX7;HSPD1;PEX2;TOMM40;TIMM21;PEX5;TIMM50
gsea,regulation of microtubule-based process (GO:0032886),-0.6223287757388392,-2.0376241175776797,0.0,0.01911443521408352,0.154,9/21,11.84%,MACF1;CLASP1;TAOK1;DIAPH1;BICD2;CLASP2;ROCK1;TRIM36;GSK3B
gsea,positive regulation of axonogenesis (GO:0050772),-0.6512296813226967,-2.0341166473590078,0.0,0.017907926599935335,0.157,10/16,24.03%,MACF1;GOLGA4;ARHGDIA;PLXND1;METRN;LIMK1;PLXNA1;TIAM1;SEMA7A;MAP3K13
gsea,MAPK cascade (GO:0000165),0.46235556348506296,2.0330951050206703,0.0,0.0011366413309062081,0.094,48/142,25.02%,UBB;PSMB2;RPS27A;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;CDK1;PEBP1;CCL3;YWHAE;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;DUSP5;ZFP36L1;PSMB7;PSMC6;PSMD7;ACTN2;PSMD3;PSMD2;PSMD1;ZFP36;PSMC5;PSME3;PPP1CB;PPP5C;PDE6D;PDGFA;IL2RA;PSMC1;MAP3K8;SHOC2;DUSP7;MEN1;CSF2RA;ARL2;HRAS;ABHD17C;DUSP6;CTSH
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.6644756267987293,2.030341615684826,0.0,0.001161502932129037,0.096,15/19,31.59%,NDUFAB1;NDUFA12;NDUFA5;NDUFV1;NDUFAF5;NDUFAF7;NDUFAF4;NDUFAF1;TIMM21;BCS1L;TIMMDC1;ECSIT;NDUFAF2;NUBPL;NDUFAF6
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6644756267987293,2.030341615684826,0.0,0.001161502932129037,0.096,15/19,31.59%,NDUFAB1;NDUFA12;NDUFA5;NDUFV1;NDUFAF5;NDUFAF7;NDUFAF4;NDUFAF1;TIMM21;BCS1L;TIMMDC1;ECSIT;NDUFAF2;NUBPL;NDUFAF6
gsea,regulation of DNA metabolic process (GO:0051052),0.620352777641481,2.0268864818039893,0.0,0.001244657277384434,0.103,11/28,19.81%,UBE2N;SUB1;ALYREF;HNRNPD;KPNA2;UBE2V2;IL7R;WRNIP1;PDGFA;CDT1;USP1
gsea,positive regulation of cell projection organization (GO:0031346),-0.5155105828977633,-2.0256742675420174,0.0,0.018015424746898226,0.174,19/44,24.43%,RAPGEF1;EP300;SETX;PTK2B;RAPGEF2;ARHGDIA;KIDINS220;ARHGAP35;PLXND1;CARMIL2;CAPRIN1;METRN;DVL3;PLXNA1;TIAM1;DVL1;MAP3K13;FBXW8;NDNF
gsea,cellular amino acid catabolic process (GO:0009063),0.5102800890032708,2.0255485222879805,0.0,0.0012519509216523885,0.104,20/47,24.52%,GLDC;GOT1;SHMT2;BCKDK;CARNMT1;GCSH;IVD;BCAT2;DLD;SHMT1;HIBADH;BCKDHA;GLUL;BCAT1;HIBCH;IL4I1;ACAD8;ACADSB;HSD17B10;MTRR
gsea,protein deubiquitination (GO:0016579),0.4588969799314096,2.0249936540210407,0.0,0.00124267721112163,0.104,44/144,19.81%,UBB;PSMB2;RPS27A;TOMM20;ACTB;PSMA3;PSMA5;PSMA4;UCHL3;PSME2;PSMD6;PSMB5;PSMD14;PSMC4;CDK1;UCHL5;PSMD11;PSMB6;SHMT2;PSMA6;PSMC2;USP14;PSMD12;CCNA2;PSMB7;INO80C;ACTL6A;PSMC6;ADRM1;PSMD7;PSMD3;RAD23B;CDC20;PSMD2;BRCC3;PSMD1;PSMC5;PSME3;COPS5;INO80E;ABRAXAS1;PSMC1;RAD23A;USP1
gsea,purine ribonucleotide metabolic process (GO:0009150),0.5739891579141031,2.023245693139563,0.0,0.0012580472934952613,0.106,5/29,7.16%,RAN;HINT1;DBI;GIMAP7;TPST2
gsea,DNA synthesis involved in DNA repair (GO:0000731),0.6128679050680431,2.0198891907942906,0.0,0.0013380690712879737,0.112,12/35,13.36%,UBB;RPS27A;RPA3;PCLAF;RFC5;RFC4;RPA2;POLD2;CDKN2D;WRNIP1;RFC3;UBE2L6
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5993304360135708,2.016830171232351,0.0,0.001376677388364662,0.115,17/44,15.50%,MAGOH;C1QBP;HNRNPK;SF3B4;SRSF3;HNRNPA1;SMU1;SRSF7;RBM8A;SRSF9;SRSF6;DAZAP1;PTBP1;RBMXL1;U2AF2;NCBP1;RNPS1
gsea,RNA export from nucleus (GO:0006405),0.5446329058671505,2.014461815060985,0.0,0.0014227230160204283,0.118,36/77,19.67%,RAN;MAGOH;SRSF2;HNRNPA2B1;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;HNRNPA1;NXT1;SLBP;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;AAAS;NUP62;THOC6;CPSF3;NUP43;NUP37;U2AF2;NCBP2;SEH1L;NCBP1;RNPS1;RAE1;CPSF2;NUP54;THOC5;NUP35;THOC3
gsea,fatty acid beta-oxidation (GO:0006635),0.6019666495952477,2.012669428062325,0.0,0.0014443036460387157,0.12,12/28,14.59%,SLC25A17;HADH;MTLN;ECI1;ACADL;BDH2;DECR1;PEX2;ACAT2;IVD;MCAT;MECR
gsea,protein polyubiquitination (GO:0000209),0.46525057172200873,2.0109965202948303,0.0,0.001497095977890649,0.126,39/139,18.13%,UBB;PSMB2;RPS27A;UBE2N;PSMA3;PSMA5;PSMA4;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;IFI27;PSMD11;UBE2V2;PSMB6;RNF5;PSMA6;PSMC2;PRPF19;UBE2C;PSMD12;UBE2E3;RNF126;UBE2T;PSMB7;CTNNB1;PSMC6;PSMD7;PSMD3;PSMD2;PSMD1;PSMC5;UBE2L6;PSME3;CDC23;CDC16;PSMC1
gsea,ribonucleoprotein complex assembly (GO:0022618),0.5465222263607941,2.0089714353301447,0.0,0.0015256728655338545,0.13,40/87,20.53%,SNRPE;RPL10;RPLP0;RPS27L;SNRPF;SNRPD1;SNRPD3;PTGES3;CLNS1A;MRPL20;RSL24D1;EIF6;RPL23A;STRAP;SMN1;SNRPB;BRIX1;DDX39B;SRSF9;SRSF6;PRPF19;DENR;RPF2;RPL3;CPSF6;EIF2S2;EIF5;HSP90AB1;EIF2D;NCBP1;WDR77;GEMIN6;NAF1;PRMT5;MRPS7;SNUPN;DDX1;GEMIN2;RPL5;PPAN
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.7710392201685411,2.0061623896113057,0.0,0.0015538500764268055,0.132,11/17,16.58%,NOP10;CCT8;TCP1;CCT4;CCT2;NHP2;CCT5;CCT6A;CCT3;CCT7;NAF1
gsea,positive regulation of Notch signaling pathway (GO:0045747),-0.5859539441187772,-2.0017118572179387,0.002932551319648094,0.021380943655659432,0.212,11/23,19.61%,STAT3;EP300;CREBBP;NOTCH1;AAK1;BMP2K;IL6ST;ZMIZ1;KAT2B;JAG2;MAML2
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6220913325201555,2.000481961710063,0.0,0.00170508069324015,0.147,10/29,15.76%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2;POLD2;RFC3;GTF2H3;ERCC3
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6907142615750211,1.9988081130880115,0.0,0.0017392940458927767,0.149,11/18,19.11%,LSM2;LSM3;EXOSC3;EXOSC8;EXOSC9;EXOSC5;EXOSC7;EXOSC1;LSM7;EXOSC4;HBS1L
gsea,purine-containing compound biosynthetic process (GO:0072522),0.7028873441512019,1.9985305754256435,0.0020491803278688526,0.001727381072975703,0.149,10/18,16.30%,APRT;PAICS;PRPS1;SHMT2;ADSL;PPAT;ADK;DCK;SHMT1;PRPSAP1
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5393705812038316,1.9949849734399168,0.002109704641350211,0.001844113498866806,0.156,41/78,23.31%,RPL15;RPL10;RPS27A;RPLP0;RPS2;MAGOH;MAGOHB;RPS25;RPS17;RPS26;RPL23A;RPL14;EIF4A3;RBM8A;EXOSC8;RPL10A;EXOSC9;ZFP36L1;EXOSC5;EXOSC7;RPL3;RPL7A;RPS6;MRTO4;RPL7;NCBP2;ZFP36;NCBP1;RNPS1;RPL31;RPS18;EXOSC4;CNOT10;PYM1;RPL41;RPL5;GSPT1;CNOT9;DXO;ERI1;THRAP3
gsea,endosome organization (GO:0007032),-0.5903665841859307,-1.9849471297115782,0.0,0.0261735404210314,0.264,13/24,23.83%,DNAJC13;RAB27A;HOOK3;CORO1C;LAPTM4B;ALS2CL;VPS11;EEA1;VPS18;ARFGEF2;WASHC4;EXOC8;HOOK1
gsea,mitochondrial membrane organization (GO:0007006),0.6453402750267987,1.9828696494682365,0.0,0.002199485282169146,0.18,8/21,13.80%,SLC25A5;PPIF;MTX2;APOO;BAK1;MTX1;IMMT;SAMM50
gsea,ribosomal large subunit assembly (GO:0000027),0.7281877685207759,1.982352376619469,0.0,0.0021921800306421396,0.18,8/17,9.33%,RPL10;RPLP0;MRPL20;RSL24D1;RPL23A;BRIX1;RPF2;RPL3
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",0.6119386880975346,1.9813287652912925,0.0,0.002199785553197428,0.182,10/30,15.76%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2;POLD2;RFC3;GTF2H3;ERCC3
gsea,positive regulation of translation (GO:0045727),0.5270118601235618,1.9799754172596498,0.0,0.0022367208782260294,0.184,20/52,21.04%,CNBP;EIF5A;RPS27L;NPM1;C1QBP;VIM;YBX3;EIF6;EIF4A3;HNRNPD;CDC123;PKM;METTL5;BCL3;EIF3D;MRPS27;TRMT10C;PYM1;RPL5;EEF2
gsea,"DNA-templated transcription, termination (GO:0006353)",0.547487932113696,1.9789054292559687,0.0,0.0022658609831579042,0.184,23/47,19.23%,SNRPE;SNRPF;SNRPD3;POLR3K;SLBP;SMN1;SNRPB;TAF1B;POLR2H;CPSF3;TBP;POLR2L;NCBP2;POLR2E;POLR1E;GTF2H3;NCBP1;ERCC3;CDK7;PRMT5;CSTF1;CPSF2;POLR1C
gsea,mRNA transport (GO:0051028),0.5204015541954552,1.9763267698008329,0.002066115702479339,0.002330927452882995,0.189,36/79,19.67%,MAGOH;SRSF2;HNRNPA2B1;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;NXT1;SLBP;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;AAAS;NUP62;THOC6;CPSF3;ZFP36L1;NUP43;NUP37;U2AF2;NCBP2;ZFP36;SEH1L;NCBP1;RNPS1;RAE1;CPSF2;NUP54;THOC5;NUP35;THOC3
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5259498313618699,1.974924532029522,0.0,0.0023735059917419452,0.192,38/98,20.36%,PSMB2;CDK4;PSMA3;PSMA5;PSMA4;PSME2;TUBA1A;PSMD6;TUBB4B;PSMB5;PSMD14;PSMC4;CDK1;YWHAE;PSMD11;PSMB6;PSMA6;PSMC2;CDK2;TUBA4A;HAUS1;PSMD12;HAUS4;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;HAUS8;PSMD1;PSMC5;PSME3;CCNB1;TPX2;PSMC1;AVEN;PLK1;FBXO5
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6994317155487475,1.97437137033938,0.0,0.002365360809889708,0.192,11/17,19.11%,LSM2;LSM3;EXOSC3;EXOSC8;EXOSC9;EXOSC5;EXOSC7;EXOSC1;LSM7;EXOSC4;HBS1L
gsea,regulation of axon extension (GO:0030516),-0.6160971361167973,-1.9735960899955174,0.0,0.028268218598993974,0.293,11/20,24.03%,MACF1;GOLGA4;PTPRS;MAP2;ABL1;GSK3B;LIMK1;SIN3A;TRIM46;SEMA7A;MAP3K13
gsea,chordate embryonic development (GO:0043009),-0.587502618046943,-1.9730385934546157,0.0029940119760479044,0.02660579137331495,0.295,12/19,30.42%,CHD7;ARNT2;BRCA1;PTCH1;TGFB3;WNT11;DVL1;FUT8;XYLT1;HINFP;GATA3;FOXF1
gsea,positive regulation of ATPase activity (GO:0032781),0.6829876130652152,1.9709634652779713,0.0,0.0024641472462001756,0.196,11/19,23.01%,PFN1;PLSCR1;DNAJB1;AHSA1;DNAJB11;DNAJC9;DYNLL2;PFN2;TPM1;FXYD2;DNAJC10
gsea,chemical homeostasis (GO:0048878),-0.5616825905331785,-1.9656183667885636,0.0,0.026955625308327392,0.314,12/26,21.90%,WNK1;DDX3X;TENT4B;ACOXL;ATP13A2;ZBTB20;SLC4A7;IRS2;FBXW7;THADA;EIF5A2;SLC4A8
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6159734173402558,-1.9645833008546596,0.0025974025974025974,0.02573632106699746,0.317,7/16,10.04%,RAPGEF1;ERBIN;NOTCH1;RASGRP1;JAK2;IRS2;NOTCH2
gsea,regulation of primary metabolic process (GO:0080090),0.5140305397395587,1.963851446430248,0.0,0.0026748984723303994,0.21,30/71,15.33%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;ID2;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;ODC1;PSMB6;PSMA6;PSMC2;PSMD12;SC5D;PSMB7;PSMC6;PSMD7;PSMD3;NFYB;PSMD2;NFYC;PSMD1;FDFT1;PSMC5;PSME3;IDI1;FDPS
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.7771100412445638,1.9633327522663455,0.002074688796680498,0.0026860953884459073,0.212,11/15,16.58%,NOP10;CCT8;TCP1;CCT4;CCT2;NHP2;CCT5;CCT6A;CCT3;CCT7;NAF1
gsea,'de novo' posttranslational protein folding (GO:0051084),0.6351544618091901,1.9626796485714897,0.0019083969465648854,0.002690164023826345,0.215,8/24,8.40%,HSPE1;SDF2L1;PTGES3;CCT2;DNAJB1;CHCHD4;HSPA8;DNAJC7
gsea,glycolytic process (GO:0006096),0.7545201195175089,1.9607835761641519,0.0,0.0027913945466709793,0.223,7/17,8.12%,PGAM1;ALDOA;PGK1;ENO1;GAPDH;LDHA;PKM
gsea,regulation of ion transport (GO:0043269),-0.588693980024898,-1.9603228824838588,0.0,0.02574364292220856,0.329,7/16,23.30%,WNK1;NEDD4;ITGB3;SYT11;KCNJ14;PER1;KCNJ10
gsea,JNK cascade (GO:0007254),0.6727029891543591,1.9567547271891292,0.0,0.0029327713787217114,0.233,3/18,0.35%,UBB;RPS27A;UBE2N
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6621743823076339,1.9562179154220107,0.0019083969465648854,0.0029283839357005298,0.235,7/20,12.08%,UBE2N;RPS2;PIN1;UBE2S;UBE2C;CDC20;DCUN1D1
gsea,translesion synthesis (GO:0019985),0.6000448394178585,1.9558954563332462,0.0019801980198019802,0.0029172343582093926,0.236,10/33,13.36%,UBB;RPS27A;RPA3;PCLAF;RFC5;RFC4;RPA2;POLD2;RFC3;UBE2L6
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.523225905757863,1.9553694430988107,0.0,0.0029197695658662592,0.236,13/42,18.94%,CYCS;RPS27L;HSPE1;FAM162A;BAX;ANP32B;RACK1;DAP;IFT57;HSPD1;CASP1;FADD;FAS
gsea,cytoplasmic translation (GO:0002181),0.7216069392827953,1.9536190970584688,0.002061855670103093,0.0029761408463828075,0.244,17/35,10.13%,RPL15;RPL10;RPS27A;RPLP0;RPS2;RPL22L1;EIF4A1;RPS25;RPS17;RPS26;RPL23A;RPL14;DRG1;RPL10A;RPL3;RPL7A;RPS6
gsea,protein tetramerization (GO:0051262),0.6054741586513804,1.9505089528648065,0.0,0.0030920680466630522,0.253,15/30,19.34%,ALDOA;TK1;SOD2;FARSB;SHMT2;ALDH9A1;THG1L;SAMHD1;APIP;CPSF6;CBY1;FARSA;SHMT1;KRT10;ALDH1A3
gsea,positive regulation of protein dephosphorylation (GO:0035307),0.7075219784121464,1.9503749531644339,0.0,0.003073552669138124,0.253,5/15,12.26%,PPIA;CALM2;PIN1;PTBP1;HSP90AB1
gsea,negative regulation of viral process (GO:0048525),0.5313372116264097,1.9486584195107368,0.0019801980198019802,0.0031081626082334994,0.257,6/38,17.57%,PPIA;BANF1;PLSCR1;BST2;ZFP36;TRIM28
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5204245082852276,1.9480870048831604,0.0,0.0030963450946027995,0.257,25/59,15.93%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PIN1;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;ZBED3;PSMD1;PSMC5;PSME3;AXIN2
gsea,regulation of cardiac conduction (GO:1903779),-0.547866022776306,-1.9421606405924514,0.0,0.030132362935738653,0.38,9/23,21.15%,ITPR3;ATP2A2;ITPR1;ATP2B4;ITPR2;ATP2A3;ATP2B2;TRPC1;FXYD1
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.62204263229756,1.940633906623588,0.004228329809725159,0.003372220277628856,0.28,28/49,20.67%,RPL15;RPL10;RPS27A;RPLP0;RPS2;MAGOH;MAGOHB;RPS25;RPS17;RPS26;RPL23A;RPL14;EIF4A3;RBM8A;RPL10A;RPL3;RPL7A;RPS6;RPL7;NCBP2;NCBP1;RNPS1;RPL31;RPS18;PYM1;RPL41;RPL5;GSPT1
gsea,synapse assembly (GO:0007416),-0.6026572257208342,-1.9402367281190476,0.0027472527472527475,0.02921420229226739,0.382,7/15,24.48%,DSCAM;FARP1;PLXND1;NLGN2;CDH1;DVL1;SPOCK2
gsea,regulation of endopeptidase activity (GO:0052548),0.6347773887215769,1.9381100052594058,0.0,0.0034889386321313104,0.291,8/25,13.74%,PSMA3;HDAC1;SERPINB9;PSME2;PRELID1;GAPDH;AKT1;PSME3
gsea,positive regulation of protein metabolic process (GO:0051247),-0.47752942769776685,-1.9378449218178513,0.0,0.02868303497786253,0.389,21/49,15.91%,HUWE1;ABCA2;IDE;VCP;NEDD4;AREL1;SLC25A37;RASGRP1;TNFAIP3;ROCK2;FOXO1;BARD1;EIF4G1;GSK3B;FZR1;HECW1;MAPK8;CD80;TIPARP;DDB1;ABCB10
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),0.7390698514329135,1.9335708977891461,0.00199203187250996,0.0037076488945716585,0.304,6/17,8.12%,PGAM1;ALDOA;PGK1;ENO1;GAPDH;PKM
gsea,chaperone-mediated protein complex assembly (GO:0051131),0.7084568049323992,1.9322573313600135,0.0,0.00373117126877943,0.309,8/15,17.81%,PTGES3;CCT2;HOPX;PSMG1;HSPD1;HSP90AB1;PSMG2;NDUFAF1
gsea,Golgi to plasma membrane transport (GO:0006893),-0.6350537628726407,-1.9294619709765717,0.0,0.030012602851807617,0.402,11/18,25.82%,MACF1;GOLGA4;SPTBN1;EXOC4;GCC2;OPTN;ARFGEF2;EXOC2;EXOC8;LLGL1;NSF
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6931261682704805,1.9289872280102842,0.0,0.0038438143011286768,0.318,8/20,13.07%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2;POLD2;RFC3
gsea,regulation of stress fiber assembly (GO:0051492),0.521227267972518,1.9270914880611927,0.0,0.0038916841099856385,0.323,9/41,20.48%,PFN1;S100A10;ACTG1;STMN1;RGCC;RHOC;EVL;PFN2;TPM1
gsea,histone mRNA metabolic process (GO:0008334),0.658473412734225,1.9245911787497794,0.0,0.004052635230580662,0.335,11/19,18.46%,SNRPE;SNRPF;SNRPD3;SSB;SLBP;SNRPB;CPSF3;NCBP2;NCBP1;EXOSC4;CPSF2
gsea,regulation of programmed cell death (GO:0043067),0.43133957609362567,1.924576961725049,0.0,0.004029738986340093,0.335,43/101,36.04%,TPT1;NME2;NME1;ANP32A;BAX;ANP32B;PRELID1;LGALS1;BIRC5;PERP;ANP32E;PHB;NUP62;NAE1;APEX1;IFT57;HAX1;ACTN2;AKT1;PSMC5;RSL1D1;BCL3;CASP1;SGK1;RTKN;FAS;RABGGTB;TIGAR;CXCL10;BID;RIPK3;ACTN1;BIRC3;TNFSF9;MAGED1;NDRG1;TGM2;PINK1;TNFRSF25;BNIP3;TRAF2;CHM;DNAJA3
gsea,cotranslational protein targeting to membrane (GO:0006613),0.7237630315620123,1.919019254338636,0.004123711340206186,0.004256763554876422,0.348,17/32,12.22%,RPL15;RPL10;RPS27A;RPLP0;RPS2;ARL6IP1;SSR2;RPS25;RPS17;RPS26;RPL23A;RPL14;RPL10A;RPL3;RPL7A;RPS6;RPL7
gsea,glucose catabolic process to pyruvate (GO:0061718),0.7478909106139031,1.9118926355518624,0.002004008016032064,0.004592144925866686,0.368,6/16,8.12%,PGAM1;ALDOA;PGK1;ENO1;GAPDH;PKM
gsea,canonical glycolysis (GO:0061621),0.7478909106139031,1.9118926355518624,0.002004008016032064,0.004592144925866686,0.368,6/16,8.12%,PGAM1;ALDOA;PGK1;ENO1;GAPDH;PKM
gsea,muscle organ development (GO:0007517),-0.565790034904195,-1.9115567010431025,0.0029498525073746312,0.034639697003688484,0.451,6/18,13.69%,CHD2;NEB;UTRN;TCF12;ZBTB42;COL6A3
gsea,branched-chain amino acid catabolic process (GO:0009083),0.6572754444107374,1.9112832690795483,0.005660377358490566,0.004547786205827739,0.368,12/15,28.72%,BCKDK;IVD;BCAT2;DLD;HIBADH;BCKDHA;BCAT1;HIBCH;ACAD8;ACADSB;HSD17B10;MCCC2
gsea,branched-chain amino acid metabolic process (GO:0009081),0.6572754444107374,1.9112832690795483,0.005660377358490566,0.004547786205827739,0.368,12/15,28.72%,BCKDK;IVD;BCAT2;DLD;HIBADH;BCKDHA;BCAT1;HIBCH;ACAD8;ACADSB;HSD17B10;MCCC2
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),0.6442628388122192,1.9101695227666884,0.0038022813688212928,0.004565432290126583,0.371,6/20,8.40%,HSPE1;SDF2L1;PTGES3;DNAJB1;HSPA8;DNAJC7
gsea,protein homotetramerization (GO:0051289),0.6117603038347943,1.909838636113705,0.0017574692442882249,0.004558734334277718,0.371,11/23,19.34%,ALDOA;TK1;SOD2;SHMT2;ALDH9A1;THG1L;SAMHD1;APIP;CBY1;SHMT1;ALDH1A3
gsea,regulation of hydrolase activity (GO:0051336),-0.5396144644400547,-1.9095086159411712,0.002881844380403458,0.03422235125665609,0.457,20/27,36.59%,SIPA1L1;PLXND1;NF1;RAB3GAP2;VAV2;PLXNA1;WRN;ARHGAP27;ADAP1;CHN2;ARHGEF5;FGD3;TBC1D10B;FGD2;DAB2IP;RASIP1;GPR137B;TDG;VAV3;NOS1
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.5857381614827161,1.9082388901724423,0.002074688796680498,0.0046301792561157995,0.378,20/40,20.44%,NPM1;RPS25;RPS17;NIP7;RPL14;EMG1;EBNA1BP2;LTV1;RPF2;RPS6;WDR12;MRTO4;RPL7;NOP16;WDR74;GTF3A;NAF1;RIOK2;GLUL;RPL5
gsea,positive regulation of establishment of protein localization (GO:1904951),0.702090087363261,1.9064280654454215,0.0021551724137931034,0.004688909686271264,0.383,8/16,14.50%,CCT8;TCP1;CCT4;CCT2;CCT5;CCT6A;CCT3;CCT7
gsea,mRNA export from nucleus (GO:0006406),0.5109031182236848,1.9049356147989815,0.00205761316872428,0.004770776749358653,0.39,35/77,19.67%,MAGOH;SRSF2;HNRNPA2B1;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;NXT1;SLBP;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;AAAS;NUP62;THOC6;CPSF3;NUP43;NUP37;U2AF2;DDX19A;NCBP2;SEH1L;NCBP1;RNPS1;RAE1;CPSF2;NUP54;THOC5;NUP35;THOC3
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5159031214084877,1.9027310220805822,0.002074688796680498,0.004881320833175037,0.398,34/74,19.67%,MAGOH;SRSF2;HNRNPA2B1;ALYREF;MAGOHB;U2AF1;SRSF3;SARNP;NXT1;SLBP;EIF4A3;SRSF7;RBM8A;EIF4E;DDX39B;SRSF9;SRSF6;AAAS;NUP62;THOC6;CPSF3;NUP43;NUP37;U2AF2;NCBP2;SEH1L;NCBP1;RNPS1;RAE1;CPSF2;NUP54;THOC5;NUP35;THOC3
gsea,negative regulation of interferon-gamma production (GO:0032689),0.5860291149207054,1.9025256160423416,0.0035842293906810036,0.004879007025690411,0.4,5/19,14.49%,C1QBP;HMGB1;XCL1;PDCD1LG2;TNFSF4
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5845583839354448,1.9023183081310457,0.0019646365422396855,0.004865022807709358,0.401,14/31,19.79%,ACTB;CCNB2;BCCIP;CCND3;CCNA2;CDKN2C;CDKN2D;GTPBP4;CDKN3;HSP90AB1;CCNB1;CDK7;CCNG1;CCNK
gsea,regulation of proteolysis (GO:0030162),0.5875841405083094,1.8997937636167412,0.0019723865877712033,0.005025688079651431,0.411,10/20,22.71%,CST3;PERP;HDAC2;PARL;BAK1;GSAP;AKT1;FADD;PLK1;CAMK2N1
gsea,rRNA modification (GO:0000154),0.6611130220976935,1.8970829748457965,0.0,0.005109455606779591,0.414,9/17,19.99%,NOP10;GAR1;NHP2;BUD23;FBL;METTL5;DIMT1;TFB1M;MTERF4
gsea,nucleotide-excision repair (GO:0006289),0.49360105965974743,1.8912675042061027,0.002012072434607646,0.005480179637420715,0.441,36/72,29.35%,UBB;RPS27A;RPA3;POLR2C;RFC5;RFC4;COPS4;HMGN1;RPA2;POLR2H;COPS3;PRPF19;POLD2;COPS2;RAD23B;POLR2L;POLR2E;RFC3;GTF2H3;COPS5;ERCC3;CDK7;COPS7A;PPIE;RAD23A;XRCC1;GTF2H2;POLR2F;GTF2H4;COPS7B;POLR2B;CHD1L;GPS1;OGG1;CUL4B;ERCC2
gsea,ribosomal small subunit biogenesis (GO:0042274),0.6352984164749413,1.8910328961612626,0.0020491803278688526,0.0054519312887742165,0.441,12/25,17.38%,RPS27L;NPM1;SNU13;RPS25;RPS17;EMG1;LTV1;RPS6;UTP4;SRFBP1;RIOK2;MRPS7
gsea,peptidyl-serine phosphorylation (GO:0018105),-0.4355436452133988,-1.8889389677366113,0.0,0.04041833042413698,0.514,43/81,29.52%,WNK1;GRK2;RPS6KA3;HIPK1;MAST2;HIPK3;DYRK1A;LMTK2;TAF1;ULK2;EIF2AK3;MAST3;ERN1;ROCK2;ATR;PRKDC;ROCK1;CSNK1G1;GSK3B;LATS1;MAPK8;PRKD2;PRKCA;RICTOR;MAST4;IKBKE;CAMK2D;RIPK1;PDGFB;MAPKAPK2;HIPK2;LATS2;ULK1;GAS6;MAST1;MAP3K13;DYRK2;PDPK1;RPS6KA5;STK38L;NLK;CHUK;PRKCE
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6551109183221343,1.8861980792027382,0.0,0.005743029882473472,0.459,4/18,4.18%,UBB;EIF5A;BAX;RACK1
gsea,clathrin-dependent endocytosis (GO:0072583),-0.6133885308217948,-1.8846096798024812,0.0,0.040683481710713114,0.527,7/15,17.49%,AP2A2;PICALM;AP2B1;CLTC;PIP5K1C;GAK;FCHSD2
gsea,regulated exocytosis (GO:0045055),0.45612897620941506,1.8751038021205737,0.0,0.0065073021414931145,0.504,20/70,23.41%,TMSB4X;TAGLN2;MANF;ALDOA;OLA1;ANXA5;CD9;TUBA4A;SYNGR2;FAM3C;ACTN2;VAMP7;SDF4;PLEK;PDGFA;CD63;APP;VEGFB;SELENOP;CYB5R1
gsea,peptidyl-threonine phosphorylation (GO:0018107),-0.5491503849276902,-1.8730700565682565,0.005747126436781609,0.0447156157534705,0.559,22/30,25.75%,WNK1;HIPK1;HIPK3;DYRK1A;LMTK2;TAF1;CIT;ROCK2;PRKDC;ROCK1;CAD;GSK3B;MAPK8;PRKD2;PRKCA;CAMK2D;HIPK2;ULK1;OXSR1;DYRK2;ACVR1;PDPK1
gsea,DNA replication-independent nucleosome assembly (GO:0006336),0.6058928683164138,1.8715156006198472,0.0,0.006784448598924541,0.514,13/32,15.35%,NPM1;CENPW;RBBP4;CENPA;RBBP7;MIS18A;ASF1B;HAT1;ASF1A;NASP;OIP5;CENPU;CENPQ
gsea,regulation of receptor-mediated endocytosis (GO:0048259),-0.6110331658510972,-1.8712377171388088,0.0,0.04357665248324417,0.561,7/15,5.21%,HIP1R;CBL;PICALM;TNK2;HIP1;AAK1;BMP2K
gsea,chromatin remodeling at centromere (GO:0031055),0.6311244068974357,1.871069275629177,0.0,0.00678946158394268,0.515,16/28,24.14%,NPM1;CENPW;RBBP4;CENPA;RBBP7;MIS18A;NASP;CENPV;OIP5;CENPU;CENPQ;HELLS;CENPK;ITGB3BP;CENPN;CENPH
gsea,granulocyte chemotaxis (GO:0071621),0.5823266588078505,1.8692319210463357,0.0013736263736263737,0.0069228315465326914,0.524,6/32,7.51%,PPIA;BSG;CCL3;XCL1;CCL4;ANXA1
gsea,regulation of anatomical structure morphogenesis (GO:0022603),-0.4330843274611184,-1.8670385948376804,0.0,0.04368218818939029,0.569,34/59,33.09%,KIF13B;SIPA1L1;ETS1;CLASP1;NEDD4;ARHGAP35;PHIP;PLXND1;PDZD8;TNFAIP3;INF2;TNIK;NF1;TANC2;BCL9L;CLASP2;ABI3;GSK3B;CAMSAP1;HECW1;LARP4;CEACAM1;DAG1;VASH1;ZMYM4;STAT2;STRIP1;DLL1;MEF2C;KNDC1;PDLIM5;ABI2;GPNMB;SH3D19
gsea,nucleosome assembly (GO:0006334),0.6193388398000959,1.8638056671661163,0.002,0.007349283552727772,0.541,9/23,7.70%,NPM1;RBBP4;ANP32B;NAP1L1;ASF1B;HAT1;HMGB2;ASF1A;NASP
gsea,RNA metabolic process (GO:0016070),0.4853820749740686,1.8627535311421966,0.0,0.007379048478613415,0.546,27/83,15.58%,LSM8;HNRNPF;PCBP1;HNRNPA2B1;HNRNPK;HNRNPA3;SNRNP40;HNRNPA1;POLR2C;RNASEH2B;HNRNPD;POLR2H;DDX39B;PTBP1;MRPL44;EXOSC7;HNRNPA0;HNRNPC;POLR2L;RNASEH1;HNRNPR;NCBP2;POLR2E;GTF2F2;NCBP1;WDR74;HNRNPM
gsea,positive regulation of telomerase activity (GO:0051973),0.6425202930820038,1.86107595027693,0.005607476635514018,0.007452518813337623,0.55,8/21,16.58%,PTGES3;TCP1;CCT4;CCT2;AURKB;CTNNB1;HSP90AB1;NAF1
gsea,protein autophosphorylation (GO:0046777),-0.43591255854328004,-1.860183764627369,0.0,0.04547722366049735,0.581,39/76,25.86%,TAOK2;TAOK1;PTK2B;AAK1;DYRK1A;LMTK2;ATP13A2;TAF1;ULK2;EIF2AK3;ERN1;SLK;JAK2;PEAK1;MAP3K11;MINK1;TNIK;ATR;TEC;CDK12;ABL1;CAD;GSK3B;SIK2;PRKD2;GRK5;TXK;CAMK2D;MAP3K3;RIPK1;STK10;MAPKAPK2;ULK1;OXSR1;EIF2AK2;MAP3K13;EEF2K;PDPK1;EIF2AK4
gsea,chromosome organization (GO:0051276),0.4735660751207484,1.8582340315451205,0.0038461538461538464,0.007656615387677769,0.558,31/70,28.51%,UBB;RPS27A;HMGN2;CENPW;HDAC1;COPS4;HDAC2;HMGN1;GEM;HMGB2;COPS3;EZH2;COPS2;RAD23B;CENPV;COPS5;HMGN3;AXIN2;RAE1;COPS7A;CDCA8;CDT1;POLE3;CENPH;NUF2;HHEX;COPS7B;MYC;CENPT;GPS1;CUL4B
gsea,cell-cell junction organization (GO:0045216),-0.5029425221088205,-1.8575938932830585,0.0,0.045203761225445886,0.593,18/30,31.70%,PKP4;CDH17;JUP;NLGN2;CDH1;PKP3;PKP2;TGFB3;F2R;CTNND2;SMAD3;DSG2;CTNNA1;PVR;F2RL1;MARVELD2;DSP;TJP1
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",0.7105591385864214,1.8572783113903237,0.001996007984031936,0.0077171126185401956,0.563,4/15,3.78%,CENPA;CDK1;AURKB;BUB3
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),0.6504679350120623,1.8569620041372468,0.0019267822736030828,0.007706565796124029,0.565,6/15,19.86%,PPIA;SOD2;HTRA2;AKT1;HSPB1;BAG5
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5163198971900018,1.8538874481721432,0.0019305019305019305,0.007944209374962765,0.576,21/45,25.23%,ACTB;CCNB2;BCCIP;RGCC;CCND3;CCNA2;CDKN2C;CDKN2D;GTPBP4;AKT1;CDKN3;CDK5RAP1;CCNB1;CDK7;CCNG1;CCNK;PLK1;MEN1;TFAP4;HHEX;CCNE1
gsea,heart morphogenesis (GO:0003007),-0.5777593301070854,-1.8536101051152984,0.010101010101010102,0.04573097640209476,0.605,8/15,29.07%,CHD7;NOTCH1;MDM4;TTN;ALPK2;ZFPM1;ACVR1;TGFBR3
gsea,protein targeting to ER (GO:0045047),0.6825517353217634,1.8518832377618273,0.008213552361396304,0.00802390914465953,0.584,21/34,20.44%,RPL15;RPL10;RPS27A;RPLP0;RPS2;RPS25;RPS17;RPS26;RPL23A;RPL14;RPL10A;RPL3;RPL7A;RPS6;RPL7;RPL31;RPS18;SRP72;SRPRB;RPL41;RPL5
gsea,peptidyl-lysine trimethylation (GO:0018023),-0.6101117225812174,-1.8499360542644459,0.008064516129032258,0.04644812666972261,0.62,9/17,16.86%,KMT2A;KMT2D;SETD1B;TET2;SETD2;TET3;CTR9;SETD1A;KMT5C
gsea,cartilage development (GO:0051216),-0.5924770559355595,-1.8498776337046,0.005376344086021506,0.04514488566470381,0.62,7/16,12.84%,RUNX3;SLC39A14;WNT10B;RUNX2;CREB3L2;ITGB8;SNX19
gsea,CENP-A containing nucleosome assembly (GO:0034080),0.631118245896421,1.8481882414505195,0.004166666666666667,0.008196968061066248,0.599,14/26,24.14%,NPM1;CENPW;RBBP4;CENPA;RBBP7;MIS18A;NASP;OIP5;CENPU;CENPQ;CENPK;ITGB3BP;CENPN;CENPH
gsea,CENP-A containing chromatin organization (GO:0061641),0.631118245896421,1.8481882414505195,0.004166666666666667,0.008196968061066248,0.599,14/26,24.14%,NPM1;CENPW;RBBP4;CENPA;RBBP7;MIS18A;NASP;OIP5;CENPU;CENPQ;CENPK;ITGB3BP;CENPN;CENPH
gsea,protein K63-linked ubiquitination (GO:0070534),0.5939891601516878,1.8400974712212401,0.005639097744360902,0.008967379780350266,0.639,8/23,8.15%,UBE2N;UBE2S;UBE2V2;RNF5;PRPF19;UBE2E3;RNF126;UBE2T
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),-0.444487267270176,-1.8395273748579546,0.0,0.048643965404108716,0.648,17/42,36.13%,RAPGEF1;NEDD9;TNK2;PTK2B;LMTK2;AHI1;JAK2;IL6ST;CD4;BCAR1;MTSS1;KIT;FES;CSF1;CSF1R;FLT1;LYN
gsea,positive regulation of ATP metabolic process (GO:1903580),0.5872153510336307,1.839201132012724,0.0,0.0090459849212341,0.643,3/18,6.38%,TMSB4X;ENO1;IFNG
gsea,water-soluble vitamin metabolic process (GO:0006767),0.49939136072786006,1.838617700611998,0.00186219739292365,0.009071442711513123,0.645,12/40,19.12%,MTHFD2;MMADHC;SHMT2;GSTO1;DHFR;PDZD11;AASDHPPT;CD320;MTHFD2L;ACP5;SHMT1;SLC19A1
gsea,regulation of Notch signaling pathway (GO:0008593),-0.4652702664728142,-1.8385097579292602,0.0,0.0478030074573858,0.652,17/38,23.09%,STAT3;EP300;SREBF2;CREBBP;NOTCH1;AAK1;BMP2K;IL6ST;FBXW7;ZMIZ1;KAT2B;ARRB1;JAG2;POFUT1;MAML2;DTX1;LLGL1
gsea,regulation of sodium ion transport (GO:0002028),-0.5863202453978292,-1.8370061885879128,0.0049504950495049506,0.04726989724282664,0.658,6/16,21.48%,WNK1;NEDD4;ATP2B4;PKP2;SLMAP;PER1
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.5531678557902466,1.8367808376475325,0.00390625,0.009289652559028359,0.655,13/34,16.58%,CCT8;TCP1;HNRNPA1;CCT4;CCT2;AURKB;CTNNB1;CCT5;CCT6A;HNRNPC;CCT3;CCT7;NAF1
gsea,regulation of endocytosis (GO:0030100),-0.5107182769312063,-1.835405986590793,0.0,0.04680693070563281,0.662,9/30,15.55%,HIP1R;ABCA7;PICALM;HIP1;ROCK1;ABL1;TSC2;SYT11;ZFYVE16
gsea,vesicle cytoskeletal trafficking (GO:0099518),-0.5227418718957596,-1.8343755046080563,0.0,0.04609583775972762,0.665,11/20,25.30%,HTT;MYO5A;MYO1F;MYO1G;TANC2;KIF5B;BICDL1;ACTN4;CLN3;MYO1E;TRAK1
gsea,DNA methylation (GO:0006306),-0.6116384329959312,-1.833994228549209,0.0041753653444676405,0.04509369900862179,0.665,7/17,16.67%,EHMT2;ATRX;BAZ2A;ATF7IP;DNMT3A;DNMT1;TEX15
gsea,phosphorylation (GO:0016310),-0.37350795594983105,-1.8339636195005002,0.0,0.04402003950841651,0.665,97/196,29.57%,WNK1;STAT3;BIRC6;CDK6;MAP3K1;RUNX3;GRK2;DGKH;TAOK2;HIPK1;TAOK1;TNK2;PTK2B;PIK3CA;MAP3K5;MAST2;AAK1;HK1;HIPK3;BCR;DYRK1A;LMTK2;GNPTAB;BMP2K;TAF1;EIF2AK3;ERN1;CERK;JAK2;PANK3;PI4KA;PEAK1;ROCK2;SNRK;MAP3K11;MINK1;TNIK;TYK2;PRKDC;TEC;BRD2;ROCK1;CDK12;DGKG;ABL1;PIK3CG;ILF3;GSK3B;LIMK1;CREB1;SIK2;LATS1;MAPK8;PRKD2;PRKCA;GRK5;CDKL2;TXK;IKBKE;PAK6;CAMK2D;FAM20B;TBCK;WNT11;LMTK3;DGKE;STK10;CDK19;DGKD;PIK3CD;TRIB2;PDGFB;MAPKAPK2;FAM20A;HIPK2;LATS2;ULK1;RARA;GAS6;POMK;CDK14;OXSR1;MAST1;EIF2AK2;MAP3K13;DYRK2;ACVR1;PDPK1;EIF2AK4;PDK1;RPS6KA5;STK38L;CLK2;NLK;CHUK;PRKCE;TRIB1
gsea,positive regulation of fibroblast proliferation (GO:0048146),0.606700191380714,1.8313215652627757,0.006289308176100629,0.009796552768062747,0.672,3/18,0.90%,CDK4;S100A6;MIF
gsea,regulation of macromolecule metabolic process (GO:0060255),0.4449284963998443,1.8291631765164271,0.0015151515151515152,0.010055867245765083,0.681,29/83,37.44%,CDK4;CRIP1;PCBP1;HNRNPK;HNRNPAB;YBX1;YBX3;PIN1;HNRNPD;CDK2;ZFP36L1;COQ7;NFKBIZ;HNRNPDL;TCF19;APP;FUBP1;IL10;IGF2BP3;MYC;UTY;PEG3;ZC3H12A;CACTIN;TOB1;SIRPA;PCBP4;NFKBID;FLOT1
gsea,histone exchange (GO:0043486),0.5814962082350503,1.8261956137468314,0.0041753653444676405,0.010353928915512588,0.689,12/32,15.35%,NPM1;CENPW;RBBP4;CENPA;RBBP7;ANP32E;MIS18A;NASP;OIP5;ACTR6;CENPU;CENPQ
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.46764168879247403,-1.825809061094446,0.0,0.046412729356020824,0.691,10/35,15.55%,HIP1R;PICALM;HIP1;USP7;DNAJC13;STXBP5;NRP1;ABL1;TSC2;ZFYVE16
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5149213677212521,1.824254679295464,0.0,0.010526367586868484,0.694,11/35,17.57%,SUB1;CDK4;MED30;BAX;CDK1;CEBPB;MED8;CTNNB1;CCNB1;RELA;TRIM28
gsea,nucleic acid-templated transcription (GO:0097659),0.588088498201171,1.8199365989358898,0.0018050541516245488,0.011023390213061899,0.71,13/25,15.69%,PTMA;POLR2C;TAF1B;POLR2H;DRG1;MLF1;NFKBIB;POLR2L;POLR2E;PPP5C;BCL3;RNPS1;E2F1
gsea,regulation of osteoblast differentiation (GO:0045667),-0.46205922696003,-1.819385281745366,0.003663003663003663,0.04856386874558735,0.711,19/36,34.28%,CDK6;HDAC7;SKI;IFITM1;NOTCH1;RUNX2;ATF4;IL6ST;LTF;PTCH1;ZHX3;TMEM119;ACVR1;MEF2C;NPNT;RORB;REST;NOCT;YAP1
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5794009709599408,-1.8190854089289077,0.006564551422319475,0.04768870736090124,0.712,6/16,14.40%,CNOT1;KMT2D;VPS11;BRCA1;LATS1;VPS18
gsea,cell-matrix adhesion (GO:0007160),-0.46401492727184124,-1.8187975120862063,0.0031446540880503146,0.046779014602152384,0.713,20/37,32.31%,TAOK2;ITGA4;ITGB3;ITGA3;BCR;PPFIA1;PEAK1;TSC1;RCC2;ITGB8;VCL;ADAM9;TIAM1;ITGA1;CTTN;ITGB4;CD44;ITGB1;NPNT;PTPRK
gsea,peptidyl-threonine modification (GO:0018210),-0.5310461393569114,-1.818670141130769,0.007952286282306162,0.04590803217356304,0.713,23/32,25.75%,WNK1;HIPK1;HIPK3;DYRK1A;LMTK2;TAF1;CIT;ROCK2;PRKDC;ROCK1;CAD;GSK3B;MAPK8;PRKD2;PRKCA;CAMK2D;HIPK2;ULK1;GALNT1;OXSR1;DYRK2;ACVR1;PDPK1
gsea,rRNA methylation (GO:0031167),0.6076759916303739,1.8160716325203685,0.0,0.011419485448658761,0.721,7/18,19.99%,EMG1;BUD23;FBL;METTL5;DIMT1;TFB1M;MTERF4
gsea,response to unfolded protein (GO:0006986),0.54898473492073,1.8145755628959273,0.008976660682226212,0.011529179104567789,0.723,12/35,23.51%,HSPE1;BAX;DNAJA1;DNAJB1;BAK1;HSPA8;HSPD1;HERPUD1;HSP90AB1;HSPB1;HSPA9;DNAJB5
gsea,global genome nucleotide-excision repair (GO:0070911),0.5914475020535873,1.811915682032917,0.00390625,0.011854048024223083,0.733,10/18,29.35%,UBB;RPS27A;RAD23B;GTF2H3;ERCC3;GTF2H2;GTF2H4;CHD1L;CUL4B;ERCC2
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.4888632404563615,-1.8075470895659995,0.0,0.049646754490728216,0.746,19/36,15.92%,MACF1;CDK6;CLASP1;PTK2B;JUP;UTRN;CORO1C;SLK;PEAK1;ROCK2;MINK1;RASA1;NF1;ROCK1;NF2;TSC1;GSK3B;VCL;SLC9A1
gsea,neutrophil chemotaxis (GO:0030593),0.5672378359420094,1.8075206921758205,0.0013605442176870747,0.012386179916652187,0.748,5/31,7.15%,PPIA;BSG;CCL3;XCL1;CCL4
gsea,negative regulation of cell-matrix adhesion (GO:0001953),-0.5489426187587447,-1.8061864475850433,0.0058823529411764705,0.04924679814982217,0.747,6/16,11.81%,CORO1C;RASA1;CLASP2;NF2;BCAS3;RCC2
gsea,neutrophil migration (GO:1990266),0.5598395444209604,1.805922940848785,0.0013531799729364006,0.012594686502883316,0.755,5/32,7.15%,PPIA;BSG;CCL3;XCL1;CCL4
gsea,apoptotic process (GO:0006915),0.406698417830204,1.8057460935396852,0.0,0.012553339725700512,0.755,52/126,34.02%,PPIA;FAM162A;VDAC1;PLSCR1;BAX;GAPDH;DDIT4;IFI27;MRPS30;DAP;GZMB;BAK1;IFNG;CASP3;NAE1;IFT57;HSPD1;CASP7;CD14;LTA;MELK;AKT1;ADORA2A;CASP1;FADD;ERCC3;TNFSF12;TRAIP;IL2RA;FAS;APP;DDX41;ELMO1;NLRP3;BID;NFKBIA;MYC;PDCD4;IRF1;IL1B;GADD45A;MCM2;TNFSF14;ERCC2;ZBTB16;PPP1R15A;TNFAIP1;BBC3;NSG1;CSRNP1;TNFRSF25;BNIP3
gsea,stress-activated protein kinase signaling cascade (GO:0031098),0.5846844219740629,1.803463875534464,0.007736943907156673,0.01278393893878371,0.761,2/17,0.29%,UBB;RPS27A
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7045838760135651,1.8021181243744857,0.014462809917355372,0.012924010501823633,0.768,15/30,12.22%,RPL15;RPL10;RPS27A;RPLP0;RPS2;RPS25;RPS17;RPS26;RPL23A;RPL14;RPL10A;RPL3;RPL7A;RPS6;RPL7
gsea,carboxylic acid metabolic process (GO:0019752),0.5737227112353,1.8001555274476,0.0034965034965034965,0.01309221366707409,0.778,5/17,18.15%,MIF;GSTO1;CARNMT1;GRHPR;PON3
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.609299634436456,1.7989373434984366,0.006048387096774193,0.013176103437546178,0.781,10/16,29.35%,UBB;RPS27A;RAD23B;GTF2H3;ERCC3;GTF2H2;GTF2H4;CHD1L;CUL4B;ERCC2
gsea,negative regulation of cytokine production (GO:0001818),0.43489960279586615,1.7979936458495764,0.0056657223796034,0.01322044822121431,0.784,39/89,38.03%,TMSB4X;C1QBP;TBX21;PIN1;RGCC;EZR;HMGB1;XCL1;PDCD1LG2;IFNG;CCR7;ANXA1;SELENOS;ZFP36;UBE2L6;TNFSF4;BCL3;IL10;CD33;PRNP;TLR4;IRAK3;PDCD4;ISG15;CX3CL1;ZC3H12A;LEF1;ABCD1;CACTIN;FCGR2B;SIRPA;AXL;ACOD1;GHSR;HDAC9;SLC11A1;APPL2;PTPN6;FN1
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.40466115372729106,1.794213855802353,0.0018867924528301887,0.013674995391088976,0.793,54/168,21.34%,PSMB2;ELOC;PSMA3;PSMA5;PSMA4;TBX21;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;AURKB;BUB3;MAD2L1;IFI27;PSMD11;PSMB6;RNF5;PSMA6;NSFL1C;PSMC2;COPS3;UBE2C;PSMD12;RNF126;PSMB7;CTNNB1;ANAPC15;PSMC6;ADRM1;PSMD7;PSMD3;HERPUD1;RAD23B;CDC20;KCTD13;PSMD2;PSMD1;PLAA;RNF130;PSMC5;UBE2L6;PSME3;CDC23;UBXN2B;CDC16;MTA1;PSMC1;RAD23A;PLK1;XBP1;FBXL14;NUB1
gsea,positive regulation of ion transport (GO:0043270),0.5434348367928051,1.7934682390909913,0.00909090909090909,0.013702367923957046,0.796,6/22,9.88%,CCL3;VAMP8;ORAI1;CCL4;ACTN2;VAMP7
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.48185509401608356,1.79342023372522,0.001937984496124031,0.01364809479844277,0.797,20/56,21.04%,RPS27L;NPM1;VIM;EIF6;PERP;EZR;EIF4A3;HNRNPD;HDAC2;BAK1;METTL5;AKT1;ATG10;BCL3;EIF3D;FADD;PYM1;PLK1;RPL5;EEF2
gsea,RNA catabolic process (GO:0006401),0.5298849651626256,1.7905541366219213,0.0019880715705765406,0.013904223941396152,0.8,10/31,18.44%,LSM2;RNASEH2B;HNRNPD;FEN1;RIDA;EXOSC7;RNASEH1;ZFP36;NCBP1;CNOT10
gsea,histone monoubiquitination (GO:0010390),-0.6158911859068368,-1.7879811113469761,0.0019305019305019305,0.05664216478723615,0.798,8/15,15.66%,ATXN7L3;CDC73;BCOR;KDM2B;RNF168;RNF40;CTR9;DDB1
gsea,zymogen activation (GO:0031638),0.6461223492153751,1.7872574008495161,0.004559270516717325,0.014291104452914314,0.809,6/15,18.65%,PGK1;PERP;BAK1;FADD;RIPK2;CTSL
gsea,interstrand cross-link repair (GO:0036297),0.5081260857533055,1.7856137302534456,0.009765625,0.014452491803405413,0.812,7/41,9.35%,UBB;RPS27A;RPA3;RPA2;FANCL;UBE2T;RAD51
gsea,termination of RNA polymerase II transcription (GO:0006369),0.5900281381842611,1.7824479559891835,0.008298755186721992,0.014956169111685137,0.82,10/21,18.46%,SNRPE;SNRPF;SNRPD3;SLBP;SNRPB;CPSF3;NCBP2;NCBP1;CSTF1;CPSF2
gsea,DNA duplex unwinding (GO:0032508),0.5086946323538745,1.7811525041469174,0.005905511811023622,0.015071198383688643,0.827,18/38,29.35%,UBB;RPS27A;HMGA1;MCM4;MCM6;ANXA1;RAD51;RAD23B;GTF2H3;ERCC3;MCM7;DDX1;GTF2H2;GTF2H4;CHD1L;CUL4B;MCM2;ERCC2
gsea,negative regulation of mitochondrion organization (GO:0010823),0.5677967994882119,1.7801654333250132,0.0019120458891013384,0.015189929102165418,0.836,6/19,11.57%,SLC25A5;PRELID1;PPIF;GPX1;FXN;AKT1
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4929430106480273,1.7762882451239803,0.0,0.01575857534622223,0.846,24/46,33.86%,UBB;RPS27A;RPA3;RFC5;RFC4;RPA2;FEN1;POLD2;RFC3;GTF2H3;ERCC3;MUS81;DDX1;DXO;GTF2H2;GTF2H4;CHD1L;OGG1;CUL4B;ERCC2;ZC3H12A;ENPP1;GTF2H1;PCNA
gsea,tRNA processing (GO:0008033),0.49487640307866343,1.7758423636555996,0.00796812749003984,0.01573920639913985,0.849,22/42,30.37%,SSB;ELP5;THG1L;POP5;RPP30;TRMT6;TRDMT1;TYW5;TSEN15;DDX1;ELAC2;TRMT10C;NSUN2;TRMT1;DTWD1;THUMPD1;CPSF4;TRUB1;CTU2;TRMT61A;RPP40;CSTF2
gsea,DNA metabolic process (GO:0006259),0.4297366209505278,1.7746899850096705,0.007462686567164179,0.015844467384088942,0.849,83/204,31.54%,UBB;RAN;RPS27A;UBE2N;CNBP;RPA3;NPM1;PTGES3;RFC5;CDK1;DCTPP1;ORC6;TYMS;RFC4;NSMCE4A;KPNA2;HMGB1;UBE2V2;TSN;RPA2;HMGB3;CDK2;FEN1;MCM4;HMGB2;SMARCB1;MCM6;FANCL;SAMHD1;CDC45;APEX1;ASF1A;TDP1;GMNN;UBE2T;NUDT1;POLD2;RAD51;SP100;RNASEH1;RFC3;GTF2H3;ENDOG;UNG;ERCC3;AXIN2;ORC2;MCM7;RAD1;MUS81;TRIM28;POLE2;CDT1;HELLS;PRIM2;EXO1;RAD51D;POLE3;MEN1;MGMT;XRCC1;TIMELESS;TOP1MT;RAD17;ORC5;RAD51C;TERF2IP;PARK7;MCM3;PARP3;PARP2;GTF2H4;RMI2;CHD1L;OGG1;GADD45A;MCM2;RPAIN;LRWD1;FANCG;RAD51AP1;NEIL1;DBF4
gsea,protein phosphorylation (GO:0006468),-0.3542765146828009,-1.7744242875950438,0.0,0.062307265056953484,0.826,129/229,37.30%,WNK1;BIRC6;CDK6;MAP3K1;RUNX3;GRK2;RPS6KA3;TAOK2;HIPK1;TAOK1;PTK2B;BAZ1B;MAP3K5;MAST2;AAK1;SMAD7;HIPK3;BCR;DYRK1A;LMTK2;ATP13A2;BMP2K;TAF1;ULK2;EIF2AK3;MAST3;ERN1;CIT;SLK;JAK2;PEAK1;ROCK2;SNRK;MAP3K11;MINK1;TNIK;ATR;TYK2;PRKDC;TEC;BRD2;ROCK1;CDK12;CSNK1G1;ABL1;ILF3;CAD;ABI3;GSK3B;LIMK1;CREB1;SIK2;LATS1;MAPK8;PRKD2;PRKCA;RICTOR;GRK5;CDKL2;TXK;MAST4;IKBKE;PAK6;CAMK2D;FAM20B;TBCK;MAP3K3;WNT11;LMTK3;RIPK1;ERC1;STK10;CDK19;USP15;PIK3CD;TRIB2;PDGFB;MAPKAPK2;FAM20A;HIPK2;LATS2;ULK1;RARA;GAS6;CDK14;OXSR1;MAST1;EIF2AK2;MAP3K13;EEF2K;DYRK2;ACVR1;PDPK1;EIF2AK4;PDK1;RPS6KA5;STK38L;CLK2;MAP3K7;TGFBR3;NLK;CHUK;PRKCE;TRIB1;KIT;PASK;ABI2;DAB2IP;CAMKK2;CSNK2A2;NEK1;HUNK;FES;COQ8B;CDKL3;CSF1R;MASTL;PAK1;CHEK2;FLT1;CLSPN;LYN;MATK;MAP4K4;PIM1;TTBK2;DAPK2;HASPIN;CSNK1E
gsea,regulation of viral genome replication (GO:0045069),0.4706521546422013,1.7741473671030468,0.001876172607879925,0.01588458555401766,0.851,13/40,29.86%,PPIA;BANF1;PLSCR1;PPIH;BST2;PPIE;TMEM39A;RAD23A;PPID;TARBP2;SRPK1;ISG15;OAS3
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6199964718285416,1.7718691379086002,0.011013215859030838,0.016175835073393402,0.858,6/15,13.20%,SUB1;MED30;PSMC4;PSMC2;PSMC6;PSMC5
gsea,regulation of telomerase activity (GO:0051972),0.5641716586330584,1.771139579746302,0.009140767824497258,0.01623703279247812,0.86,15/27,34.10%,PTGES3;TCP1;CCT4;CCT2;AURKB;CTNNB1;HSP90AB1;NAF1;MEN1;NEK2;MYC;PINX1;NEK7;PKIB;DKC1
gsea,protein homooligomerization (GO:0051260),0.4755432933473227,1.7695100113978621,0.004885993485342019,0.01640202916082271,0.861,24/57,24.49%,MIF;ALDOA;TK1;PRMT1;SOD2;SHMT2;ALDH9A1;THG1L;SAMHD1;APIP;ALAD;LETM1;CBY1;FUS;TRMT61B;SHMT1;EHD4;ALDH1A3;TMEM120A;SIGMAR1;NINJ1;SLC1A5;HSD17B10;EHD3
gsea,cellular protein-containing complex assembly (GO:0034622),0.44721858476049586,1.7686715950236485,0.0017985611510791368,0.016439228491497575,0.862,25/79,21.64%,CENPW;HIGD1A;PTGES3;CENPA;TCP1;CCT2;HOPX;VAMP8;PSMD11;PSMG1;VBP1;CHCHD4;HSPD1;ADRM1;HSP90AB1;DNAAF2;IMMP2L;SAMM50;PSMG2;NCK2;MID1IP1;NDUFAF1;USH1C;SGIP1;ARL2
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),0.647197273904941,1.7676941171859206,0.0031496062992125984,0.01649861654833388,0.862,9/16,20.35%,TNFRSF4;PHB2;XCL1;PHB;SCIMP;CD86;TNFSF4;IL21;XBP1
gsea,receptor-mediated endocytosis (GO:0006898),-0.4110942265428278,-1.7663806087828058,0.0,0.06528250589156676,0.839,29/68,32.89%,HIP1R;GRK2;ITGAM;AP2A2;PICALM;AP2B1;NEDD4;DNAJC13;IGF2R;CLTC;TFRC;AP1G1;PIP5K1C;HYOU1;GAK;LRP6;LDLR;FCHSD2;CALCRL;ARHGAP27;AP4E1;HSPH1;CLN3;DLL1;CTTN;ITGB1;APOE;CALR;PIKFYVE
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.557210033126268,1.7660446515595254,0.00808080808080808,0.016669521919696218,0.867,14/25,22.46%,LSM2;LSM3;EXOSC3;EXOSC8;EXOSC9;EXOSC5;EXOSC7;EXOSC1;LSM7;ZFP36;EXOSC4;CNOT10;HBS1L;CNOT9
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.6164918307723837,-1.7620591114472084,0.014256619144602852,0.06668082614849602,0.849,6/15,14.54%,CDC73;RECQL5;RNF168;CDK12;EAF1;HEXIM1
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5673981264201455,1.7615631060509647,0.0057361376673040155,0.017365553878228857,0.873,5/20,15.10%,HINT1;RPS27L;DDIT4;TMEM109;BCL3
gsea,endomembrane system organization (GO:0010256),-0.3899050023398117,-1.7603888177635085,0.0,0.06671349052562225,0.853,56/97,31.42%,HUWE1;ARFGEF1;GOLGB1;HTT;CLASP1;ATP8B2;SPTBN1;DNAJC13;SYNE1;SYNGR1;LEMD3;NUP155;SUN2;HOOK3;SEC16A;EIF2AK3;COG3;SMPD4;LAPTM4B;CLASP2;PLEKHM2;ATL3;MIA3;BCAS3;ALS2CL;VPS11;GAK;AP3D1;DYNC2H1;SEC31A;ATP8B4;SEC61A1;OPTN;VPS18;DOP1B;ATL2;ARFGEF2;WASHC4;LMAN2L;TRAPPC11;EXOC8;LNPK;NPLOC4;RAB30;ARHGAP21;HOOK1;FBXW8;TRAPPC12;GOLGA2;ALS2;BNIP1;CUL7;SEC23IP;NUP93;MYO18A;SYP
gsea,positive regulation of protein catabolic process (GO:0045732),-0.45798988687759834,-1.7573179634555645,0.0027472527472527475,0.06726095821263849,0.856,24/41,33.09%,HUWE1;IDE;VCP;NEDD4;AREL1;TNFAIP3;FOXO1;VPS11;BARD1;GSK3B;FZR1;HECW1;FAF1;TIPARP;DDB1;ADAM9;PLK3;ADAM8;NSF;DTL;PACSIN3;APOE;DAB2IP;SH3D19
gsea,epidermis development (GO:0008544),0.5993181951302837,1.7541673406255902,0.0026702269692923898,0.018584854916104333,0.89,6/22,13.66%,HDAC1;YBX1;FABP5;HDAC2;OVOL2;LAMC2
gsea,lysosome localization (GO:0032418),-0.5368829420137428,-1.7521237400343868,0.01639344262295082,0.06866828059207952,0.863,9/20,19.25%,MYH9;NR4A3;TFEB;PLEKHM2;PIK3CG;KIF5B;FAM98A;PLEKHM1;PIK3CD
gsea,histone H3 acetylation (GO:0043966),-0.5096187576123837,-1.751438004528274,0.004366812227074236,0.0680053912006465,0.865,16/26,29.05%,BRPF1;KAT6A;JADE2;KAT14;KAT6B;BRCA2;ING5;KAT2B;BRPF3;YEATS2;TAF6L;JADE1;PER1;SPI1;KAT2A;MAP3K7
gsea,negative regulation of cell junction assembly (GO:1901889),-0.5572061070390342,-1.7502800752924357,0.02849002849002849,0.0674804899253408,0.867,6/15,11.81%,CORO1C;ROCK2;CLASP2;ROCK1;BCAS3;RCC2
gsea,prostaglandin metabolic process (GO:0006693),0.6279341500971812,1.7493751363673633,0.004322766570605188,0.019387220256357873,0.905,4/15,12.29%,MIF;PTGES3;PTGR2;PLAA
gsea,positive regulation of actin filament bundle assembly (GO:0032233),0.5451767462304782,1.747707002274405,0.005934718100890208,0.019632124956686203,0.908,8/28,20.48%,PFN1;S100A10;RGCC;RHOC;EVL;PLEK;PFN2;TPM1
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.6585472308868279,1.7470976985430378,0.015238095238095238,0.019637962618075818,0.909,7/15,23.76%,CDK4;NPM1;CDK1;CCNB1;DYRK3;FBXO5;RAD51C
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),-0.49679692586937063,-1.7455402380154634,0.003968253968253968,0.06888326923053265,0.873,9/23,19.38%,PTK2B;DYRK1A;JAK2;TEC;ABL1;ABI3;PIBF1;TXK;PDGFB
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4949477399663903,-1.7452308142012818,0.013550135501355014,0.06790215304217007,0.875,11/24,24.17%,STAT3;ETS1;SMARCA4;JUN;NR3C1;FOXO3;FOSL1;PDGFB;SMAD3;GNL3;SPI1
gsea,regulation of cell population proliferation (GO:0042127),0.36656421883783336,1.7445362095930814,0.0,0.020028668671142575,0.912,132/339,38.59%,SLC25A5;CNBP;CDK4;COX17;S100A11;NPM1;NME1;EEF1E1;RBBP4;HDAC1;PRDX3;JUNB;HILPDA;ID2;TSPAN31;TIPIN;RGCC;BIRC5;PRMT1;IGFBP7;SOD2;NAP1L1;HMGA1;DNAJA2;JUND;HDAC2;CDK2;CDC123;HMGB2;IFNG;PHB;NUP62;TESC;ZFP36L1;RNF126;CDKN2C;EZH2;FXN;CTNNB1;BST1;CDKN2D;GTPBP4;RPS6;IL7R;DERL2;CDCA7;DUSP22;HMGN5;AKT1;TBRG1;PRKRA;CDKN3;CD86;LAMC2;ITGAX;CIAO1;IL12RB2;ASH2L;NCK2;TNFSF4;WDR77;OSM;RELA;KLF10;UFL1;SGK1;DHPS;AXIN2;GSDME;PDGFA;SLC25A33;IER5;APP;IL21;XBP1;FBXO5;MEN1;TBRG4;OSR2;HRAS;TIMELESS;CXCL10;CAMK2N1;TFAP4;HHEX;CTSH;IL10;PIM2;P3H3;CD33;LMNA;VDR;SHCBP1;MYC;GCNT2;TNFRSF9;IRF1;NUDT6;PINX1;IL1B;CX3CL1;HCK;NAMPT;SAPCD2;SINHCAF;SIX3;CD81;LEF1;ENG;P3H2;LIF;BAMBI;FGF2;SH3BP4;TOB1;DLL4;WWTR1;RBFOX2;VEGFA;P3H1;CBFA2T3;PLPP1;DNAJA3;IL2;TGFA;NUPR1;TIMP1;PTPN6;FN1;WNT1;CDC6;RPRD1B
gsea,inner mitochondrial membrane organization (GO:0007007),0.5854134118656905,1.743676361524441,0.01002004008016032,0.020085187958487117,0.914,13/19,30.07%,MTX2;APOO;TIMM8B;MTX1;LETM1;IMMT;SAMM50;TIMM10;HSPA9;AGK;CHCHD6;SPG7;TIMM9
gsea,histone H4 acetylation (GO:0043967),-0.5047641251541466,-1.7426424029043606,0.008113590263691683,0.06851311984889126,0.883,15/32,24.61%,KMT2A;EP300;TRRAP;HCFC1;EP400;JADE2;BRCA2;MSL1;ZZZ3;BRD8;ING5;JADE1;PER1;PHF20;APBB1
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5707047279486926,1.741149634238842,0.007380073800738007,0.02046241493711702,0.917,6/23,6.31%,MAGOH;HNRNPA1;SMU1;RBM8A;SRSF6;PTBP1
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.4514079999524022,1.7394477409227969,0.0,0.02067675647711217,0.918,27/67,18.13%,PSMB2;PSMA3;PSMA5;PSMA4;PSME2;PIN1;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;PSMB7;PSMC6;PSMD7;PSMD3;PSMD2;ZBED3;PSMD1;PSMC5;PSME3;AXIN2;DEPDC1B;PSMC1
gsea,positive regulation of microtubule polymerization (GO:0031116),-0.5762171548805095,-1.7384316809242937,0.009153318077803204,0.06996599507507541,0.89,7/15,10.33%,CLASP1;DCTN1;TOGARAM1;NUMA1;CDK5RAP2;CKAP5;CLIP1
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.48618198821236963,-1.7377774164614808,0.013123359580052493,0.06918665050803642,0.892,11/25,24.17%,STAT3;ETS1;SMARCA4;JUN;NR3C1;FOXO3;FOSL1;PDGFB;SMAD3;GNL3;SPI1
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5331884508386142,-1.7372601406917927,0.004524886877828055,0.06827515580358028,0.893,11/23,18.26%,PADI2;ARID1A;NEDD4;UBR5;TRERF1;SAFB;ZMIZ1;MED1;NR3C1;KDM3A;PMEPA1
gsea,regulation of actin filament bundle assembly (GO:0032231),0.5996524281823181,1.7359320468311243,0.006024096385542169,0.021388957095629994,0.924,2/19,0.45%,PFN1;ACTG1
gsea,regulation of response to DNA damage stimulus (GO:2001020),0.5563074196278706,1.735251617757591,0.007692307692307693,0.021469378522197123,0.926,10/24,26.87%,UBE2N;NSMCE1;NSMCE4A;UBE2V2;RPA2;WRNIP1;USP1;FBXO5;CRY1;MYC
gsea,vascular transport (GO:0010232),-0.4353864706495428,-1.729314624686784,0.0056022408963585435,0.07184767552757629,0.905,20/40,24.15%,ABCA2;SLC38A2;SLC7A1;TFRC;SLC5A3;ATP2B4;SLC16A1;ATP2A3;SLC44A1;ABCC1;ABCC5;ABCC4;SLC12A2;SLCO3A1;ABCG2;SLC7A5;SLC4A8;SLC38A1;SLC27A1;ATP8A1
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.6110781945169333,1.7292713612721218,0.0036101083032490976,0.02276273823209538,0.934,6/16,15.84%,PPIA;EZR;DUSP19;DUSP1;DUSP10;DUSP3
gsea,monocarboxylic acid metabolic process (GO:0032787),0.4191956728251732,1.7275251478767146,0.0031645569620253164,0.023050115659592234,0.934,26/61,36.00%,VDAC1;BSG;LDHA;PDZD11;AASDHPPT;ME2;GATM;ALKBH7;DLD;MSMO1;MECR;GRHPR;SCPEP1;PDHA1;UGT1A9;ALDH1A3;SLC16A3;ACADSB;CD36;MCCC2;GNPAT;ECHDC3;ALDH4A1;CKB;CYP2S1;GBA2
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.584903382027058,1.726437606956312,0.006329113924050633,0.023199604367227875,0.935,4/18,15.71%,UBB;RPS27A;CD14;FADD
gsea,amyloid fibril formation (GO:1990000),0.5666177381971398,1.7256087984840116,0.0030911901081916537,0.02330993717122443,0.939,9/21,29.34%,UBB;RPS27A;CST3;UBE2L6;TSPAN5;APP;RIPK3;CD36;MFGE8
gsea,central nervous system development (GO:0007417),-0.3739212917736503,-1.7253238191742073,0.0,0.07308609309394513,0.908,38/93,27.43%,ATXN1;STAT3;CHD7;CHD8;BPTF;RPS6KA3;ITGAM;ADGRG1;ARNT2;CIC;AHI1;NCKAP1;ATN1;NF1;JARID2;CDK5RAP2;NCOA6;DHX30;ANKLE2;PTCH1;DHX37;EML1;SOX10;SETD1A;EIF2B5;PTPN11;TBC1D23;EGR2;C1QA;POMK;MAST1;CXCR4;SOX4;SYNJ1;DLL1;MARCKS;ABCB6;EOMES
gsea,regulation of cellular localization (GO:0060341),-0.49808784143748763,-1.7241640481474807,0.007894736842105263,0.07266799231163995,0.909,10/23,22.12%,DYNC1H1;MAP2;NUMA1;SPAG5;TTL;CAMK2D;DVL3;MAD1L1;TRIM46;DVL1
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.48944332639765453,1.721558843798593,0.001639344262295082,0.024172727688946336,0.939,19/41,26.70%,HNRNPF;HNRNPA1;POLR2C;POLR2H;PTBP1;ZFP36L1;POLR2L;NCBP2;POLR2E;ZFP36;GTF2F2;NCBP1;NR4A1;HNRNPM;SHOC2;HYAL2;POLR2F;SHCBP1;POLR2B
gsea,regulation of T cell differentiation (GO:0045580),0.5335129373807451,1.720479983729547,0.012096774193548387,0.024345635043677278,0.942,9/23,24.05%,CTLA4;TBX21;PRELID1;IFNG;TNFRSF18;CLPTM1;IL2RA;XBP1;TCF7
gsea,regulation of protein dephosphorylation (GO:0035304),0.5527767868083806,1.719703182978666,0.008350730688935281,0.02447965202265157,0.943,5/21,6.31%,PPIA;CALM2;PIN1;TIPRL;PTBP1
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),0.5701953063727384,1.7191507286627248,0.01727447216890595,0.024500316530901636,0.943,6/17,20.36%,TPT1;MIF;DDX39B;CDKN2D;THOC5;FBXO5
gsea,brain development (GO:0007420),-0.41348030607881786,-1.7177537363352293,0.0,0.07518360884039402,0.916,24/54,27.43%,ATXN1;CHD8;BPTF;ADGRG1;ARNT2;CIC;RAPGEF2;CENPF;NF1;CDK5RAP2;NCOA6;PTCH1;DHX37;EML1;SETD1A;PTPN11;TBC1D23;EGR2;POMK;MAST1;CXCR4;SYNJ1;ABCB6;EOMES
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4542901521085212,1.7165556175983894,0.0014367816091954023,0.025101201425845075,0.946,28/77,37.44%,PPIA;UBB;RPS27A;UBE2N;NPM1;PRDX3;PSMA6;NFKBIB;RELA;RIPK2;APP;RHEBL1;CD40LG;TERF2IP;NLRP3;NFKBIA;TLR4;IRAK3;RIPK3;CD36;IL1B;CX3CL1;TNFSF11;SPHK1;CD40;TRAF2;TRAF5;FLOT1
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5944451334522219,1.7149975217682008,0.006420545746388443,0.02544981145807997,0.949,4/17,15.71%,UBB;RPS27A;CD14;FADD
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.42258772096642266,1.7122239594643676,0.0035335689045936395,0.026013924929506438,0.95,19/59,28.10%,CYCS;RPS27L;HSPE1;FAM162A;BAX;ANP32B;RACK1;DAP;HMGB1;IFT57;HSPD1;HTRA2;CASP1;FADD;FAS;NLRP3;BID;MYC;PRR7
gsea,positive regulation of histone methylation (GO:0031062),-0.6143613691077034,-1.7105290163451343,0.009501187648456057,0.07834003066034105,0.926,7/15,14.27%,KMT2A;RIF1;JARID2;DNMT1;BRCA1;PHF19;CTR9
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.4103808786844914,1.710439546918579,0.0030303030303030303,0.0263852916999863,0.952,31/108,18.13%,PSMB2;PSMA3;PSMA5;HDAC1;PSMA4;PSME2;PIN1;PSMD6;PSMB5;PSMD14;PSMC4;PSMD11;PSMB6;PSMA6;PSMC2;PSMD12;FRMD8;PSMB7;CTNNB1;PSMC6;PSMD7;PSMD3;PSMD2;ZBED3;PSMD1;PSMC5;TMEM64;PSME3;AXIN2;DKKL1;PSMC1
gsea,nervous system development (GO:0007399),-0.3353391712696076,-1.7092037408799117,0.0,0.07804365469505717,0.927,56/137,37.40%,ATXN1;STAT3;CHD7;EP300;RPS6KA3;DPYSL2;SREBF2;ARNT2;DSCAM;ZEB2;DCTN1;DYRK1A;FARP1;APAF1;PLXND1;AHI1;NLGN2;ST8SIA4;HDAC4;NCKAP1;ATN1;NF1;MTR;JARID2;CDK5RAP2;WDR62;NOTCH2;DHX30;ARHGAP26;CDH1;ANKLE2;LIMK1;SOX10;PMP22;EFNB3;GDF11;EGR2;LRCH4;DVL1;KALRN;CXCR4;SPOCK2;TRAK1;MARCKS;PPP2R5D;SMPD1;MEF2C;ERCC6;ECT2;IL3;IGF2BP2;GSN;YAP1;STIL;CRIM1;WWP1
gsea,"transcription, DNA-templated (GO:0006351)",0.40242427298493516,1.707616421807797,0.0,0.02695815628918417,0.955,54/124,31.28%,BTF3;ELOC;PTMA;POLR3K;POLR2C;TFDP1;SMN1;GTF2E2;TAF1B;POLR2H;DRG1;MLF1;POLR3H;TFAM;COPS2;TBP;NFKBIB;POLR2L;NCBP2;POLR2E;GTF2H3;GTF2F2;NCBP1;PPP5C;IRF9;BCL3;GTF3A;RNPS1;E2F1;ERCC3;CDK7;SLC25A33;PRMT5;TAF9;POLR1C;MRPL12;TAF15;CCNK;PMF1;POLR3GL;XBP1;NR4A2;TEFM;GTF2H2;POLR2F;GTF2H4;TRIP13;POLR2B;THRB;RNMT;ERCC2;LEO1;BRF2;SSRP1
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.4499645787613592,1.7073575444983988,0.001953125,0.02693266139612347,0.955,18/47,21.04%,RPS27L;NPM1;VIM;EIF6;RACK1;EIF4A3;HNRNPD;IFNG;CASP3;GSAP;METTL5;RELA;BCL3;EIF3D;TNFRSF1A;PYM1;RPL5;EEF2
gsea,integrin-mediated signaling pathway (GO:0007229),-0.44450226955890726,-1.7065793405244685,0.01646090534979424,0.07874314967951991,0.928,20/36,30.69%,MYH9;NEDD9;CDH17;ERBIN;PTK2B;ITGB3;TEC;CUL3;NRP1;ABL1;RCC2;ITGB8;TXK;CEACAM1;ADAM9;SEMA7A;BCAR1;ITGB4;FBLN1;ITGB1
gsea,stress-activated MAPK cascade (GO:0051403),0.501335843628939,1.7045528287496878,0.005208333333333333,0.027560168113770777,0.958,8/30,18.34%,UBB;RPS27A;UBE2N;ZFP36L1;MAP2K3;ZFP36;RIPK2;MAP3K8
gsea,nuclear membrane reassembly (GO:0031468),0.5481834244092163,1.7038735551204025,0.010351966873706004,0.02768214988155882,0.958,13/32,16.10%,RAN;BANF1;CCNB2;CDK1;REEP4;NSFL1C;NUP43;NUP37;RCC1;VRK1;SEH1L;CCNB1;UBXN2B
gsea,response to metal ion (GO:0010038),0.49502269615143424,1.7015349725026647,0.008896797153024912,0.02820175959907258,0.959,6/29,14.26%,CRIP1;CALM2;PLSCR1;PPP2CB;FXN;PPP5C
gsea,regulation of cellular component organization (GO:0051128),-0.4039694093137519,-1.6985475418979292,0.0,0.08249534266340267,0.939,37/75,32.41%,RAPGEF1;MKI67;HIP1R;TAOK2;PICALM;HCFC1;NEDD4;HIP1;RAPGEF2;TFRC;RPTOR;BAP1;ROCK2;NCLN;ROCK1;HJURP;ABL1;TSC2;LATS1;MLLT3;CAMK2D;ZFYVE16;CEACAM1;SETD1A;PTPN11;KIF14;ERMN;CAMSAP2;ARHGEF11;STK38L;BCAR1;PACSIN3;RUFY1;APOE;TJP1;DAB2IP;HNRNPU
gsea,telomere maintenance via telomerase (GO:0007004),0.5490038409904381,1.6949079591075213,0.017475728155339806,0.029900815554619896,0.967,6/23,12.26%,NOP10;PTGES3;GAR1;NHP2;CDK2;HSP90AB1
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3834692316820959,-1.6924992206052691,0.0,0.08577884367772602,0.945,37/68,31.56%,PREX1;MYO9B;SRGAP3;ABR;BCR;ARHGDIA;ARHGAP35;ARHGEF12;FOXM1;ARHGAP26;SRGAP2;ARHGEF18;ARHGAP11A;ARAP2;VAV2;SOS1;SOS2;ARAP1;ARHGAP10;ARHGAP39;RHOQ;ARHGEF2;TIAM1;ARHGAP31;KALRN;ARHGAP21;RHOT2;MYO9A;ARHGEF11;ARHGAP5;SYDE2;RASGRF1;CHN2;ARHGEF5;FGD3;FGD2;ECT2
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),-0.46882364607835725,-1.6896247886279232,0.015384615384615385,0.0864469677096283,0.947,13/26,27.74%,CBL;ERBIN;PTK2B;PIK3CA;PLCG1;PIK3C2A;SOS1;PTPN11;DGKD;ADAM17;PDPK1;RPS6KA5;BCAR1
gsea,positive regulation of intracellular transport (GO:0032388),-0.5514397024911685,-1.6877399774901836,0.010822510822510822,0.0866187186440827,0.949,12/18,23.66%,DYNC1H1;NEDD4;NUMA1;PCNT;BCAS3;ICE1;SPAG5;PCM1;KIF20B;PGAP1;PRR5L;PLK3
gsea,positive regulation of interleukin-12 production (GO:0032735),0.631356555525998,1.6819372877846748,0.009900990099009901,0.03375370391378803,0.979,9/17,17.29%,HMGB1;LTB;IFNG;CCR7;IRF5;HSPD1;SCIMP;TNFSF4;RIPK2
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5767807469551125,1.6809262578567763,0.011650485436893204,0.033967218364241096,0.98,6/19,12.06%,EXOSC3;EXOSC8;NOP9;EXOSC9;EXOSC7;WDR12
gsea,7-methylguanosine mRNA capping (GO:0006370),0.5585222072807976,1.6783203116798617,0.0,0.03455179184980108,0.982,16/20,29.35%,POLR2C;POLR2H;POLR2L;NCBP2;POLR2E;GTF2H3;GTF2F2;NCBP1;ERCC3;CDK7;GTF2H2;POLR2F;GTF2H4;POLR2B;RNMT;ERCC2
gsea,7-methylguanosine RNA capping (GO:0009452),0.5585222072807976,1.6783203116798617,0.0,0.03455179184980108,0.982,16/20,29.35%,POLR2C;POLR2H;POLR2L;NCBP2;POLR2E;GTF2H3;GTF2F2;NCBP1;ERCC3;CDK7;GTF2H2;POLR2F;GTF2H4;POLR2B;RNMT;ERCC2
gsea,positive regulation of TOR signaling (GO:0032008),-0.542204152722367,-1.6764347846307723,0.020242914979757085,0.09277156645217394,0.957,10/16,23.49%,PIK3CA;RPTOR;TELO2;WDR24;SLC38A9;RICTOR;SMCR8;KLHL22;GAS6;RRAGB
gsea,epithelium development (GO:0060429),0.42639147929589805,1.6756280551809584,0.0051813471502590676,0.03522903219552154,0.985,20/44,35.50%,TAGLN2;VDAC1;PGK1;CDK1;ANXA7;BDH2;CNN3;DHRS9;LGALS3;DNPH1;PIH1D1;TIMELESS;ALDOC;PTER;GSTK1;MFSD2A;VIL1;PCNA;VEGFA;CBR1
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.47859570115057537,1.6754708067672162,0.013793103448275862,0.03517913827712131,0.985,4/30,3.85%,UBB;RPS27A;PIN1;STRAP
gsea,positive regulation of programmed cell death (GO:0043068),0.3598818104814372,1.6733590559686355,0.0,0.03568118514495971,0.985,48/154,34.16%,UBB;RPS27A;C1QBP;FAM162A;EEF1E1;CTLA4;MTCH2;BAX;TNFAIP8;DNAJA1;RACK1;HMGB1;UTP11;BAK1;IFNG;CASP3;PSEN2;IRF5;CTNNB1;HSPD1;RPS6;HTRA2;MELK;GADD45B;ZBP1;RNPS1;E2F1;FADD;ERCC3;DKKL1;PHLDA1;FAS;PPID;ITGB3BP;TFAP4;DUSP6;ATG7;BID;PRR7;GADD45A;GADD45G;SYK;ARHGEF9;TGM2;TCTN3;RRP1B;BNIP3;MLLT11
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5051290646881679,1.6730261322631763,0.020676691729323307,0.03566513915683728,0.985,15/30,26.70%,HNRNPF;HNRNPA1;POLR2C;POLR2H;PTBP1;POLR2L;NCBP2;POLR2E;GTF2F2;NCBP1;HNRNPM;SHOC2;POLR2F;SHCBP1;POLR2B
gsea,centromere complex assembly (GO:0034508),0.5666920303127823,1.6724945134872005,0.01680672268907563,0.03566474387918625,0.986,16/32,24.14%,NPM1;CENPW;RBBP4;CENPA;RBBP7;MIS18A;NASP;CENPV;OIP5;CENPU;CENPQ;HELLS;CENPK;ITGB3BP;CENPN;CENPH
gsea,regulation of regulatory T cell differentiation (GO:0045589),0.5751541143918385,1.671107970869826,0.030476190476190476,0.03598565181875074,0.986,8/17,21.84%,CTLA4;SOCS1;IFNG;TNFRSF18;TNFSF4;DUSP10;IL2RA;IL4I1
gsea,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5713687096793946,-1.6696456009710794,0.024742268041237112,0.09624968540001563,0.957,5/15,7.20%,EP300;NOTCH1;CHD6;RUNX2;ATF4
gsea,protein destabilization (GO:0031648),-0.5458942438454688,-1.6667189969075742,0.01293103448275862,0.09715594967454054,0.957,6/18,8.91%,EP300;CREBBP;HTT;CDC73;CCDC88C;CUL3
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.44759237849103173,1.6663610920949692,0.018832391713747645,0.03740376108972058,0.988,27/60,28.51%,CDK4;RRM2;TFDP1;TYMS;EIF4E;CDK2;DHFR;CDC45;NASP;CDKN2C;CDKN2D;EIF4EBP1;RCC1;CDKN3;E2F1;CDK7;CDT1;TFDP2;BCAT1;FBXO5;GSPT1;PLK2;CCNE1;PIM2;CUL5;MYC;CUL4B
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.4381339143389713,1.6629410589507092,0.014705882352941176,0.038323830309715076,0.989,19/59,21.57%,CALM2;ACTB;CCNB2;BCCIP;CCND3;IFNG;DUSP19;CCNA2;CDKN2C;EZH2;CDKN2D;GTPBP4;AKT1;CDKN3;CCNB1;CDK7;CCNG1;CCNK;PIH1D1
gsea,ncRNA catabolic process (GO:0034661),0.547844034385028,1.6617563625640122,0.0189873417721519,0.038586276718572794,0.989,6/19,18.06%,EXOSC3;EXOSC8;EXOSC9;EXOSC5;EXOSC7;EXOSC4
gsea,cell-substrate junction assembly (GO:0007044),-0.5284774822665352,-1.6615171340584156,0.015625,0.09971921925295467,0.959,6/19,11.81%,PLEC;TAOK2;BCR;PEAK1;LAMC1;RCC2
gsea,maturation of 5.8S rRNA (GO:0000460),0.5958225608224985,1.6610910309585762,0.020637898686679174,0.03868656845178511,0.989,9/15,25.04%,EIF6;RRP15;RPF1;MPHOSPH6;WDR12;EXOSC4;LAS1L;MAK16;PES1
gsea,epidermal cell differentiation (GO:0009913),0.5457347591350826,1.6586636587900092,0.012658227848101266,0.039360698678267955,0.99,11/18,29.35%,HDAC1;HDAC2;CASP3;ANXA1;CTNNB1;OVOL2;ERCC3;KRT10;TXNIP;ST14;ERCC2
gsea,"base-excision repair, gap-filling (GO:0006287)",0.5808014158288178,1.6571778909044061,0.023668639053254437,0.039738257312905596,0.991,9/26,15.37%,RPA3;RFC5;RFC4;RPA2;FEN1;APEX1;POLD2;RFC3;UNG
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5101330469734509,1.6566022527234692,0.01890359168241966,0.03986761764968197,0.991,8/23,24.80%,UBE2N;RPS2;PIN1;DCUN1D1;BAG5;PLK1;FBXO5;PARK7
gsea,lipid homeostasis (GO:0055088),-0.46286124866204664,-1.6559180143398873,0.013262599469496022,0.10232274352866653,0.962,15/27,36.38%,ABCA2;DDX3X;ACOXL;ATP13A2;ZBTB20;IRS2;FBXW7;THADA;RCN3;APOE;ABCB4;SIRT1;ABCG1;ADCK1;LIPG
gsea,regulation of interleukin-12 production (GO:0032655),0.538846869736578,1.652990762585729,0.009641873278236915,0.04099035432460334,0.992,14/26,26.25%,C1QBP;HMGB1;LTB;IFNG;CCR7;IRF5;HSPD1;SCIMP;TNFSF4;RIPK2;CD40LG;IL10;TLR4;IRAK3
gsea,neural tube closure (GO:0001843),-0.49408006111373387,-1.6515728378445504,0.01991150442477876,0.10434674159135789,0.964,10/20,27.01%,SKI;KDM2B;TSC2;LRP6;DVL3;SCRIB;SEMA4C;DVL1;MTHFR;MTHFD1L
gsea,peptidyl-serine modification (GO:0018209),-0.3730454964659489,-1.6508675227038137,0.0,0.1035424619222801,0.965,43/89,29.52%,WNK1;GRK2;RPS6KA3;HIPK1;MAST2;HIPK3;DYRK1A;LMTK2;TAF1;ULK2;EIF2AK3;MAST3;ROCK2;ATR;PRKDC;ROCK1;CSNK1G1;GSK3B;LATS1;MAPK8;PRKD2;PRKCA;RICTOR;MAST4;IKBKE;CAMK2D;PDGFB;MAPKAPK2;HIPK2;LATS2;ULK1;GALNT1;GAS6;NAA10;MAST1;MAP3K13;NDNF;DYRK2;PDPK1;RPS6KA5;STK38L;CHUK;PRKCE
gsea,polyol metabolic process (GO:0019751),-0.5093514557868672,-1.6486411177255633,0.004796163069544364,0.1036928192205057,0.967,11/21,24.42%,ITPKB;SLC5A3;PLCG1;PLCG2;INPPL1;IP6K2;PLD4;IPMK;NUDT4;PPIP5K1;SYNJ1
gsea,protein modification process (GO:0036211),0.4590797399417722,1.6465633682849325,0.017985611510791366,0.04322776790911614,0.993,9/34,14.54%,ADPRH;UBE2S;UBE2M;SERP1;RPN2;DUSP12;SLC35A1;UBE2L6;ST3GAL6
gsea,mononuclear cell differentiation (GO:1903131),-0.5090565914423437,-1.645993638054781,0.014124293785310734,0.10440599438260323,0.967,6/15,36.13%,MYH9;IKZF1;GAS6;BATF3;CSF1R;LYN
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4879154642071748,-1.6418226589378724,0.020958083832335328,0.10655573414231713,0.967,7/15,23.89%,NEDD9;FBXW7;LRP8;PDGFB;GAS6;NCF1;ADAM17
gsea,positive regulation of signal transduction (GO:0009967),-0.33943049844788503,-1.6409939534311713,0.0,0.10590876259575475,0.967,54/119,38.19%,MACF1;FLNA;STAT3;EP300;CREBBP;HTT;SMARCA4;PTK2B;SKI;CDC73;NOTCH1;AAK1;ITGB3;ASXL1;PHIP;BMP2K;SLC39A14;ERN1;TNFAIP3;JAK2;NLGN2;ARNT;IL6ST;ZDHHC5;NRP1;ZMIZ1;TRIM44;ING5;PRKD2;PRKCA;CD80;KAT2B;JAG2;MGAT5;TRIM39;PTPN11;C1QTNF12;MAML2;HOMER1;GAS6;DLL1;GKAP1;GATA3;DAB2IP;RAB34;SIRT1;CTBP2;YAP1;NEPRO;SORBS1;HIF1A;MT3;LRRK2;TMEM108
gsea,protein acylation (GO:0043543),-0.49157739243649834,-1.640647170043714,0.019736842105263157,0.10497924515007875,0.967,16/24,26.60%,EP300;CREBBP;KAT6A;ZDHHC5;NAT10;FOXO1;ZDHHC8;ING5;ZDHHC21;NAT9;KAT2B;ZDHHC14;NAA10;CLOCK;HHAT;KAT2A
gsea,DNA replication (GO:0006260),0.4693218006956842,1.639465212896456,0.02734375,0.04581670825351512,0.995,35/89,24.89%,RPA3;DUT;CDK2AP1;TIPIN;PCLAF;RFC5;CDK1;ORC6;NAP1L1;RFC4;RPA2;CDK2;FEN1;MCM4;MCM6;SET;CDC45;POLD2;WRNIP1;DONSON;TBRG1;RFC3;ORC2;RHNO1;MCM7;RAD1;POLE2;EXO1;POLE3;TIMELESS;TOP1MT;RAD17;ORC5;GRWD1;MCM3
gsea,histone lysine demethylation (GO:0070076),-0.5251800981308047,-1.6394105863433115,0.02030456852791878,0.10476326763574459,0.968,12/20,25.59%,KDM6B;KDM3B;KDM2A;JMJD1C;KDM2B;KDM5B;PHF2;KDM3A;KDM7A;KDM4D;KDM5C;KDM4A
gsea,myelination (GO:0042552),-0.5092487530349602,-1.6390320099181068,0.015197568389057751,0.10387688750855655,0.968,9/18,23.31%,B4GALT5;SKI;NF1;MALL;SOX10;EIF2B5;PMP22;FAM126A;CXCR4
gsea,regulation of transport (GO:0051049),0.5764323543572133,1.638640009812105,0.023255813953488372,0.04599104227551264,0.995,4/17,10.33%,ACTG1;ACTB;DNAJA1;YRDC
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.541121506513726,1.6385052465635048,0.019148936170212766,0.045754798837970075,0.995,11/30,14.68%,RAN;BANF1;CCNB2;CDK1;REEP4;NUP43;NUP37;RCC1;VRK1;SEH1L;CCNB1
gsea,mitotic nuclear membrane organization (GO:0101024),0.541121506513726,1.6385052465635048,0.019148936170212766,0.045754798837970075,0.995,11/30,14.68%,RAN;BANF1;CCNB2;CDK1;REEP4;NUP43;NUP37;RCC1;VRK1;SEH1L;CCNB1
gsea,histone acetylation (GO:0016573),-0.42893741056576096,-1.6381533832316972,0.01910828025477707,0.10339972741475846,0.969,23/46,26.60%,EP300;TRRAP;CREBBP;EP400;BRPF1;KAT6A;JADE2;KAT14;KAT6B;BRCA2;ZZZ3;BRD8;ING5;KAT2B;BRPF3;YEATS2;TAF6L;JADE1;PER1;PHF20;SPI1;APBB1;KAT2A
gsea,positive regulation of apoptotic process (GO:0043065),0.3500266401408249,1.6374096642259401,0.0,0.04604940528489398,0.995,51/160,34.16%,UBB;RPS27A;C1QBP;FAM162A;EEF1E1;CTLA4;MTCH2;BAX;TNFAIP8;DNAJA1;RACK1;CCL3;HMGB1;UTP11;BAK1;CASP3;PSEN2;IRF5;CTNNB1;HSPD1;RPS6;HTRA2;MELK;GADD45B;PTRH2;ZBP1;RNPS1;E2F1;FADD;ERCC3;DKKL1;PHLDA1;FAS;PPID;ITGB3BP;TFAP4;DUSP6;ATG7;BID;PRNP;PRR7;GADD45A;GRN;GADD45G;ZC3H12A;ARHGEF9;TGM2;TCTN3;RRP1B;BNIP3;MLLT11
gsea,cellular response to heat (GO:0034605),0.5503484152325162,1.6358383003230523,0.02564102564102564,0.04651496510573999,0.995,7/19,18.69%,HIKESHI;RBBP7;YWHAE;HTRA2;HSP90AB1;IER5;HSBP1L1
gsea,mitochondrial gene expression (GO:0140053),0.5057252104685511,1.6347945331993627,0.015625,0.046808784832013825,0.995,15/27,23.65%,MRPS6;MRPS28;MRPL51;MRPL16;TFAM;MRPS12;MRPS18B;MRPS2;MRPL2;SLC25A33;MRPS7;MRPL12;TEFM;NOA1;MRPS18A
gsea,regulation of translation (GO:0006417),0.39278219044043494,1.633798088959054,0.012170385395537525,0.04702027001501548,0.996,43/115,26.83%,RPL10;RPS27L;NPM1;VIM;YBX1;GAPDH;EIF6;RACK1;TYMS;EIF4A3;HNRNPD;GZMB;EIF4E;SHMT2;DHFR;MRPL13;RIDA;EIF2A;TSFM;MIF4GD;METTL5;EIF5;MTG1;NCBP2;METAP1;NCBP1;BCL3;EIF3D;SHMT1;DDX1;CNOT10;PYM1;HSPB1;TRAP1;APP;RPL5;GSPT1;EEF2;CNOT9;MTG2;PUS7;IGF2BP3;PIWIL2
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4711732419205813,1.6306564419417386,0.007920792079207921,0.04819930856086831,0.996,10/31,15.69%,CRIP1;RPS27L;BAX;DDIT4;TMEM109;BAK1;HTRA2;HIC1;BCL3;E2F1
gsea,sensory organ development (GO:0007423),-0.44833932655433295,-1.6300375999372396,0.02694610778443114,0.10838148015241178,0.973,7/23,21.87%,CHD7;HIPK1;AHI1;SMCHD1;ECE1;HIPK2;ATF6
gsea,regulation of cellular component biogenesis (GO:0044087),-0.48317899097330536,-1.62675747160671,0.008130081300813009,0.10959862226415841,0.975,12/26,17.89%,RAPGEF1;HCFC1;NOTCH1;RAPGEF2;SPTY2D1;ROCK2;NCLN;ROCK1;HJURP;VPS11;LATS1;PTPN11
gsea,negative regulation of peptidase activity (GO:0010466),0.6049872209909379,1.6260996619200974,0.010269576379974325,0.0498208512592842,0.996,4/18,11.57%,SERPINB9;GAPDH;CST3;AKT1
gsea,protein ubiquitination (GO:0016567),0.35365658738044703,1.6259949808436154,0.00530035335689046,0.04969837627424124,0.996,73/216,36.82%,UBB;PSMB2;RPS27A;UBE2N;ELOC;PSMA3;PSMA5;PSMA4;UCHL3;PSME2;PSMD6;UBE2S;PSMB5;PSMD14;PSMC4;RACK1;PSMD11;UBE2V2;PSMB6;PSMA6;PSMC2;PRPF19;UBE2C;FANCL;PSMD12;UBE2E3;RNF126;UBE2T;PSMB7;CTNNB1;SELENOS;PSMC6;PSMD7;PSMD3;KCTD13;PSMD2;PSMD1;PEX2;PSMC5;UBE2L6;PSME3;CDC23;CDC16;BSPRY;TRAIP;PSMC1;PLK1;FBXL14;PEX5;RNF141;NUB1;PJA2;LMO7;CUL5;CRBN;ISG15;HERC6;CUL4B;KLHL3;FBXL15;UBE2E2;LEO1;TNFAIP1;HECW2;PINK1;PCNA;DTX4;AKTIP;PSMA8;TRAF2;STUB1;FBXO15;TRIM35
gsea,negative regulation of cell-substrate adhesion (GO:0010812),-0.47511011478472226,-1.6237085224824352,0.011494252873563218,0.11049340842399503,0.975,6/18,20.86%,NOTCH1;CORO1C;RASA1;NF2;RCC2;ACTN4
gsea,negative regulation of cell adhesion (GO:0007162),-0.4339060906352483,-1.6234796089404149,0.0,0.10950442026390317,0.975,12/30,18.97%,B4GALNT2;SPN;DSCAM;NOTCH1;ARHGDIA;PLXND1;RASA1;NF2;MIA3;CDH1;PDE3B;PLXNA1
gsea,regulation of cell cycle (GO:0051726),0.3570524837455266,1.6232124792266782,0.0037735849056603774,0.050666056474175325,0.996,54/159,32.41%,CKS1B;CDK4;MIF;RBBP4;CKS2;JUNB;ID2;CCNB2;RGCC;PCLAF;BIRC5;RACK1;JUND;CDC123;CITED2;IFNG;MLF1;GMNN;PIM3;CDKN2C;DUSP1;CDKN2D;HTRA2;GADD45B;TBRG1;WDR12;CDKN3;HSP90AB1;CCNB1;NR4A1;GADD45GIP1;CDK7;RAD23A;FIGNL1;PLK1;FBXO5;MEN1;TBRG4;HRAS;CAMK2N1;TFAP4;PES1;PIM2;MYC;PDCD4;IRF1;NUDT6;MAP2K6;BIRC3;GADD45A;PPP1R15A;GADD45G;NEK7;GAS2L1
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5464464381137111,1.6206974387248683,0.027237354085603113,0.05162387789351228,0.996,10/25,20.36%,ID2;RRM2;TFDP1;TYMS;DHFR;CDC45;E2F1;CDT1;TFDP2;FBXO5
gsea,receptor metabolic process (GO:0043112),-0.4491476608033952,-1.6206661649217904,0.013986013986013986,0.11034621551536426,0.975,9/28,19.47%,GRK2;PICALM;NEDD4;CLTC;LMTK2;TFRC;SNX25;ARFGEF2;CALCRL
gsea,telomere maintenance via telomere lengthening (GO:0010833),0.512895777060957,1.615594703498983,0.029644268774703556,0.05372236142461625,0.996,7/27,12.26%,NOP10;PTGES3;GAR1;NHP2;CDK2;RAD51;HSP90AB1
gsea,phosphatidylinositol metabolic process (GO:0046488),-0.40521805134645617,-1.6141057629929156,0.0025252525252525255,0.1140484200796641,0.979,35/53,37.08%,PIK3CA;SBF1;MTMR3;PITPNM2;PI4KA;PIP5K1C;PLCG1;PIK3C2A;PLCG2;PIK3CG;MTMR12;PIP4K2B;INPPL1;MTMR14;LCLAT1;PGAP1;PIK3CD;MTMR4;FIG4;SLC27A1;SYNJ1;PTPN13;VAC14;PLEKHA1;RUFY1;PIKFYVE;INPP4B;PI4KB;CSF1R;MTMR1;PLCB2;SYNJ2;PIK3R5;PGAP3;PLEKHA8
gsea,erythrocyte differentiation (GO:0030218),0.46940875579587976,1.6136281013210214,0.014652014652014652,0.05429981553249686,0.996,8/24,22.04%,SLC25A5;ID2;CASP3;LYAR;UFL1;ALAS1;DYRK3;HSPA9
gsea,calcium ion transmembrane transport (GO:0070588),0.447318019709739,1.6107934409972837,0.020761245674740483,0.05535429037887533,0.996,16/33,35.32%,PHB2;STOML2;PMPCB;PARL;ORAI1;PHB;MCUB;LETM1;PMPCA;SLC35G1;SLC24A5;SPG7;MCU;GRIN1;TRPM1;TRPA1
gsea,positive regulation of protein transport (GO:0051222),0.43007846332040606,1.6105630405132754,0.01935483870967742,0.05531232174052913,0.996,8/39,26.07%,PPIA;EZR;RACK1;PPID;MYOM1;EXPH5;CD33;RUFY3
gsea,synapse organization (GO:0050808),-0.40752258646989376,-1.6079758086270057,0.022988505747126436,0.11786360200211678,0.981,21/40,24.48%,NEDD4;DSCAM;DCTN1;PTPRS;FARP1;PPFIA1;PLXND1;NLGN2;CDH1;C1QB;CYFIP1;ARHGAP39;F2R;PPFIBP1;CTNND2;C1QC;C1QA;UNC13B;DVL1;PPFIA3;SPOCK2
gsea,tRNA aminoacylation for protein translation (GO:0006418),0.5152148843545309,1.6079408158788941,0.02895752895752896,0.05634977919356342,0.996,8/22,15.56%,EEF1E1;PPA1;FARSB;YARS2;FARSA;PPA2;AIMP2;NARS2
gsea,protein maturation (GO:0051604),0.43073299664544645,1.6061912520456119,0.012152777777777778,0.05704911227027161,0.996,12/46,22.29%,NDUFAB1;GLRX3;PSEN2;TESC;CTSS;HSPD1;DNAJB11;GCSH;CIAO1;TSPAN5;TYSND1;AEBP1
gsea,regulation of cellular amide metabolic process (GO:0034248),0.504519008732529,1.5986489873921188,0.017699115044247787,0.060282449646981054,0.996,7/24,21.30%,RPL10;PGAM1;EIF4E;EIF2A;METAP1;APP;TIGAR
gsea,ERBB signaling pathway (GO:0038127),-0.4151479542912099,-1.5985365390731696,0.028747433264887063,0.1242668254939304,0.983,14/34,27.74%,CBL;ERBIN;PTK2B;PIK3CA;PLCG1;PIK3C2A;PRKCA;SOS1;PTPN11;DGKD;ADAM17;PDPK1;RPS6KA5;BCAR1
gsea,DNA strand elongation (GO:0022616),0.6352377350412022,1.597887816264731,0.03937007874015748,0.0604707961872167,0.996,7/15,16.71%,RFC4;GINS2;MCM4;POLD2;RFC3;GINS4;MCM7
gsea,protein depolymerization (GO:0051261),0.5794953346975178,1.5978642060063448,0.022222222222222223,0.06028413017029036,0.996,4/18,20.13%,CFL1;STMN1;DSTN;NCKAP5L
gsea,tRNA aminoacylation (GO:0043039),0.5359702736881155,1.5970051841498447,0.025490196078431372,0.060502635493090345,0.996,7/19,15.28%,EEF1E1;PPA1;FARSB;YARS2;FARSA;PPA2;AIMP2
gsea,substantia nigra development (GO:0021762),0.5399945156318156,1.5918522390214538,0.023715415019762844,0.06292442134809058,0.996,6/15,26.53%,CALM2;ACTB;YWHAE;RAD1;S100A1;SYNGR3
gsea,regulation of myeloid cell differentiation (GO:0045637),-0.404745754509365,-1.5909687675105466,0.017676767676767676,0.12965541207806291,0.984,21/42,24.87%,KMT2A;KMT2D;CDK6;EP300;CREBBP;TNRC6A;KMT2B;PTK2B;NR4A3;CDC73;AGO1;KMT2C;RBM15;CTR9;MOV10;KAT2B;SETD1A;SIN3A;ZFPM1;SPI1;RBBP5
gsea,chromatin assembly (GO:0031497),0.5113262234253186,1.5906445773896367,0.03868471953578337,0.06339638122331932,0.997,11/25,23.89%,NPM1;RBBP4;ANP32B;NAP1L1;HMGB2;ASF1A;NAP1L4;POLE3;CHAF1B;NAP1L3;GRWD1
gsea,positive regulation of Ras protein signal transduction (GO:0046579),-0.43088522770399057,-1.5906044234306795,0.011961722488038277,0.1285591839158578,0.984,18/32,36.28%,RAPGEF1;ERBIN;ADGRG1;NOTCH1;RASGRP1;JAK2;IRS2;NOTCH2;PIK3CG;ARRB1;F2R;ALS2;RASGRF1;F2RL1;ARHGEF3;GPR65;LYN;MAP4K4
gsea,regulation of cellular catabolic process (GO:0031329),-0.4296111308618241,-1.5862312630316218,0.0175,0.13088954339602005,0.985,16/34,31.28%,EP300;ITPR1;MTMR3;RPTOR;DEPDC5;ROCK1;ABL1;WDR24;PIP4K2B;SMCR8;MTMR4;RRAGB;BOK;HDAC6;USP10;TRIB3
gsea,ERBB2 signaling pathway (GO:0038128),-0.5223837260569654,-1.584395150721776,0.04633204633204633,0.13108748081787994,0.988,4/15,13.90%,ERBIN;PIK3CA;PRKCA;SOS1
gsea,positive regulation of protein ubiquitination (GO:0031398),0.45206441042172785,1.5836569057033645,0.014084507042253521,0.06687063775412411,0.997,16/37,36.55%,UBB;UBE2N;RPS2;PIN1;HSPBP1;DCUN1D1;RIPK2;MTA1;PLK1;CRY1;BIRC3;TBC1D7;PINK1;SPHK1;STUB1;DCUN1D2
gsea,apoptotic mitochondrial changes (GO:0008637),0.5129796658320133,1.582819024856277,0.024518388791593695,0.06710732111030089,0.997,10/21,34.11%,BAX;SOD2;BAK1;HSPD1;GGCT;TIMM50;BID;BBC3;BNIP3;VPS35
gsea,platelet aggregation (GO:0070527),0.5493382977288016,1.5815177178883177,0.03238095238095238,0.0675414266762217,0.997,7/17,18.96%,PPIA;ACTG1;ACTB;CSRP1;PLEK;METAP1;HSPB1
gsea,negative regulation of cellular metabolic process (GO:0031324),-0.4802874624043644,-1.5807224951277998,0.03110047846889952,0.1329833729864377,0.989,5/17,17.21%,ABCA2;ITGB3;BRCA1;OPTN;NFKB1
gsea,positive regulation of phosphorylation (GO:0042327),0.3579716104363455,1.5772775439500142,0.006934812760055479,0.0697162806090262,0.997,38/107,41.63%,PPIA;MIF;PTGES3;CDK2AP1;PIN1;RACK1;CCND3;IFNG;AKT1;MYDGF;AXIN2;FAS;APP;VEGFB;HRAS;RAP2A;RET;IL1B;RYK;LMO4;CD74;ENG;PINK1;FGF2;ENTPD5;CD40;VEGFA;AKTIP;DAB2;DVL2;PECAM1;AXL;EPHA3;FLOT1;NBN;MMP9;NTRK3;DAXX
gsea,insulin receptor signaling pathway (GO:0008286),-0.42641547984925904,-1.576155480041567,0.015479876160990712,0.13580591126029026,0.992,15/32,27.74%,IDE;PIK3CA;PHIP;SLC39A14;TCIRG1;PIK3C2A;IRS2;FOXO1;C2CD5;GSK3B;SOS1;ATP6V0A2;RHOQ;SH2B2;BCAR1
gsea,regulation of osteoclast differentiation (GO:0045670),0.5861242199225416,1.576086686870202,0.0234009360374415,0.07016016791174855,0.997,7/15,26.14%,CCL3;CEBPB;IFNG;PRXL2A;TCTA;CCR1;TLR4
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),-0.5113410880776085,-1.5758600730857855,0.015873015873015872,0.13470330825645468,0.992,7/17,11.79%,PTK2B;ARHGDIA;BCAS3;NRP1;NOTCH2;ABL1;ABI3
gsea,homotypic cell-cell adhesion (GO:0034109),0.531433610308749,1.574695219316391,0.031088082901554404,0.07066929154929497,0.997,7/20,18.96%,PPIA;ACTG1;ACTB;CSRP1;PLEK;METAP1;HSPB1
gsea,regulation of dendrite morphogenesis (GO:0048814),-0.5254191779744065,-1.5715444422711695,0.02981029810298103,0.13741699304645774,0.993,9/15,29.42%,NEDD4;RAPGEF2;TNIK;CAPRIN1;GSK3B;HECW1;FBXW8;CUL7;KNDC1
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37227837279314957,1.5709453682039334,0.0013717421124828531,0.07248277139207898,0.997,50/126,41.37%,PPIA;UBB;RPS27A;UBE2N;NPM1;PRDX3;PHB2;RGCC;TFDP1;PSMA6;SMARCB1;CTNNB1;NFKBIB;AKT1;RELA;COPS5;RIPK2;BEX1;APP;TCF3;RHEBL1;ANXA3;CD40LG;TERF2IP;PARK7;NLRP3;IL10;NFKBIA;TLR4;IRAK3;RIPK3;CD36;IL1B;CX3CL1;MBTPS2;TNFSF11;BUD31;SPHK1;CD40;VEGFA;DVL2;TRAF2;TRAF5;FLOT1;WNT1;PRKCZ;PRKCB;FOXA1;HSF1;EDN1
gsea,positive regulation of response to stimulus (GO:0048584),0.4687428325220969,1.5691561064123827,0.025889967637540454,0.07325527003394403,0.997,7/28,19.39%,EEF1E1;NSMCE1;HMGA1;NSMCE4A;IER5;TAF9;YPEL3
gsea,tRNA modification (GO:0006400),0.42271346087444506,1.5690008491194045,0.02529182879377432,0.07311408457114868,0.997,29/45,43.21%,SSB;ELP5;THG1L;TRMT6;TRDMT1;PUS1;PUSL1;TRMT61B;TYW5;TYW3;NSUN2;TRMT1;DTWD1;PUS7;TRMT5;THUMPD1;TRUB1;TRMO;CTU2;TRMT61A;ADAT2;METTL1;FTSJ1;CTU1;MTO1;GTPBP3;LCMT2;WDR4;TRMT44
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3922231361749807,1.5670605045058366,0.009419152276295133,0.07403440743824297,0.997,22/70,32.93%,TMSB4X;TNFRSF4;PHB2;ID2;BHLHE40;HDAC2;DAP;XCL1;SP100;EGLN1;TNFSF4;UFL1;MEN1;ID3;NLRP3;NFKBIA;PRNP;IRAK3;SETD6;ZC3H12A;GFI1;CACTIN
gsea,macroautophagy (GO:0016236),0.41892677787380017,1.5670159986566239,0.009784735812133072,0.07383818338703489,0.997,11/44,17.04%,TOMM20;VDAC1;TOMM5;VAMP8;EI24;VAMP7;PRKAG2;PLAA;ATG10;TOMM40;DYNLL2
gsea,microtubule polymerization or depolymerization (GO:0031109),0.5726869524170017,1.5667520664382357,0.03355704697986577,0.0737632462699699,0.997,5/16,29.61%,STMN1;PIN1;NCKAP5L;TPPP3;HDGFL3
gsea,DNA replication initiation (GO:0006270),0.5301938624468653,1.5665283632639517,0.05776892430278884,0.07365216796542894,0.997,14/34,19.41%,RPA3;ORC6;RPA2;CDK2;MCM4;MCM6;CDC45;GMNN;ORC2;MCM7;POLE2;CDT1;PRIM2;POLE3
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.48611116388991293,-1.5653967903928852,0.025252525252525252,0.14227199503507948,0.994,5/18,21.48%,STAT3;IL17RA;NLRC3;PLD4;PER1
gsea,spliceosomal complex assembly (GO:0000245),0.4845770728967784,1.5641129746023932,0.043824701195219126,0.07474229912921822,0.998,15/29,27.24%,SNRPE;SNRPD1;SMN1;DDX39B;SRSF9;SRSF6;PRPF19;SF3A3;NCBP1;DDX1;SF3A2;SF3A1;SRPK1;TXNL4A;SRSF10
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4335349087072541,1.5636972999218361,0.026415094339622643,0.07472816483625222,0.998,18/46,30.74%,RPS27L;BAX;RGCC;TFDP1;PRMT1;CDK1;E2F4;RPA2;CDK2;CCNB1;E2F1;CNOT10;TFDP2;CNOT9;PLK2;MUC1;GADD45A;AURKA
gsea,ceramide metabolic process (GO:0006672),-0.5101402953799448,-1.5627040958170397,0.036290322580645164,0.14352056522947235,0.994,10/17,31.37%,ABCA2;CERK;SMPD4;ST6GALNAC3;CERS6;SAMD8;SGPL1;FUT7;SMPD1;CLN6
gsea,regulation of DNA recombination (GO:0000018),0.5058575782401338,1.5616241561668032,0.04046242774566474,0.07559434513505535,0.998,8/24,25.27%,ALYREF;KPNA2;RPA2;RAD51;IL7R;FIGNL1;TERF2IP;IL10
gsea,glutathione metabolic process (GO:0006749),0.5289365287356681,1.5598354711742812,0.030852994555353903,0.07628776358878596,0.999,15/17,37.97%,GPX1;GSR;GGCT;GSTT2;CHAC1;CHAC2;GSS;GSTM1;MGST2;PARK7;GSTK1;GSTM5;GSTT1;MMACHC;GSTZ1
gsea,heterotypic cell-cell adhesion (GO:0034113),-0.495448971766136,-1.5552815303955843,0.037037037037037035,0.14920301899411215,0.994,8/17,31.17%,ITGA4;JUP;ITGB3;DSC2;PKP2;DSG2;ITGB1;DSP
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.41514832550412945,1.553457944308132,0.025500910746812388,0.07974968214818721,0.999,14/39,38.36%,UBB;RPS27A;GZMB;PSMA6;PRPF19;CTSS;CTSL;CTSH;CTSZ;ISG15;CUL4B;PSMA8;STUB1;GZMA
gsea,negative regulation of cellular process (GO:0048523),0.3335928305315574,1.550334191747468,0.0012706480304955528,0.08135808185310395,1.0,96/250,38.39%,S100A11;NPM1;MIF;NME1;EEF1E1;RBBP4;PLSCR1;LPXN;ENO1;ANP32B;RBBP7;RGCC;CD9;HOPX;ORC6;IGFBP7;SOD2;RACK1;HMGA1;VAMP8;BST2;TMEM109;SRSF6;EI24;PHB;NUP62;TESC;GMNN;CDKN2C;DUSP1;CTNNB1;KLK8;CDKN2D;GTPBP4;HTRA2;SP100;TBRG1;PRKRA;CDKN3;NCK2;OSM;NR4A1;KLF10;AXIN2;GSDME;CRYAB;APP;FBXO5;MEN1;HRAS;TXNIP;CAMK2N1;HYAL2;TFAP4;PARK7;IL10;PIM2;P3H3;CD33;LMNA;VDR;SUZ12;PIWIL2;MYC;PDCD4;IRF1;NUDT6;ACTN1;PINX1;IL1B;SINHCAF;P3H2;ST7L;FGF2;ENPP1;SH3BP4;GNG4;TOB1;NR1H3;NME6;DLL4;BNIP3;VPS35;CCN4;P3H1;CBFA2T3;PLPP1;CRYAA;FCGR2B;DNAJA3;SIRPA;APPL2;NUPR1;PTPN6;WNT1;CDC6
gsea,acylglycerol metabolic process (GO:0006639),-0.5081709201608343,-1.549264378903608,0.04143646408839779,0.15373499699774995,0.994,8/15,26.90%,DGKH;DGAT1;DGKG;DGKE;PGS1;DGKD;APOBR;LPL
gsea,regulation of apoptotic signaling pathway (GO:2001233),0.519591982884437,1.5489863613151214,0.03185840707964602,0.08189817448787547,1.0,4/18,20.46%,PPIA;PTPMT1;FAS;NR4A2
gsea,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5186307310659399,1.5480603170683322,0.03317535545023697,0.08217522498919332,1.0,11/21,32.37%,ID2;IFNG;TESC;ZFP36L1;HAX1;FADD;CCR1;CD74;LEF1;LIF;TNFSF11
gsea,protein targeting (GO:0006605),0.41397788496914717,1.5474067617835556,0.016245487364620937,0.08235672685395914,1.0,23/47,39.06%,TOMM20;TIMM23;TOMM5;TIMM17A;TIMM8B;GIPC1;TIMM10;ZDHHC2;TOMM40;SRPRB;AP4M1;SPCS3;MYO1C;ZDHHC6;MGARP;TIMM9;ZDHHC12;ZDHHC15;CHM;HAP1;RTP4;HACL1;AP4B1
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.472487724103128,-1.546548704178843,0.05555555555555555,0.15503454534354616,0.994,6/15,24.69%,CBLB;CBL;FBXW7;NCF1;ADAM17;SOCS5
gsea,glycoprotein metabolic process (GO:0009100),-0.4610211321513692,-1.544144493741959,0.023310023310023312,0.15609476199273992,0.995,17/25,34.26%,B4GALT5;MAN2A1;MAN1B1;OGA;ST8SIA4;GANAB;ST6GALNAC3;PRKCSH;STT3B;FUT8;FBXO44;MGAT4B;GCNT1;GANC;TNIP1;HPSE;MAN1C1
gsea,positive regulation of viral process (GO:0048524),0.44314158572800555,1.5440682985852308,0.027559055118110236,0.08410355824350223,1.0,16/35,26.70%,PPIA;POLR2C;PPIH;KPNA2;POLR2H;POLR2L;POLR2E;GTF2F2;PPIE;TMEM39A;RAD23A;PPID;POLR2F;TARBP2;SRPK1;POLR2B
gsea,positive regulation of binding (GO:0051099),0.40294728227160637,1.5435926043537098,0.016,0.08417214871830535,1.0,25/49,43.37%,RAN;NME1;STMN1;PIN1;HMGB1;HMGB2;GMNN;NCBP1;RIPK2;CDT1;APP;MEN1;ADD1;PARP9;CLN5;HFE;BAMBI;AKTIP;FLOT1;LRP1;MMP9;NVL;TCF7L2;PPARG;PLAUR
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.4034972828318067,1.5426637845446207,0.019120458891013385,0.08449401098680027,1.0,17/51,26.23%,YBX1;GAPDH;CST3;RACK1;TYMS;EIF4A3;GZMB;DHFR;MRPL13;RIDA;AKT1;SHMT1;CNOT10;CNOT9;CAMK2N1;PUS7;IGF2BP3
gsea,regulation of microtubule polymerization (GO:0031113),-0.4558922403844547,-1.5424140127440717,0.03160270880361174,0.1563384555033728,0.995,11/21,19.23%,CLASP1;DCTN1;DYRK1A;TOGARAM1;MAP2;NUMA1;CDK5RAP2;ABL1;CLIP1;CAMSAP1;CAMSAP2
gsea,regulation of cellular response to heat (GO:1900034),0.4127009649517112,1.5410057423981853,0.033264033264033266,0.08524305092470576,1.0,23/62,19.86%,RPA3;HIKESHI;PTGES3;FKBP4;YWHAE;RPA2;DNAJB1;AAAS;DNAJC2;NUP62;HSPA8;NUP43;DNAJC7;NUP37;HSP90AB1;SEH1L;CHORDC1;RAE1;IER5;NUP54;CRYAB;NUP35;BAG5
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5506337268143153,1.539133466215228,0.021671826625386997,0.08614422033833478,1.0,3/18,13.94%,MIF;EEF1E1;HIC1
gsea,positive regulation of fat cell differentiation (GO:0045600),0.4871616331182269,1.5380786397278015,0.03241491085899514,0.08664230181669764,1.0,11/23,35.79%,ID2;CEBPB;ZFP36L1;AKT1;ZFP36;TMEM64;XBP1;ZBTB16;ZC3H12A;PTGS2;METRNL
gsea,regulation of cellular response to stress (GO:0080135),0.38808441962113344,1.5363993775538418,0.040229885057471264,0.08736608626356829,1.0,27/87,19.86%,RPA3;MANF;NPM1;HIKESHI;PTGES3;FKBP4;YWHAE;CEBPB;RPA2;DNAJB1;AAAS;DNAJC2;NUP62;HSPA8;NUP43;DNAJC7;NUP37;HSP90AB1;SEH1L;RSL1D1;CHORDC1;RAE1;NUP54;DYRK3;CRYAB;NUP35;BAG5
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.4618177950876555,-1.5362567869205428,0.03512396694214876,0.16124921731393604,0.996,14/27,23.74%,CNOT1;UPF1;TNRC6A;AGO2;ROCK2;ROCK1;PABPC1;BTG2;GIGYF2;MOV10;FTO;EIF4ENIF1;PRR5L;CELF1
gsea,hemopoiesis (GO:0030097),-0.36918240905787564,-1.5360209209124789,0.016891891891891893,0.16005753762710076,0.996,27/46,35.20%,KMT2A;PRRC2C;RUNX3;HIPK1;TET2;KAT6A;WNT10B;SNRK;RUNX2;ATF4;NCOA6;NOTCH2;PLD4;PDGFB;ZFPM1;ARMC6;FST;BMI1;DLL1;TGFBR3;KIT;TOX;SH2B3;RUNX1;IL3;CSF1R;FLT1
gsea,establishment of protein localization to organelle (GO:0072594),0.4214781096455216,1.5353057575106883,0.037109375,0.0878483528208602,1.0,18/48,37.61%,RAN;NUTF2;HIKESHI;PHB2;NXT1;NUP62;RALA;LAMP1;CD68;AKT1;NUP85;RPAIN;SYK;NUP88;PINK1;ZDHHC15;CSE1L;APPL2
gsea,positive regulation of chemotaxis (GO:0050921),0.4917299723021462,1.5350329275152295,0.0436817472698908,0.0877692215669681,1.0,2/20,5.33%,TMSB4X;XCL1
gsea,regulation of neuron projection development (GO:0010975),-0.3559270153893928,-1.5346798327673163,0.009146341463414634,0.15998013782364062,0.996,33/62,38.02%,RAPGEF1;KIF13B;SIPA1L1;EP300;SETX;PTK2B;RAPGEF2;PTPRS;KIDINS220;ARHGAP35;TANC2;DENND5A;GAK;ABI3;GSK3B;CAMSAP2;PTPN9;RTN4IP1;NDNF;PAQR3;KNDC1;PDLIM5;APOE;ABI2;DAB2IP;TOX;FES;ITGA6;PAK1;SCN1B;LYN;MT3;LRRK2
gsea,histone H3-K4 methylation (GO:0051568),-0.5147973463957928,-1.5344678590036804,0.05476673427991886,0.1588054073323253,0.996,9/16,16.23%,KMT2A;KMT2D;SETD1B;KMT2B;TET2;TET3;KMT2C;CTR9;SETD1A
gsea,cellular response to BMP stimulus (GO:0071773),-0.43660745727826045,-1.5314132611391782,0.03460207612456748,0.1606498179805532,0.996,11/22,29.07%,USP9X;HIVEP1;SMAD7;RUNX2;TGFB3;ZFYVE16;USP15;SMAD3;AMH;ACVR1;TGFBR3
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.4249036574342225,1.529532360529338,0.0216998191681736,0.0910392836463628,1.0,14/35,25.55%,BAX;SIVA1;IFI27;BAK1;IFNG;CASP3;DDX47;BLOC1S2;FADD;TNFSF12;TNFRSF1A;FAS;CD70;BID
gsea,protein import (GO:0017038),0.42309395452514453,1.5294562133250025,0.04208416833667335,0.09082604849274321,1.0,20/52,37.61%,RAN;NUTF2;HIKESHI;PHB2;SLC25A17;NXT1;NUP62;PXMP2;AKT1;PEX2;SAMM50;PEX5;NUP85;RPAIN;SYK;ABCD1;NUP88;PEX3;CSE1L;APPL2
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.4675140850669099,1.5290371147361188,0.029574861367837338,0.09078614185901863,1.0,8/24,25.27%,RGCC;MAD2L1;ZFP36L1;CTNNB1;ZWINT;BUB1;PLK2;IL10
gsea,DNA geometric change (GO:0032392),0.5207847544126704,1.5288959912961209,0.04911591355599214,0.09060914446648242,1.0,6/21,17.90%,HNRNPA2B1;HMGB1;HMGB3;HMGB2;ANXA1;DDX1
gsea,alpha-amino acid metabolic process (GO:1901605),0.503366325425208,1.5287770845034185,0.04091653027823241,0.09042069044528094,1.0,10/21,30.48%,ASS1;GOT1;ASNS;OAT;PYCR2;GLUL;KYAT3;MTRR;ALDH18A1;SLC25A13
gsea,activation of GTPase activity (GO:0090630),-0.3678138630924768,-1.528036391322542,0.02932551319648094,0.1625474007013216,0.996,28/50,31.56%,SIPA1L1;ABR;BCR;TBC1D8B;CORO1C;RASGRP1;RANGAP1;RALGAPB;TBC1D13;RALGAPA2;TBC1D22B;BCAS3;TSC1;SCRIB;TBCK;EVI5L;TIAM1;TBC1D5;SGSM2;TBC1D4;TBC1D8;SYDE2;TBC1D1;RASGRF1;ARHGEF5;TBC1D25;TBC1D10B;ECT2
gsea,regulation of lipid metabolic process (GO:0019216),-0.402421151805546,-1.5269742025287403,0.04072398190045249,0.162305761020897,0.996,20/45,27.05%,NCOR2;ABCA7;SREBF2;CREBBP;FASN;ACACA;SP1;NCOA1;TBL1XR1;HELZ2;NFYA;IRS2;NCOA6;MED1;HMGCS1;NCOA2;SIN3A;SQLE;OPA3;CARM1
gsea,secondary alcohol metabolic process (GO:1902652),0.5066926075589683,1.5254675360481584,0.04355108877721943,0.09237460749460337,1.0,2/18,5.98%,IDH3A;FDX1
gsea,cellular response to virus (GO:0098586),0.5110613169328815,1.5250413648179484,0.038817005545286505,0.0923865368442121,1.0,5/19,22.62%,EIF5A;BAX;GSDME;IL21;CXCL10
gsea,positive regulation of cellular process (GO:0048522),0.3366355614538246,1.5221409840750457,0.0012690355329949238,0.09395688996506132,1.0,119/277,38.59%,SLC25A5;CNBP;CDK4;COX17;NPM1;C1QBP;HDAC1;PRDX3;HILPDA;TSPAN31;TIPIN;BIRC5;PRMT1;NSMCE1;NAP1L1;DNAJA2;NSMCE4A;HDAC2;PA2G4;CDK2;CDC123;CITED2;IFNG;PHB;CCR7;TNFRSF18;EXOSC9;ZFP36L1;LYAR;EZH2;MTLN;FXN;LMAN2;BST1;RPS6;IL7R;DERL2;HMGN5;AKT1;HSP90AB1;ZFP36;CD86;LAMC2;ITGAX;CIAO1;NCBP1;IL12RB2;ASH2L;TNFSF4;N6AMT1;WDR77;OSM;RELA;UFL1;DHPS;AXIN2;PDGFA;SLC25A33;RIPK2;IER5;EXOSC4;RAD23A;IL21;XBP1;FBXO5;TPM1;DNPH1;TBRG4;OSR2;FCER1G;AGPAT1;HRAS;RAMP3;TUB;CTSH;LMNA;TLR4;MYC;GCNT2;CAPN10;PRR7;CD36;IL1B;P4HB;CX3CL1;HCK;GRN;NAMPT;SAPCD2;SINHCAF;ZC3H12A;MFSD2A;CD81;LEF1;LIF;BAMBI;ECHDC3;TGM2;FGF2;SPHK1;GRIN1;WWTR1;VEGFA;DVL2;FCGR2B;SIRPA;CXCL16;IL2;FLOT1;SLC11A1;TGFA;NUPR1;TIMP1;PTPN6;FN1;WNT1;LRP1;CDC6;RPRD1B
gsea,positive regulation of mitochondrion organization (GO:0010822),0.4359033983655281,1.5220291247633775,0.02443280977312391,0.09376125054382167,1.0,18/32,34.16%,FAM162A;BAX;PPIF;BAK1;CHCHD10;RALA;HTRA2;PARK7;BID;ZDHHC6;MGARP;MCU;AURKA;PINK1;BBC3;BNIP3;VPS35;MLLT11
gsea,positive regulation of protein modification process (GO:0031401),0.37258028407796306,1.5210111262468382,0.012747875354107648,0.09420505825575516,1.0,35/98,37.44%,PPIA;UBE2N;CALM2;CDK2AP1;PIN1;RACK1;CCND3;PTBP1;IFNG;AKT1;ATG10;MYDGF;AXIN2;FAS;APP;VEGFB;HRAS;TERF2IP;ATG7;PPP1R7;RAP2A;IL1B;CD74;ENG;PINK1;FGF2;CD40;VEGFA;AKTIP;DAB2;RAMP1;DVL2;PECAM1;CAMK1;FLOT1
gsea,regulation of phosphorylation (GO:0042325),0.3617910529263819,1.5206880577227657,0.021442495126705652,0.09416896499537868,1.0,23/74,24.54%,PGAM1;MIF;PTGES3;PIN1;EIF6;SOCS1;AAAS;NUP62;CDKN2C;NUP43;CDKN2D;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;MCM7;NUP54;HSPB1;NUP35;APP;RAD17;NUP85
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),0.45772126399896784,1.5201766328372053,0.04146730462519936,0.09423379283135949,1.0,9/27,24.77%,C1QBP;HMGB1;XCL1;CCR7;CCL1;VEGFB;CXCL10;CREB3;CCR1
gsea,regulation of interferon-gamma production (GO:0032649),0.41433608638524644,1.519627040518353,0.025449101796407185,0.09433783540922638,1.0,25/46,38.90%,C1QBP;HMGB1;XCL1;PDCD1LG2;CCR7;HSPD1;CD14;SLAMF6;IL12RB2;TNFSF4;FADD;IL21;TLR7;PRNP;TLR4;RIPK3;ISG15;IL1B;CD226;ZC3H12A;CCR2;SIRPA;AXL;SLC11A1;CRTAM
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.4230038189753362,1.5170059775024758,0.036637931034482756,0.09594389520879715,1.0,24/41,31.28%,ELOC;POLR2C;POLR2H;ELOF1;ADRM1;POLR2L;NCBP2;POLR2E;POLR1E;GTF2H3;GTF2F2;NCBP1;ERCC3;CDK7;CCNK;GTF2H2;POLR2F;GTF2H4;POLR2B;ELP2;ERCC2;LEO1;PCID2;SSRP1
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.4944682362680555,1.5152340746082749,0.025297619047619048,0.09679649776165988,1.0,14/27,34.58%,UBB;RPS27A;HMGB1;CTSS;CD14;CTSL;CNPY3;TLR7;TLR4;S100A1;CD36;TIFA;CLEC4E;MAPKAPK3
gsea,cellular response to organonitrogen compound (GO:0071417),-0.37558610384405,-1.5142760631910583,0.034229828850855744,0.17337439107710892,0.997,18/38,28.22%,LARP1;RAPGEF1;JUP;RAPGEF2;CIB2;DIAPH1;TAF1;RPTOR;SSH1;CDH1;BRCA1;SLC38A9;IPO5;IMPACT;CAPN2;RRAGB;CTNNA1;MEF2C
gsea,carboxylic acid transmembrane transport (GO:1905039),-0.4823497942699313,-1.5139225729457126,0.04430379746835443,0.17232274312303017,0.997,11/18,23.94%,SLC38A2;SLC16A1;SLC38A9;ABCC1;ABCC5;SLC23A2;SLC7A5;SLC7A6;SLC38A6;SLC38A1;SLC27A1
gsea,negative regulation of kinase activity (GO:0033673),0.4454893787453442,1.513635033527826,0.020676691729323307,0.09765956175179843,1.0,9/31,24.80%,PPIA;PRDX3;DUSP19;PRKAG2;AKT1;HSPB1;CAMK2N1;TARBP2;PARK7
gsea,double-strand break repair via homologous recombination (GO:0000724),0.4155905137708678,1.5134946145133885,0.05058365758754864,0.09747619458099524,1.0,22/70,24.89%,UBE2N;RPA3;PSMD14;NSMCE1;RPA2;GINS2;FEN1;MCM4;MCM6;SAMHD1;CDC45;ZSWIM7;RAD51;SFPQ;GINS4;MMS22L;MCM7;MUS81;RAD51D;XRCC1;RAD51C;MCM3
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.44252647324324335,1.512718666350055,0.04203152364273205,0.097744225126512,1.0,23/45,34.38%,RAN;CCT8;TCP1;CCT4;CDK1;CCT2;IFNG;CCT5;CCT6A;AKT1;CCT3;CCT7;TRIM28;PLK1;HYAL2;PARK7;PARP9;PINX1;ZC3H12A;MCRS1;LIF;DKC1;WWTR1
gsea,internal peptidyl-lysine acetylation (GO:0018393),-0.5047896702805351,-1.511848551537942,0.07,0.17307294198884726,0.997,9/18,21.82%,EP300;TRRAP;CREBBP;KAT6A;KAT6B;BRD8;KAT2B;TAF6L;PHF20
gsea,metal ion transport (GO:0030001),0.4135400375361435,1.5114074309184182,0.03270223752151463,0.09838214323721735,1.0,13/34,44.00%,TPT1;CCL3;PSEN2;SLC3A2;RAMP3;CCR1;CCL8;RAMP1;RAMP2;SLC11A1;CACNB3;CACNA1B;CACNA2D1
gsea,negative regulation of viral genome replication (GO:0045071),0.4356792781668165,1.5096276424026227,0.04296875,0.09941085848230911,1.0,6/28,29.86%,BANF1;PLSCR1;BST2;SRPK1;ISG15;OAS3
gsea,BMP signaling pathway (GO:0030509),-0.444264227623285,-1.5087047891453345,0.03859649122807018,0.1749486446027718,0.997,11/21,29.07%,USP9X;HIVEP1;SMAD7;RUNX2;TGFB3;ZFYVE16;USP15;SMAD3;AMH;ACVR1;TGFBR3
gsea,positive regulation of developmental growth (GO:0048639),-0.4894304601280838,-1.5080468160291427,0.05014749262536873,0.1742101311092489,0.997,8/15,26.45%,MACF1;GOLGA4;LIMK1;RNF157;SEMA7A;MAP3K13;CPNE9;DLL1
gsea,response to organic cyclic compound (GO:0014070),0.4675791276817896,1.5067485470009065,0.042232277526395176,0.10112508370109391,1.0,6/26,9.48%,GLDC;CCL3;DHFR;ANXA1;CTNNB1;CDKN2D
gsea,modification-dependent protein catabolic process (GO:0019941),0.3613257781351913,1.5065361089545095,0.02666666666666667,0.10100619615921104,1.0,36/99,37.56%,UBB;RPS27A;ELOC;UBE2S;PSMD14;AURKB;BUB3;MAD2L1;PSMD11;RNF5;PSMC2;COPS3;UBE2C;RNF126;ANAPC15;ADRM1;PSMD3;HERPUD1;CDC20;RNF130;UBE2L6;CDC23;CDC16;PLK1;XBP1;FBXL14;NUB1;ISG15;KLHL3;AURKA;RNF215;PINK1;PCYOX1L;STUB1;KCTD21;RNF149
gsea,positive regulation of secretion by cell (GO:1903532),0.40768947158925994,1.5061794470833796,0.04173106646058733,0.10096793488615269,1.0,10/35,33.30%,PPIA;RGCC;EZR;PPID;MYOM1;EXPH5;CD33;IL1B;RAB2B;APBB3
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45183548528179096,1.5047597834225148,0.05938697318007663,0.10171880731359,1.0,14/40,23.76%,CDK4;PHB2;RGCC;TFDP1;CDK1;CCND3;UBE2C;ANXA1;AKT1;CCNB1;CDC23;CDC16;FBXO5;RAD51C
gsea,regulation of type I interferon production (GO:0032479),0.38795237010209305,1.5044328770345046,0.011131725417439703,0.10171422228734192,1.0,21/54,27.71%,POLR3K;PIN1;GAPDH;POLR2H;G3BP1;POLR3H;IRF5;CTNNB1;CD14;POLR2L;POLR2E;IRF8;UBE2L6;ZBP1;RELA;POLR1C;DDX41;POLR3GL;POLR2F;IRF1;ISG15
gsea,negative regulation of binding (GO:0051100),0.3751492099499702,1.504303540517805,0.020484171322160148,0.10152449438638443,1.0,22/50,38.36%,ACTB;BAX;PIN1;AURKB;RACK1;SUMO3;GTPBP4;SP100;AKT1;TMC8;E2F1;TFAP4;PARK7;NFKBIA;CTSZ;BAG2;AURKA;LEF1;DAB2;CAMK1;CPNE1;GZMA
gsea,regulation of actin cytoskeleton organization (GO:0032956),-0.36404393084926656,-1.5030640804124835,0.02972972972972973,0.17818676037582956,0.997,19/45,35.04%,HIP1R;NEB;TAOK2;TAOK1;PTK2B;PIK3CA;ARHGDIA;ARHGAP35;ROCK2;ROCK1;NOTCH2;ABL1;ABI3;RICTOR;RHOQ;ARHGEF5;IQGAP2;CSF1R;PAK1
gsea,protein stabilization (GO:0050821),0.36286770724689593,1.5015318272196638,0.029411764705882353,0.10324704428075827,1.0,31/99,20.45%,PFN1;PTGES3;PHB2;CCT8;PIN1;GAPDH;TCP1;CCT4;CCT2;PHB;TESC;HSPD1;ZSWIM7;CCT5;CCT6A;GTPBP4;LAMP1;ZBED3;TBRG1;PRKRA;HSP90AB1;CCT3;CRTAP;CCT7;CDK7;TAF9;RABL3;CRYAB;BAG5;RPL5;PFN2
gsea,protein localization to organelle (GO:0033365),0.37411712013209897,1.5002419468540378,0.029411764705882353,0.10391384653341708,1.0,20/61,30.68%,MTCH2;YBX1;DNAJA1;SSB;SERP1;YWHAE;ARL1;RPA2;LAMP1;CD68;GET4;DDX1;APP;TUB;HHEX;LMNA;PRNP;ISG15;TTC21B;PPP1R15A
gsea,regulation of filopodium assembly (GO:0051489),-0.46652855419135864,-1.4999215747361891,0.05275779376498801,0.17997131639351138,0.997,9/18,22.40%,MYO10;DOCK11;BCAS3;NRP1;TGFB3;ARAP1;RHOQ;FXR2;FMR1
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4626266964421419,1.4991242506520188,0.0408997955010225,0.10446633983310516,1.0,4/18,11.57%,C1QBP;CD160;ZFP36L1;AKT1
gsea,anion transmembrane transport (GO:0098656),0.4373132332060871,1.497637578345292,0.040983606557377046,0.10520207709325902,1.0,11/31,25.30%,SLC25A5;SLC35A1;SLC3A2;SLC35C2;SLC7A3;SLC35B1;SLC13A3;SLC19A1;SFXN1;SLC25A14;SLC6A9
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.40560751574097015,1.4966507831380014,0.04869565217391304,0.10575702415601426,1.0,13/46,15.69%,CDK4;PSME2;ID2;RGCC;TFDP1;CCND3;ANXA1;CDKN2C;CDKN2D;AKT1;TM4SF5;PSME3;E2F1
gsea,negative regulation of protein kinase activity (GO:0006469),0.3990988708308059,1.496483250502629,0.02952029520295203,0.10561759735305151,1.0,13/42,24.80%,PPIA;NPM1;IFNG;DUSP19;PRKAG2;AKT1;DUSP10;DUSP3;HSPB1;CAMK2N1;HYAL2;TARBP2;PARK7
gsea,negative regulation of epithelial cell proliferation (GO:0050680),-0.3926471874110853,-1.496401025363073,0.03761755485893417,0.18224314987991003,0.998,19/34,32.31%,CDK6;RUNX3;CDC73;NLRC3;BRCA2;XDH;NF1;FBXW7;MED1;CEACAM1;CDKN2B;VASH1;STAT1;TGFBR3;GATA3;MTSS1;APOE;DAB2IP;PTPRK
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.41791622834819264,1.4957494443076378,0.0328125,0.10589155302975158,1.0,14/39,47.06%,UBB;RPS27A;PIN1;STRAP;RBPMS2;BAMBI;SPRY1;STUB1;WNT1;SMAD5;EID2;SMAD1;PPARG;CIDEA
gsea,steroid metabolic process (GO:0008202),0.49334855193010213,1.4956453436412784,0.053082191780821915,0.10568630047607733,1.0,9/19,26.09%,FDX1;HSD11B1;FDFT1;FDXR;MSMO1;DHRS9;HSD17B7;HSD17B10;VDR
gsea,morphogenesis of an epithelium (GO:0002009),0.5702527632118026,1.4948967155326125,0.036231884057971016,0.10598162929996276,1.0,2/15,0.94%,ACTG1;ACTB
gsea,positive regulation of osteoblast differentiation (GO:0045669),-0.42855706777625424,-1.4936875268275198,0.05934718100890208,0.18379389061170656,0.998,11/18,36.66%,IFITM1;RUNX2;IL6ST;LTF;ZHX3;TMEM119;ACVR1;MEF2C;NPNT;YAP1;BMP7
gsea,regulation of ion transmembrane transporter activity (GO:0032412),0.4723390632625668,1.492073191256026,0.05448717948717949,0.10767564295329078,1.0,6/20,30.47%,PHB2;PPIF;YWHAE;FXYD2;RANGRF;STK39
gsea,regulation of Rho protein signal transduction (GO:0035023),-0.3698900993736224,-1.4919216618167168,0.01652892561983471,0.18433840611230698,0.998,20/39,34.43%,MYO9B;ADGRG1;ITGA3;BCR;ARHGDIA;ARHGAP35;SCAI;CUL3;NRP1;ABL1;ARHGEF18;ARRB1;ARHGEF28;F2R;ARHGEF2;F2RL1;APOE;ARHGEF3;GPR65;RASIP1
gsea,cellular defense response (GO:0006968),-0.43116725585105276,-1.4915048593008526,0.05263157894736842,0.183415491207243,0.998,15/25,35.54%,SPN;KLRG1;PTK2B;KLRC2;TCIRG1;FOSL1;NCF1;ADORA2B;TYROBP;PRF1;CXCL9;ITGB1;RAB23;CCR3;CX3CR1
gsea,protein methylation (GO:0006479),0.47787046894037843,1.4889388544507294,0.0508130081300813,0.10980077846936608,1.0,14/23,33.46%,SNRPD3;PRMT1;SNRPB;EZH2;N6AMT1;ATPSCKMT;EEF2KMT;PRMT5;GSPT1;ETFBKMT;PRMT3;METTL22;PRMT6;ETF1
gsea,phospholipid translocation (GO:0045332),-0.49030363173387,-1.4885933074447713,0.07321772639691715,0.18516239643337096,0.998,8/15,14.02%,ABCA7;ATP8B2;ATP10A;ANO6;ATP11A;ATP11C;ATP8B4;ABCC1
gsea,cellular calcium ion homeostasis (GO:0006874),0.3715127915882042,1.4872375748516382,0.026234567901234566,0.11081825667564511,1.0,20/57,35.44%,TPT1;BAX;STOML2;CCL3;YWHAE;BAK1;HERPUD1;MCUB;LETM1;CCL1;SLC35G1;TMEM203;SLC24A5;CCR1;CCL8;STC2;MCU;CD40;CCR2;CCL7
gsea,DNA integrity checkpoint signaling (GO:0031570),0.46409005978855244,1.4870118494270244,0.06095238095238095,0.11068258887300036,1.0,11/28,23.04%,TIPIN;TIPRL;PRPF19;CDC45;DONSON;E2F1;RHNO1;RAD1;CDT1;TIMELESS;RAD17
gsea,protein acetylation (GO:0006473),-0.47794721402725165,-1.4865917068070966,0.0614406779661017,0.18599185803085638,0.998,11/20,24.08%,EP300;CREBBP;KAT6A;NAT10;FOXO1;NAA15;ING5;NAT9;KAT2B;NAA10;CLOCK
gsea,negative regulation of cellular component organization (GO:0051129),-0.3978785689829343,-1.4827629994464957,0.030690537084398978,0.18884583601165683,0.998,19/40,29.67%,ABCA7;EP300;DDX3X;SACS;RTEL1;CARMIL2;HSPA5;AIDA;TFIP11;GSK3B;SPRY2;IMPACT;SYT11;TERF2;ULK1;HSPA1A;HDAC6;AR;PACSIN3
gsea,actomyosin structure organization (GO:0031032),-0.4259353087453689,-1.4824753090708678,0.04228855721393035,0.18773139136510364,0.998,17/27,31.70%,MYH9;EPB41;FLII;CIT;ROCK2;CUL3;ROCK1;TMOD1;TTN;EPB41L2;ARRB1;FRMD6;MYH10;LMOD3;ITGB1;MYO18A;TJP1
gsea,positive regulation of immunoglobulin production (GO:0002639),0.5183383338042502,1.4820828107907122,0.05695142378559464,0.1142745741920742,1.0,10/18,25.27%,TNFRSF4;PHB2;XCL1;PHB;CD86;TNFSF4;SHLD1;IL21;XBP1;IL10
gsea,positive regulation of macroautophagy (GO:0016239),0.44504099879281445,1.4816891810434387,0.048598130841121495,0.11431172877514485,1.0,5/26,34.02%,SLC25A5;VDAC1;C9ORF72;PINK1;BNIP3
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.4003042327476223,1.4814378814562017,0.03442340791738382,0.11417668670783608,1.0,20/49,36.27%,YBX1;PIN1;GAPDH;RACK1;TYMS;EIF4A3;GZMB;DHFR;MRPL13;RIDA;RTN3;SHMT1;CNOT10;CNOT9;PUS7;PRNP;IGF2BP3;SPHK1;TOB1;HAP1
gsea,inositol phosphate metabolic process (GO:0043647),-0.4567038002888378,-1.4804249148217492,0.03856749311294766,0.18848070428477556,0.998,10/21,24.42%,ITPKB;PLCG1;PLCG2;INPPL1;IP6K2;PLD4;IPMK;NUDT4;PPIP5K1;SYNJ1
gsea,protein K48-linked ubiquitination (GO:0070936),0.47926386479787864,1.4787934135166794,0.047787610619469026,0.11588462418781134,1.0,6/21,8.15%,IFI27;RNF5;UBE2C;UBE2E3;RNF126;UBE2T
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.4125785544942713,1.474828728968718,0.024890190336749635,0.11884082778273884,1.0,22/50,34.72%,PFN1;BAX;RGCC;RACK1;BAK1;IFNG;RHOC;MTLN;PLEK;CDC42EP2;CDT1;LGALS3;PFN2;PIH1D1;PARK7;BID;CX3CL1;AJUBA;SYK;CHGA;VIL1;VEGFA
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5033467025514577,1.4743441151844903,0.05714285714285714,0.11864281709303728,1.0,9/17,29.35%,RPA3;RPA2;GTF2H3;ERCC3;GTF2H2;GTF2H4;CHD1L;CUL4B;ERCC2
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5033467025514577,1.4743441151844903,0.05714285714285714,0.11864281709303728,1.0,9/17,29.35%,RPA3;RPA2;GTF2H3;ERCC3;GTF2H2;GTF2H4;CHD1L;CUL4B;ERCC2
gsea,nucleobase-containing compound catabolic process (GO:0034655),0.4726346450952364,1.471215740732417,0.05128205128205128,0.12089047059266797,1.0,7/23,14.04%,RNASEH2B;HNRNPD;NUDT5;EXOSC7;NUDT1;RNASEH1;NCBP1
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.48830592175309795,1.471098515726994,0.053231939163498096,0.12069656718963921,1.0,8/19,18.45%,BAX;TFDP1;YWHAE;GZMB;BAK1;CHCHD10;E2F1;TFDP2
gsea,positive regulation of wound healing (GO:0090303),0.46372648658183585,1.4704686190828575,0.04340567612687813,0.12082778881142227,1.0,5/18,22.31%,ACTG1;ANXA1;ST3GAL4;XBP1;HRAS
gsea,negative regulation of gene expression (GO:0010629),0.31307631426268556,1.470270176512018,0.014539579967689823,0.12068475242100771,1.0,77/176,49.84%,MIF;LSM2;RBBP4;HDAC1;YBX1;ID2;GAPDH;RBBP7;RGCC;RPS26;RACK1;TYMS;CCL3;EIF4A3;GZMB;DHFR;CITED2;PTBP1;IFNG;ANXA7;MRPL13;RIDA;EZH2;OVOL2;CENPV;PTRH2;ZFP36;SHMT1;HELLS;CNOT10;APP;HRAS;CNOT9;DXO;CCR1;PARK7;PUS7;IL10;PPHLN1;EED;VDR;SUZ12;IGF2BP3;PARP9;STC2;AURKA;ZC3H12A;ENG;PINK1;FGF2;TOB1;DLL4;VEGFA;MYADM;FCGR2B;METTL3;CPNE1;HDAC9;SLC11A1;CREB3L1;FOXP1;ACVRL1;DNMT3B;MTF2;KLF4;PNPT1;TGFB2;NOS2;ZC3H12D;APLN;FFAR4;CIDEA;PRKAA1;IGF1;WNT4;MSR1;NANOS3
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4108297371170877,1.4700753832417564,0.053304904051172705,0.12053966905782935,1.0,24/40,33.42%,ELOC;POLR2C;POLR2H;ELOF1;ADRM1;POLR2L;NCBP2;POLR2E;GTF2H3;GTF2F2;NCBP1;ERCC3;CDK7;CCNK;GTF2H2;POLR2F;GTF2H4;POLR2B;ELP2;ERCC2;LEO1;PCID2;SSRP1;GTF2H1
gsea,regulation of immune effector process (GO:0002697),0.537315474227991,1.4693914316389476,0.041278295605858856,0.12075005482466482,1.0,2/16,2.13%,C1QBP;PHB2
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.39372374306317276,-1.4692676566528786,0.04497354497354497,0.19939378486319811,0.999,13/34,22.68%,PTK2B;PIK3CA;ITGB3;ROCK2;NCKAP1;ROCK1;NRP1;PRKD2;VAV2;CYFIP1;MAPKAPK2;ELMO2;NCF1
gsea,actin cytoskeleton reorganization (GO:0031532),-0.40345466901604404,-1.4685403417174552,0.029900332225913623,0.19888641817274044,0.999,15/31,35.04%,MYH9;FLNA;SIPA1L1;NEDD9;MINK1;TNIK;NRP1;RICTOR;CTTN;BCAR1;KIT;S1PR2;GPR65;GSN;PAK1
gsea,response to organonitrogen compound (GO:0010243),0.4575780758350326,1.4656115691624474,0.07720588235294118,0.12355997117735201,1.0,3/17,7.96%,RNF5;DHFR;IRF5
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),0.4923357987941393,1.4635538794774081,0.06261859582542695,0.12488109357829259,1.0,6/17,21.91%,EEF1A1;ZFP36L1;DUSP22;ZFP36;DUSP3;KNSTRN
gsea,inorganic anion transmembrane transport (GO:0098661),-0.4104708337239866,-1.4615858445910819,0.04878048780487805,0.2053220975903816,0.999,10/22,28.19%,SLC20A1;XPR1;ANO6;SLC26A2;SLC37A3;SLC12A2;SLC12A6;SLC4A8;SLC37A1;SLC12A3
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),0.47784091175509674,1.4595069491656991,0.07722007722007722,0.12799735014695782,1.0,7/20,15.69%,PHB2;PSME2;ID2;EZH2;TM4SF5;PSME3;E2F1
gsea,positive regulation of multicellular organismal process (GO:0051240),0.33654011102244524,1.4592714437520664,0.01079136690647482,0.1278361217325293,1.0,71/149,44.85%,CFL1;NME2;PLAC8;MIF;C1QBP;ENO1;FABP5;HILPDA;GAPDH;RGCC;VAMP8;CEBPB;IFNG;HADH;EZH2;CTNNB1;ACADL;VAMP7;ZBED3;GATM;DECR1;ITGAX;TNFSF4;AGPAT2;AXIN2;GLIPR2;SHLD1;IL21;XBP1;FBXO5;TBXA2R;AGPAT1;IL10;VDR;GCNT2;GRB10;CD36;IL1B;TWIST1;BATF;ZBTB16;GADD45G;SYK;LEF1;BAMBI;FGF2;CCR2;WWTR1;SMTNL2;VEGFA;DAB2;HAP1;GHSR;IL2;FLOT1;SLC11A1;APPL2;LRP1;CRTAM;FGR;LOXL2;HSF1;SOX8;INHBA;TSHR;NFAM1;TGFB2;IL23A;GPR3;COL1A1;CADM1
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.35738298968036386,1.4553109424099142,0.024890190336749635,0.1308484232267913,1.0,45/95,42.11%,RPS27L;NPM1;VIM;RGCC;PRMT1;EIF6;EIF4A3;HNRNPD;ASS1;IFNG;METTL5;AKT1;GIPC1;HSP90AB1;PAOX;MID1IP1;BCL3;KLF2;EIF3D;CDT1;LPGAT1;PYM1;RPL5;EEF2;PARK7;SLC6A9;TLR4;PIWIL2;MYC;CD36;IL1B;TYRP1;MFSD2A;FGF2;NR1H3;PCNA;PTGS2;METTL3;SCARB1;DNA2;CTDNEP1;EGR1;EDN1;PLXNB2;KLF4
gsea,B cell receptor signaling pathway (GO:0050853),0.4518173376233994,1.4551219661189816,0.06962025316455696,0.13069186650740572,1.0,4/22,17.22%,CTLA4;BAX;LAT2;CD38
gsea,regulation of interleukin-17 production (GO:0032660),0.5287182747919511,1.4544727098276047,0.05718475073313783,0.13093343758782944,1.0,12/18,33.04%,IFNG;PHB;SLAMF6;CCL1;TNFSF4;OSM;LY9;IL21;PRNP;TLR4;RFTN1;SPHK1
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42293824328969065,1.453452989085971,0.04006677796327212,0.1315378781742392,1.0,10/37,17.57%,CDK4;MED30;BAX;CDK1;CEBPB;MED8;CTNNB1;CCNB1;RELA;TRIM28
gsea,mRNA stabilization (GO:0048255),0.4823886776173401,1.4529203494099114,0.08982035928143713,0.1316686277873179,1.0,11/22,23.31%,YBX1;YBX3;HNRNPA0;HNRNPC;FUS;ZFP36;TENT5A;E2F1;AXIN2;TAF15;THRAP3
gsea,negative regulation of double-strand break repair (GO:2000780),-0.4690100827300645,-1.4518779958738608,0.061611374407582936,0.2160360449102671,1.0,6/20,15.72%,RIF1;UBR5;POLQ;SMCHD1;TFIP11;UBQLN4
gsea,regulation of protein localization (GO:0032880),-0.4168140819674688,-1.4502334432216755,0.056640625,0.21671195896967066,1.0,18/30,29.66%,CTSD;PICALM;AAK1;ITGB3;MAP2;PLEKHM2;FBXW7;TRIM25;MAPK8;BORA;DVL3;TRIM14;TRIM46;DVL1;TRIM5;PPM1F;CEP290;ATCAY
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.41598820011430243,1.449266679238808,0.04132231404958678,0.13442328861710387,1.0,17/38,35.26%,UBB;RPS27A;PRDX4;CD14;AKT1;RELA;BCL3;RIPK2;TNFRSF1A;TLR7;NFKBIA;TLR4;IRAK1BP1;BIRC3;NKIRAS2;TIFA;TRAF2
gsea,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.553585639206397,1.4488045674828112,0.056338028169014086,0.13449291301147911,1.0,8/17,28.85%,ASS1;IFNG;AKT1;HSP90AB1;KLF2;TLR4;CD36;IL1B
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3554113090148642,-1.4480052820339864,0.0380952380952381,0.21788387049647395,1.0,26/49,36.13%,CBL;NEDD4;PIK3CA;MAZ;NLRC3;JAK2;PIP5K1C;IRS2;PIK3CG;PIP4K2B;TSC2;CEACAM1;F2R;PIK3CD;PDGFB;NCF1;PTPN13;STAMBP;CCL5;F2RL1;KIT;DAB2IP;SIRT1;FLT1;PIK3R5;LYN
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.3703458381485076,1.447015050155179,0.03403565640194489,0.13572928975403034,1.0,34/74,31.01%,RPA3;CAPG;BAX;PSMC4;RACK1;RPA2;PSMC2;BAK1;IFNG;RHOC;MTLN;PSMC6;PLEK;PSMC5;GTF2H3;ERCC3;CDC42EP2;CDT1;LGALS3;PIH1D1;GTF2H2;PARK7;BID;TLR4;GTF2H4;ISG15;CHD1L;TPPP3;CUL4B;CD36;CXCL13;ERCC2;AJUBA;SYK
gsea,regulation of fibroblast proliferation (GO:0048145),0.43467241201034734,1.445749897472039,0.054628224582701064,0.13655743106016302,1.0,13/27,38.17%,CDK4;S100A6;MIF;CTNNB1;PEX2;E2F1;PDGFA;MYC;CD300A;CD74;SPHK1;FN1;WNT1
gsea,positive regulation of hydrolase activity (GO:0051345),0.36033394210791886,1.4445435960724173,0.03392330383480826,0.13727263600839446,1.0,30/81,35.82%,S100A10;CALM2;PIN1;RGS10;RACK1;CCL3;XCL1;HMGB2;RHOC;RSU1;CCL4;EZH2;SH3BP1;CCL1;RASGRP2;EVI5;RGS16;HRAS;CTSH;CCL8;RIPK3;CX3CL1;TBC1D7;CCL25;TGM2;SGSM3;PINK1;CD40;CCL7;CCL2
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2685680949262619,-1.443987999367664,0.0,0.22126328996862737,1.0,242/442,41.61%,KMT2A;STAT3;KMT2D;CHD8;ZMIZ2;BPTF;EPAS1;EP300;RPS6KA3;ATRX;ETS1;GABPB2;AKNA;DDX3X;SREBF2;CREBBP;MED13;MEPCE;HCFC1;SMARCA4;ARNT2;ELK4;HIVEP1;ATAD2;SETX;KDM6B;YY1;SKI;TMPRSS6;NFAT5;SP1;BCL11B;NCOA1;JUP;NR4A3;PAXBP1;ZEB2;TET2;NCOA3;CDC73;NOTCH1;KAT6A;SMAD7;TBL1XR1;AGO1;AGO2;ASXL1;TRERF1;TCF20;PHIP;HELZ2;ZBTB38;MLLT6;PLXND1;ATMIN;AHI1;TFEB;DOT1L;MLXIP;CAMTA2;LPIN2;FOSL2;DHX9;MED12;GCN1;TET3;ELF4;NKRF;GLYR1;KAT6B;KMT2C;RUNX2;PRDM4;SBNO2;HDAC4;ATF4;ACTR2;ARNT;NFKB2;BCLAF1;TCF12;BCL9L;PRKDC;MICAL2;FOXM1;NCOA6;MED16;PRPF6;FOXO1;CDK12;BCAS3;ABL1;BRD8;ZMIZ1;MED1;BRCA1;E2F7;JUN;POU2F1;FUBP3;STAT6;ZBED4;HSF2;NR3C1;ELK3;GTF2F1;CREB1;E2F3;STAT5B;PRKD2;TXK;TGFB3;KAT2B;LRP6;TFE3;PRDM2;NPAT;SENP1;AKIRIN2;DVL3;ARRB1;FOXO3;NCOA2;DCAF6;SLC9A1;E2F2;NRIP1;CEBPZ;POU2AF1;TAF6L;CDKN2B;SIN3A;RIPK1;NFKB1;RHOQ;ARHGEF2;NFIC;FOSL1;PPRC1;PDGFB;ZFPM1;MAML2;SMAD3;EGR2;HIPK2;PFKM;TNIP2;RARA;PER1;DDX58;HDAC5;ATF6;DVL1;MYBL1;CREBRF;STAT1;E4F1;INO80;GNL3;FOXK2;SOX4;ARNTL;CLOCK;SPI1;MED14;APBB1;SPIB;ACVR1;FHOD1;MC1R;RPS6KA5;DLL1;KAT2A;TNIP3;PAXIP1;HINFP;EOMES;MRTFB;MAPK7;EPCAM;AR;MEF2C;CITED4;RARG;PELP1;CHUK;F2RL1;GATA3;NR5A2;LPIN1;FOXF1;SSBP2;GLIS1;BCLAF3;UHRF1;RFX5;PRDM10;TAF6;XRCC6;DAB2IP;RORB;HNRNPU;TNIP1;IL33;SERPINE1;RUNX1;LARP7;TBL1X;MYO6;FOXO4;MED24;SIRT1;REST;CTBP2;ITGA6;PLAGL1;YAP1;TCF4;NFATC2IP;SMARCA2;MITF;MED4;RBL1;HIF1A;ETV5;NOS1;DLGAP5;E2F5;POU2F2;TFCP2;KDM1B;TCERG1;SRF;RBM14;KAT7;IKBKG;WWC1;TNF;SMARCA5;RBMX;ETV4;AHR
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.36657528431550895,1.443822530214415,0.0304,0.1375893449475839,1.0,29/73,35.88%,RPS27L;NPM1;VIM;RGCC;PRMT1;EIF6;EIF4A3;HNRNPD;IFNG;METTL5;AKT1;BCL3;EIF3D;CDT1;PYM1;XBP1;RPL5;EEF2;SLC6A9;CIITA;TLR4;PIWIL2;MYC;IL1B;NAMPT;FGF2;PCNA;CCL2;METTL3
gsea,positive regulation of monooxygenase activity (GO:0032770),0.5173393437109014,1.44379696838562,0.04754601226993865,0.13728555847209395,1.0,8/17,28.85%,DHFR;IFNG;AKT1;GCH1;PARK7;VDR;S100A1;IL1B
gsea,regulation of neuron death (GO:1901214),0.39707113462559146,1.4412799181086138,0.0467741935483871,0.13918938700286135,1.0,18/43,35.81%,UBB;EIF2S1;DDIT4;IFNG;NAE1;HTRA2;LANCL1;AKT1;SIGMAR1;PARK7;PRNP;CTSZ;RRAS2;CHGA;VPS35;FOS;TRAF2;FCGR2B
gsea,phosphatidylinositol biosynthetic process (GO:0006661),-0.34965257580760467,-1.4412447759630476,0.044642857142857144,0.22318143469428,1.0,41/65,37.08%,ITPKB;PIK3CA;SBF1;MTMR3;PITPNM2;PI4KA;PIP5K1C;PIK3C2A;PLCG2;PIK3CG;MTMR12;PIGN;PIP4K2B;INPPL1;IP6K2;MTMR14;FAM126B;PIK3CD;MTMR4;FAM126A;PIGQ;FIG4;SLC27A1;SYNJ1;SOCS5;PTPN13;VAC14;PLEKHA1;SOCS7;SOCS6;RUFY1;PIGG;PIKFYVE;INPP4B;PI4KB;MTMR1;SYNJ2;PIK3R5;PIGV;PGAP3;PLEKHA8
gsea,positive regulation of cell cycle (GO:0045787),0.3994392176796591,1.438857482769711,0.04538087520259319,0.14103153848823907,1.0,12/39,19.69%,CDK4;RGCC;EIF4E;CCND3;CITED2;ASNS;EIF4EBP1;AKT1;CCNB1;DUSP3;RAD23A;APP
gsea,termination of RNA polymerase I transcription (GO:0006363),0.4535604236004635,1.437481203573817,0.07212475633528265,0.14199824026084218,1.0,14/22,29.35%,TAF1B;POLR2H;TBP;POLR2L;POLR2E;POLR1E;GTF2H3;ERCC3;CDK7;POLR1C;GTF2H2;POLR2F;GTF2H4;ERCC2
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),0.4354912497171692,1.4369588299474052,0.07678571428571429,0.14212188943667253,1.0,9/34,21.30%,UBE2N;EEF1E1;NSMCE1;NSMCE4A;BRCC3;HIC1;ABRAXAS1;TRIM28;TIGAR
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.405166914754702,-1.4369329890076867,0.0700218818380744,0.22549819589313166,1.0,20/40,36.79%,CTSD;DYNC1H1;AP2A2;AP2B1;DCTN1;CLTC;KLC1;CENPE;AP1G1;SEC24A;AP1B1;SEC31A;DYNC1I2;KIF3B;KIF11;DYNC1LI2;KIF2A;PIKFYVE;KIF15;LGMN
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.405166914754702,-1.4369329890076867,0.0700218818380744,0.22549819589313166,1.0,20/40,36.79%,CTSD;DYNC1H1;AP2A2;AP2B1;DCTN1;CLTC;KLC1;CENPE;AP1G1;SEC24A;AP1B1;SEC31A;DYNC1I2;KIF3B;KIF11;DYNC1LI2;KIF2A;PIKFYVE;KIF15;LGMN
gsea,regulation of cilium assembly (GO:1902017),-0.40912306360353723,-1.4362061610429917,0.0532994923857868,0.22489541500288332,1.0,16/29,35.39%,HTT;ARHGAP35;TBC1D13;TBC1D22B;CEP97;EVI5L;TBC1D5;SDCCAG8;CCP110;TBC1D8;KCTD17;TBC1D1;TBC1D10B;YAP1;CEP120;TCHP
gsea,negative regulation of macroautophagy (GO:0016242),-0.4550033240096864,-1.435547695873079,0.07177033492822966,0.22419362345988678,1.0,6/15,15.72%,PIK3CA;USP36;TSC1;TSC2;SMCR8;UBQLN4
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.36918150079245743,1.4355100321300147,0.04634581105169341,0.1430919329898049,1.0,17/43,32.83%,SLC25A5;PRELID1;PPIF;GPX1;FXN;HERPUD1;AKT1;PSME3;RELA;LGALS3;NR4A2;PIH1D1;URI1;PARK7;CX3CL1;PINK1;MPV17L
gsea,recombinational repair (GO:0000725),0.390276873230655,1.4352567411362642,0.05642023346303502,0.14299857929929363,1.0,15/56,23.76%,UBE2N;RPA3;PSMD14;NSMCE1;RPA2;FEN1;SAMHD1;ZSWIM7;RAD51;SFPQ;MMS22L;RHNO1;RAD51D;XRCC1;RAD51C
gsea,cytosolic transport (GO:0016482),-0.36283140363786215,-1.4352306861682451,0.05496828752642706,0.22313712477576117,1.0,28/53,24.56%,DCTN1;ANKFY1;CLTC;LMTK2;HOOK3;GCC2;STX16;AP1G1;VPS13C;DENND5A;RGP1;GAK;WDR81;EEA1;PTPN23;DOP1B;UBE2O;ERC1;TBC1D23;TMEM87A;RBSN;TBC1D5;CLN3;ANKRD27;HEATR5A;HOOK1;KLHL20;HEATR5B
gsea,positive regulation of proteolysis (GO:0045862),0.4196706510516755,1.4349703079528564,0.05023547880690738,0.14287704218145197,1.0,13/32,35.53%,PERP;HDAC2;BAK1;IFNG;FADD;TNP2;PLK1;CTSH;IL1B;BAG2;ZC3H12A;PINK1;STUB1
gsea,negative regulation of cell-cell adhesion (GO:0022408),-0.42245426869797276,-1.4347735672433581,0.05846153846153846,0.2221726172802034,1.0,10/22,28.02%,WNK1;B4GALNT2;AKNA;NOTCH1;NF2;MIA3;CDH1;PPM1F;MAPK7;EPCAM
gsea,regulation of B cell proliferation (GO:0030888),0.4594087291081451,1.4346840379144274,0.05898876404494382,0.14279501000824898,1.0,16/31,37.40%,MIF;CTLA4;TNFRSF4;BST1;CD320;CD38;IL21;GPR183;IL10;CD300A;CD74;CD81;TNFRSF13B;CD40;FCGR2B;IL2
gsea,lymphocyte migration (GO:0072676),0.4874288298222698,1.4342389993138551,0.0847457627118644,0.14284284777578884,1.0,14/21,38.90%,TBX21;CCL3;XCL1;CCL4;CCL1;S1PR1;CCL8;RET;CX3CL1;CCL25;CCL7;CCL2;CCR6;CRTAM
gsea,negative regulation of B cell activation (GO:0050869),0.533840290685042,1.434016678409116,0.07100591715976332,0.14268376484587125,1.0,8/15,35.81%,CTLA4;ID2;BANK1;PARP3;IL10;CD300A;TNFRSF13B;FCGR2B
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.40239514564555035,-1.4335877411651181,0.06986899563318777,0.22232090860789067,1.0,18/41,29.61%,CTSD;DYNC1H1;AP2A2;AP2B1;DCTN1;CLTC;KLC1;CENPE;AP1G1;SEC24A;AP1B1;SEC31A;DYNC1I2;MFSD6;KIF3B;KIF11;DYNC1LI2;KIF2A
gsea,cell cycle G1/S phase transition (GO:0044843),0.3929828454112444,1.4328132852091162,0.06998158379373849,0.14349722535727863,1.0,20/44,28.51%,CDK4;EIF4E;CDK2;CCNA2;NASP;CDKN2C;CDKN2D;EIF4EBP1;RCC1;CDKN3;E2F1;CDK7;BCAT1;GSPT1;PLK2;CCNE1;PIM2;CUL5;MYC;CUL4B
gsea,protein localization to nucleus (GO:0034504),0.36200663520928095,1.4310589294141378,0.054409005628517824,0.14478784004332917,1.0,28/69,40.82%,RAN;NUTF2;HIKESHI;PHB2;NXT1;YWHAE;NUP62;CHCHD10;RPF2;AKT1;TBRG1;BCL3;PLK1;ARL2;NUP85;HHEX;LMNA;PINX1;RPAIN;SYK;NUP88;CSE1L;BBS4;RRS1;APPL2;INTS13;CTDNEP1;GBP2
gsea,positive regulation of neuron death (GO:1901216),0.4479368764596815,1.4308679587075372,0.0576,0.14464845984265873,1.0,15/28,43.49%,BAX;EIF2S1;DDIT4;CCL3;IFNG;CTNNB1;PRNP;TLR4;GRN;FOS;FCGR2B;NUPR1;EGR1;DAXX;TGFB2
gsea,positive regulation of phospholipase C activity (GO:0010863),0.4633390877746349,1.4303140871375561,0.06962025316455696,0.14486299011996612,1.0,6/17,22.31%,PHB2;PHB;CD86;GNA15;S1PR4;HRAS
gsea,regulation of protein export from nucleus (GO:0046825),0.48688023284865517,1.4274253763358855,0.08021390374331551,0.147168284159227,1.0,4/15,11.09%,ANP32B;IFI27;YWHAE;SP100
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4853725241385361,1.426808042280665,0.08847736625514403,0.14736585825284226,1.0,11/17,37.99%,SAMHD1;HSP90AB1;ZBP1;IFNAR2;FADD;ISG15;USP18;OAS3;CACTIN;METTL3;PTPN6
gsea,regulation of TOR signaling (GO:0032006),-0.38242110904947013,-1.4267191106574124,0.05077262693156733,0.22956761782485682,1.0,18/35,26.42%,PIK3CA;RPTOR;DEPDC5;TELO2;TMEM127;TSC1;WDR24;TSC2;SLC38A9;RICTOR;UBR1;SMCR8;TBCK;TTI1;GAS6;RRAGB;ARNTL;ITFG2
gsea,membrane organization (GO:0061024),0.32664012974572976,1.4255663705619923,0.03079416531604538,0.14817268984057108,1.0,46/101,53.29%,UBB;RPS27A;ACTG1;ACTB;SERP1;VAMP8;REEP4;NSFL1C;M6PR;COX18;HSPA8;SYNGR2;TMEM33;VAMP7;IL7R;TLCD1;UBXN2B;EPN2;TRIP10;SGIP1;EPS15L1;TIMM50;STX11;TMEM43;TLCD2;CLTB;DAB2;DVL2;MYADM;CPTP;TGFA;RTP4;CTDNEP1;FNBP1L;AREG;LPCAT2;REPS2;PACSIN2;BTC;DNM1;HBEGF;PICK1;VPS33B;NEMP1;EPS15;DNM3
gsea,phospholipid biosynthetic process (GO:0008654),0.43873171656458804,1.425496504331105,0.0773286467486819,0.14789527289415763,1.0,13/25,36.96%,AGPAT5;CRLS1;IDI1;FDPS;CPNE3;MBOAT1;DPAGT1;DHDDS;AGK;GNPAT;DOLPP1;IDI2;CPNE1
gsea,regulation of cellular senescence (GO:2000772),0.4618901776558027,1.4238367293131007,0.07142857142857142,0.1491223901159721,1.0,6/21,20.36%,EEF1E1;YBX1;HMGA1;RSL1D1;YPEL3;FBXO5
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.3990285299466227,1.4238283148108444,0.059033989266547404,0.14879862563122642,1.0,12/34,29.61%,PFN1;STMN1;CORO1A;PFDN4;VBP1;HSPA8;MID1IP1;TPX2;CRYAB;PFN2;PFDN6;HDGFL3
gsea,"phagocytosis, engulfment (GO:0006911)",-0.4506670299967661,-1.4230884238678059,0.10106382978723404,0.23280254984461746,1.0,4/15,33.89%,MYH9;ITGAM;AIF1;GSN
gsea,regulation of dendrite development (GO:0050773),-0.4379436989696687,-1.4228173149861478,0.08241758241758242,0.2315835290058829,1.0,9/18,31.96%,NEDD4;TNIK;GSK3B;HECW1;LRP8;CAMSAP2;RTN4IP1;KNDC1;DAB2IP
gsea,tRNA transport (GO:0051031),0.4555313122830901,1.422812452263292,0.08658008658008658,0.14939334765410056,1.0,12/30,19.66%,RAN;TOMM20;YBX1;SSB;AAAS;NUP62;NUP43;NUP37;SEH1L;RAE1;NUP54;NUP35
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5046107508883524,1.4223295148331228,0.07142857142857142,0.14952790688400822,1.0,13/21,37.24%,PIN1;EZR;PHB;DUSP10;DUSP3;CAMK2N1;DUSP6;TLR4;RPS6KA6;DUSP4;SPRY1;SIRPA;CNKSR3
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3571493316640847,-1.4210751638217323,0.06168831168831169,0.23222194386164918,1.0,14/32,24.89%,EP300;CREBBP;ZEB2;NOTCH1;JAK2;NUMA1;TGFB3;UBE2O;CDKN2B;TWSG1;GDF11;HIPK2;ADAM17;ACVR1
gsea,regulation of macrophage activation (GO:0043030),0.5176090561217767,1.419296814234738,0.06881405563689605,0.15198167260564716,1.0,10/16,35.81%,MIF;HSPD1;PJA2;TLR4;ZC3H12A;CD74;SPHK1;NR1H3;MFHAS1;FCGR2B
gsea,nucleosome organization (GO:0034728),0.4148597183595828,1.419161850900838,0.07945736434108527,0.15179951608963738,1.0,16/39,23.89%,NPM1;ANP32B;ANP32E;NAP1L1;HMGA1;HMGB2;SMARCB1;SET;ASF1A;NASP;ACTR6;NAP1L4;POLE3;CHAF1B;NAP1L3;GRWD1
gsea,protein export from nucleus (GO:0006611),0.4945747518968465,1.4184412612827386,0.09018036072144289,0.15209503563816518,1.0,3/17,8.17%,RAN;NUTF2;DESI1
gsea,mismatch repair (GO:0006298),0.4657310374135058,1.4178566533137753,0.09645669291338582,0.15225471395228068,1.0,4/24,18.43%,RPA3;RPA2;POLD2;EXO1
gsea,inositol lipid-mediated signaling (GO:0048017),-0.43628648808767634,-1.4177153024125924,0.0764872521246459,0.2351368743472496,1.0,7/20,19.25%,PIK3CA;PITPNM2;PI4KA;PIK3C2A;IRS2;PIK3CG;PIK3CD
gsea,cellular response to alcohol (GO:0097306),-0.4318360343581645,-1.4161546030676333,0.06398104265402843,0.23583490436445662,1.0,7/21,14.61%,LARP1;GRAMD1B;JUP;CDH1;BRCA1;PTCH1;LRP6
gsea,cell junction organization (GO:0034330),0.4522433826008291,1.41602452305675,0.07782672540381791,0.15372848874744555,1.0,6/24,19.69%,ACTG1;ACTB;PIN1;SH3BP1;RAB39B;APP
gsea,beta-catenin-TCF complex assembly (GO:1904837),-0.4258850984456596,-1.4154333588259949,0.06971677559912855,0.2352931927477934,1.0,10/23,24.87%,KMT2D;EP300;TRRAP;CREBBP;SMARCA4;CDC73;BCL9L;TLE4;TLE3;RBBP5
gsea,amide biosynthetic process (GO:0043604),0.46354697421212376,1.4149296316287496,0.08362989323843416,0.15445170909844994,1.0,4/15,25.05%,NMRAL1;ASS1;NANP;AGK
gsea,regulation of protein binding (GO:0043393),0.3493702798113495,1.4147842653766325,0.039603960396039604,0.15423886152505964,1.0,26/64,40.99%,RAN;ACTB;BAX;PIN1;AURKB;RACK1;AKT1;TMC8;RIPK2;APP;PLK1;MEN1;ADD1;PARK7;CTSZ;BAG2;AURKA;HFE;BAMBI;AKTIP;DAB2;CAMK1;FLOT1;LRP1;NVL;TCF7L2
gsea,regulation of complement activation (GO:0030449),0.5323349868129594,1.4146307836191518,0.07044198895027624,0.15401955325552005,1.0,3/16,7.19%,C1QBP;PHB2;PHB
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4321373049425979,-1.414544448705975,0.06779661016949153,0.2348370395943018,1.0,9/21,29.91%,ITGAM;RAB27A;SLC5A3;XDH;PLCG2;RIPK1;PDGFB;TYROBP;F2RL1
gsea,negative regulation of MAPK cascade (GO:0043409),0.4316245737391702,1.413371687549106,0.048051948051948054,0.15478412244849157,1.0,20/46,29.20%,PPIA;PIN1;EZR;PEBP1;PHB;DUSP1;DUSP10;DUSP3;RGS2;DUSP7;CAMK2N1;HYAL2;DUSP6;TLR4;IRAK3;MYC;RPS6KA6;DUSP4;IL1B;CD300A
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5327199545180179,1.4132510151994555,0.11731843575418995,0.15453999853198122,1.0,8/17,26.57%,BUB3;MAD2L1;CDC20;ZWINT;BUB1;PLK1;FBXO5;TRIP13
gsea,positive regulation of mononuclear cell migration (GO:0071677),0.44395992308882304,1.4126602759931688,0.08488964346349745,0.15474086303815032,1.0,8/21,24.77%,C1QBP;HMGB1;CCR7;CCL1;LGALS3;CXCL10;CREB3;CCR1
gsea,negative regulation of cellular biosynthetic process (GO:0031327),-0.3925422183974754,-1.4124266023118686,0.07505518763796909,0.23610292273989958,1.0,15/28,31.28%,ABCA2;EP300;RAPGEF2;ATP2B4;ROCK2;FBXW7;BRCA1;CEACAM1;NFKB1;C1QTNF12;ERLIN2;SLC27A1;CLK2;KHSRP;TRIB3
gsea,positive regulation of protein secretion (GO:0050714),0.3915966414477321,1.4116924880976445,0.06881405563689605,0.15531770266084588,1.0,12/38,33.30%,PPIA;EZR;PPID;MYOM1;EXPH5;CD33;TLR4;CAPN10;WLS;MCU;AACS;APBB3
gsea,response to reactive oxygen species (GO:0000302),0.43190298617127054,1.4111923383567568,0.06747404844290658,0.1555159750062651,1.0,8/24,26.45%,PRDX3;SOD2;GPX1;AKT1;APTX;TPM1;HYAL2;TXNRD2
gsea,vesicle organization (GO:0016050),-0.3986131734595165,-1.4085640167584266,0.0730593607305936,0.23968606927703748,1.0,13/26,27.65%,DNAJC13;HOOK3;LAPTM4B;ALS2CL;VPS11;VPS18;ARFGEF2;ZFYVE16;WASHC4;EXOC8;SNX11;HOOK1;ALS2
gsea,regulation of protein catabolic process (GO:0042176),-0.3729950370607073,-1.4082206666460426,0.060948081264108354,0.23862902380318732,1.0,27/45,37.40%,HUWE1;FLNA;IDE;VCP;NEDD4;AREL1;ATP13A2;MDM4;TNFAIP3;FOXO1;BARD1;GSK3B;FZR1;HECW1;BANP;FAF1;TIPARP;DDB1;HGS;NSF;DTL;DAB2IP;CHEK2;SF3B3;FURIN;HACE1;WWP1
gsea,cytoskeleton organization (GO:0007010),-0.32950691715252545,-1.4076069545267522,0.04152249134948097,0.23796388790914386,1.0,30/60,33.09%,DPYSL2;NEDD9;MAST2;PHIP;DIAPH1;MAST3;PDZD8;TNFAIP3;TNIK;SYNE3;MICAL2;CAMSAP1;LARP4;MAST4;BRWD3;DIAPH3;PAK6;ARHGAP10;NCKIPSD;ZMYM4;MAST1;STRIP1;KLHL20;PLD2;PACSIN3;FGD3;FGD2;APOE;ABI2;SH3D19
gsea,regulation of humoral immune response (GO:0002920),0.5190124421205485,1.4058749121209053,0.09428950863213811,0.16007942384561696,1.0,3/17,7.20%,C1QBP;PHB2;CCR7
gsea,organelle organization (GO:0006996),0.30332556900348295,1.4057641346584824,0.01812688821752266,0.15984583240311664,1.0,82/211,47.84%,PPIA;TMED2;CFL1;CYCS;CENPW;PRDX3;PHB2;HILPDA;STOML2;MTX2;CCL3;ARL1;GEM;GORASP2;NSFL1C;PHB;MTX1;CHCHD10;PEX7;HAX1;TFAM;LMAN2;GABPB1;PEX2;LMAN1;KIFAP3;UBXN2B;ALAS1;SLC25A33;PRPF40A;CDCA8;DYRK3;TFB1M;MTFR1;PPID;BAG5;TPM1;BCS1L;HSD17B10;PARK7;NECTIN2;MYC;DYM;NIPSNAP2;CENPT;FMNL2;SIRT4;FANCG;NRF1;TMED1;AJUBA;CEP78;PTCD2;REEP6;CHGA;PLEKHF1;ABCD1;PINK1;MICAL3;PEX3;CCL7;CCL2;DNAJA3;GABPA;PACSIN1;RAB38;KIF3A;COG7;CAV2;FNBP1L;PARP1;FAM174B;POLG2;DMTN;ESRRA;DST;MICAL1;FMNL3;CIDEA;ANK1;PEX1;CATIP
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4429002528424788,1.4051856104513927,0.09292929292929293,0.1600086615720621,1.0,14/23,29.35%,TAF1B;POLR2H;TBP;POLR2L;POLR2E;POLR1E;GTF2H3;ERCC3;CDK7;POLR1C;GTF2H2;POLR2F;GTF2H4;ERCC2
gsea,transport across blood-brain barrier (GO:0150104),-0.3519144053725899,-1.4051764209167283,0.06441717791411043,0.23977531083467057,1.0,20/42,24.15%,ABCA2;SLC38A2;SLC7A1;TFRC;SLC5A3;ATP2B4;SLC16A1;ATP2A3;SLC44A1;ABCC1;ABCC5;ABCC4;SLC12A2;SLCO3A1;ABCG2;SLC7A5;SLC4A8;SLC38A1;SLC27A1;ATP8A1
gsea,regulation of wound healing (GO:0061041),0.4878687511146556,1.4036277418534027,0.08175182481751825,0.16112687298392026,1.0,3/18,7.51%,ACTG1;SRSF6;ANXA1
gsea,positive regulation of gene expression (GO:0010628),0.29084263708296176,1.4032756183211137,0.025297619047619048,0.1611147284614559,1.0,103/227,45.50%,ACTG1;RPS27L;NPM1;MIF;ACTB;PLSCR1;VIM;SERPINB9;HILPDA;ID2;GAPDH;RGCC;EIF6;EZR;CCL3;EIF4A3;HNRNPD;TAF1B;POLR2H;CITED2;IFNG;HNRNPLL;PHB;TESC;TBP;U2AF2;OVOL2;METTL5;POLR2L;HMGN5;AKT1;POLR2E;POLR1E;ITGAX;TNFSF4;AGPAT2;BCL3;EIF3D;E2F1;PYM1;POLR1C;APP;IL21;RPL5;DNAJA4;MYOM1;EEF2;OSR2;CALCOCO1;AGPAT1;CAMK2N1;RAMP3;POLR2F;FUBP1;MYO1C;PARK7;CTSH;IL10;VDR;TLR4;PIWIL2;MYC;CD36;IL1B;TWIST1;BATF;ZC3H12A;HFE;CD74;LEF1;FGF2;TLE1;DLL4;VPS35;VEGFA;RAMP2;METTL3;GABPA;FLOT1;SLC11A1;FN1;NFE2L2;CRTAM;FGR;CSF2;PID1;DNMT3B;ZPR1;EGR1;PF4;NTRK3;SMAD1;PLXNB2;KLF4;INHBA;NFAM1;DEK;F3;PIK3R1;CADM1;THBS1;TLR2;WNT6
gsea,response to endoplasmic reticulum stress (GO:0034976),0.34217287123975487,1.4029145914765209,0.056910569105691054,0.16114601634577802,1.0,25/61,44.94%,PDIA3;BAX;EIF2S1;CEBPB;RNF5;GORASP2;BAK1;PDIA4;TMEM33;SELENOS;HERPUD1;ATG10;CHAC1;UFL1;DNAJC10;P4HB;MBTPS2;PPP1R15A;BBC3;TRAF2;FLOT1;CREB3L1;ATF3;PIK3R1;THBS1
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),0.376927418306113,1.4024217135246067,0.0406885758998435,0.1613022167194354,1.0,21/47,37.24%,MIF;DDIT4;RACK1;HAX1;AKT1;HSP90AB1;NCK2;OSM;DOCK7;RIPK2;APP;PFN2;CNOT9;RAMP3;TERF2IP;PARK7;LIF;PINK1;VEGFA;CAMK1;CNKSR3
gsea,peptidyl-tyrosine modification (GO:0018212),-0.40525712930126073,-1.3999626822292641,0.0625,0.2453385944191141,1.0,14/23,36.13%,PTK2B;DYRK1A;JAK2;TEC;ABL1;ABI3;TTL;PDGFB;KIT;ABI2;FES;CSF1R;FLT1;LYN
gsea,regulation of DNA binding (GO:0051101),0.4139092789653405,1.3984034670154317,0.07276119402985075,0.1647667550344715,1.0,10/24,25.67%,NME1;HMGB1;SUMO3;HMGB2;SP100;BCL3;E2F1;CDT1;TFAP4;NFKBIA
gsea,cellular protein modification process (GO:0006464),0.27890772486863025,1.3975194655173975,0.002840909090909091,0.165256878385776,1.0,188/480,41.04%,PSMB2;ELOC;CDK4;PSMA3;DDOST;PSMA5;PSMA4;UCHL3;ADPRH;PSME2;GLRX;CST3;PSMD6;LGALS1;RBBP7;UBE2S;PSMB5;PPP2CB;BIRC5;PSMD14;UBE2M;PSMC4;CDK1;AURKB;IGFBP7;PPM1G;SERP1;RPN2;COPS4;PSMD11;PSMB6;PSMA6;PSMC2;CDK2;COPS3;DUSP12;OARD1;PSMD12;BCKDK;NAE1;ANXA1;PDIA6;SLC35A1;DUSP5;PIM3;UBLCP1;PSMB7;DUSP1;PSMC6;PSMD7;PSMD3;COPS2;PRKAG2;ST3GAL4;DCAF13;PSMD2;DUSP2;STT3A;MELK;VRK1;SOCS3;AKT1;PSMD1;DCUN1D1;PDXP;SERP2;LRR1;PSMC5;UBE2L6;ATG10;PSME3;PPP1CB;METAP1;PPP5C;ST3GAL6;AGA;ALG3;COPS5;UFL1;SGK1;DUSP10;CDK7;COPS7A;TRIOBP;KRT10;PENK;PSMC1;DYRK3;DUSP7;ST8SIA1;APP;RABGGTB;PLK1;CISH;MEN1;DCAF4;FBXL14;JMJD7;STRADA;NUB1;RAB13;TIMM50;PDP1;RCN1;SERPIND1;B3GNT3;ART3;ERG;DUSP6;PARK7;PLK2;PARP3;NUAK2;ATG7;CCNE1;PIM2;LMO7;NEK2;ST3GAL5;IRAK3;PARP2;SRPK1;COPS7B;CUL5;ZDHHC6;SUMF2;GMFB;GCNT2;RIPK3;ISG15;GPS1;PARP9;DUSP4;PPP4R1;RET;CUL4B;MAP4K1;SENP8;KLHL3;P4HB;FBXL15;RPN1;HCK;MFGE8;UBE2E2;SIRT4;STC2;RYK;STK39;COQ8A;ZBTB16;AURKA;SYK;MCRS1;NEK7;PTPRM;MPI;PPM1M;TGM2;NEURL2;DCAF7;PINK1;QPCT;PIGH;PSMA8;P3H1;METAP2;CHM;CCL2;EVPL;CTSG;FBXO15;CAMK1;TIMP1;PTPN6;FN1;FGR;BTBD6;ANKRD9;CTDNEP1;LOXL2;RAB38;PRKCZ;ACVRL1;PRKCB;VGF;COG7;CUL1
gsea,cell-cell junction assembly (GO:0007043),0.47283952540549395,1.3925820665956565,0.0946372239747634,0.169766007056468,1.0,5/21,8.78%,ACTG1;ACTB;CD9;RHOC;CTNNB1
gsea,carbohydrate homeostasis (GO:0033500),-0.40250913392265736,-1.3923981724376338,0.08359133126934984,0.25376632724374365,1.0,6/20,32.66%,STAT3;TENT4B;HECTD4;CRY2;SOX4;PYGL
gsea,negative regulation of growth (GO:0045926),0.3546844329941574,1.3911409645155859,0.059800664451827246,0.170877476432045,1.0,21/55,45.76%,ENO1;RBBP7;RACK1;BST2;EI24;PHB;CDKN2C;CDKN2D;HYAL2;ST7L;ENPP1;SH3BP4;GNG4;NME6;ACVRL1;INHBA;PNPT1;PSRC1;TGFB2;CGRRF1;DNAJB2
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.47215507030587356,-1.3907329500864127,0.09001956947162426,0.2546108946057131,1.0,7/16,10.58%,HUWE1;SREBF2;NPEPPS;BAP1;USP36;FBXW7;VPS11
gsea,chromatin organization (GO:0006325),0.3399299343800026,1.3901348735756989,0.06043956043956044,0.17149886548449833,1.0,29/90,42.43%,HMGN2;NPM1;NPM3;RBBP4;HDAC1;HDAC2;HMGN1;NUDT5;HMGB2;SMARCB1;EZH2;INO80C;ACTL6A;HMGN3;MTA2;RUVBL2;PIH1D1;MYC;CHD1L;SUV39H2;RUVBL1;LRWD1;TADA2B;LOXL2;MTF2;FOXA1;DAXX;TADA2A;KDM4B
gsea,regulation of focal adhesion assembly (GO:0051893),-0.36137737252922236,-1.389355833687959,0.06806282722513089,0.25512246148055073,1.0,19/32,36.28%,MACF1;CLASP1;PTPRJ;CORO1C;SLK;PEAK1;ROCK2;CLASP2;ROCK1;BCAS3;NRP1;TSC1;ABL1;RCC2;VCL;SLC9A1;PPM1F;LIMCH1;MAP4K4
gsea,regulation of megakaryocyte differentiation (GO:0045652),0.39414282105534176,1.3882046765768676,0.07992895204262877,0.1730315650106343,1.0,12/32,46.66%,DPY30;HDAC1;PRMT1;EIF6;PITHD1;HMGB2;TESC;ASH2L;PRMT6;PF4;THBS1;WDR5
gsea,regulation of nucleic acid-templated transcription (GO:1903506),-0.2867977025770926,-1.3880628216686701,0.015463917525773196,0.2554304141925938,1.0,91/177,36.62%,DENND4A;ATXN1;STAT3;CHD7;KMT2D;RUNX3;EP300;ATRX;TRRAP;CHD3;BAZ2A;CREBBP;NSD2;HCFC1;ARNT2;SP1;NOTCH1;JMJD1C;ZBTB38;MLLT6;SPTY2D1;FOXN3;NFYA;TFEB;KAT6B;BRCA2;ATXN1L;SBNO2;ATF4;NFKB2;POLR2A;GON4L;ABL1;ZBTB11;ATF7;ZMIZ1;ZBTB4;ZFAT;NR3C1;PHF19;CTR9;PRDM2;PAK6;NCOA2;TAF6L;SRRT;POFUT1;ERC1;MED23;NFATC2;HP1BP3;ACTN4;DVL1;MYBL1;FOXK2;SOX4;ARNTL;CLOCK;SPI1;CCAR2;APBB1;BRDT;RPS6KA5;HINFP;GTF2IRD1;CARM1;TRIP4;MYBBP1A;MEF2C;PML;NLK;NFXL1;MSC;NR5A2;SSBP2;FOXN2;RB1;RORB;CALR;FOXO4;REST;NUP107;SMARCA2;CHEK2;MITF;PSPC1;TULP3;GCFC2;HIF1A;MAFA;NFX1
gsea,protein sumoylation (GO:0016925),0.4131464590389128,1.3877593788089604,0.09876543209876543,0.17314824733460366,1.0,13/36,19.66%,SUMO2;UBA2;SUMO3;AAAS;NUP62;NUP43;NUP37;SEH1L;RAE1;SAE1;TRIM28;NUP54;NUP35
gsea,heme biosynthetic process (GO:0006783),0.4779858983918661,1.3874673206852126,0.08893280632411067,0.1727196568249108,1.0,7/15,20.39%,FXN;ALAD;HMBS;PGRMC1;ALAS1;FECH;CPOX
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),0.4779858983918661,1.3874673206852126,0.08893280632411067,0.1727196568249108,1.0,7/15,20.39%,FXN;ALAD;HMBS;PGRMC1;ALAS1;FECH;CPOX
gsea,cellular glucose homeostasis (GO:0001678),-0.4222127848945291,-1.3868597682812969,0.08064516129032258,0.2555874454326015,1.0,10/21,23.43%,HK1;SLC39A14;ERN1;ZBTB20;FOXO1;UNC13B;GAS6;LRRC8D;FOXK2;SOX4
gsea,protein targeting to membrane (GO:0006612),0.4101272731625578,1.3867801495299727,0.06474820143884892,0.17304339446248732,1.0,15/31,37.68%,ARL6IP1;SSR2;SLC25A17;PXMP2;PEX2;ZDHHC2;PEX5;MYO1C;ZDHHC6;ZDHHC12;ABCD1;ZDHHC15;PEX3;CHM;RTP4
gsea,negative regulation of protein binding (GO:0032091),0.3727674374768326,1.386348651195847,0.04745166959578207,0.17315436734806974,1.0,14/43,36.72%,ACTB;BAX;PIN1;AURKB;RACK1;AKT1;TMC8;PARK7;CTSZ;BAG2;AURKA;HFE;DAB2;CAMK1
gsea,regulation of calcium ion transport (GO:0051924),0.42439375607172874,1.3862924052151793,0.10082644628099173,0.17285937940881085,1.0,6/23,25.40%,CCL3;ORAI1;CCL4;CTNNB1;CCR1;CD33
gsea,positive regulation of stress fiber assembly (GO:0051496),0.444016164675445,1.3853116279796276,0.09693877551020408,0.17351758750611845,1.0,6/22,20.48%,S100A10;RGCC;RHOC;EVL;PFN2;TPM1
gsea,regulation of developmental growth (GO:0048638),-0.4519257847567207,-1.3851166905306505,0.09392265193370165,0.2563039822827696,1.0,10/15,31.34%,ABL1;GSK3B;LATS1;STAT5B;SIN3A;STAT5A;LATS2;DLL1;CTTN;APOE
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.49241316940819,1.3843997993416197,0.10479573712255773,0.17411701307505195,1.0,3/17,28.96%,SUB1;MED30;TWIST1
gsea,regulation of protein kinase activity (GO:0045859),0.34123786565878816,1.3837642917886006,0.043478260869565216,0.17436688252442567,1.0,21/59,43.15%,PPIA;DUSP19;LCP2;CCR7;MMD;PRKAG2;AKT1;MAP2K3;MRNIP;TRAF4;HSPB1;CAMK2N1;TARBP2;PARK7;CEP85;WWTR1;RAP2B;PRKRIP1;FGR;DAXX;SMG8
gsea,regulation of heart contraction (GO:0008016),-0.33002903419909596,-1.3808376619318035,0.06752411575562701,0.2607585933173428,1.0,18/36,36.59%,ITPR3;ATP2A2;ITPR1;SMAD7;ATP2B4;ITPR2;ATP2A3;ATP2B2;CAMK2D;TRPC1;FXYD1;CELF2;TMEM65;ATP1A1;AHCYL1;ASPH;ATP1B1;NOS1
gsea,regulation of defense response (GO:0031347),0.379880299872645,1.380435185551993,0.06591639871382636,0.17743040188494283,1.0,27/46,39.62%,TMSB4X;XCL1;PSMA6;SAMHD1;ANXA1;BST1;ZBP1;TNFSF4;RELA;CASP1;UFL1;TKFC;PARK7;SETD6;IRF1;ZMPSTE24;BIRC3;HCK;GRN;USP18;PIK3AP1;CCR2;PTGS2;FCGR2B;APPL2;FGR;FOXP1
gsea,Golgi organization (GO:0007030),-0.3401187947359595,-1.3800787201798599,0.05466970387243736,0.26026452753951773,1.0,32/58,31.13%,HUWE1;ARFGEF1;GOLGB1;HTT;CLASP1;ATP8B2;SYNE1;SEC16A;GCC2;COG3;STX16;CLASP2;PLEKHM2;ATL3;BCAS3;GAK;DYNC2H1;ATP8B4;OPTN;ATL2;LMAN2L;TRAPPC11;NPLOC4;RAB30;ARHGAP21;PLK3;FBXW8;TRAPPC12;GOLGA2;CUL7;SEC23IP;MYO18A
gsea,protein import into nucleus (GO:0006606),0.389133225209885,1.3793012230470063,0.09722222222222222,0.1781849028418697,1.0,16/47,37.61%,RAN;NUTF2;HIKESHI;PHB2;NXT1;KPNA2;NUP62;AKT1;NUP54;NUP35;NUP85;RPAIN;SYK;NUP88;CSE1L;APPL2
gsea,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3906654948721984,-1.3774398315096057,0.07920792079207921,0.26220346192003996,1.0,7/21,21.15%,WNK1;NEDD4;UTRN;HECW1;CAMK2D;SLMAP;FXYD1
gsea,dephosphorylation (GO:0016311),0.3479981172964398,1.3767027925810094,0.06394316163410302,0.1805564724682502,1.0,33/65,40.20%,PSPH;PPP2CB;PPM1G;DUSP12;DUSP5;UBLCP1;DUSP1;ACP6;DUSP2;PDXP;PPP1CB;PPP5C;HDHD2;DUSP10;DUSP3;DUSP7;TIMM50;PDP1;DUSP6;FRA10AC1;PLPP5;ACP2;DUSP4;PPP4R1;PLPP2;PTPRM;PPM1M;PXYLP1;ALPL;PLPP1;PTPN6;CTDNEP1;DUSP18
gsea,response to hydrogen peroxide (GO:0042542),0.3910743405908918,1.376382747825881,0.08670520231213873,0.18050446398630024,1.0,9/28,27.17%,PRDX3;PPIF;GPX1;ANXA1;FXN;RELA;APTX;PARK7;RIPK3
gsea,cellular response to unfolded protein (GO:0034620),0.4614836594127737,1.3763315302375787,0.12384473197781885,0.18018298805377023,1.0,6/20,30.51%,BAX;BAK1;HSPA8;HSPD1;HSPA9;HSPA2
gsea,axon development (GO:0061564),0.4305998219849958,1.3755846029556182,0.06902086677367576,0.18061271267233628,1.0,8/24,31.65%,S100A6;ACTB;DHFR;DOCK7;APP;RYK;NRCAM;ACTBL2
gsea,visual system development (GO:0150063),-0.3885201429533777,-1.3746226735488745,0.11299435028248588,0.2647784509143902,1.0,5/19,21.87%,ITGAM;HIPK1;HIPK2;C1QA;ATF6
gsea,receptor internalization (GO:0031623),-0.3962427999357443,-1.3742606673891864,0.054878048780487805,0.2637008587754779,1.0,10/24,30.69%,GRK2;PICALM;NEDD4;CLTC;TFRC;ARRB1;CEACAM1;CALCRL;SAG;ITGB1
gsea,positive regulation of protein localization to cell periphery (GO:1904377),-0.390486158755154,-1.3725334704080032,0.07317073170731707,0.2646349297877594,1.0,16/30,31.10%,EPB41;SPTBN1;ITGA3;ATP2B4;NUMA1;ZDHHC5;ZDHHC8;KIF5B;EPB41L2;PTPN9;PDPK1;GPSM2;PRKCE;ITGB1;CNPY4;AKAP5
gsea,lipid biosynthetic process (GO:0008610),0.40459953975411517,1.3724308604727629,0.07219662058371736,0.1836069862296547,1.0,15/37,36.39%,NDUFAB1;AGPAT5;FDFT1;ACSL5;FDXR;MCAT;PDSS1;XBP1;MVK;MBOAT1;GNPAT;DOLPP1;OXSM;IDI2;PDSS2
gsea,negative regulation of cellular protein localization (GO:1903828),0.4385650928487057,1.3702846530047947,0.09666080843585237,0.1856038994712782,1.0,8/21,17.93%,DNAJA1;NSFL1C;TAX1BP3;ACTN2;GPM6B;UBXN2B;LZTFL1;CDT1
gsea,regulation of response to external stimulus (GO:0032101),0.34728339565206023,1.370116292970929,0.05555555555555555,0.18540030753566306,1.0,33/64,39.62%,TMSB4X;XCL1;PSMA6;USP14;SAMHD1;ANXA1;BST1;METAP1;ZBP1;TNFSF4;RELA;CASP1;UFL1;TKFC;PARK7;SETD6;IRF1;ZMPSTE24;CD36;BIRC3;CX3CL1;HCK;GRN;USP18;PIK3AP1;NMT1;CCR2;METAP2;PTGS2;FCGR2B;APPL2;FGR;FOXP1
gsea,sterol metabolic process (GO:0016125),0.4212135773931437,1.3695866004020452,0.10465116279069768,0.18558765741414554,1.0,13/26,38.96%,FDX1;SC5D;PRKAG2;FDXR;MSMO1;RXRA;DHCR7;TM7SF2;CH25H;GBA2;PMVK;NSDHL;INSIG1
gsea,regulation of DNA repair (GO:0006282),0.4309604082203467,1.3694535919206354,0.12773722627737227,0.18535078347824085,1.0,9/26,21.30%,UBE2N;UBE2V2;WRNIP1;BRCC3;AXIN2;ABRAXAS1;TRIM28;USP1;TIGAR
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.32389206002414944,-1.3689598307732167,0.04559270516717325,0.2681469871073397,1.0,28/53,38.56%,IQSEC1;ETS1;CLASP1;PTK2B;ITGB3;ROCK2;PLCG1;CLASP2;PLCG2;BCAS3;NRP1;ABL1;PIK3CG;DOCK5;PRKD2;PRKCA;PIK3CD;ADAM9;HDAC6;BCAR1;PPM1F;RIN2;PRKCE;GATA3;CALR;MAP4K4;HIF1A;PIK3CB
gsea,defense response to virus (GO:0051607),0.35816862679874556,1.367792359239019,0.07528641571194762,0.18675525468103885,1.0,33/70,38.19%,PLSCR1;PHB2;SERINC3;DDIT4;IFI27;BST2;G3BP1;SAMHD1;PHB;EXOSC5;ZBP1;IFNAR2;RELA;FADD;NDUFAF4;EXOSC4;IL21;CXCL10;IRF2;ATG7;TLR7;IRF1;RIPK3;ISG15;CLPB;OAS3;TTC4;CD40;BNIP3;RNASE6;ACOD1;RTP4;IRF7
gsea,regulation of peptide hormone secretion (GO:0090276),-0.3672818974636588,-1.3671176816851043,0.07911392405063292,0.26900847821845386,1.0,11/27,31.43%,CHD7;ITPR3;ITPR1;ITPR2;PRKCA;CACNA1A;ARNTL;CLOCK;CACNA2D2;CCL5;PASK
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.46778702817871287,1.3666855132790972,0.13733075435203096,0.1876143634146304,1.0,9/22,20.36%,UBE2C;DUSP1;ANAPC15;CCNB1;CDC23;RIOK2;CDC16;PLK1;FBXO5
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.35069286891108303,1.366535159917153,0.064030131826742,0.18736123265383642,1.0,17/56,35.26%,HINT1;CRIP1;C1QBP;BAX;CEBPB;BAK1;HTRA2;HIC1;CHAC1;E2F1;DNAJC10;CUL5;PPP1R15A;BBC3;BNIP3;MLLT11;TRAF2
gsea,cellular response to nutrient levels (GO:0031669),-0.3850100577438372,-1.3655896242429177,0.07857142857142857,0.2696934589072983,1.0,12/30,26.90%,EHMT2;SREBF2;RPTOR;TFEB;FOXO1;TSC1;EIF4G1;CDKN2B;WRN;ULK1;RRAGB;LPL
gsea,positive regulation of intracellular protein transport (GO:0090316),-0.320022566142412,-1.3653710380924005,0.041474654377880185,0.2685400833280686,1.0,38/71,38.17%,HUWE1;FLNA;SFN;ITGAM;SREBF2;JUP;UBR5;NPEPPS;SEC16A;BAP1;USP36;FBXW7;PCNT;BCAS3;ICE1;YWHAG;VPS11;CDH1;C2CD5;GSK3B;MAPK8;XPO4;IPO5;PCM1;TM9SF4;KIF20B;SMAD3;GAS6;PRR5L;PLK3;BAG3;CEP290;BCL2;AKAP5;ECT2;CSNK2A2;DMAP1;PMAIP1
gsea,calcium ion transport (GO:0006816),0.3577994659760621,1.3644871036503896,0.07413793103448275,0.18928371563774746,1.0,21/41,50.90%,TPT1;CCL3;ORAI1;PSEN2;SLC3A2;RAMP3;SLC24A5;CCR1;CCL8;TRPM1;RAMP1;TRPA1;RAMP2;CACNB3;CACNA1B;CACNA2D1;CACNA1S;CACNA2D4;GRIN3A;RYR1;CCR5
gsea,negative regulation of protein-containing complex assembly (GO:0031333),-0.3857358942103446,-1.3643637679943927,0.09248554913294797,0.2682524185678198,1.0,13/26,26.89%,EP300;DDX3X;NLRC3;HSPA5;AIDA;TFIP11;GSK3B;IMPACT;KIF14;PMEPA1;ULK1;ANKRD27;HDAC6
gsea,extracellular matrix disassembly (GO:0022617),0.45888068700957896,1.3632257720167302,0.08997050147492626,0.19023613135279172,1.0,4/22,18.65%,CAPG;BSG;CTSS;CTSL
gsea,calcium ion transmembrane import into cytosol (GO:0097553),-0.4109933300493737,-1.3630068982085386,0.10301507537688442,0.2686611933519335,1.0,7/17,17.71%,ITPR3;ITPR1;ATP2B4;ITPR2;PLCG2;IBTK;F2R
gsea,RNA modification (GO:0009451),0.37650589390781336,1.3627987963545332,0.08519269776876268,0.19031882862407393,1.0,25/42,42.19%,NOP10;SSB;ELP5;THG1L;TRMT6;TRDMT1;TYW5;NSUN2;TFB1M;TRMT1;DTWD1;PUS7;THUMPD1;TRUB1;CTU2;TRMT61A;ADAT2;METTL1;METTL3;TSR3;FTSJ1;CTU1;NOP2;LCMT2;WDR4
gsea,carbohydrate derivative biosynthetic process (GO:1901137),0.4757897733777062,1.362442112918891,0.11787819253438114,0.19039221396452552,1.0,4/15,11.08%,RRM2;TKT;ST3GAL4;RRM1
gsea,regulation of cytokine production (GO:0001817),0.3290552721742679,1.3623344757045321,0.061068702290076333,0.190120354944904,1.0,30/70,39.62%,MIF;HILPDA;GAPDH;RGCC;IFNG;CCR7;ANXA1;IRF8;ZBP1;TNFSF4;AGPAT2;IL21;AGPAT1;IL10;IGF2BP3;RIPK3;ISG15;BATF;CCN4;CCR2;DTX4;FCGR2B;SIRPA;FLOT1;HDAC9;SLC11A1;IRF7;CRTAM;FGR;FOXP1
gsea,regulation of telomere maintenance (GO:0032204),-0.44709380669546506,-1.3620830088255704,0.10039370078740158,0.2684848699794791,1.0,13/20,29.97%,ATRX;UPF1;USP7;RTEL1;YLPM1;SMG6;TERF2;RAD50;ERCC4;GNL3;SIRT6;PML;PPP1R10
gsea,gene silencing by miRNA (GO:0035195),-0.4602057442578689,-1.3613950432672082,0.12525667351129363,0.2680893723558666,1.0,10/17,14.43%,CNOT1;DICER1;PUM2;TNRC6A;ZC3H7B;AGO1;AGO2;ADAR;SPOUT1;MOV10
gsea,telomere organization (GO:0032200),0.40142717442856934,1.3609403968485962,0.09819639278557114,0.19123778457663843,1.0,16/35,42.92%,RPA3;PTGES3;RPA2;APEX1;POLD2;SP100;RAD51D;TERF2IP;PARP3;PCNA;POLD1;DNA2;NBN;PARP1;POLD3;HUS1
gsea,primary neural tube formation (GO:0014020),-0.42275847344262696,-1.3603890583618874,0.11670480549199085,0.2664317394691277,1.0,7/17,27.01%,SKI;TSC2;LRP6;SCRIB;SEMA4C;MTHFR;MTHFD1L
gsea,tube closure (GO:0060606),-0.42275847344262696,-1.3603890583618874,0.11670480549199085,0.2664317394691277,1.0,7/17,27.01%,SKI;TSC2;LRP6;SCRIB;SEMA4C;MTHFR;MTHFD1L
gsea,spindle assembly checkpoint signaling (GO:0071173),0.519590445477857,1.3581789529270787,0.14391143911439114,0.19313450555390635,1.0,7/16,26.57%,BUB3;MAD2L1;CDC20;ZWINT;BUB1;PLK1;TRIP13
gsea,mitotic spindle checkpoint signaling (GO:0071174),0.519590445477857,1.3581789529270787,0.14391143911439114,0.19313450555390635,1.0,7/16,26.57%,BUB3;MAD2L1;CDC20;ZWINT;BUB1;PLK1;TRIP13
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),0.519590445477857,1.3581789529270787,0.14391143911439114,0.19313450555390635,1.0,7/16,26.57%,BUB3;MAD2L1;CDC20;ZWINT;BUB1;PLK1;TRIP13
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3881808891894477,-1.3576121577618583,0.0943952802359882,0.2687928603307234,1.0,8/21,23.89%,HIP1R;CBL;HIP1;FBXW7;ARAP1;DGKD;NCF1;ADAM17
gsea,regulation of interleukin-8 production (GO:0032677),0.4060136238873994,1.357028619267364,0.08671328671328671,0.1939664537259548,1.0,17/36,32.93%,TMSB4X;HMGB1;ANXA1;CD14;RELA;BCL3;FADD;HYAL2;PARK7;IL10;TLR7;CD33;TLR4;IL1B;SYK;CD74;CACTIN
gsea,negative regulation of lymphocyte proliferation (GO:0050672),0.45132240508849686,1.3568525597420331,0.12098009188361408,0.19378810274968128,1.0,9/23,35.81%,CTLA4;CEBPB;PDCD1LG2;CD86;IL4I1;IL10;CD300A;TNFRSF13B;FCGR2B
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),0.3824595202148321,1.3567254460333198,0.07348242811501597,0.19353536331733345,1.0,11/35,34.72%,TMSB4X;RGCC;HMGB1;SH3BP1;AKT1;MAP2K3;HSPB1;GADD45A;FGF2;CD40;VEGFA
gsea,positive regulation of viral genome replication (GO:0045070),0.43592758320041797,1.3555650021913381,0.10964083175803403,0.19443871703676882,1.0,8/19,26.33%,PPIA;PPIH;PPIE;TMEM39A;RAD23A;PPID;TARBP2;SRPK1
gsea,regulation of protein polymerization (GO:0032271),0.46799368574925426,1.355332895500592,0.1044776119402985,0.19431549053521638,1.0,5/18,28.11%,PFN1;HAX1;PFN2;ARL2;TPPP3
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.2629803206244119,-1.3550199789375665,0.015772870662460567,0.2708463489312433,1.0,156/295,40.96%,CNOT1;ATXN1;TLE5;NCOR2;STAT3;EHMT2;DICER1;CHD8;RUNX3;BPTF;EP300;USP9X;ATRX;TRPS1;CHD3;SREBF2;CREBBP;SKIL;HCFC1;SMARCA4;ELK4;HIVEP1;NEDD4;YY1;SKI;TMPRSS6;NR4A3;ZEB2;FOSB;CDC73;RIF1;NOTCH1;SPEN;SMAD7;CBX5;TBL1XR1;MAZ;MXI1;MXD4;CBX6;MDM4;TAF1;BCOR;JDP2;GATAD2B;TRIM33;DNMT3A;HDAC4;ATF4;ATN1;KDM2B;FOXM1;MIER3;ZBTB4;MED1;E2F7;JUN;CC2D1A;PTCH1;NR3C1;ARID5B;CRY2;ZMYM5;SAP130;IMPACT;CTR9;HEXIM1;PRDM2;MNT;SOX10;KLF11;FOXO3;YEATS2;NRIP1;ZHX1;MTDH;MCPH1;SIN3A;FOXP4;NFKB1;ZEB1;NFIC;PDGFB;ZFPM1;SMAD3;IKZF5;MAFK;RARA;PER1;HDAC5;STAT1;E4F1;PHF21A;ETS2;OTUD7B;ZBTB1;KMT5A;PLK3;BAG3;SPI1;FST;CXXC5;APBB1;BMI1;BRMS1L;HOXB13;MXD1;HSPA1A;SATB1;SIRT6;GTF2IRD1;EOMES;BATF3;RIPPLY3;AR;MEF2C;RARG;ZKSCAN3;GATA3;GLIS1;PRDM1;UHRF1;RB1;TRIB3;DAB2IP;CALR;HNRNPU;NCOA5;IL33;PRDM16;RUNX1;LARP7;TBL1X;ARID5A;ZFP90;SIRT1;REST;CTBP2;YAP1;ZBTB21;PRDM5;SMARCA2;MITF;ZBTB32;ETV5;NFX1;TAF3;ERF;DMAP1;FNIP1;KDM1B;TCERG1;SRF;CTCF;WWC1;TNF
gsea,regulation of cell division (GO:0051302),0.395024929391104,1.3548617699950871,0.1016949152542373,0.19446720830952113,1.0,12/38,30.74%,CALM2;PIN1;AURKB;ORC6;RACK1;PDXP;PRPF40A;PLK1;TXNIP;PLK2;MYC;AURKA
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2555800387298467,-1.3544005260220715,0.009708737864077669,0.2703258231356965,1.0,232/427,41.87%,FLNA;CNOT1;ATXN1;TLE5;NCOR2;STAT3;EHMT2;DICER1;CHD8;RUNX3;BPTF;EP300;USP9X;TRPS1;CHD3;SREBF2;CREBBP;SKIL;IKZF1;HCFC1;SMARCA4;ELK4;HIVEP1;ATF7IP;CIC;YY1;SKI;TMPRSS6;CALCA;BTAF1;NR4A3;ZEB2;USP47;FOSB;CDC73;RIF1;NOTCH1;SPEN;KAT6A;SMAD7;CBX5;TBL1XR1;KDM2A;MAZ;TRERF1;PHC3;MXI1;ZBTB38;MXD4;CBX6;MDM4;TAF1;FOXN3;SMARCC2;BAP1;BCOR;JDP2;GATAD2B;NACC1;NKRF;KAT6B;TRIM33;RUNX2;SBNO2;DNMT3A;HDAC4;ATF4;CENPF;ATN1;JARID2;BCLAF1;KDM2B;RBM15;FOXM1;IKZF4;FOXO1;MIER3;ZBTB4;MED1;RLIM;MBTD1;BRCA1;ILF3;E2F7;JUN;POU2F1;GCLC;SAMD1;PTCH1;CBX3;NR3C1;ARID5B;ELK3;CREB1;CRY2;ZMYM5;SAP130;IMPACT;CTR9;HEXIM1;PRDM2;MNT;SOX10;KLF11;FOXO3;BAHD1;YEATS2;NRIP1;ZHX3;WNT11;ZHX1;MTDH;MCPH1;SIN3A;FOXP4;NFKB1;ZEB1;BTRC;NFIC;PDGFB;ZFPM1;SMAD3;IKZF5;MAFK;RARA;GAS6;PER1;HDAC5;CIPC;KDM5C;PHC1;PAX9;STAT1;E4F1;L3MBTL3;PHF21A;ETS2;OTUD7B;FOXK2;ZBTB1;KMT5A;PLK3;ARNTL;CLOCK;SPI1;CCAR2;FST;CXXC5;APBB1;SPINDOC;BMI1;BRMS1L;KDM4A;HOXB13;MXD1;SATB1;RPS6KA5;HINFP;SIRT6;HDAC6;GTF2IRD1;EOMES;BATF3;RIPPLY3;MYBBP1A;PPM1F;AR;MEF2C;PML;RARG;RBM15B;ZKSCAN3;GATA3;BCL7A;GLIS1;PRDM1;UHRF1;RB1;TRIB3;XRCC6;DAB2IP;RORB;PTPRK;CALR;HNRNPU;NCOA5;IL33;PRDM16;RUNX1;LARP7;TBL1X;ARID5A;ZFP90;SIRT1;REST;CTBP2;ZBTB14;YAP1;BASP1;ZBTB21;EHMT1;PRDM5;SMARCA2;MITF;PSPC1;ZBTB32;GCFC2;ETV5;NFX1;BMP7;TAF3;ERF;MT3;WWP1;L3MBTL2;DMAP1;PRMT2;RCOR3;FNIP1;CIART;KDM1B;TCERG1;SETDB2;SCML4;CDKN2A;CTCF;KAT7;WWC1;TNF;AHR;XRCC5;E2F8
gsea,steroid biosynthetic process (GO:0006694),0.4646064654677657,1.3528729542269915,0.10232558139534884,0.19622895295930043,1.0,14/23,38.96%,HSD11B1;SC5D;PRKAG2;FDFT1;FDXR;MSMO1;HSD11B2;HSD17B10;OSBPL9;DHCR7;TM7SF2;CH25H;PMVK;INSIG1
gsea,natural killer cell activation (GO:0030101),0.48594826125344154,1.3519965010595532,0.10431654676258993,0.1967721561857077,1.0,3/15,18.18%,PRDX1;SLAMF7;RABL3
gsea,organic anion transport (GO:0015711),0.39838272498471317,1.35188363635152,0.08458646616541353,0.19647942723563705,1.0,9/27,23.41%,SLC25A17;SLC35A1;SLC35C2;SLC35B1;SLC2A6;SLC19A1;SLCO4A1;SLC4A5;CYB5R1
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.456138164611788,1.351434821008659,0.10060975609756098,0.19662135517973212,1.0,6/19,20.14%,CALM2;DDIT4;PRKAG2;RIPK2;APP;PLK1
gsea,phosphatidylcholine biosynthetic process (GO:0006656),-0.4571711158728076,-1.349845348554128,0.1360824742268041,0.2751597656141098,1.0,10/15,32.49%,CHKA;LPIN2;STARD10;PCYT1A;SLC44A1;GPAT4;SLC27A1;STARD7;LPIN1;CSNK2A2
gsea,substrate adhesion-dependent cell spreading (GO:0034446),-0.4410984895483455,-1.3497461229138354,0.12128712871287128,0.273817936217033,1.0,7/15,18.00%,ITGA4;ITGB3;PEAK1;LAMC1;NRP1;SRGAP2;KIF14
gsea,neuron differentiation (GO:0030182),0.32875378620300516,1.3495658347195014,0.10136157337367625,0.1983259585849851,1.0,28/54,49.29%,MANF;PIN1;ID2;DDIT4;CASP3;CTNNB1;ERCC3;TDP2;NIF3L1;XBP1;NR4A2;ERCC2;RYK;WNT10A;VEGFA;WNT1;FOXA1;INHBA;INSM1;TGFB2;FZD3;PBX4;WNT6;FZD7;MET;BHLHA15;WNT2B;WNT4
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3848014684108893,1.349369279785156,0.0873634945397816,0.19816427564181735,1.0,18/38,36.72%,MIF;IFNG;HAX1;AKT1;HSP90AB1;OSM;DOCK7;RIPK2;APP;PFN2;CNOT9;RAMP3;TERF2IP;PARK7;LIF;PINK1;VEGFA;CAMK1
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.41652126184338056,-1.3488464896260504,0.11697247706422019,0.27354959425436043,1.0,8/17,29.80%,TNRC6A;AGO1;AGO2;MOV10;WNT11;MAP3K7;NLK;FZD6
gsea,regulation of RNA splicing (GO:0043484),0.38417694104087236,1.347856107039428,0.10040160642570281,0.19938277233304594,1.0,14/37,35.83%,HNRNPF;HNRNPK;SRSF3;RPS26;PTBP1;HNRNPLL;U2AF2;RBM38;FUS;GRSF1;SRPK1;SRSF10;RRP1B;MBNL3
gsea,regulation of actin filament-based process (GO:0032970),0.352724262955627,1.3476519320422509,0.0992,0.1992196624485129,1.0,18/36,52.37%,CORO1A;EZR;BST2;RHOC;SH3BP1;BST1;GPM6B;PDGFA;IQGAP3;EPHA3;LRP1;DMTN;SMIM22;ARHGEF19;MLST8;RHOBTB3;RND3;FSCN1
gsea,regulation of cellular metabolic process (GO:0031323),-0.4273075175443938,-1.3466687083760103,0.13247863247863248,0.27512980556426075,1.0,7/19,16.14%,NCOR2;ABCA2;FASN;ACACA;SSH1;FOXM1;ACLY
gsea,nucleus organization (GO:0006997),-0.43499315697876967,-1.3463786749690119,0.1400437636761488,0.27408272336647227,1.0,13/21,24.36%,SYNE1;NUP98;LEMD3;NUP155;SUN2;USP36;NUMA1;NDC1;NUP205;PRM2;WDR73;NUP133;CEP55
gsea,protein processing (GO:0016485),0.35756641535190026,1.345916792659528,0.08856682769726248,0.2007938020348701,1.0,16/43,28.71%,STOML2;PARL;PSEN2;CTSS;FXN;HTRA2;CASP1;CTSL;TYSND1;AEBP1;ATP23;SPCS3;CTSH;ZMPSTE24;CLN5;SPG7
gsea,ion transport (GO:0006811),0.3801464783532715,1.3458009401022533,0.08547008547008547,0.2005144751763469,1.0,17/39,44.73%,VDAC2;VDAC1;PLP2;SLC9A9;SLC15A1;SLC24A5;SLC15A4;SLC32A1;GRIN1;TRPA1;SLC12A4;SLC9A2;SLC12A5;SLC1A2;GABRB1;SLC26A11;SLC12A7
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.44849653955186786,-1.3457121641535383,0.11618257261410789,0.2737277064923876,1.0,11/18,19.74%,DICER1;PUM2;ZC3H7B;AGO1;AGO2;ADAR;DROSHA;SPOUT1;DGCR8;SRRT;SMAD3
gsea,peptidyl-lysine modification (GO:0018205),0.3520702252422286,1.345009479529579,0.09927797833935018,0.20098191161942705,1.0,20/65,25.36%,SUMO2;NDUFAB1;UBA2;SUMO3;AAAS;NUP62;NUP43;NUP37;GCSH;SEH1L;ATPSCKMT;RAE1;SAE1;TRIM28;NUP54;NUP35;ETFBKMT;NUP85;PARK7;P3H3
gsea,blood vessel morphogenesis (GO:0048514),-0.4237150561972131,-1.3436313839584493,0.10599078341013825,0.2752956605856101,1.0,10/19,35.20%,SMAD7;RASA1;NF1;NRP1;ITGB8;CUL7;TGFBR3;TNNI3;RASIP1;FLT1
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.28002149170126855,1.3435783761744906,0.028169014084507043,0.20226899903025414,1.0,104/277,43.33%,S100A11;HDAC1;YBX1;ENO1;TNFRSF4;PHB2;TBX21;ID2;BHLHE40;GAPDH;BIRC5;DBI;NONO;RACK1;TYMS;HMGA1;EIF4A3;HDAC2;DAP;GZMB;PA2G4;XCL1;DHFR;HMGB2;CITED2;IFNG;MRPL13;SET;RIDA;PHB;GMNN;HSPA8;EZH2;CTNNB1;SELENOS;GTPBP4;CBY1;SFPQ;TNFSF4;RELA;BCL3;KLF10;E2F1;SHMT1;CD38;TRIM28;CNOT10;TFDP2;CRYAB;MEN1;ID3;RIOX1;TIMELESS;CNOT9;CBX4;KAT8;RAD17;TFAP4;PHF10;PUS7;HHEX;EED;CIITA;VDR;IGF2BP3;LBH;CRY1;PDCD4;IRF1;BHLHE41;SUV39H2;TWIST1;ZBTB16;SIX3;GFI1;LEF1;PRMT6;ENPP1;TLE1;TOB1;RBFOX2;CBFA2T3;ZHX2;GZF1;ZMYND15;HDAC9;DKK3;CDC6;PCGF6;NFIL3;CREB3L1;CSF2;FOXP1;LOXL2;BRD7;ID1;ACVRL1;TCF7L2;EID2;DAXX;SOX8;KLF4;PPARG;FOXE1
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.33120478830676103,1.343547692200987,0.07755102040816327,0.20191566193709176,1.0,45/99,43.55%,RPA3;RBBP4;HDAC1;PIN1;RBBP7;RFC5;CDK1;AURKB;RFC4;HDAC2;RPA2;CDK2;RPF2;TBP;PRKAG2;AKT1;RFC3;SGK1;TPX2;RHNO1;RAD1;PRMT5;CCNG1;TAF9;EXO1;TAF15;RPL5;MTA2;RAD17;RMI2;MAP2K6;AURKA;USP2;SSRP1;MBD3;RRS1;DNA2;NOC2L;NBN;BRD7;NOP2;DAXX;PRR5;HUS1;RFC2
gsea,negative regulation of cell migration (GO:0030336),-0.31059721887226394,-1.3429769153774147,0.0472972972972973,0.2748074197732073,1.0,30/60,35.37%,ADGRG1;CLASP1;SRGAP3;IFITM1;SMAD7;PTPRJ;ARID2;CORO1C;SCAI;NF1;CLASP2;NF2;MIA3;SRGAP2;CDH1;ZMYND8;VCL;PTPN23;FOXO3;WNT11;DAG1;RAP2C;CLIC4;TRIB1;LIMCH1;DAB2IP;PTPRK;CALR;SERPINE1;MITF
gsea,regulation of protein secretion (GO:0050708),0.33751181932990454,1.3425494410509302,0.07887323943661972,0.20264263847956807,1.0,24/58,52.90%,PPIA;EZR;IFNG;HADH;PPID;MYOM1;EXPH5;CD33;IL1B;APBB3;P3H1;GLP1R;KCNG2;TGFB2;NOS2;SYTL4;ACHE;RAPGEF4;IGF1;SLC2A1;ADRA2A;PICK1;DRD4;RSAD2
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.41367341200912644,1.3425412980051372,0.11851851851851852,0.20226648373551492,1.0,9/21,45.79%,S100A10;C1QBP;SS18L2;TRIOBP;P4HB;MYADM;CASS4;DMTN;DOCK1
gsea,telomere maintenance (GO:0000723),0.3956280586533867,1.3423633914828412,0.109979633401222,0.2020322418163558,1.0,18/40,42.92%,RPA3;PTGES3;RPA2;APEX1;POLD2;RAD51;SP100;RAD51D;TERF2IP;PARP3;PCNA;POLD1;DNA2;SMC6;NBN;PARP1;POLD3;HUS1
gsea,positive regulation of epithelial cell proliferation (GO:0050679),0.3370684317007274,1.3416829935711974,0.08433734939759036,0.20241069070326959,1.0,21/46,34.72%,NME2;NME1;SRSF6;HMGB2;AKT1;MYDGF;NR4A1;TNFSF12;XBP1;OSR2;VEGFB;HRAS;EGFL7;MYC;GRN;NRARP;EGR3;JAML;FGF2;ECM1;VEGFA
gsea,positive regulation of B cell proliferation (GO:0030890),0.4632766256928387,1.3415101418409547,0.1111111111111111,0.20221311161722025,1.0,10/20,33.58%,MIF;TNFRSF4;BST1;CD320;CD38;IL21;GPR183;CD74;CD81;CD40
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3533683393715454,1.3412724466428456,0.06728971962616823,0.20213055978759556,1.0,24/54,36.30%,RPS27L;BAX;RGCC;TFDP1;PRMT1;CDK1;E2F4;SP100;CCNB1;BCL3;E2F1;CNOT10;TFDP2;CNOT9;TFAP4;PLK2;RPS6KA6;MUC1;GADD45A;BATF;AURKA;NDRG1;PCNA;PCBP4
gsea,positive regulation of erythrocyte differentiation (GO:0045648),-0.46556039387157727,-1.3408347639949307,0.1402061855670103,0.2763499954093377,1.0,10/15,26.04%,STAT3;ETS1;ARNT;PRKDC;MED1;STAT5B;FOXO3;ABCB10;STAT1;HSPA1A
gsea,cellular response to interferon-gamma (GO:0071346),0.38796239200552624,1.3400362739912892,0.10085227272727272,0.20309807164156,1.0,31/57,38.19%,GAPDH;CCL3;XCL1;IFI30;IFNG;CCL4;IRF5;SP100;IRF8;CCL1;IRF9;CASP1;ICAM1;IRF2;CIITA;TLR4;GBP3;CCL8;IRF1;PTAFR;VCAM1;CX3CL1;HCK;OAS3;CCL25;GBP6;CCL7;CCL2;SIRPA;ACOD1;IRF7
gsea,negative regulation of translation (GO:0017148),0.3572879037045604,1.3399397686746344,0.1089866156787763,0.20279279656553525,1.0,17/50,35.88%,YBX1;GAPDH;RACK1;TYMS;EIF4A3;GZMB;DHFR;MRPL13;RIDA;EIF4EBP1;SHMT1;CNOT10;CNOT9;PUS7;IGF2BP3;TOB1;METTL3
gsea,histone lysine methylation (GO:0034968),-0.4226578923812859,-1.3399213405266985,0.13291139240506328,0.2762369765032695,1.0,9/22,26.70%,KMT2A;EHMT2;KMT2D;SETD1B;KMT2B;DOT1L;SETDB1;RBBP5;PAXIP1
gsea,DNA modification (GO:0006304),0.45644712906246754,1.338654036906273,0.12164948453608247,0.2038332437287535,1.0,9/17,31.26%,EXOSC3;EXOSC5;UNG;EXOSC4;TERF2IP;PARP3;PARP2;OGG1;NEIL1
gsea,cellular response to decreased oxygen levels (GO:0036294),0.3712017445515182,1.3368000894409595,0.09710391822827939,0.2055040159442901,1.0,21/45,35.55%,FAM162A;PGK1;HILPDA;RGCC;ZFP36L1;EGLN1;TIGAR;LMNA;MYC;SUV39H2;TWIST1;P4HB;MGARP;RORA;NDRG1;AK4;PINK1;BNIP3;VEGFA;STUB1;PTGS2
gsea,negative regulation of cell growth (GO:0030308),0.3372707117265552,1.3359651849110132,0.09212730318257957,0.20605119185924758,1.0,20/58,45.76%,ENO1;RBBP7;RACK1;BST2;EI24;PHB;CDKN2C;CDKN2D;HYAL2;ST7L;ENPP1;SH3BP4;GNG4;NME6;ACVRL1;INHBA;PSRC1;TGFB2;CGRRF1;DNAJB2
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.3957079534637621,1.3357446449780241,0.10608695652173913,0.205889114855561,1.0,11/25,40.14%,EIF6;PARL;COQ7;BST1;SLC25A33;GADD45A;ZC3H12A;PINK1;CBR1;ACOD1;PID1
gsea,regulation of activated T cell proliferation (GO:0046006),0.43939794010092037,1.33498808102524,0.10333333333333333,0.2063165621844258,1.0,8/16,38.90%,HMGB1;PDCD1LG2;FADD;PRNP;RIPK3;TNFSF9;IL2;CRTAM
gsea,negative regulation of catabolic process (GO:0009895),0.4219604969516856,1.3346808539417456,0.12232415902140673,0.20628591474992278,1.0,9/23,37.85%,PIN1;CST3;MAD2L1;PHB;TIGAR;IRAK3;IL1B;CBFA2T3;NUPR1
gsea,"regulation of gene expression, epigenetic (GO:0040029)",0.3719393831256444,1.3343078932874506,0.11468812877263582,0.20630531481013978,1.0,18/52,26.20%,ACTB;RBBP4;RBBP7;TAF1B;POLR2H;GPX1;EZH2;TBP;POLR2L;POLR2E;POLR1E;MTA1;POLR1C;POLR2F;MYO1C;PPHLN1;EED;SUZ12
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.37914252212280164,1.3331430846268708,0.09666666666666666,0.2071885249014072,1.0,18/39,43.49%,UBB;RPS27A;LPXN;DUSP22;LRRC32;NRROS;GCNT2;ENG;BAMBI;FOS;APPL2;SMAD5;ID1;PRKCZ;ACVRL1;EID2;SMAD1;TGFB2
gsea,canonical Wnt signaling pathway (GO:0060070),-0.33268465556739313,-1.3324511919778141,0.10115606936416185,0.28534821553814665,1.0,16/34,38.02%,DIXDC1;WNT10B;BCL9L;GSK3B;WNT3;LRP6;DVL3;WNT11;DVL1;RARG;FZD6;GATA3;SFRP4;FRZB;CSNK1E;LRRK2
gsea,negative regulation of G0 to G1 transition (GO:0070317),0.41867207738544004,1.3313922558226503,0.14591439688715954,0.2086612506306335,1.0,10/29,26.20%,RBBP4;RRM2;RBBP7;TFDP1;EZH2;RAD51;E2F1;TFDP2;EED;SUZ12
gsea,RNA stabilization (GO:0043489),0.4576909831451018,1.3308340997280297,0.15057915057915058,0.20888714743202827,1.0,10/19,23.31%,YBX1;FUS;TENT5A;TRDMT1;E2F1;AXIN2;NAF1;NSUN2;TAF15;THRAP3
gsea,negative regulation of phosphorylation (GO:0042326),0.35366793965407173,1.330347340179935,0.06956521739130435,0.20903579721228047,1.0,25/52,43.08%,PPIA;PRDX3;CDKN2C;CDKN2D;ZBED3;MEN1;TIGAR;DNAJC10;TERF2IP;PARK7;C9ORF72;PRNP;ZC3H12A;CACTIN;WWTR1;MYADM;CBFA2T3;SIRPA;NUPR1;PRKRIP1;TRAF3IP1;PID1;NTRK3;INHBA;INSM1
gsea,ATP-dependent chromatin remodeling (GO:0043044),0.3998275602568096,1.3302564526674456,0.14316702819956617,0.20872630242445903,1.0,11/30,20.66%,ACTB;RBBP4;HDAC1;ANP32E;HDAC2;SMARCB1;NASP;ACTL6A;HNRNPC;ACTR6;MTA2
gsea,positive regulation of cytokine production (GO:0001819),0.296870144059734,1.330217992366009,0.04507042253521127,0.2083829778994092,1.0,80/179,40.59%,MIF;POLR3K;HILPDA;GAPDH;STOML2;RGCC;HMGB1;CEBPB;POLR2H;XCL1;LTB;G3BP1;IFNG;PHB;CCR7;ANXA1;POLR3H;IRF5;CTNNB1;HSPD1;CD14;SCIMP;POLR2L;POLR2E;CD86;SLAMF6;ZBP1;CCL1;IL12RB2;TNFSF4;OSM;RELA;AGPAT2;FADD;RIPK2;POLR1C;LY9;APP;DDX41;POLR3GL;IL21;XBP1;FCER1G;AGPAT1;HYAL2;POLR2F;CD40LG;PARK7;NLRP3;IL10;TLR7;TLR4;IRF1;ISG15;IL1B;TWIST1;RORA;CD226;BATF;RFTN1;POLR3D;SYK;CD74;SPHK1;CD40;CCR2;AIRE;TRAF2;PTGS2;IL2;FLOT1;SLC11A1;IRF7;CRTAM;FGR;CSF2;FOXP1;PRKCZ;POLR3E;EGR1
gsea,cellular response to ketone (GO:1901655),-0.4216425947280086,-1.3297458209308999,0.11645569620253164,0.2877784871913253,1.0,7/18,28.18%,LARP1;TRERF1;ROCK2;NR3C1;NDOR1;SPP1;AR
gsea,positive regulation of nitric oxide metabolic process (GO:1904407),0.4942925917027422,1.3292327931516366,0.13333333333333333,0.2091129068181207,1.0,8/18,28.85%,ASS1;IFNG;AKT1;HSP90AB1;KLF2;TLR4;CD36;IL1B
gsea,positive regulation of type I interferon production (GO:0032481),0.34855348280054144,1.3288956567758807,0.09904761904761905,0.20909400754729665,1.0,24/54,30.75%,POLR3K;GAPDH;POLR2H;G3BP1;POLR3H;IRF5;CTNNB1;HSPD1;CD14;POLR2L;POLR2E;ZBP1;RELA;RIPK2;POLR1C;DDX41;POLR3GL;POLR2F;TLR7;TLR4;IRF1;ISG15;OAS3;POLR3D
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.43107098728434506,1.3287571929232396,0.12080536912751678,0.20887261936465265,1.0,9/19,45.79%,S100A10;C1QBP;TRIOBP;P4HB;SPRY4;MYADM;CASS4;DMTN;DOCK1
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.37712291634083844,1.3284344041499931,0.12681912681912683,0.20886648498872382,1.0,12/40,41.12%,UBE2N;PSMD14;HMGB1;UBE2V2;HMGB2;PRPF19;BRCC3;ABRAXAS1;ATP23;CYREN;NBN;DCLRE1A
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),0.35899357111592123,1.326799114961106,0.11616954474097331,0.21023230869770881,1.0,14/35,44.94%,PGK1;RGCC;CD160;CTNNB1;CXCL10;HHEX;PTPRM;CCR2;FOXJ2;PF4;KLF4;PPARG;TGFB2;THBS1
gsea,positive regulation of organelle organization (GO:0010638),0.44508847814319985,1.3256017268873068,0.1346153846153846,0.21111495052663967,1.0,6/17,30.14%,ANXA2;ANXA1;HTRA2;LMAN1;MGARP;SORBS3
gsea,negative regulation of fat cell differentiation (GO:0045599),-0.40429161137988495,-1.3243410082098286,0.1132596685082873,0.29402521851026836,1.0,13/20,34.28%,ASXL1;WNT10B;FOXO1;TRIB2;ZFPM1;SMAD3;ZADH2;ANKRD26;ARNTL;GATA3;TRIB3;SIRT1;YAP1
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.39161355118990526,1.324055664832672,0.13186813186813187,0.21251635366660512,1.0,15/28,29.84%,DNAJA1;CTNNB1;GTPBP4;U2AF2;AKT1;UFL1;BAG5;RPL5;PRMT3;PARK7;CRY1;ISG15;PRR7;PINX1;BAG2
gsea,mRNA destabilization (GO:0061157),-0.4191295651037855,-1.323554998827901,0.14450867052023122,0.2936477409119672,1.0,15/22,37.11%,CNOT1;UPF1;RC3H2;ROCK2;ROCK1;GIGYF2;MOV10;FTO;CELF1;KHSRP;DIS3L2;PLEKHN1;METTL14;TARDBP;ZFP36L2
gsea,protein monoubiquitination (GO:0006513),-0.43277006762359344,-1.3230500792324853,0.15234375,0.292903424431894,1.0,13/19,31.15%,HUWE1;ATXN7L3;CDC73;CUL3;TRIM25;RNF40;CTR9;UBE2O;KLHL22;MGRN1;RAD18;DTL;UHRF1
gsea,toll-like receptor signaling pathway (GO:0002224),0.36485468559233114,1.3228115316705196,0.104199066874028,0.21342607162519328,1.0,19/44,30.67%,UBB;RPS27A;HMGB1;CTSS;HSPD1;CD14;SCIMP;FADD;RIPK2;CTSL;CNPY3;TLR7;TLR4;IRAK3;S100A1;CD36;BIRC3;RFTN1;PIK3AP1
gsea,O-glycan processing (GO:0016266),-0.40097205330632996,-1.3222916638641846,0.13063063063063063,0.2926606661811219,1.0,9/22,29.63%,B4GALT5;GALNT6;GXYLT1;POFUT1;GALNT1;ST3GAL3;GALNT7;ST6GALNAC4;GCNT1
gsea,regulation of kinase activity (GO:0043549),0.3833715920426197,1.3218104372927626,0.12235649546827794,0.2141321307248068,1.0,14/32,46.24%,EEF1A1;PRDX3;RET;RYK;LMO4;CD74;AXL;EPHA3;FGR;NBN;NTRK3;SMG8;FLT3;MET
gsea,positive regulation of organelle assembly (GO:1902117),-0.3919268124639537,-1.3205711851229198,0.11778290993071594,0.29354527239095674,1.0,13/28,26.96%,CNOT1;DYNC1H1;HTT;ARHGAP35;NUMA1;RAB3GAP2;PIP4K2B;SPAG5;CCP110;ASAP1;GPSM2;SDC1;KCTD17
gsea,regulation of endothelial cell migration (GO:0010594),-0.33404648090837147,-1.320485815294281,0.0661764705882353,0.292246359359432,1.0,20/43,32.35%,ETS1;PTK2B;ITGB3;ROCK2;NF1;BCAS3;NRP1;ABL1;PIK3CG;PRKD2;PRKCA;CEACAM1;VASH1;PIK3CD;BCAR1;RIN2;GATA3;APOE;DAB2IP;CALR
gsea,negative regulation of endopeptidase activity (GO:0010951),0.4894484860488663,1.320271710084765,0.12921348314606743,0.21556080416745377,1.0,5/18,22.86%,SERPINB9;GAPDH;AKT1;SPINK2;SERPIND1
gsea,cellular component assembly (GO:0022607),0.31346963919888493,1.3201853694296752,0.06543385490753911,0.21528048538358452,1.0,49/110,43.53%,ACTG1;ACTB;CAPG;ARL6IP1;RBBP4;LPXN;CAPZA2;PPIH;EZR;GORASP2;CHCHD10;SH3BP1;GPM6B;SYCE2;TLCD1;NIFK;TSPAN4;RTN3;KIFAP3;ST13;PDGFA;NDUFAF1;FAS;PPID;USH1C;ADD1;SPAG16;CHAF1B;TFAP4;EPS8;TRIP13;TLCD2;SPG7;CCDC40;HFE;CD74;SYCE1;CD40;VIL1;TRAF2;LIN7A;PLS1;NOC2L;DNAJB13;PARVB;PAWR;MYO1B;DMTN;LRGUK
gsea,regulation of interferon-beta production (GO:0032648),-0.37586474023512395,-1.319981449779027,0.12285012285012285,0.2916507930003296,1.0,11/32,21.56%,DDX3X;YY1;PTPRS;TRAF3;NLRC3;DHX9;POLR3A;TRIM56;PTPN11;POLR3F;DDX58
gsea,DNA strand elongation involved in DNA replication (GO:0006271),0.5189547832315045,1.317456557176855,0.1949317738791423,0.21788536162983166,1.0,9/17,24.89%,RFC4;GINS2;MCM4;POLD2;RFC3;GINS4;MCM7;POLE3;MCM3
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3475514698286007,1.3163971586707028,0.1183206106870229,0.2186927654554157,1.0,15/38,44.94%,CYCS;ARL6IP1;YWHAE;HMGB1;GPX1;CDKN2D;HTRA2;AKT1;CASP1;NLRP3;MYC;SYK;VEGFA;KLF4;THBS1
gsea,regulation of postsynapse organization (GO:0099175),0.433715275195803,1.3163476222963946,0.1419031719532554,0.2183581757779499,1.0,5/15,35.81%,CFL1;ABHD17C;ZDHHC15;VPS35;FCGR2B
gsea,positive regulation of actin filament polymerization (GO:0030838),0.45239876552134106,1.3158400563924881,0.12080536912751678,0.2185432598045526,1.0,9/23,31.15%,PFN1;CCR7;EVL;NCK2;CDC42EP2;PFN2;SPIRE2;HCK;CDC42EP3
gsea,transcription by RNA polymerase I (GO:0006360),0.40615875604587937,1.3157483705064486,0.14198782961460446,0.21824211388586398,1.0,14/25,29.35%,TAF1B;POLR2H;TBP;POLR2L;POLR2E;POLR1E;GTF2H3;ERCC3;CDK7;POLR1C;GTF2H2;POLR2F;GTF2H4;ERCC2
gsea,ncRNA export from nucleus (GO:0097064),0.4152036063472439,1.3149735166732792,0.14925373134328357,0.2187418915156495,1.0,13/31,24.54%,RAN;NPM1;SSB;AAAS;NUP62;NUP43;NUP37;NCBP2;SEH1L;RAE1;NUP54;NUP35;NUP85
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3370256999906889,-1.3144139630373,0.12,0.2981319280729388,1.0,18/36,36.13%,CBL;NEDD4;PIK3CA;MAZ;JAK2;IRS2;PIK3CG;F2R;PIK3CD;PDGFB;NCF1;CCL5;F2RL1;KIT;SIRT1;FLT1;PIK3R5;LYN
gsea,regulation of neurogenesis (GO:0050767),0.42325208422344757,1.3143039149975615,0.11922503725782414,0.21915426291629644,1.0,10/26,32.46%,BHLHE40;NAP1L1;HMGB2;IFNG;CTNNB1;DOCK7;BHLHE41;IL1B;CX3CL1;TGM2
gsea,positive regulation of cell-matrix adhesion (GO:0001954),-0.40924430911807086,-1.3138630443938142,0.10476190476190476,0.2975813632275985,1.0,14/21,36.28%,CDK6;PTK2B;JUP;UTRN;PTPRJ;ROCK1;NRP1;TSC1;ABL1;GSK3B;PPM1F;RIN2;CSF1;MAP4K4
gsea,regulation of epithelial cell proliferation (GO:0050678),0.36060990403181514,1.3130592130440775,0.11589895988112928,0.22025084044360044,1.0,20/37,40.99%,NME2;NME1;SRSF6;GPX1;ZFP36L1;PEX2;ZFP36;NR4A1;DUSP10;OSR2;HRAS;MYC;GRN;MAGED1;FGF2;VEGFA;TGFA;NUPR1;ACVRL1;TCF7L2
gsea,negative regulation of DNA metabolic process (GO:0051053),0.4480385694335638,1.3123818213759515,0.13108614232209737,0.2206054783309355,1.0,4/15,51.05%,SUB1;TERF2IP;ACVRL1;MSH3
gsea,snRNA 3'-end processing (GO:0034472),0.4408239232087942,1.3121098698122424,0.147117296222664,0.2205251449348624,1.0,7/17,18.79%,EXOSC3;EXOSC8;EXOSC9;EXOSC5;EXOSC7;EXOSC4;TOE1
gsea,response to amino acid starvation (GO:1990928),-0.3490979380370105,-1.311590431273928,0.10888888888888888,0.2993943895833689,1.0,19/36,30.87%,LARP1;MAP3K5;EIF2AK3;RPTOR;TFEB;GCN1;DEPDC5;TCIRG1;ATF4;WDR24;MAPK8;SLC38A9;IMPACT;RRAGB;EIF2AK2;EIF2AK4;ITFG2;SESN1;SESN3
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.355733393967888,1.3113881321761518,0.09121621621621621,0.22100850631835517,1.0,21/53,35.68%,SUMO2;RACK1;UCHL5;DESI1;HERPUD1;HSPBP1;RAD23B;GIPC1;HSP90AB1;UFL1;TAF9;RAD23A;BAG5;PLK1;NUB1;PARK7;BAG2;HFE;DAB2;STUB1;CBFA2T3
gsea,positive regulation of phagocytosis (GO:0050766),-0.3614356393465512,-1.3105881245490616,0.11267605633802817,0.29945830939881923,1.0,27/27,93.64%,DOCK2;ABCA7;RAB27A;PTPRJ;ANO6;GAS6;F2RL1;MYO18A;IL15RA;CALR;TNF;CAMK1D;C3;C4A;CD300LF;APPL2;SLC11A1;SIRPA;CCL2;FCGR2B;IL1B;C2;TUB;FCER1G;LMAN2;LYAR;IFNG
gsea,regulation of G0 to G1 transition (GO:0070316),0.39182466199997396,1.3101522038091131,0.16536964980544747,0.22210781291514625,1.0,11/32,26.20%,RBBP4;RRM2;RBBP7;TFDP1;EZH2;RAD51;E2F1;RHNO1;TFDP2;EED;SUZ12
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.3801015510329749,1.3093055547784014,0.1187800963081862,0.2226752979430748,1.0,13/30,48.74%,C1QBP;EZR;CD160;ZFP36L1;AKT1;PTAFR;PLCB4;INPP5F;EDN1;PLCH1;PIK3R1;HTR2A;IGF1
gsea,negative regulation of cell cycle process (GO:0010948),0.3905905322393913,1.3084866758111768,0.15444015444015444,0.2232388077977989,1.0,13/41,26.20%,RBBP4;RRM2;RBBP7;TFDP1;AURKB;EZH2;RAD51;E2F1;TFDP2;FBXO5;EED;NEK2;SUZ12
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3703001794616977,1.307910149490631,0.102803738317757,0.22356281525133662,1.0,17/39,36.30%,BAX;RGCC;TFDP1;PRMT1;CDK1;E2F4;CCNB1;E2F1;CNOT10;TFDP2;CNOT9;PLK2;MUC1;GADD45A;AURKA;PCNA;PCBP4
gsea,cellular response to retinoic acid (GO:0071300),-0.3946074990057422,-1.306108805171946,0.11396011396011396,0.30428405386203683,1.0,9/17,36.13%,SETX;PTK2B;WNT10B;CREB1;WNT3;WNT11;ADNP2;RORB;LYN
gsea,cellular macromolecule catabolic process (GO:0044265),0.4022719064959467,1.305735868160026,0.11879432624113476,0.22582160710713595,1.0,7/26,14.04%,RNASEH2B;HNRNPD;RNF5;EXOSC7;HTRA2;RNASEH1;NCBP1
gsea,double-strand break repair (GO:0006302),0.3162382008343898,1.3054833556292964,0.12352941176470589,0.22571156451061428,1.0,46/116,42.92%,UBE2N;RPA3;PSMD14;NSMCE1;KPNA2;HMGB1;HPF1;UBE2V2;RPA2;FEN1;HMGB2;PRPF19;SAMHD1;TDP1;ZSWIM7;RAD51;BRCC3;SFPQ;PPP5C;MMS22L;TDP2;ABRAXAS1;MTA1;DDX1;APTX;RAD51D;XRCC1;ATP23;RAD51C;PARP3;PARP2;TRIP13;PARP9;CYREN;RAD51AP1;EME1;AUNIP;TONSL;DNA2;SMC6;NBN;CDCA5;DCLRE1A;PARP1;KDM4B;HUS1
gsea,regulation of mitotic nuclear division (GO:0007088),0.39367785651846693,1.3052763269242762,0.1519434628975265,0.22561167147334793,1.0,15/31,33.61%,PIN1;RGCC;NUP62;DUSP1;ANAPC15;RCC1;PDXP;CCNB1;PRMT5;NUSAP1;FBXO5;NEK2;IL1B;AURKA;NME6
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.25700025862353926,-1.3045492965598382,0.03255813953488372,0.30515544565804675,1.0,162/162,99.57%,STAT3;RAPGEF1;SIPA1L1;CBL;AP2A2;NEDD9;IDE;AP2B1;TNK2;SETX;PTK2B;NR4A3;PIK3CA;ITGB3;RAPGEF2;LMTK2;PHIP;PTPRJ;AHI1;EIF2AK3;SLC39A14;JAK2;TCIRG1;ROCK2;NCKAP1;ACTR2;RASA1;PIK3C2A;ROCK1;IRS2;POLR2A;FOXO1;NRP1;GSK3B;TSC2;GTF2F1;PRKD2;VAV2;SOS1;GIGYF2;SPRED2;CYFIP1;ARHGEF28;ATP6V0A2;RHOQ;EFNB3;PTPN11;PDGFB;MAPKAPK2;CD4;TIAM1;ELMO2;KALRN;NCF1;SH2B2;HNRNPH1;BCAR1;MTSS1;KIT;FES;CSF1;FOXO4;NUS1;KIF16B;CSF1R;PAK1;FLT1;SORBS1;LYN;VAV3;ITSN1;PIK3CB;SOCS2;BAIAP2;ADRB2;SPRED1;GRB7;SULF2;MUC20;BCAR3;SHC1;PIK3R2;EFNB2;MVP;PDK2;CEP57;FLRT3;ESRP2;HSP90AA1;CNKSR1;DNM1;IGF1;GFRA2;ATP6V1G3;PGF;MET;DOCK1;ANKS1B;BLNK;PLAT;COL1A1;PIK3R1;STYK1;CD7;FLT3;CLNK;NTRK3;CAV2;MMP9;NRP2;FGR;GALNT3;FOXC2;CASS4;EPHA3;AXL;HAP1;VEGFA;RBFOX2;MAPKAPK3;ATP6V0E2;GRIN1;FGF2;SYK;RYK;NAMPT;HCK;RET;GRB10;MPZL1;CYBB;POLR2B;SHCBP1;NCF2;ELMO1;POLR2F;HRAS;VEGFB;SHOC2;SLA;PDGFA;HNRNPM;NCK2;NCBP1;GTF2F2;POLR2E;NCBP2;AKT1;POLR2L;PSEN2;LCP2;CASP3;PTBP1;POLR2H;POLR2C;DDIT4;HNRNPA1;STMN1;AP3S1;ACTB;HNRNPF;ACTG1
gsea,mitotic cell cycle phase transition (GO:0044772),0.3204024189445568,1.3039285375333451,0.10857142857142857,0.2267693163221705,1.0,54/139,31.54%,CDK4;TUBA1A;CCNB2;TUBB4B;UBE2S;CDK1;YWHAE;EIF4E;CCND3;CDK2;TACC3;UBE2C;TUBA4A;HAUS1;HAUS4;CCNA2;NASP;CDKN2C;CDKN2D;EIF4EBP1;RCC1;HAUS8;MELK;CDKN3;PPP1CB;CCNB1;E2F1;CDK7;CDC23;CCNG1;CDC16;PHLDA1;BCAT1;USH1C;PLK1;GSPT1;NDE1;HAUS2;PLK2;CCNE1;PIM2;EPS8;NEK2;CUL5;MYC;CEP41;CUL4B;ACTR1A;FBXL15;AURKA;AJUBA;HAUS6;CEP78;DBF4
gsea,regulation of neurotransmitter receptor activity (GO:0099601),-0.38441087972906085,-1.3038881348442737,0.11254019292604502,0.3047010384583709,1.0,7/16,33.02%,PTK2B;NLGN2;MINK1;DLGAP4;MEF2C;DLG2;NEFL
gsea,cellular component disassembly (GO:0022411),0.43204575366659376,1.3005674268626157,0.12084592145015106,0.23028889483255324,1.0,5/23,18.65%,CAPG;BSG;CTSS;DYRK3;CTSL
gsea,eye development (GO:0001654),-0.35973623864861093,-1.3004195183297367,0.16231884057971013,0.30813578897023786,1.0,6/21,37.71%,HIPK1;SKI;HIPK2;ATF6;CEP290;PBX3
gsea,DNA repair (GO:0006281),0.2982305945615054,1.300417023739867,0.11175337186897881,0.2300785808165171,1.0,96/218,43.55%,UBB;RPS27A;UBE2N;RPA3;NPM1;RFC5;CDK1;NSMCE1;RFC4;NSMCE4A;KPNA2;HPF1;UBE2V2;RPA2;FEN1;FANCL;APEX1;ASF1A;TDP1;UBE2T;NUDT1;POLD2;RAD51;CDKN2D;RAD23B;WRNIP1;BRCC3;RFC3;GTF2H3;PPP5C;UNG;ERCC3;TDP2;RHNO1;RAD1;MUS81;ABRAXAS1;TRIM28;TRAIP;POLE2;MTA1;DDX1;APTX;EXO1;RAD51D;RAD23A;USP1;MEN1;MGMT;XRCC1;TIMELESS;GTF2H2;RAD17;RAD51C;PARK7;PARP3;MGME1;PARP2;GTF2H4;TRIP13;ALKBH2;RMI2;CHD1L;PARP9;OGG1;CUL4B;GADD45A;RPAIN;ERCC2;FANCG;RAD51AP1;NEIL1;PRMT6;GTF2H1;PCNA;POLD1;EME1;FAAP24;FANCF;ALKBH5;MLH3;DNA2;NBN;CDCA5;INTS3;DCLRE1A;PARP1;ATXN3;ASCC1;KDM4B;EXO5;POLD3;CENPS;HUS1;MLH1;RFC2
gsea,maturation of SSU-rRNA (GO:0030490),0.4148523329410431,1.300347580743866,0.16666666666666666,0.2297701158144341,1.0,9/24,23.61%,SNU13;DCAF13;UTP3;UTP4;SRFBP1;RIOK2;TSR2;NOL11;UTP6
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.33768797239574655,1.2989246791217162,0.1148036253776435,0.23105374355698963,1.0,24/45,53.88%,PLAC8;FABP5;CEBPB;HADH;ACADL;GATM;DECR1;GRB10;CD36;GADD45G;SYK;CCR2;VEGFA;APPL2;HSF1;TSHR;GPR3;FFAR4;ACHE;FABP4;OMA1;PPARGC1B;CPT2;ACSL1
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.25252985799310246,-1.2985596766734246,0.045454545454545456,0.3094599569944859,1.0,145/258,40.96%,KMT2A;STAT3;CHD8;ARID1A;RUNX3;EP300;ETS1;CREBBP;MED13;PICALM;HCFC1;SMARCA4;ARNT2;ATXN7L3;ATAD2;ATF7IP;KMT2B;SP1;BRPF1;NCOA1;MAP3K5;NOTCH1;KAT6A;TBL1XR1;MAZ;TRERF1;DYRK1A;PHIP;ATMIN;NFYA;SMARCC2;TFEB;ARID1B;MED12;ELF4;KAT6B;BRCA2;RUNX2;HDAC4;ATF4;CDK5RAP2;RAI1;ZBTB48;FOXM1;NCOA6;MED16;CREB3L2;FOXO1;NAA15;ZMIZ1;MED1;CDH1;BRCA1;ILF3;TRIM44;ING5;JUN;FUBP3;CREB1;CD80;MLLT3;TGFB3;LRP6;TFE3;NPAT;DVL3;SOX10;FOXO3;HIVEP3;WNT11;KDM3A;NFKB1;TRIM56;F2R;MMS19;BTRC;NFATC2;PDGFB;SMAD3;EGR2;CD4;HIPK2;RARA;MYBL1;NCF1;STAT1;ETS2;FOXK2;SOX4;ARNTL;BICRAL;CLOCK;MED14;APBB1;ACVR1;ARHGEF11;EDRF1;SMARCC1;SPP1;KAT2A;HINFP;BICRA;EOMES;TRIP4;AR;MEF2C;PML;CEP290;CHUK;BLM;ZKSCAN3;GATA3;NR5A2;XPC;FOXF1;USP22;APOE;XRCC6;RORB;CAMKK2;PRDM16;RUNX1;TBL1X;MED24;ZFP90;REST;YAP1;TCF4;SMARCA2;CHEK2;MITF;MED4;ANKRD49;HIF1A;NOS1;BMP7;PHF8;MT3;TADA3;DTX3L;PRMT2;NAA16;ING1;CTCF;TNF
gsea,ameboidal-type cell migration (GO:0001667),-0.3843668234094128,-1.2985407779419469,0.12894736842105264,0.3080697660902389,1.0,10/21,23.35%,ITGA4;CORO1C;SEMA6D;PDXDC1;SRGAP2;SOX10;SGPL1;SEMA4C;SEMA4B;SEMA7A
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.42971193795331725,1.2971354433847155,0.1625,0.2328681200324174,1.0,7/21,11.57%,PHB2;RGCC;TFDP1;CCND3;ANXA1;EZH2;AKT1
gsea,response to tumor necrosis factor (GO:0034612),0.3575948830470279,1.2971014262181126,0.10662824207492795,0.23250241158807802,1.0,29/52,40.82%,YBX3;CCL3;XCL1;CASP3;CCL4;ZFP36L1;AKT1;ZFP36;CCL1;GCH1;RELA;GSDME;NUB1;HYAL2;GBP3;CCL8;CX3CL1;ZC3H12A;CCL25;CACTIN;SPHK1;CD40;CCL7;CCL2;CXCL16;ACOD1;NFE2L2;PID1;GBP2
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.43892983583942036,-1.2966160600684309,0.18526315789473685,0.30950740005146715,1.0,13/18,33.88%,NLRC3;TNFAIP3;RIPK1;TRIM39;PER1;STAT1;OTUD7B;TNIP3;USP10;TRIM59;DAB2IP;TNIP1;SIRT1
gsea,cellular response to UV (GO:0034644),0.3519967542685896,1.2964614108016503,0.12939001848428835,0.23290431238661113,1.0,18/45,41.57%,CRIP1;NPM1;EIF2S1;AURKB;BAK1;RHNO1;PPID;RUVBL2;HYAL2;MYC;CUL4B;PCNA;POLD1;METTL3;TIMP1;NOC2L;MMP9;PARP1
gsea,regulation of protein ubiquitination (GO:0031396),0.3522940494451313,1.2955903152071298,0.12316176470588236,0.23349703754304638,1.0,23/51,33.04%,UBB;UBE2N;DNAJA1;GTPBP4;HSPBP1;U2AF2;AKT1;DCUN1D1;HSP90AB1;UFL1;RIPK2;BAG5;PRMT3;PARK7;CRY1;ISG15;PRR7;BIRC3;PINX1;BAG2;TBC1D7;PINK1;SPHK1
gsea,regulation of interferon-alpha production (GO:0032647),-0.41536270356943883,-1.294672686721653,0.15365853658536585,0.3109358006351914,1.0,9/18,31.74%,DDX3X;PTPRS;NLRC3;SETD2;DHX9;DDX58;STAT1;CHUK;HAVCR2
gsea,regulation of nervous system development (GO:0051960),0.4596463245534415,1.294366163297104,0.16519174041297935,0.23458277353417178,1.0,7/16,29.06%,BHLHE40;HMGB2;CTNNB1;DOCK7;BHLHE41;IL1B;CX3CL1
gsea,positive regulation of cellular catabolic process (GO:0031331),-0.2915155310528342,-1.2943361970585197,0.08483290488431877,0.3100014129983843,1.0,42/73,39.69%,CNOT1;UPF1;TFEB;ARNT;ZSWIM8;ZBTB20;PIK3C2A;ROCK1;IRS2;FOXO1;VPS11;ZC3H18;GSK3B;OPTN;MOV10;FAF1;TRIM14;FOXO3;MTDH;ADAM9;ULK1;SUPV3L1;MID2;ATF6;PRR5L;ADAM8;TRIM5;KHSRP;PACSIN3;PFKFB1;APOE;SH3D19;SVIP;TRIM65;FURIN;HIF1A;LRRK2;RNF152;DTX3L;PIK3CB;TRIM21;PFKFB3
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38686133873652595,1.29383648817521,0.14925373134328357,0.23481235828383276,1.0,12/28,33.20%,CYCS;PERP;HMGB1;BAK1;HTRA2;CASP1;FADD;RIPK2;NLRP3;MYC;SYK;GRIN1
gsea,lipid transport (GO:0006869),0.35603285446726834,1.2937613198359754,0.1111111111111111,0.23451146636157288,1.0,17/43,41.90%,PRELID3B;FABP5;PRELID1;SLC25A17;PRELID2;RXRA;STARD5;CD36;MFSD2A;ABCD1;NME4;PEX3;CPTP;SCARB1;SLC27A3;PRELID3A;PCTP
gsea,regulation of cell growth (GO:0001558),0.30156077529273084,1.2933441325894346,0.0921875,0.2346334840676139,1.0,42/104,45.76%,ENO1;RBBP7;RACK1;BST2;NUBP1;TMEM97;EI24;PHB;EXOSC9;CDKN2C;FXN;CDKN2D;CHPT1;DERL2;AKT1;NCBP1;EBAG9;N6AMT1;TMC8;RASGRP2;SGK1;SLC25A33;EXOSC4;CISH;DNPH1;HYAL2;URI1;MFSD2A;ST7L;SPHK1;ENPP1;SH3BP4;GNG4;NME6;CXCL16;IL2;ACVRL1;INHBA;PSRC1;TGFB2;CGRRF1;DNAJB2
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.3262075091990554,-1.2926970996006848,0.10822510822510822,0.3110666874697212,1.0,20/35,38.19%,ABR;BCR;CLSTN1;NLGN2;MCTP2;DLGAP4;SLC12A2;LRP8;HOMER1;CACNA1A;SLC4A8;CLN3;FMR1;MEF2C;BAIAP3;ITGB1;USP46;CX3CR1;LRRK2;TMEM108
gsea,myeloid cell differentiation (GO:0030099),0.3835124564464803,1.2926720486551921,0.12794612794612795,0.2349723290194824,1.0,12/26,42.60%,SLC25A5;PRDX3;CASP3;UFL1;DYRK3;HSPA9;KAT8;ZBTB16;MFHAS1;CSF2;FLVCR1;INHBA
gsea,positive regulation of GTPase activity (GO:0043547),-0.2761809775201663,-1.2922880568245434,0.06204379562043796,0.310277931412019,1.0,60/110,40.62%,PKP4;RAPGEF1;DOCK8;SIPA1L1;PICALM;ABR;RAPGEF2;BCR;TBC1D8B;DOCK9;RGS8;CORO1C;RASGRP1;RANGAP1;RALGAPB;TBC1D13;DOCK11;RALGAPA2;TBC1D22B;NF1;RGP1;ADRB1;BCAS3;TSC1;RAP1GDS1;SRGAP2;GSK3B;ARHGAP11A;ARAP1;DVL3;SCRIB;TBCK;WNT11;F2R;EVI5L;TIAM1;TBC1D5;ARHGAP27;SGSM2;TBC1D4;TBC1D8;CCL5;SYDE2;ALS2;TBC1D1;RASGRF1;ARHGEF5;TBC1D25;F2RL1;TBC1D10B;ITGB1;ECT2;GPR65;ITGA6;MAP4K4;TBC1D14;ARHGAP24;GNB5;MMUT;SNX9
gsea,glycolipid biosynthetic process (GO:0009247),0.42981776530509586,1.2920591309872957,0.15992970123022848,0.2353537687908768,1.0,5/18,25.99%,PIGF;ST3GAL4;PGAP2;ST8SIA1;ST3GAL5
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3102159867080516,-1.291876643442828,0.08463949843260188,0.3094850572993533,1.0,28/55,36.13%,STAT3;NEDD9;PARP14;TNK2;PTK2B;ITGB3;PTPRJ;JAK2;IL6ST;TEC;PLCG2;NRP1;ABL1;CLCF1;CD80;PIBF1;LRP8;PTPN11;ARHGEF2;PDGFB;GAS6;ACVR1;CCL5;KIT;CD44;IL3;CSF1R;LYN
gsea,organelle assembly (GO:0070925),0.2806960365678146,1.2916669529112428,0.09152542372881356,0.23538446087748913,1.0,61/166,41.51%,NPM1;CENPW;LSM3;CENPA;EIF2S1;CORO1A;E2F4;GORASP2;G3BP1;NSFL1C;TMEM107;MRPL22;RILPL2;HAUS1;HAUS4;NUP62;HSPB11;EIF2A;TMEM138;RCC1;HAUS8;CFAP298;PDE6D;UBXN2B;LZTFL1;DYNLL2;RP2;TTC39C;EHD4;CEP19;TMEM237;SPAG16;HAUS2;EHD3;ATG7;C9ORF72;POC1B;NEK2;TMEM216;CENPT;CEP41;B9D1;HAUS6;NEK7;TCTN3;PTPDC1;CLUAP1;BBS4;FARP2;CCDC28B;IQCB1;IFT81;IFT43;RAB38;TRAF3IP1;KIF3A;HAUS7;IFT74;IFT88;SAC3D1;FNBP1L
gsea,regulation of cellular component movement (GO:0051270),-0.37678784005916705,-1.2913370663860544,0.14596949891067537,0.3088506261047495,1.0,15/24,32.93%,CDK6;ETS1;DIAPH1;ROCK2;ZSWIM8;ROCK1;ABL1;ARAP1;ZSWIM6;ACTN4;ADAM17;HDAC6;TGFBR3;ZSWIM4;FES
gsea,regulation of organelle assembly (GO:1902115),0.37337706315841634,1.2907199309117754,0.11616161616161616,0.2361241182623337,1.0,11/36,43.16%,NPM1;ADPRH;EZR;EVI5;PLK2;C9ORF72;HCK;SGSM3;NPRL3;IFT88;RABGAP1
gsea,positive regulation of cell growth (GO:0030307),-0.30769380944829383,-1.2905612855954962,0.09973045822102426,0.30856742778605445,1.0,24/47,33.82%,MACF1;GOLGA4;RPS6KA3;DDX3X;USP47;RPTOR;EIF4G2;EIF4G1;LIMK1;RNF157;EXOSC2;KLHL22;SUPV3L1;INO80;SEMA7A;ADAM17;MAP3K13;CPNE9;BRAT1;BCL2;ADNP2;SHTN1;PRSS2;HDGFL2
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34697944971094147,1.2901439013669322,0.11645962732919254,0.236367266197805,1.0,23/50,43.49%,UBB;RPS27A;LPXN;XCL1;ZFP36L1;OVOL2;DUSP22;LRRC32;NRROS;HYAL2;WWOX;GCNT2;WNT10A;ENG;BAMBI;FOS;APPL2;SMAD5;ID1;PRKCZ;ACVRL1;SMAD1;TGFB2
gsea,snRNA metabolic process (GO:0016073),-0.45366548641839083,-1.289495019882412,0.16923076923076924,0.3088212090935474,1.0,5/15,14.07%,INTS1;MEPCE;INTS7;INTS6;INTS2
gsea,positive regulation of telomere maintenance (GO:0032206),0.429980517530132,1.2893763378664793,0.16515426497277677,0.23687411157677868,1.0,7/19,33.27%,HNRNPA2B1;AURKB;HNRNPD;NAF1;NEK2;NEK7;PKIB
gsea,transcription by RNA polymerase II (GO:0006366),0.2878681318976773,1.2885673087620397,0.06722689075630252,0.23735282838185934,1.0,73/172,41.57%,BTF3;SNRPE;ELOC;SNRPF;SNRPD3;HDAC1;POLR2C;TFDP1;SLBP;GTF2E2;SNRPB;POLR2H;ELOF1;CPSF3;INTS11;ADRM1;COPS2;TBP;POLR2L;NCBP2;POLR2E;GTF2H3;GTF2F2;NCBP1;IRF9;NR4A1;ERCC3;CDK7;CSTF1;TAF9;INTS4;CPSF2;TAF15;CCNK;PMF1;XBP1;NR4A2;RXRA;NR2C2AP;GTF2H2;POLR2F;INTS10;VDR;GTF2H4;TRIP13;POLR2B;THRB;CPSF4;ELP2;RNMT;RORA;ERCC2;LEO1;MED7;CSTF2;INTS14;PCID2;NR2F6;SSRP1;INTS5;GTF2H1;NR1H3;WWTR1;NFIX;HDAC9;INTS13;RPRD1B;CEBPD;MAML3;GTF2E1;ELP4;INTS3;PARP1
gsea,regulation of keratinocyte differentiation (GO:0045616),0.44395460537796433,1.2881676511861315,0.16967509025270758,0.23739681962985773,1.0,6/16,26.09%,NME2;SRSF6;ZFP36L1;ZFP36;CTSL;VDR
gsea,regulation of smooth muscle cell proliferation (GO:0048660),0.382996348782665,1.2878360620113976,0.1510673234811166,0.2373805061870868,1.0,14/27,44.94%,ID2;IFNG;PHB;CTNNB1;AKT1;RBPMS2;CX3CL1;CCN4;FOXP1;TCF7L2;EDN1;PPARG;HMOX1;THBS1
gsea,response to interferon-gamma (GO:0034341),0.3686344113452036,1.2866582115209457,0.13544668587896252,0.23842082653806723,1.0,26/46,37.51%,GAPDH;CCL3;BST2;XCL1;CCL4;SP100;IRF8;CCL1;GCH1;CASP1;NUB1;CIITA;TLR4;GBP3;CCL8;CX3CL1;CCL25;CD74;GBP6;CD40;CCL7;CCL2;SIRPA;CXCL16;ACOD1;SLC11A1
gsea,positive regulation of cell migration (GO:0030335),0.30082994485144476,1.28562721075056,0.08094645080946451,0.23930775588555092,1.0,57/134,44.94%,PFN1;ACTG1;S100A11;C1QBP;SOD2;RACK1;CCL3;ELP5;IFNG;RHOC;TNFRSF18;PLAA;LAMC2;ITGAX;PDGFA;GLIPR2;XBP1;FBXO5;FAM110C;CPNE3;HRAS;MYO1C;CCR1;CTSH;RUFY3;GCNT2;RET;IL1B;GRN;LGR6;LEF1;ARHGEF39;SPHK1;VIL1;PLET1;CCN4;CCR2;SEMA4A;VEGFA;DAB2;PECAM1;MYADM;CCL7;CXCL16;CASS4;FN1;FGR;MMP9;EDN1;NTRK3;CCAR1;TGFB2;DMTN;F3;SMIM22;COL1A1;THBS1
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.4027940258295884,1.2848226454912897,0.14661654135338345,0.23989617967440002,1.0,6/22,26.87%,PPIA;SCIMP;COPS5;FAS;RAP2A;MYC
gsea,regulation of T cell receptor signaling pathway (GO:0050856),0.4450871414343111,1.2844022594241256,0.13504823151125403,0.24004756060432475,1.0,13/20,31.87%,SH2D1A;EZR;CD160;PVRIG;RELA;DUSP3;LGALS3;PRNP;NECTIN2;CD300A;CD226;CD81;TRAT1
gsea,macrophage activation (GO:0042116),-0.40239221194983726,-1.2842255559455416,0.17525773195876287,0.31509786147996655,1.0,9/18,21.93%,ITGAM;JAK2;SBNO2;PLCG2;TMEM106A;AIF1;CD93;C1QA;IL13
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.26222500340278965,-1.2841756239379385,0.04736842105263158,0.31381133992728616,1.0,208/208,99.84%,DENND4A;ANKRD17;ATXN1;STAT3;CHD7;EHMT2;KMT2D;RUNX3;EP300;ATRX;TRRAP;CHD3;BAZ2A;CREBBP;NSD2;HCFC1;ARNT2;SP1;NOTCH1;RBBP6;JMJD1C;ZBTB38;MLLT6;SPTY2D1;FOXN3;NFYA;TFEB;KAT6B;BRCA2;ATXN1L;SBNO2;ATF4;NFKB2;POLR2A;GON4L;USP37;TSC1;ABL1;ZBTB11;ATF7;ZBTB4;ZFAT;NR3C1;GEMIN5;PHF19;PKP3;CTR9;PRDM2;PAK6;FOXO3;NCOA2;CYFIP1;TAF6L;SRRT;POFUT1;ERC1;MED23;NFATC2;HP1BP3;DVL1;MYBL1;FOXK2;SOX4;ARNTL;CLOCK;SPI1;CCAR2;APBB1;BRDT;RPS6KA5;HINFP;GTF2IRD1;CARM1;TRIP4;MYBBP1A;DDX25;MEF2C;PML;ATXN2;NLK;NFXL1;EIF2B4;MSC;NR5A2;SSBP2;FOXN2;RB1;RORB;CALR;FOXO4;REST;NUP107;SMARCA2;CHEK2;MITF;PSPC1;TULP3;GCFC2;NOLC1;HIF1A;MAFA;NFX1;ZSCAN26;LIN54;KAT7;WWC1;AHR;THAP1;FOXP3;CCDC88A;HDAC10;MYBL2;CRABP2;PATZ1;NAB1;MYB;NUCKS1;TAF5;ATF2;BACH1;ATF5;FADS1;HMG20A;RBM4B;DDIT3;HCFC2;PPARGC1B;ORC3;ASCC2;MAPKAPK5;NANOS3;SOX15;ZSCAN21;FZD7;LYL1;ESRRA;CCAR1;ASCC1;DAXX;MAFB;MTF2;ACVRL1;TCOF1;NFIL3;TGIF2;PUM3;GZF1;DVL2;AIRE;WWTR1;APBB3;ENG;AJUBA;MAGED1;SPIN4;RORA;OGG1;SNAI3;SRSF10;TERF2IP;TCF7;PTP4A3;NAB2;ORC5;IRF2;SMC3;FBXO5;TCF3;APP;NUP35;ESCO2;RABL3;PRMT5;PPIE;PDGFA;E2F1;PCGF1;RELA;METAP1;HIC1;UTP4;SAP30;FUS;NFYC;SFPQ;HMGN5;MYCBP;DSCC1;NFYB;CREM;EZH2;GMNN;EIF2A;ZNHIT3;CCNA2;PHB;MLF1;EIF4E;CEBPB;HNRNPD;HMGA1;NONO;BHLHE40;TBX21;YBX1;HINT1;CNBP;RPL10
gsea,regulation of neuron apoptotic process (GO:0043523),0.36012025208131493,1.284056439157705,0.11746031746031746,0.24003998515798325,1.0,16/43,37.85%,BAX;SOD2;CCL3;SET;NAE1;CTNNB1;LANCL1;SIGMAR1;PARK7;PRNP;RETREG1;GRN;PINK1;FOXQ1;CCL2;NUPR1
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.38649581044472936,-1.2839974959461486,0.15883668903803133,0.3126985593284512,1.0,9/22,32.85%,CBLB;CBL;PTPRJ;SPRY2;HGS;ITGA1;SOCS5;DAB2IP;STAM2
gsea,response to growth factor (GO:0070848),0.4298331906459848,1.2837940989399046,0.14638157894736842,0.2399561350649118,1.0,9/18,33.04%,RACK1;CTNNB1;HTRA2;AKT1;CPNE3;URI1;MYC;TBC1D7;SPHK1
gsea,positive regulation of mitotic cell cycle (GO:0045931),0.4379748977328202,1.2828842391197655,0.16346153846153846,0.24060456391032922,1.0,6/18,19.69%,EIF4E;ASNS;EIF4EBP1;CCNB1;DUSP3;APP
gsea,embryonic limb morphogenesis (GO:0030326),0.41707032684633194,1.2828704532503576,0.14982578397212543,0.24021030589247983,1.0,5/16,28.96%,HDAC1;HDAC2;CTNNB1;OSR2;TWIST1
gsea,histone modification (GO:0016570),-0.32202194523120675,-1.28158257925999,0.11934156378600823,0.3148945617522674,1.0,41/68,40.19%,HUWE1;EHMT2;PADI2;EP300;TRRAP;BAZ2A;CREBBP;ATXN7L3;BAZ1B;KAT6A;TBL1XR1;TRERF1;KAT6B;USP36;HDAC4;BRD8;MIER3;TAF6L;SIN3A;EYA3;HDAC5;PHF20;PHC1;BRMS1L;KDM4A;RPS6KA5;KAT2A;HDAC6;CARM1;USP22;UHRF1;TAF6;TBL1X;SIRT1;EHMT1;PRDM5;MT3;PRMT7;PRMT2;RCOR3;RBM14
gsea,regulation of interleukin-2 production (GO:0032663),0.40118681964405695,1.2787095179667816,0.13989637305699482,0.2448613148011124,1.0,11/27,35.26%,TBX21;STOML2;EZR;XCL1;ANXA1;ZFP36;CD86;PRNP;IL1B;CCR2;TRAF2
gsea,axon guidance (GO:0007411),-0.29761998294186126,-1.2785437925325438,0.07727272727272727,0.3180317887063914,1.0,28/68,27.96%,SPTAN1;DSCAM;SPTBN1;PIK3CA;NOTCH1;ARHGAP35;PLXND1;SEMA6D;PLCG1;IRS2;NRP1;NOTCH2;KIF5B;PRKCA;SOS1;CYFIP1;DAG1;EFNB3;PTPN11;SEMA4C;PLXNA1;PIK3CD;ENAH;SEMA4B;CXCR4;SEMA7A;RPS6KA5;MAPK7
gsea,long-chain fatty acid metabolic process (GO:0001676),0.371832015329262,1.2780858740374492,0.150997150997151,0.24520811651408098,1.0,15/29,46.92%,GPX1;EPHX1;ACADL;ACSL5;ABCD1;PTGS2;SLC27A3;HACL1;PNPLA8;ACSL6;ACOX1;PLA2G4A;ELOVL2;ACOT4;LTC4S
gsea,monocyte chemotaxis (GO:0002548),0.4488293465694927,1.2762368361358036,0.1807044410413476,0.24707816525896148,1.0,12/19,35.82%,CCL3;XCL1;CCL4;ANXA1;CCL1;LGALS3;CCL8;CX3CL1;CCL25;TNFSF11;CCL7;CCL2
gsea,regulation of androgen receptor signaling pathway (GO:0060765),-0.42132613637301164,-1.2756346487349335,0.14634146341463414,0.3208354347955676,1.0,10/16,38.59%,NCOR2;EP300;SMARCA4;SAFB2;NCOA2;HDAC6;AR;SIRT1;KDM5D;PRMT2
gsea,negative regulation of cell population proliferation (GO:0008285),0.2889972067629934,1.275193726772918,0.06751592356687898,0.24800419986610706,1.0,70/163,44.81%,S100A11;NPM1;NME1;EEF1E1;RBBP4;RGCC;TFDP1;IGFBP7;SOD2;HMGA1;IFNG;PHB;NUP62;TESC;CDKN2C;CTNNB1;CDKN2D;GTPBP4;TBRG1;PRKRA;PEX2;CDKN3;NCK2;OSM;KLF10;E2F1;DUSP10;AXIN2;GSDME;APP;MEN1;HRAS;CAMK2N1;TFAP4;IL10;PIM2;P3H3;CD33;LMNA;VDR;MYC;IRF1;NUDT6;PINX1;IL1B;CD300A;MAGED1;P3H2;SH3BP4;TOB1;DLL4;P3H1;CBFA2T3;PLPP1;DNAJA3;APPL2;NUPR1;PTPN6;CDC6;BRD7;ACVRL1;KLF4;INHBA;PPARG;INSM1;HMOX1;TGFB2;CHERP;KANK2;CGRRF1
gsea,glycerophospholipid biosynthetic process (GO:0046474),-0.28122599316231206,-1.2751665376477692,0.11029411764705882,0.320244487182421,1.0,51/90,35.44%,DGKH;PIK3CA;CHKA;SBF1;MTMR3;PITPNM2;LPIN2;PI4KA;STARD10;PIP5K1C;PIK3C2A;PLCG2;DGKG;PIK3CG;MTMR12;PCYT1A;PIP4K2B;SLC44A1;SELENOI;INPPL1;GPAT4;MTMR14;PLA2G4B;DGKE;LCLAT1;PGS1;DGKD;PIK3CD;MTMR4;CLN3;CPNE7;FIG4;SLC27A1;DDHD1;SYNJ1;PTPN13;VAC14;FAR1;PLEKHA1;PLD2;AGPAT4;STARD7;LPIN1;RUFY1;CSNK2A2;PIKFYVE;INPP4B;PI4KB;MTMR1;SYNJ2;PIK3R5
gsea,small GTPase mediated signal transduction (GO:0007264),-0.29925999966759753,-1.2748330954565286,0.10736196319018405,0.319350843532167,1.0,29/56,35.76%,TNK2;ABR;RAPGEF2;BCR;RASGRP1;GRAP2;KSR1;CCDC88C;NF1;DNMT1;SETDB1;ARHGEF18;JUN;SOS1;HACD3;RALGDS;TIAM1;ARHGAP31;PLD2;NRAS;RGL1;RIN2;MRAS;RB1;KSR2;SHTN1;RAB42;RALB;USP8
gsea,negative regulation of developmental process (GO:0051093),0.34409468838920726,1.2747274935620672,0.15110356536502548,0.24813438301958315,1.0,19/36,50.51%,MIF;ANP32B;CST3;HOPX;WDR77;PARP3;SUZ12;RPS6KA6;SINHCAF;PINK1;BNIP3;WNT1;LOXL2;KLF7;SFMBT1;TBX2;BCL11A;GRIN3A;OMA1
gsea,glucose homeostasis (GO:0042593),-0.3486034440288207,-1.2744018507776071,0.12561576354679804,0.31858096404480185,1.0,12/29,38.05%,STAT3;HK1;HECTD4;FOXO1;CRY2;LRRC8D;FOXK2;SOX4;PYGL;SIRT1;HIF1A;HK3
gsea,protein localization to Golgi apparatus (GO:0034067),-0.4335898399960151,-1.2743512531566263,0.19834710743801653,0.31732305202933414,1.0,8/15,32.07%,VPS13D;GCC2;BICD2;VPS13C;GAK;OPTN;PAQR3;GBP5
gsea,regulation of cell differentiation (GO:0045595),-0.3032975138952598,-1.2742154576863964,0.09144542772861357,0.3161874243311929,1.0,63/63,97.75%,CDK6;RUNX3;RPS6KA3;TRPS1;CREBBP;CLASP1;SMAD7;RUNX2;ATF4;NF1;CLASP2;CDK5RAP2;ROCK1;BIRC2;YWHAG;DAG1;TIAM1;EIF2AK2;SPOCK2;DLL1;TRIP4;AR;GATA3;FES;RUNX1;CSF1;REST;SRF;TNF;FLOT2;ALOX5;SMYD5;FADS1;SCIN;BCL6;SLC6A6;PHLDB2;INSM1;KLF4;MAFB;PRKCB;CSF2;CEBPD;CAMK1;EPHA3;ST7;LIF;SINHCAF;SUZ12;SMOC1;HEMGN;NSUN2;LGALS3;MBOAT2;CDK5RAP1;HSP90AB1;ZFP36L1;PTBP1;PA2G4;CEBPB;HOPX;ID2;ANP32B
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.38070055909867745,1.2734840792415378,0.172147001934236,0.24924108373630602,1.0,13/39,23.04%,RPS27L;TIPIN;CDK1;RPA2;CDK2;DONSON;BRCC3;MRNIP;MUS81;ABRAXAS1;PLK1;RINT1;RAD17
gsea,cellular response to lipopolysaccharide (GO:0071222),0.3693310941807924,1.2727266240105326,0.12097812097812098,0.24982529733232253,1.0,36/62,40.86%,VIM;CCL3;HMGB1;PDCD1LG2;HMGB2;SELENOS;CD14;NFKBIB;CD68;PLAA;ZFP36;CD86;TNFSF4;RELA;CASP1;XBP1;CXCL10;NLRP3;IL10;TLR4;PDCD4;IL1B;CXCL13;HCK;ZC3H12A;GFI1;CACTIN;NR1H3;CCL2;CTSG;SIRPA;AXL;ACOD1;CD180;CXCL2;PF4
gsea,protein N-linked glycosylation (GO:0006487),0.3715807917385092,1.272697679301633,0.14612676056338028,0.24945399051909334,1.0,17/36,33.49%,DDOST;RPN2;MPDU1;ALG14;ALG13;STT3A;LMAN1;ALG3;MCFD2;DPAGT1;MOGS;DERL3;PGM3;RPN1;DOLPP1;ALG6;ENTPD5
gsea,chromatin remodeling (GO:0006338),-0.3157857310701761,-1.2723168568970007,0.12694877505567928,0.3176001134916498,1.0,41/70,40.10%,CHD4;CHD8;ARID1A;BPTF;ATRX;SRCAP;CHD3;BAZ2A;HCFC1;SMARCA4;KDM6B;BAZ1B;PBRM1;SMARCC2;ARID1B;GATAD2B;HDAC4;JARID2;KDM5B;CBX3;BAZ2B;KAT2B;BAHD1;TAF6L;KDM4D;HDAC5;KDM5C;INO80;ZBTB1;KDM4A;SMARCC1;BRDT;SATB1;KAT2A;RB1;ERCC6;SIRT1;SMARCA2;PAK1;KDM5D;BAZ1A
gsea,chloride transport (GO:0006821),-0.3393603247828091,-1.2713625614422641,0.1695906432748538,0.31768150457094657,1.0,10/22,28.19%,ANO6;ANO8;SLC12A2;SLC12A6;CLCN6;FXYD1;ANO10;SLC4A8;CLIC4;SLC12A3
gsea,glycosphingolipid metabolic process (GO:0006687),-0.42306419906895054,-1.2699434500500968,0.17312072892938496,0.3183485765255839,1.0,7/17,31.37%,ABCA2;CERK;SMPD4;ST6GALNAC3;GALC;SMPD1;CLN6
gsea,cellular response to interleukin-6 (GO:0071354),-0.42627656197765773,-1.2696771471108446,0.1789709172259508,0.31746443318705897,1.0,10/16,24.17%,STAT3;CBL;JAK2;SBNO2;IL6ST;CTR9;NFKB1;PTPN11;STAT1;SPI1
gsea,modulation by host of symbiont process (GO:0051851),0.4086079384464249,1.2679545853121073,0.16699410609037327,0.2550135171181997,1.0,8/19,33.16%,HDAC1;CCL3;SMARCB1;CCL4;SAP30;TFAP4;LEF1;RRP1B
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3857019187661008,-1.267809178347376,0.15019762845849802,0.3188966220008734,1.0,12/24,32.49%,HUWE1;SFN;SREBF2;NPEPPS;BAP1;USP36;FBXW7;YWHAG;VPS11;MAPK8;BCL2;CSNK2A2
gsea,proteolysis (GO:0006508),0.2908399226819664,1.2675225103495247,0.10058309037900874,0.2551767295608329,1.0,49/104,45.43%,PSMD6;PSMB5;PSMC4;GZMB;PARL;PSMA6;LAP3;CASP3;PSEN2;DESI1;CTSS;CASP7;RNPEP;HTRA2;BACE2;CASP1;NLN;ENDOU;CTSL;TYSND1;AEBP1;PRSS50;SPCS3;PRSS16;CTSH;CTSZ;ST14;ZMPSTE24;CAPN10;RET;SPG7;ATG4C;METAP2;CTSG;CPNE1;DESI2;CPM;UFSP2;GZMA;PCSK4;MMP9;DPP3;TASP1;F3;VASH2;PLAT;SPRTN;CTSK;CAPN11
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3714727476235058,-1.2664598011303982,0.16753926701570682,0.3195641936807451,1.0,10/23,30.61%,MYO10;TBC1D13;TBC1D22B;FXR2;TBC1D5;FMR1;SDCCAG8;TBC1D8;TBC1D1;TBC1D10B
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.31909070018177055,1.264874609557234,0.10737179487179487,0.25808595151907204,1.0,34/76,40.37%,UBE2N;LITAF;GAPDH;LGALS1;EEF1D;BST2;RHOC;CCR7;NUP62;S100A4;PPP5C;RELA;CASP1;FADD;RIPK2;TNFRSF1A;DDX1;TSPAN6;TERF2IP;PLK2;PIM2;BIRC3;CX3CL1;WLS;CD74;PINK1;TIFA;CD40;ECM1;TRAF2;TRAF5;LTBR;TMEM101;PRKCB
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.4172643139566643,1.2641963359060373,0.14915254237288136,0.25853089814148883,1.0,8/20,40.37%,SNX5;SOCS1;GRB10;IL1B;ENPP1;PRKCZ;PID1;PRKCB
gsea,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4156147721573681,-1.263923451483103,0.18162839248434237,0.32203483618572565,1.0,8/17,23.83%,MYO10;CCDC88B;HOOK3;CCDC88C;KIF1C;KIF5B;DYNC1I2;HOOK1
gsea,regulation of cellular protein metabolic process (GO:0032268),0.3771599688813281,1.2637523616961281,0.16352201257861634,0.25868574780445563,1.0,15/33,42.60%,RPL10;EIF4E;EIF2A;AKT1;METAP1;APP;NFKBIA;NR1H3;VPS35;PUM3;TCOF1;EDN1;KLF4;EDNRB;INHBA
gsea,regulation of cytoskeleton organization (GO:0051493),-0.29437899042259424,-1.2635979978480811,0.11965811965811966,0.3212345697745108,1.0,25/52,41.37%,HIP1R;TAOK2;CLASP1;TAOK1;ARHGAP35;DIAPH1;ROCK2;BICD2;ROCK1;ABL1;TRIM36;GSK3B;RICTOR;RHOQ;CAPN2;CLN3;BICD1;CLIC4;ARHGEF5;IQGAP2;TJP1;PAK1;BAIAP2;RHOF;RHOB
gsea,neuron projection morphogenesis (GO:0048812),0.33186300579576367,1.2635315159474385,0.12400635930047695,0.2585682318556399,1.0,18/53,48.75%,UBB;S100A6;ACTB;CTNNB1;KLK8;SGK1;DOCK7;APP;ALCAM;RYK;NRCAM;ACTBL2;CPNE1;MAP6;PACSIN1;KLF7;SHANK1;ABITRAM
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),0.44278789967626453,1.2617857211439898,0.14507042253521127,0.260448732402306,1.0,7/20,34.94%,ANXA2;HNRNPK;CD63;SGIP1;HFE;VEGFA;DAB2
gsea,negative regulation of protein metabolic process (GO:0051248),0.3945968443858054,1.2613260857244621,0.17017828200972449,0.26058344969374186,1.0,10/24,27.90%,PIN1;MAD2L1;PFDN4;VBP1;PHB;HSP90AB1;CRYAB;PRNP;IRAK3;PFDN6
gsea,autophagosome organization (GO:1905037),-0.43750404931536635,-1.2613051205903882,0.1828193832599119,0.3231535044803872,1.0,10/15,32.72%,ATP2A2;ATP13A2;ULK2;PACS2;ATG2A;AMBRA1;ULK1;ATG2B;UBQLN1;RAB23
gsea,organic hydroxy compound biosynthetic process (GO:1901617),0.4439262942506617,1.2597360321729707,0.1842948717948718,0.26221289408009324,1.0,13/20,38.96%,PSAT1;SC5D;PRKAG2;MSMO1;HSD17B10;PARK7;OSBPL9;DHCR7;PNPO;TM7SF2;CH25H;PMVK;INSIG1
gsea,negative regulation of proteolysis (GO:0045861),0.43553067943584733,1.258328716544747,0.17647058823529413,0.26368400114526547,1.0,6/17,25.76%,CST3;AKT1;CHAC1;CAMK2N1;IL10;PRNP
gsea,heterochromatin assembly (GO:0031507),0.4473882287218324,1.258039082630986,0.19128787878787878,0.26363305548996707,1.0,5/15,19.41%,HDAC1;HMGA1;CENPV;HELLS;POLE3
gsea,positive regulation of histone modification (GO:0031058),0.46313544967612386,1.2573194323771004,0.18454258675078863,0.26414046809566255,1.0,6/17,42.36%,UBE2N;RUVBL2;IL1B;TADA2B;BRD7;TADA2A
gsea,cellular iron ion homeostasis (GO:0006879),0.4029910989300771,1.2572457412044813,0.1713747645951036,0.2638094079030021,1.0,14/24,43.60%,CCDC115;GLRX3;HMOX2;NUBP1;FXN;ACO1;MYC;TMEM199;HFE;SLC11A1;FLVCR1;CUL1;HMOX1;FRRS1
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3541043840193324,1.2571514999636921,0.14125200642054575,0.26352771839651035,1.0,14/42,37.85%,SUMO2;RACK1;PSMC2;PSMC6;HSPBP1;PSMC5;RAD23A;PLK1;NUB1;BAG2;DAB2;STUB1;CBFA2T3;NUPR1
gsea,negative regulation of protein phosphorylation (GO:0001933),0.3106611212978062,1.2567030478211796,0.09663250366032211,0.2637220580299681,1.0,37/78,44.44%,PPIA;CALM2;DDIT4;RACK1;DUSP19;PRKAG2;ZBED3;AKT1;NCK2;HSPB1;MEN1;CAMK2N1;DNAJC10;TARBP2;TERF2IP;PARK7;C9ORF72;PRNP;TWIST1;ZC3H12A;ENG;CEP85;CACTIN;ENPP1;WWTR1;MYADM;SIRPA;CNKSR3;PRKRIP1;PTPN6;TRAF3IP1;PRKCZ;PID1;NTRK3;INSM1;DMTN;GPD1L
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),-0.40054712448887086,-1.2557447919393043,0.1735159817351598,0.3295087140244415,1.0,8/18,25.14%,CLASP1;TAOK1;BICD2;CLASP2;ROCK1;TRIM36;GSK3B;BICD1
gsea,organonitrogen compound catabolic process (GO:1901565),0.3747659281403663,1.255511600244882,0.17857142857142858,0.2647949461440408,1.0,11/29,28.07%,UCHL3;TXN2;RIDA;BCKDK;GNPDA1;NPL;RENBP;IL4I1;PRSS16;GGACT;CLN5
gsea,regulation of gene silencing by miRNA (GO:0060964),-0.3628774727020899,-1.255077591400498,0.17490494296577946,0.329185631429269,1.0,24/43,34.62%,NUP210;STAT3;RANBP2;PUM2;TNRC6A;AGO1;NUP98;AGO2;NUP155;DHX9;POLR2A;IPO8;EIF4G1;NUP188;NUP214;POM121;NDC1;NUP205;NUP133;NUP153;FMR1;NUP93;NUP160;NUP107
gsea,cellular amide metabolic process (GO:0043603),0.3098332572299717,1.252585645789844,0.15845070422535212,0.26826266599149323,1.0,22/51,42.93%,DBI;MTHFD2;SHMT2;DHFR;PDZD11;AASDHPPT;NLN;MTHFD2L;SHMT1;ABHD4;SLC19A1;AEBP1;MTRR;SLC25A32;MCCC2;PLPP2;OXSM;PLPP1;CPM;FPGS;ACSL6;ALDH1L1
gsea,B cell activation (GO:0042113),0.33900956586128117,1.2519497658303056,0.14022662889518414,0.26867247504397485,1.0,24/45,44.20%,SLC25A5;PHB2;PHB;HSPD1;LAT2;CD86;RABL3;TCF3;BANK1;CD70;GPR183;CD40LG;HHEX;IL10;VCAM1;KLF6;CD40;HDAC9;DCAF1;PRKCB;CD79A;NFAM1;FLT3;LYL1
gsea,regulation of ATP metabolic process (GO:1903578),0.36883761020563,1.2515726220286456,0.15856236786469344,0.26874199471340193,1.0,19/38,32.81%,PGAM1;EIF6;SHMT2;AAAS;NUP62;NUP43;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;SLC25A33;NUP54;NUP35;NUP85;ABCD1;AK4;NUP88;PINK1
gsea,receptor signaling pathway via STAT (GO:0097696),-0.416932904269808,-1.2501959886942495,0.18201754385964913,0.3354661694751679,1.0,11/17,29.35%,STAT3;JAK2;CLCF1;STAT6;STAT5B;CTR9;STAT5A;STAT2;STAT1;STAMBP;SOCS6
gsea,DNA recombination (GO:0006310),0.373096764574597,1.249575236823279,0.17037037037037037,0.27090749090365246,1.0,10/32,29.29%,HMGB1;TSN;HMGB3;RAD51;ENDOG;RHNO1;EXO1;RAD51D;RAD51C;RPAIN
gsea,intracellular protein transport (GO:0006886),0.27617219146650007,1.2491215414088017,0.10344827586206896,0.271116528362853,1.0,65/158,50.76%,RAN;TMED2;NUTF2;NPM1;HIKESHI;PHB2;ADPRH;NXT1;ARL1;NUP62;COX18;DESI1;IFT27;AKT1;GIPC1;ARL4D;EIF2D;LMAN1;COPB2;RABL3;EVI5;ARL5C;STRADA;BCS1L;AP4M1;RANGRF;STX11;MYO1C;NUP85;ARL11;RPAIN;WLS;TMED1;SYK;CD74;GRTP1;ARL4C;NUP88;SGSM3;ARFIP2;VPS35;HAP1;CSE1L;NAPB;APPL2;XPO7;AP4B1;VPS33A;RAB38;SNX13;COG7;UNC93B1;KATNB1;SCFD2;RABGAP1;IFT22;GGA2;GGA3;RAB5B;IPO11;TBC1D9;TBC1D30;SCG5;SIL1;PICK1
gsea,mRNA catabolic process (GO:0006402),0.3828671832279607,1.2473018469743047,0.17695473251028807,0.27304881011842114,1.0,9/25,23.31%,LSM2;RIDA;EXOSC9;MRTO4;ZFP36;EXOSC4;CNOT10;DXO;THRAP3
gsea,embryonic organ development (GO:0048568),0.38676667147399435,1.2468888637703208,0.18270799347471453,0.27318148169012385,1.0,9/21,48.18%,RPL10;ERCC3;PDGFA;ALDH1A3;MFSD2A;FOXE1;TGFB2;PBX4;TBX2
gsea,protein modification by small protein conjugation (GO:0032446),0.2795726889363928,1.2457982754468568,0.12792792792792793,0.2741905622215252,1.0,65/180,41.48%,SUMO2;UBB;RPS27A;UBE2N;ELOC;UCHL3;UBE2S;UBA2;UBE2M;RACK1;UBE2V2;SUMO3;AAAS;UBE2C;NUP62;NAE1;UBE2E3;UBE2T;NUP43;SELENOS;NUP37;KCTD13;DCUN1D1;PEX2;SEH1L;ATG10;UFL1;CDC23;RAE1;SAE1;CDC16;TRIM28;BSPRY;TRAIP;NUP54;NUP35;PLK1;PEX5;NUB1;PJA2;NUP85;ATG7;LMO7;CUL5;CRBN;ISG15;CUL4B;KLHL3;FBXL15;LEO1;TNFAIP1;HECW2;NUP88;PINK1;PCNA;DTX4;STUB1;DCUN1D2;TRIM35;NFE2L2;ANKRD9;PIAS3;TMEM129;CUL1;PIAS2
gsea,actin filament organization (GO:0007015),-0.2703385173815393,-1.2457424399806887,0.11071428571428571,0.341130464181476,1.0,81/81,98.92%,FLNA;HIP1R;NEB;PPP1R9B;NEDD9;HIP1;MYO5A;FLII;MYO1F;CORO1C;SVIL;CARMIL2;MYO1G;TMOD1;TTN;INPPL1;AIF1;ERMN;ARHGEF2;VILL;ENAH;RFLNB;ELMO2;MYO1E;MPRIP;BAIAP2L1;FHOD1;MARCKS;BCAR1;LMOD3;ABI2;MYO6;GSN;GAS2L3;PLS3;LCP1;BAIAP2;SPIRE1;RHOF;RHOB;CD2AP;SCIN;ARHGAP12;RND3;RHOBTB3;TMOD4;MYO5B;ARHGAP25;FAT1;DMTN;MYO1B;GHSR;PLS1;CASS4;CORO7;VIL1;GAS2L1;MCU;ACTN1;SPTA1;SPIRE2;RUFY3;EPS8;ELMO1;MYO1C;TPM1;DSTN;GAS2;TPM3;CDC42EP2;TRIOBP;NEBL;MARCKSL1;EVL;ZBED3;TPM4;SH3BP1;RHOC;CORO1A;CAPG;ALDOA
gsea,peptide metabolic process (GO:0006518),0.3665380922818431,1.2456721219883702,0.16970802919708028,0.2739289921465785,1.0,18/30,38.18%,PARL;PSEN2;GPX1;CARNMT1;GSR;BACE2;GSTT2;NLN;GSTM1;AEBP1;SPCS3;CLN5;GSTK1;GSTM5;GSTT1;MMACHC;GSTZ1;CPM
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4215758865819287,1.2455593859939376,0.1973018549747049,0.2736629831012305,1.0,6/18,29.06%,CALM2;XCL1;GSTO1;F2RL3;CXCL10;CX3CL1
gsea,positive regulation of B cell activation (GO:0050871),0.37644331401171865,1.2453147091991321,0.17099236641221374,0.2735380028294824,1.0,14/33,33.58%,MIF;TNFRSF4;BST1;CD320;TNFSF4;CD38;SHLD1;IL21;XBP1;GPR183;SYK;CD74;CD81;CD40
gsea,protein complex oligomerization (GO:0051259),0.35104273314345,1.2448975435940388,0.166383701188455,0.27363036792516643,1.0,19/43,33.31%,STOML2;PRMT1;SHMT2;WDCP;CPSF6;ALAD;LETM1;FUS;TRMT61B;EHD4;HGSNAT;TMEM120A;MAT2A;NINJ1;EHD3;MCU;TMEM120B;ZC3H12A;TIFA
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.33647763944281495,1.2441994518773685,0.1664167916041979,0.27408928311327846,1.0,18/42,41.37%,TPT1;STOML2;CCL3;CCL1;SLC39A6;TMEM203;SLC24A5;CCR1;CCL8;STC2;CD40;SLC39A4;CCR2;CCL7;SLC11A1;SLC39A7;CALCB;EDN1
gsea,regulation of gene expression (GO:0010468),0.2447649616186195,1.243921080236915,0.06827880512091039,0.2740217780901276,1.0,213/453,57.06%,CNBP;ACTG1;CDK4;HINT1;CRIP1;HNRNPF;MIF;PCBP1;HNRNPK;PLSCR1;HDAC1;HNRNPAB;YBX1;SERPINB9;YBX3;TBX21;PIN1;ID2;BHLHE40;RGCC;EZR;NONO;RACK1;HMGA1;CCL3;HNRNPD;CEBPB;CDK2;CITED2;PTBP1;IFNG;ANXA7;HNRNPLL;MLF1;PHB;GPX1;TESC;ZNHIT3;ZFP36L1;EZH2;COQ7;CREM;NFKBIZ;NFYB;OVOL2;RBM38;HNRNPDL;MYCBP;HMGN5;AKT1;TCF19;SFPQ;PTRH2;NFYC;FUS;SAP30;UTP4;ITGAX;HIC1;RELA;PCGF1;E2F1;GRSF1;PPIE;PRMT5;MTA1;NUP35;APP;TCF3;RPL5;DNAJA4;MYOM1;OSR2;CALCOCO1;HRAS;CAMK2N1;IRF2;RAMP3;FUBP1;NAB2;PTP4A3;TCF7;TERF2IP;CCR1;PARK7;CTSH;IL10;VDR;TLR4;IGF2BP3;MYC;GCNT2;SRSF10;CPSF4;PARP9;SNAI3;OGG1;CD36;UTY;IL1B;TWIST1;RORA;STC2;SPIN4;MAGED1;AURKA;AJUBA;PEG3;ZC3H12A;HFE;CD74;LEF1;ENG;PINK1;CACTIN;FGF2;RRP1B;TLE1;APBB3;TOB1;DLL4;VPS35;CCN4;WWTR1;VEGFA;AIRE;DVL2;MYADM;RAMP2;MBNL3;SIRPA;PCBP4;GABPA;GZF1;CPNE1;TGIF2;NFKBID;SLC11A1;FN1;NFE2L2;NFIL3;CREB3L1;CSF2;FOXP1;PID1;ACVRL1;DNMT3B;ZPR1;EGR1;MTF2;PF4;MAFB;NTRK3;DAXX;SMAD1;ASCC1;KLF4;CCAR1;INHBA;INSM1;TGFB2;F3;ESRRA;LYL1;BTN1A1;TLR2;WNT6;NOS2;FZD7;ZSCAN21;RNF207;APLN;NOS1AP;PRKAA1;VSTM2A;ACTA2;IGF1;ATM;SOX15;MEFV;WNT4;MSR1;ASCC2;TSKU;PPARGC1B;HCFC2;BCL6;ESRP2;DDIT3;SLC8A1;HNRNPH3;HMG20A;GLMN;FADS1;ATF5;MTOR;AFDN;BACH1;RDX;ATF2;TAF5;MYB;NAB1;HSPA1B;PATZ1;CRABP2;MYBL2;ZC3H10;HDAC10;METTL16;FOXP3;ATG14;NANOS1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3707661721875682,-1.2430033616325913,0.1675531914893617,0.34390609225815394,1.0,9/21,31.19%,NOTCH1;WNT10B;ATF4;IL18R1;TFE3;TLE3;ARNTL;ADAM17;RB1
gsea,sphingolipid metabolic process (GO:0006665),-0.31702892053357334,-1.242595671025113,0.15789473684210525,0.3431699344180989,1.0,17/42,28.50%,ABCA2;CERK;SMPD4;PDXDC1;ST6GALNAC3;CERS6;PRKD2;GALC;TEX2;HACD3;SAMD8;SGPL1;PRKD3;ELOVL4;FUT7;SMPD1;PPM1L
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.35035803078162353,1.2424837504977406,0.15737704918032788,0.27546078158745385,1.0,14/42,39.28%,SUMO2;RACK1;HERPUD1;HSPBP1;CDC20;RAD23A;PLK1;NUB1;BAG2;DAB2;STUB1;CBFA2T3;NFE2L2;CDC20B
gsea,positive regulation of cell junction assembly (GO:1901890),0.43063331894637213,1.242080605515607,0.2112676056338028,0.2756017192105224,1.0,15/15,95.36%,S100A10;VEGFA;FLOT1;DLG5;BHLHB9;COL16A1;MAP4K4;PPM1F;ABL1;TSC1;NRP1;ROCK1;NLGN2;PTPRJ;CLSTN1
gsea,regulation of GTPase activity (GO:0043087),-0.2658435347012784,-1.2407745941484436,0.06934306569343066,0.3446490278493139,1.0,57/104,42.04%,WNK1;PKP4;RAPGEF1;DOCK8;SIPA1L1;ARFGEF1;PICALM;RAPGEF2;DOCK9;PLXND1;RGS8;RASGRP1;DOCK11;NF1;RAB3GAP2;RGP1;ADRB1;BCAS3;RAP1GDS1;SRGAP2;RCC2;GSK3B;ARHGAP11A;VAV2;ARAP1;DVL3;WNT11;F2R;EVI5L;PLXNA1;ARHGAP27;SGSM2;ADAP1;CCL5;ALS2;RASGRF1;CHN2;ARHGEF5;CPEB2;F2RL1;FGD3;TBC1D10B;ITGB1;FGD2;ECT2;DAB2IP;ITGA6;RASIP1;GPR137B;MAP4K4;GPSM1;VAV3;LRRK2;GNB5;MMUT;SNX9;ASAP3
gsea,positive regulation of protein binding (GO:0032092),0.3726397448368254,1.2402707350224256,0.182370820668693,0.27758925856624145,1.0,15/32,40.99%,RAN;PIN1;PPP2CB;RIPK2;APP;MEN1;ADD1;HFE;BAMBI;AKTIP;FLOT1;LRP1;MMP9;NVL;TCF7L2
gsea,regulation of defense response to virus by host (GO:0050691),-0.4231668320659665,-1.2400005210133935,0.20618556701030927,0.34448630903875216,1.0,7/16,25.86%,DHX9;TNFAIP3;TRIM44;SIN3A;DDX58;STAT1;EIF2AK4
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4088356884482178,1.2393911310500056,0.18657937806873978,0.27833826738714906,1.0,9/17,37.01%,HTRA2;FADD;TNFSF12;HYAL2;WWOX;BID;RET;TRAF2;LTBR
gsea,regulation of erythrocyte differentiation (GO:0045646),-0.372727487193546,-1.238078095200116,0.18223234624145787,0.3462021004273755,1.0,13/23,26.04%,STAT3;CDK6;ETS1;ARNT;PRKDC;MED1;STAT5B;FOXO3;ABCB10;ZFPM1;STAT1;SPI1;HSPA1A
gsea,negative regulation of protein catabolic process (GO:0042177),0.4249909269237834,1.2374999123186494,0.20064724919093851,0.2803949570577055,1.0,6/19,26.25%,PIN1;CST3;MAD2L1;PHB;IL10;IRAK3
gsea,regulation of protein phosphorylation (GO:0001932),0.2976860981270129,1.2359515425355467,0.1243455497382199,0.28196318146879523,1.0,56/126,43.41%,PPIA;NPM1;CDK2AP1;PIN1;SOCS1;RACK1;CEBPB;CCND3;IFNG;BST1;ZBED3;AKT1;MYDGF;AXIN2;PDGFA;FAS;HSPB1;APP;MEN1;VEGFB;HRAS;DNAJC10;TERF2IP;PARK7;C9ORF72;PRNP;RAP2A;IL1B;ZC3H12A;CD74;ENG;PINK1;CACTIN;FGF2;CD40;WWTR1;VEGFA;AKTIP;DAB2;DVL2;PECAM1;MYADM;SIRPA;FLOT1;FN1;FGR;MMP9;TRAF3IP1;PID1;NTRK3;DAXX;PLXNB2;INSM1;SMG8;PLAUR;ATF3
gsea,lymphocyte chemotaxis (GO:0048247),0.4041934380227804,1.2335159381808005,0.19694868238557559,0.2849101136446415,1.0,14/23,36.21%,CCL3;XCL1;CCL4;CCL1;CXCL10;GPR183;CCL8;CX3CL1;CXCL13;CCL25;CH25H;CCL7;CCL2;CXCL16
gsea,positive regulation of vasculature development (GO:1904018),-0.2925006022159511,-1.2320710704475797,0.10843373493975904,0.35450771257804914,1.0,21/51,36.40%,ETS1;HIPK1;SP1;JUP;AGO2;PLCG1;BRCA1;ITGB8;PRKD2;PRKCA;MTDH;PIK3CD;HIPK2;PDPK1;ITGB1;SERPINE1;RUNX1;CCR3;SIRT1;FLT1;HIF1A
gsea,negative regulation of autophagy (GO:0010507),-0.3244971667671439,-1.2316676385301022,0.1640625,0.3537770608531332,1.0,18/35,30.62%,STAT3;EIF4G3;PIK3CA;SNRNP70;USP36;EIF4G2;TSC1;EIF4G1;SMCR8;TAB3;KLHL22;FOXK2;GOLGA2;KDM4A;IL10RA;ZKSCAN3;WDR6;BCL2
gsea,Wnt signaling pathway (GO:0016055),0.31570600577177255,1.2310470372778313,0.1781701444622793,0.28768254948932875,1.0,22/45,55.94%,UBB;RPS27A;CTNNB1;NR4A2;TCF7;WLS;RYK;WNT10A;LEF1;VPS35;DVL2;WNT1;TCF7L2;CUL1;FZD3;WNT6;FZD7;WNT2B;WNT4;FZD4;NXN;AXIN1
gsea,phospholipid metabolic process (GO:0006644),0.38868362580184707,1.2310026208943359,0.1717325227963526,0.2873111726644223,1.0,15/29,35.72%,AGPAT5;GDE1;ACP6;PLAA;FDFT1;PDXP;AGPAT2;PLA2G4F;MBOAT1;AGPAT1;PLBD1;GNPAT;PLPP2;IDI2;PLPP1
gsea,cellular response to topologically incorrect protein (GO:0035967),0.39304873773778426,1.2303206980529942,0.21564885496183206,0.28778235245145695,1.0,10/23,41.63%,BAX;BAK1;HSPA8;HSPA9;HSPA2;DNAJB14;STUB1;HSF1;ATXN3;DAXX
gsea,iron ion homeostasis (GO:0055072),0.38787287871887094,1.2300188705178698,0.18632478632478633,0.28778230210261685,1.0,16/26,43.60%,CCDC115;GLRX3;HMOX2;NUBP1;FXN;BDH2;ACO1;MYC;TMEM199;HFE;NEO1;SLC11A1;FLVCR1;CUL1;HMOX1;FRRS1
gsea,positive regulation of signaling receptor activity (GO:2000273),0.35279611513682085,1.2290869400043931,0.16717791411042945,0.28862277945451403,1.0,15/27,50.66%,HDAC1;HDAC2;IFNG;PARK7;IL10;HFE;BUD31;CCR2;CCL2;TGFA;EDN1;AREG;BTC;ADRA2A;HBEGF
gsea,base-excision repair (GO:0006284),0.38264817173499566,1.228868229575767,0.23984526112185686,0.28845051278756645,1.0,19/37,43.55%,RPA3;RFC5;RFC4;RPA2;FEN1;APEX1;POLD2;RFC3;UNG;XRCC1;OGG1;NEIL1;PRMT6;PCNA;POLD1;DNA2;PARP1;POLD3;RFC2
gsea,regulation of amyloid-beta formation (GO:1902003),-0.3569669891286748,-1.2280080325215403,0.18112244897959184,0.35816290975129794,1.0,21/21,97.53%,ABCA2;ABCA7;PICALM;SP1;ROCK2;ROCK1;APOE;ABCG1;RTN1;TNF;IGF1;GGA3;SLC2A13;HAP1;PRNP;RTN3;RELA;GSAP;CASP3;IFNG;PIN1
gsea,response to UV (GO:0009411),0.3116473671906729,1.2278667016249578,0.17870722433460076,0.28949046812466184,1.0,24/65,38.68%,NPM1;EIF2S1;PCLAF;AURKB;FEN1;BAK1;GPX1;CDKN2D;AKT1;SDF4;RELA;BCL3;ERCC3;RHNO1;USP1;MEN1;RUVBL2;GTF2H2;MYC;ERCC2;PCNA;POLD1;METTL3;NOC2L
gsea,protein deacetylation (GO:0006476),-0.3529407929430709,-1.2274647429590189,0.16666666666666666,0.35765411202580444,1.0,17/29,38.66%,FLNA;HDAC7;BAZ2A;TBL1XR1;TRERF1;HDAC4;MIER3;SIN3A;HDAC5;BRMS1L;SIRT6;HDAC6;TBL1X;SIRT1;PRDM5;SIRT5;RCOR3
gsea,inflammatory response (GO:0006954),0.3302290502469863,1.2273697053174077,0.17125,0.2896803493749737,1.0,54/95,40.86%,TNFRSF4;CCL3;HMGB1;CEBPB;XCL1;IFNG;CCL4;CCR7;ANXA1;CD14;HNRNPA0;CCRL2;CCL1;TNFSF4;ADORA2A;RELA;RIPK2;TNFRSF1A;IL2RA;NRROS;TBXA2R;TPST1;PJA2;CXCL10;CD40LG;CCR1;NLRP3;CIITA;TLR4;ADGRE5;CCL8;CYBB;IL1B;PTGER2;CX3CL1;CXCL13;ADM;CCL25;LTB4R2;CD40;SIGLEC1;FOS;CCR2;MFHAS1;CCL7;FCGR2B;CCL2;HDAC9;SLC11A1;IL1RN;CXCL2;C3AR1;LIAS;PF4
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3978264728958645,-1.226840429041418,0.1961206896551724,0.357216101005755,1.0,9/20,37.04%,NOTCH1;CHD6;GCN1;ATF4;HSPA5;ATF6;MAPK7;HIF1A;MT3
gsea,plasma membrane invagination (GO:0099024),-0.3731822196697312,-1.226803573085888,0.2047244094488189,0.35593086071433955,1.0,17/17,96.41%,MYH9;ITGAM;AIF1;GSN;SPIRE1;SNX9;ARHGAP12;MSR1;ARHGAP25;DOCK1;FCGR2B;CD36;SPIRE2;ELMO1;VAMP7;SH3BP1;AURKB
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",0.35588464754222293,1.2266920109151558,0.18936170212765957,0.2901605854753525,1.0,14/36,24.00%,ACTB;HMGA1;TAF1B;POLR2H;ELOF1;CDCA4;ASF1A;TBP;POLR2L;POLR2E;POLR1E;POLR1C;POLR2F;MYO1C
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3299515482484821,1.2264915373428273,0.1600633914421553,0.2900277917869346,1.0,17/46,47.06%,UBB;RPS27A;PIN1;STRAP;CITED2;GIPC1;HSP90AB1;MEN1;ENG;BAMBI;DAB2;SPRY1;STUB1;DKK3;EID2;THBS1;CIDEA
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.35074844680297773,1.2259984154998893,0.1769436997319035,0.29024312201046953,1.0,16/45,33.84%,PFN1;DRG1;CCR7;GPX1;EVL;PDXP;PLEK;NCK2;CDC42EP2;APP;PFN2;ARL2;CX3CL1;HCK;CDC42EP3;VIL1
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.38174135736686254,-1.2256974420404554,0.1960352422907489,0.35628996126767537,1.0,10/20,24.08%,CNOT1;NCOR2;SMARCA4;VPS11;BRCA1;CRY2;VPS18;PER1;ARNTL;CLOCK
gsea,positive regulation of metabolic process (GO:0009893),0.30680757101438116,1.2246186190977195,0.16793893129770993,0.29175170754239144,1.0,30/54,55.35%,PLAC8;FABP5;CEBPB;IFNG;HADH;ACADL;GATM;DECR1;AGPAT1;GRB10;CD36;GADD45G;SYK;CCR2;VEGFA;APPL2;HSF1;TSHR;GPR3;FFAR4;ACHE;FABP4;OMA1;PPARGC1B;BEND3;CAMK1D;CPT2;ACSL1;PIGA;ELOVL6
gsea,cell junction assembly (GO:0034329),-0.3389937938043375,-1.2246162951703845,0.20257234726688103,0.35662115339437267,1.0,14/26,34.04%,FLNA;PKP4;DSCAM;FARP1;PLXND1;NLGN2;CDH1;PKP3;PKP2;CTNND2;MYO9A;SPOCK2;TJP1;ITGA6
gsea,amino acid transmembrane transport (GO:0003333),-0.408734284800511,-1.224555376561013,0.22156862745098038,0.3553777484429502,1.0,8/17,23.04%,SLC38A2;SLC7A1;SLC38A9;LRRC8D;SLC7A5;SLC7A6;SLC38A6;SLC38A1
gsea,epithelial cell migration (GO:0010631),-0.3634899286461901,-1.224300124048561,0.2153209109730849,0.3544406449965428,1.0,9/19,38.45%,ZEB2;PIK3CA;PLXND1;ROCK1;NRP1;ABL1;STAT1;KIT;DPP4
gsea,regulation of interleukin-4 production (GO:0032673),0.43255821574089676,1.2241059336740587,0.2043343653250774,0.291994196783097,1.0,8/17,31.84%,CEBPB;CD86;TNFSF4;FCER1G;CD40LG;NLRP3;SYK;LEF1
gsea,positive regulation of mitotic nuclear division (GO:0045840),0.3850605972924872,1.2235543080097742,0.20517560073937152,0.2922882910518612,1.0,9/21,41.37%,RGCC;NUP62;CDC23;CDC16;NUSAP1;IL1B;AURKA;TGFA;EDN1
gsea,regulation of centriole replication (GO:0046599),0.41591777831185445,1.2235100928997933,0.2191780821917808,0.2919054500957388,1.0,4/17,24.98%,NPM1;NUP62;MDM1;PLK2
gsea,cellular response to starvation (GO:0009267),-0.28042949800095224,-1.2232673426413463,0.14414414414414414,0.3546660219650265,1.0,37/71,39.14%,EHMT2;SREBF2;MAP3K5;XPR1;MTMR3;EIF2AK3;RPTOR;TFEB;GCN1;DEPDC5;TCIRG1;ATF4;HSPA5;FOXO1;WDR24;SIK2;MAPK8;SLC38A9;IMPACT;FOXO3;TBL2;WRN;RRAGB;EIF2AK2;EIF2AK4;ITFG2;MYBBP1A;RRP8;SESN1;SESN3;SIRT1;RALB;LRRK2;RNF152;PMAIP1;FNIP1;USP33
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3135081781910636,1.2230755807306224,0.1514041514041514,0.2920658039653862,1.0,47/97,38.03%,MIF;PHB2;PIN1;EZR;CCL3;HMGB1;XCL1;CCL4;PHB;CCR7;APIP;SCIMP;CCL1;DUSP10;DUSP3;ICAM1;PDGFA;GLIPR2;APP;HRAS;CAMK2N1;RAMP3;GPR183;DUSP6;CCR1;TLR4;CCL8;GCNT2;RPS6KA6;DUSP4;CD36;IL1B;CX3CL1;SYK;CCL25;CD74;FGF2;FAM83D;GPR55;MFHAS1;SPRY1;CCL7;CCL2;SIRPA;CNKSR3;PTPN6;FN1
gsea,sprouting angiogenesis (GO:0002040),-0.3330123272148221,-1.2213214369481062,0.19420289855072465,0.3564318856198049,1.0,25/25,88.45%,PTK2B;RNF213;MIA3;NRP1;E2F7;DLL1;ESM1;SRF;E2F8;JMJD6;EFNB2;ADGRA2;PGF;THBS1;ACVRL1;LOXL2;RAMP2;VEGFA;FGF2;EGR3;NRARP;ENG;VEGFB;NR4A1;AKT1
gsea,regulation of cell death (GO:0010941),0.3523453717864742,1.2212555143215238,0.18681318681318682,0.2940812658359245,1.0,19/41,34.17%,UBB;TMEM109;SRSF6;PHB;AXIN2;RIPK2;CRYAB;NOA1;RAMP3;PARK7;CTSZ;RRAS2;PRR7;CD36;ZC3H12A;FGF2;BNIP3;VPS35;CCN4
gsea,cellular response to amino acid stimulus (GO:0071230),-0.40231812471103695,-1.2212186746222566,0.214123006833713,0.35526324857383956,1.0,9/15,30.87%,RPTOR;SLC38A9;UBR1;IPO5;CAPN2;KLHL22;RRAGB;SESN1;SESN3
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3829969454282858,1.2207685909520405,0.19169329073482427,0.29426134404965876,1.0,10/27,43.58%,S100A6;ACTB;DOCK7;APP;RYK;NRCAM;MFSD2A;ACTBL2;MAP6;KLF7
gsea,response to lipopolysaccharide (GO:0032496),0.3290483126178347,1.2198066292404848,0.15612903225806452,0.2951011129852674,1.0,44/76,40.86%,PRDX3;VIM;HMGB1;PDCD1LG2;HMGB2;SELENOS;CD14;HNRNPA0;NFKBIB;CD68;PLAA;ZFP36;CD86;TNFSF4;GCH1;RELA;CASP1;XBP1;CXCL10;NLRP3;IL10;TLR4;IRAK3;PDCD4;IL1B;CXCL13;ZC3H12A;GFI1;CACTIN;NR1H3;MAPKAPK3;CCL2;CTSG;SIRPA;AXL;ACOD1;SLC11A1;SCARB1;CD180;FOXP1;CXCL2;SELP;LIAS;PF4
gsea,calcium ion homeostasis (GO:0055074),0.35163399766047,1.2177938755281899,0.1910569105691057,0.2974810401257128,1.0,17/38,45.83%,TPT1;STOML2;CCL3;CCL1;TMEM203;SLC24A5;CCR1;CCL8;STC2;GRIN1;CD40;CCR2;CCL7;CALCB;EDN1;CHERP;HTR2A
gsea,cholesterol transport (GO:0030301),-0.37694014133748144,-1.2177600919766953,0.1745152354570637,0.3593023477495469,1.0,11/18,36.38%,ABCA7;OSBP;LDLR;NPC1;LIMA1;APOE;OSBPL5;SOAT1;OSBPL2;ABCG1;LIPG
gsea,sterol biosynthetic process (GO:0016126),0.417129110059064,1.2175379874885581,0.22281639928698752,0.2973745191212345,1.0,16/24,38.96%,SC5D;PRKAG2;FDFT1;ACAT2;MSMO1;IDI1;FDPS;MVK;HSD17B7;DHCR7;IDI2;TM7SF2;CH25H;PMVK;NSDHL;INSIG1
gsea,regulation of cell development (GO:0060284),0.38972238123406777,1.2175314031179774,0.19480519480519481,0.29693635169616245,1.0,9/21,29.46%,BHLHE40;HMGB2;CTNNB1;AKT1;DOCK7;BHLHE41;IL1B;CX3CL1;GRN
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.37576012559949734,1.2170612349839656,0.18867924528301888,0.2970741547395352,1.0,21/38,33.04%,TMSB4X;PHB2;EZR;PHB;CD14;CD86;RELA;BCL3;TSPAN6;APP;PTP4A3;TERF2IP;NLRP3;TLR7;NFKBIA;TLR4;PDCD4;IL1B;TNFSF14;ZC3H12A;SPHK1
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.29651690301783323,-1.2169613555625283,0.15185185185185185,0.35919045841466446,1.0,16/41,36.13%,MYH9;CALCA;PLCG1;PLCG2;ADRB1;CREB1;CALCRL;PRKAR2A;VIPR2;ADORA2B;ADAM17;MC1R;PRKAR2B;RHBDF2;FURIN;LYN
gsea,regulation of cell motility (GO:2000145),-0.2848411168761135,-1.216832599282321,0.12109375,0.35807042104179077,1.0,31/54,41.37%,MACF1;FLNA;CDK6;SPATA13;PLXND1;DIAPH1;SLK;ROCK2;MINK1;ROCK1;ABL1;ABI3;RCC2;CEACAM1;KIF14;PLXNA1;DDX58;SPOCK2;TBCCD1;OSGIN1;FBLN1;KIF2A;GATA3;SERPINE2;FES;CSF1R;HACE1;AMOTL2;TTBK2;ADGRG3;RHOB
gsea,regulation of macroautophagy (GO:0016241),-0.3175243376976113,-1.2162529578743593,0.16853932584269662,0.35770490735793764,1.0,24/45,30.87%,LARP1;NEDD4;PIK3CA;EXOC4;ATP13A2;RPTOR;ERN1;USP36;TSC1;TSC2;MAPK8;SLC38A9;SMCR8;ATP6V0A2;EXOC8;ULK1;CLN3;RRAGB;HDAC6;MAP3K7;TBC1D25;UBQLN1;SESN1;SESN3
gsea,regulation of cell-substrate adhesion (GO:0010810),-0.35089619264359945,-1.2159628080884415,0.1826086956521739,0.3568351665753895,1.0,10/23,32.01%,NOTCH1;CORO1C;JAK2;MINK1;NF1;TSC1;PDGFB;NDNF;PPM1F;NPNT
gsea,positive regulation of transport (GO:0051050),0.3570048823820789,1.2156416566743298,0.16054421768707483,0.29842400185251816,1.0,25/49,38.38%,ANXA2;ACTB;BAX;BAK1;IFNG;ANXA1;CHCHD10;LYAR;LMAN2;PLAA;SGK1;RXRA;FCER1G;TUB;BID;SYNGR3;CAPN10;IL1B;NR1H3;DAB2;FCGR2B;SIRPA;FLOT1;SLC11A1;LRP1
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.3425523543348674,1.2154504979651808,0.21951219512195122,0.29822537018740547,1.0,22/63,34.67%,NPM1;TUBA1A;TUBB4B;CDK1;YWHAE;CDK2;TUBA4A;HAUS1;HAUS4;HAUS8;TPX2;DYRK3;PLK1;NDE1;HAUS2;NEK2;CEP41;ACTR1A;AURKA;HAUS6;CEP78;TUBG1
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.23872319659723992,-1.2152782915509692,0.08595988538681948,0.35653726199195446,1.0,228/228,98.42%,ATXN1;TLE5;NCOR2;CHD8;IKZF1;SMARCA4;ATF7IP;CIC;TMPRSS6;CALCA;BTAF1;USP47;NOTCH1;SPEN;KAT6A;CBX5;TRERF1;PHC3;ZBTB38;FOXN3;SMARCC2;BAP1;BCOR;NACC1;NKRF;KAT6B;TRIM33;RUNX2;SBNO2;HDAC4;CENPF;JARID2;BCLAF1;RBM15;FOXM1;IKZF4;FOXO1;ZBTB4;RLIM;MBTD1;BRCA1;ILF3;JUN;POU2F1;GCLC;SAMD1;CBX3;NR3C1;ARID5B;ELK3;CRY2;HEXIM1;BAHD1;YEATS2;ZHX3;WNT11;ZHX1;SIN3A;ZEB1;BTRC;PDGFB;RARA;GAS6;PER1;HDAC5;CIPC;KDM5C;PHC1;PAX9;L3MBTL3;FOXK2;KMT5A;ARNTL;CLOCK;SPI1;CCAR2;SPINDOC;KDM4A;RPS6KA5;HINFP;HDAC6;MYBBP1A;PPM1F;PML;RBM15B;ZKSCAN3;GATA3;BCL7A;RB1;TRIB3;XRCC6;DAB2IP;RORB;PTPRK;CALR;PRDM16;ARID5A;SIRT1;REST;CTBP2;ZBTB14;BASP1;ZBTB21;EHMT1;PRDM5;SMARCA2;PSPC1;GCFC2;BMP7;MT3;WWP1;L3MBTL2;DMAP1;PRMT2;RCOR3;CIART;SETDB2;SCML4;CDKN2A;CTCF;KAT7;TNF;AHR;XRCC5;LANCL2;MDFIC;PIAS4;FOXP3;ZBTB33;HDAC10;SHC1;PATZ1;NAB1;MYB;ZC3H8;SUV39H1;ATF5;MDM2;MBD1;DDIT3;BCL6;WNT4;TBX2;KDM8;SFMBT1;FOXE1;PPARG;KLF4;SOX8;DAXX;EID2;TCF7L2;ID1;BRD7;LOXL2;FOXP1;CSF2;CREB3L1;NFIL3;PCGF6;DKK3;HDAC9;ZMYND15;GZF1;ZHX2;CBFA2T3;RBFOX2;TLE1;PRMT6;LEF1;GFI1;SIX3;ZBTB16;TWIST1;SUV39H2;BHLHE41;IRF1;PDCD4;CRY1;LBH;VDR;CIITA;EED;HHEX;PHF10;TFAP4;KAT8;CBX4;TIMELESS;RIOX1;ID3;MEN1;CRYAB;TFDP2;TRIM28;NIF3L1;CD38;E2F1;KLF10;BCL3;RELA;TNFSF4;SFPQ;CBY1;COPS2;CTNNB1;EZH2;HSPA8;GMNN;PHB;SET;IFNG;CITED2;HMGB2;XCL1;PA2G4;DAP;HDAC2;HMGA1;NONO;BIRC5;BHLHE40;ID2;TBX21;PHB2;TNFRSF4;ENO1;HDAC1
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),0.35724778493338527,1.2137512747670285,0.22163120567375885,0.30004040220612777,1.0,13/32,40.99%,RAN;ANP32B;YWHAE;IFNG;CPSF6;NCBP2;TRIM28;HYAL2;IL1B;ZC3H12A;CAMK1;ZPR1;TCF7L2
gsea,regulation of viral transcription (GO:0046782),0.3791845665325169,1.2135481076122703,0.20194174757281552,0.2998979046112672,1.0,9/22,26.70%,POLR2C;POLR2H;POLR2L;POLR2E;ZFP36;GTF2F2;POLR2F;TARBP2;POLR2B
gsea,fatty acid metabolic process (GO:0006631),0.3105553852066463,1.21193843576287,0.18681318681318682,0.30170504585846974,1.0,29/55,47.59%,NDUFAB1;NUDT19;GPX1;PEX2;ALKBH7;ACSL5;MSMO1;MCAT;MECR;PON3;XBP1;ACADSB;ALOX5AP;CD36;GNPAT;OXSM;ECHDC3;PTGS2;ACADM;SLC27A3;HACL1;PNPLA8;ACSL6;ACOX1;PPARG;UGT1A8;ACOT4;LTC4S;FA2H
gsea,transcription by RNA polymerase III (GO:0006383),0.40220865985548665,1.2118558744586154,0.23742454728370221,0.3013822095543012,1.0,6/19,20.06%,POLR3K;POLR3H;TBP;POLR2L;GTF3A;POLR3GL
gsea,positive regulation of biosynthetic process (GO:0009891),0.39543090818128257,1.2108733605932154,0.20198675496688742,0.3023180391441276,1.0,8/22,33.20%,VIM;RGCC;HDAC2;AKT1;TLR4;CD36;SIRT4;GRIN1
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.42160858914585964,-1.2108262468329578,0.22198275862068967,0.3620542155356596,1.0,9/15,32.94%,EP300;SAFB2;LATS1;NCOA2;HDAC6;CARM1;AR;CALR;RUNX1
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4224862065867864,1.2103778212032679,0.23247232472324722,0.30250384364878574,1.0,6/16,25.55%,BAX;DDX47;BLOC1S2;FADD;TNFRSF1A;BID
gsea,negative regulation of protein modification process (GO:0031400),0.33260635288689117,1.20998970634577,0.1833855799373041,0.30260856716759044,1.0,23/46,43.08%,PPIA;DBI;ZBED3;CRTAP;MEN1;XRCC1;DNAJC10;TERF2IP;PARK7;C9ORF72;PRNP;PPP1R15A;ZC3H12A;CACTIN;WWTR1;MFHAS1;P3H1;MYADM;SIRPA;TRAF3IP1;PID1;NTRK3;INSM1
gsea,regulation of immune response (GO:0050776),0.32553702078647606,1.209657931319709,0.1700404858299595,0.30258990123678514,1.0,37/70,39.62%,SH2D1A;PLSCR1;CD160;SAMHD1;ICAM2;SLAMF7;SLAMF6;TNFSF4;ICAM1;TKFC;IL4I1;CD40LG;CD33;SELL;NECTIN2;IRF1;RIPK3;LAIR1;ZMPSTE24;VCAM1;BIRC3;CXCL13;CD300A;CD226;SYK;CD81;JAML;CD40;NPDC1;NCR1;FCGR2B;APPL2;IRF7;CRTAM;FGR;CD300LF;FOXP1
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.35417206670079093,1.2093993980984983,0.19009370816599733,0.30248935800749804,1.0,16/41,33.84%,PFN1;CCR7;NUP62;HAX1;EVL;PDXP;PLEK;NCK2;CDC42EP2;PFN2;HRAS;CX3CL1;HCK;SORBS3;CDC42EP3;VIL1
gsea,plasma membrane organization (GO:0007009),-0.3301954106272206,-1.207676111282209,0.17937219730941703,0.3657930385680304,1.0,16/28,40.62%,MYH9;ABCA7;SPTBN1;ANO6;SYT11;CLN3;CXCR4;NSF;SMPD1;PACSIN3;PLSCR3;OSBPL2;EHD2;MICALL1;SYT7;SNX9
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.27919093303298725,1.2075874293006663,0.15137614678899083,0.30442622210993675,1.0,41/97,49.43%,SUB1;MIF;HDAC1;ID2;RACK1;CCL3;CITED2;IFNG;ANXA7;OVOL2;PTRH2;HSP90AB1;APP;HRAS;CCR1;PARK7;VDR;PARP9;STC2;AURKA;ZC3H12A;TRAT1;ENG;PINK1;FGF2;DLL4;VEGFA;MYADM;CPNE1;CREB3L1;FOXP1;ACVRL1;KLF4;TGFB2;NOS2;APOBEC1;APLN;PRKAA1;IGF1;WNT4;MSR1
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3406813743726909,-1.2071622199490346,0.19814241486068113,0.36530766872499765,1.0,9/22,35.68%,PADI2;PARP14;OTUD4;SIGIRR;GAS6;STAT2;F2RL1;SH2B3;OTOP1
gsea,defense response to symbiont (GO:0140546),0.3280319576618597,1.2068291430134257,0.19047619047619047,0.304984974323983,1.0,29/64,38.19%,PLSCR1;SERINC3;DDIT4;IFI27;BST2;G3BP1;SAMHD1;EXOSC5;ZBP1;IFNAR2;RELA;FADD;NDUFAF4;EXOSC4;IL21;IRF2;ATG7;TLR7;IRF1;RIPK3;ISG15;OAS3;TTC4;CD40;BNIP3;RNASE6;ACOD1;RTP4;IRF7
gsea,cellular metal ion homeostasis (GO:0006875),0.33749435252310134,1.2055566848806663,0.18467852257181944,0.3062289169584809,1.0,17/41,41.37%,TPT1;STOML2;CCL3;LETM1;CCL1;TMEM203;SLC24A5;CCR1;CCL8;STC2;CD40;CCR2;ATP1A3;CCL7;ATP1A2;CALCB;EDN1
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.34940642717521353,-1.2052835102961643,0.20416666666666666,0.3669750964066319,1.0,24/24,98.68%,RPS6KA3;SFN;DDX3X;DHCR24;USP47;GAS6;SH3RF1;CD44;MT3;FNIP1;TNF;CAAP1;THBS1;PLAUR;KLF4;MMP9;VEGFA;PARK7;PIH1D1;AKT1;CDKN2D;GPX1;YWHAE;ARL6IP1
gsea,Ras protein signal transduction (GO:0007265),-0.27324926377594533,-1.2034156026640648,0.13573407202216067,0.3684880755221509,1.0,38/75,36.11%,RAPGEF1;MYO9B;ADGRG1;RAPGEF2;ARHGDIA;RASGRP1;GRAP2;ROCK2;NCKAP1;KSR1;NF1;ROCK1;DNMT1;SETDB1;KPNB1;JUN;LIMK1;SOS1;HACD3;RALGDS;CYFIP1;AIF1;RAP2C;TIAM1;ARHGEF11;GPSM2;ARHGAP5;NRAS;MRAS;RB1;KSR2;ABI2;SHTN1;RAB42;ARHGEF3;RALB;USP8;HACE1
gsea,lytic vacuole organization (GO:0080171),-0.37320465607842224,-1.203334273347354,0.21153846153846154,0.36728201678199507,1.0,9/19,31.37%,GNPTAB;HOOK3;TFEB;GAA;VPS18;CLN3;HOOK1;ZKSCAN3;CLN6
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.28813860397263424,-1.2015985770140734,0.1523809523809524,0.3687124323835072,1.0,20/45,39.70%,MACF1;SMARCA4;SKI;CDC73;ITGA3;TNFAIP3;TSC2;FAM53B;BTRC;CTNND2;TIAM1;CDK14;HMGXB4;NLK;SFRP4;RUNX1;FRZB;SHISA2;LRRK2;NKD2
gsea,DNA damage checkpoint signaling (GO:0000077),0.38604843086577945,1.2001184540857621,0.22011385199240988,0.3131920164367464,1.0,7/22,23.04%,TIPRL;PRPF19;DONSON;E2F1;RHNO1;RAD1;RAD17
gsea,glycerophospholipid metabolic process (GO:0006650),0.3413515185745432,1.1988312273321933,0.21578099838969403,0.3145829654447182,1.0,13/36,36.96%,PIGF;CRLS1;GDE1;PLA1A;ACP6;PDXP;PLEK;PLA2G4F;CPNE3;AGK;PIGH;ABHD6;CPNE1
gsea,positive regulation of RNA splicing (GO:0033120),-0.3907603295257267,-1.197273329299362,0.25,0.3740387781413893,1.0,10/20,26.04%,CELF4;SLC38A2;SETX;NCL;NUP98;DYRK1A;ERN1;POLR2A;HABP4;HSPA1A
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.35888884977166163,1.1966874697526457,0.18679950186799502,0.31714094825990247,1.0,35/57,40.86%,VIM;HMGB1;PDCD1LG2;HMGB2;SELENOS;CD14;NFKBIB;CD68;PLAA;ZFP36;CD86;TNFSF4;RELA;CASP1;XBP1;CXCL10;NLRP3;IL10;TLR4;PDCD4;IL1B;CXCL13;ZC3H12A;GFI1;CACTIN;NR1H3;FCGR2B;CCL2;CTSG;SIRPA;AXL;ACOD1;CD180;CXCL2;PF4
gsea,regulation of ossification (GO:0030278),-0.39011734659261277,-1.1963460164808117,0.2245508982035928,0.37409994141358227,1.0,7/15,28.22%,NOTCH1;BMP2K;CHSY1;LRP6;PTPN11;ACVR1;MEF2C
gsea,glutamine family amino acid metabolic process (GO:0009064),0.3962030908945473,1.1959721041974765,0.2300556586270872,0.3176851698561429,1.0,10/17,39.14%,GOT1;OAT;PYCR2;NIT2;GLUL;ALDH18A1;SIRT4;ALDH4A1;DGLUCY;FPGS
gsea,positive regulation of cell cycle process (GO:0090068),0.3287082889096604,1.194561903060306,0.2559852670349908,0.31915579985452514,1.0,23/62,42.04%,RANBP1;PLSCR1;RGCC;AURKB;MAD2L1;NSFL1C;FEN1;NUP62;CENPV;GIPC1;CCNB1;UBXN2B;RHNO1;NUSAP1;RACGAP1;IL1B;AURKA;PCID2;DBF4;TGFA;CDC6;EDN1;KIF23
gsea,regulation of embryonic development (GO:0045995),0.4176527535583221,1.1934555123295687,0.2418426103646833,0.32034399354665444,1.0,6/15,32.30%,CFL1;CDK1;ZBED3;RACGAP1;RPS6KA6;POGLUT1
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3735940185038818,-1.192840159182655,0.19668737060041408,0.3785384295618339,1.0,13/23,29.35%,ITPKB;PIK3CA;PI4KA;PIK3C2A;PIK3CG;PIP4K2B;IP6K2;FAM126B;PIK3CD;FAM126A;SOCS5;SOCS7;SOCS6
gsea,positive regulation of double-strand break repair (GO:2000781),-0.3443031669053957,-1.191645495129823,0.21585903083700442,0.37919132992216176,1.0,18/32,38.08%,RIF1;ARID2;SMCHD1;ACTR2;PRKDC;FOXM1;SLF2;KMT5C;KDM4D;MMS19;SLF1;KMT5B;WRAP53;ERCC6;ZCWPW1;SPIDR;DDX11;DTX3L
gsea,protein O-linked glycosylation (GO:0006493),-0.2933802981954221,-1.1905568731302525,0.17676767676767677,0.37966000572223724,1.0,26/50,39.42%,B4GALT5;OGA;TET2;GALNT6;GXYLT1;TET3;POFUT1;POMT2;GALNT1;ST3GAL3;POMK;GALNT7;TRAK1;GALNT18;ST6GALNAC4;GCNT1;PLOD2;TMTC2;XXYLT1;PLOD1;POMGNT1;GALNT10;POGLUT3;GALNT14;PLOD3;FKTN
gsea,microtubule bundle formation (GO:0001578),-0.35811808698310366,-1.1904101993172134,0.25885558583106266,0.3785744715433752,1.0,8/19,38.84%,CLASP1;TOGARAM1;NUMA1;CDK5RAP2;CLIP1;CCDC66;CFAP74;KIF20A
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3835631463078208,-1.1890160830439074,0.24242424242424243,0.3795917872818818,1.0,10/19,31.23%,RIF1;SMCHD1;ACTR2;PRKDC;TFIP11;KMT5C;KDM4D;KMT5B;WRAP53;ERCC6
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.35977135323262044,-1.1884364249192259,0.24948875255623723,0.37919661689128614,1.0,21/21,98.68%,RPS6KA3;SFN;DDX3X;DHCR24;USP47;LTF;GAS6;SH3RF1;CD44;MT3;FNIP1;TNF;THBS1;KLF4;VEGFA;PCID2;AKT1;CDKN2D;GPX1;YWHAE;ARL6IP1
gsea,positive regulation of protein phosphorylation (GO:0001934),0.2726147911304036,1.1872039180286336,0.15220125786163521,0.3288067704555737,1.0,66/159,43.49%,PPIA;CALM2;MIF;CDK2AP1;PIN1;RACK1;CCND3;IFNG;DUSP19;LCP2;CCR7;MMD;HAX1;PRKAG2;AKT1;MAP2K3;HSP90AB1;MYDGF;OSM;MRNIP;AXIN2;DOCK7;PDGFA;RIPK2;TRAF4;FAS;APP;PLK1;PFN2;BANK1;VEGFB;HRAS;CNOT9;RAMP3;TERF2IP;PARK7;RBPMS;PRNP;RAP2A;IL1B;CX3CL1;HFE;CD74;CD81;ENG;LIF;PINK1;FGF2;SPHK1;CD40;VEGFA;AKTIP;DAB2;DVL2;PECAM1;CAMK1;FLOT1;NBN;MMP9;ACVRL1;TTK;NTRK3;DAXX;INHBA;PLAUR;TGFB2
gsea,axonogenesis (GO:0007409),-0.2636878246463648,-1.186945840402971,0.15040650406504066,0.38006190745332635,1.0,43/84,39.48%,B4GALT5;USP9X;TAOK2;SPTAN1;DSCAM;SPTBN1;PIK3CA;NOTCH1;LMTK2;ARHGAP35;ULK2;SEMA6D;PLCG1;IRS2;NRP1;NOTCH2;KIF5B;PRKCA;SOS1;CYFIP1;DAG1;EFNB3;AFG3L2;PTPN11;SEMA4C;PIK3CD;ULK1;ENAH;SEMA4B;LLGL1;CXCR4;SEMA7A;APBB1;RPS6KA5;SPG11;MAPK7;SHTN1;SCN1B;PALLD;PIK3CB;BAIAP2;USP33;KIF5C
gsea,regulation of mRNA processing (GO:0050684),0.39637605322585523,1.1863589788821192,0.2537313432835821,0.3294727997996055,1.0,8/18,31.49%,HNRNPK;SRSF3;ZFP36L1;NCBP1;SRPK1;SRSF10;CPSF4;PTCD2
gsea,organelle transport along microtubule (GO:0072384),0.40697666080238026,1.1855451674120956,0.2540834845735027,0.3302270669673648,1.0,16/16,98.20%,UBB;NDE1;HAP1;COPG2;COPG1;TRAK1;BICD1;RHOT2;TMEM201;ARHGAP21;CLN3;BICDL1;KIF5B;BICD2;LRPPRC;HTT
gsea,cellular senescence (GO:0090398),0.3909832075671106,1.1853046489732808,0.2419047619047619,0.3301109288545975,1.0,6/18,50.91%,ID2;HMGA1;HRAS;SMC6;TBX2;MAPKAPK5
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.34183718220063924,1.1852776146592057,0.2222222222222222,0.32968044930615836,1.0,9/41,20.79%,TMED2;KDELR2;LMAN2;ERGIC1;KIFAP3;COPB2;RACGAP1;KIF22;RINT1
gsea,negative regulation of cell differentiation (GO:0045596),-0.25960926490516034,-1.1842684905060423,0.14590747330960854,0.38318322008077055,1.0,46/82,37.13%,CDK6;HDAC7;PTK2B;SKI;CDC73;NOTCH1;SMAD7;ITGB3;ASXL1;USF3;WNT10B;XDH;FOXO1;MED1;PTCH1;PKP2;SPRY2;CTR9;SPRED2;PTPN11;TRIB2;ZFPM1;SMAD3;ZADH2;ANKRD26;DTX1;ARNTL;EIF2AK4;DLL1;GATA3;RB1;TRIB3;DAB2IP;RORB;CALR;HNRNPU;METTL14;SIRT1;REST;NOCT;YAP1;NEPRO;ABCG1;BMP7;ZFP36L2;CRIM1
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),0.34444149842594496,1.1840363626202224,0.24267782426778242,0.3308399621653675,1.0,15/35,24.54%,PGAM1;EIF6;AAAS;NUP62;NUP43;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;NUP54;NUP35;TIGAR;NOA1;NUP85
gsea,cellular response to ionizing radiation (GO:0071479),0.3397816846239802,1.1836149965755924,0.22099447513812154,0.33094276195371936,1.0,10/37,30.61%,EEF1D;TMEM109;RAD51;RHNO1;RAD1;CRYAB;FIGNL1;HRAS;GADD45A;RAD51AP1
gsea,regulation of inflammatory response (GO:0050727),0.3008153711877581,1.1834183793893418,0.2037735849056604,0.3307495313558322,1.0,53/101,37.40%,TMSB4X;CCL3;XCL1;PSMA6;IFNG;ANXA1;SELENOS;BST1;NFKBIZ;ZBP1;CCL1;TNFSF4;OSM;RELA;CASP1;UFL1;TNFRSF1A;APP;IL21;MVK;HYAL2;MGST2;NINJ1;PARK7;NLRP3;IL10;TLR7;NFKBIA;SMPDL3B;TLR4;SETD6;PDCD4;BIRC3;IL1B;CX3CL1;HCK;RORA;GRN;USP18;PIK3AP1;SPHK1;NR1H3;VPS35;CCN4;CCR2;MFHAS1;PTGS2;METRNL;SIRPA;TNFAIP8L2;ACOD1;GHSR;IL2
gsea,protein localization to plasma membrane (GO:0072659),0.2988681517070109,1.1827730344286478,0.20032840722495895,0.33118897830368543,1.0,25/64,43.79%,S100A10;TMED2;BSG;EZR;GORASP2;TESC;ACTN2;ZDHHC2;TNFRSF1A;EHD4;TSPAN5;RAB13;RAMP3;EHD3;RAP2A;TTC7B;CD81;PLEKHF1;RAMP1;MYADM;RAMP2;FLOT1;PACSIN1;TSPAN15;CACNB3
gsea,regulation of RNA metabolic process (GO:0051252),0.3523965023696455,1.1815797680482785,0.2429078014184397,0.3324066196239573,1.0,12/28,36.30%,HNRNPF;PCBP1;PTBP1;HNRNPLL;RBM38;FUS;GRSF1;IGF2BP3;OAS3;RRP1B;MBNL3;PCBP4
gsea,regulation of cell adhesion (GO:0030155),-0.2866625628330429,-1.1813162140685916,0.15634218289085547,0.38664102421500823,1.0,33/60,37.74%,PKP4;SPN;ADGRG1;DSCAM;PTK2B;ARHGDIA;PLXND1;PTPRJ;ROCK2;MINK1;RASA1;ROCK1;MIA3;ABL1;PIK3CG;PRKD2;PRKCA;TFE3;PDE3B;PTPN11;KIF14;PLXNA1;CXCR4;ADAM8;C2CD4A;CCL5;DLL1;FUT7;FBLN1;PRSS2;FES;LYN;PLAU
gsea,plasma membrane bounded cell projection assembly (GO:0120031),-0.24771465820960567,-1.1788942332228642,0.1246684350132626,0.38949251629485326,1.0,59/119,38.78%,FLNA;CEP250;PPP1R9B;SPATA13;NOTCH1;RAPGEF2;EXOC4;AHI1;ANO6;MINK1;TNIK;ACTR2;CDC14A;PCNT;NRP1;SRGAP2;DYNC2H1;CPLANE1;CEP162;VCL;PTPN23;PIBF1;PCM1;ABCC4;CYFIP1;PMP22;AIF1;WDR90;EXOC2;CCNO;RAP2C;EXOC8;CEP164;CCDC66;ASAP1;KIF3B;HDAC6;CEP83;CEP89;SCLT1;CEP290;RAB3IP;MTSS1;KIT;FGD3;ITGB1;FGD2;S1PR2;SHTN1;NEK1;RAB23;SSX2IP;IFT80;GSN;EHD2;MAP4K4;TTBK2;ABLIM2;KIF24
gsea,positive regulation of DNA repair (GO:0045739),0.3603352993968837,1.1773134362013347,0.24763705103969755,0.3381125340560746,1.0,10/31,27.10%,UBE2N;HMGB1;BRCC3;ABRAXAS1;TRIM28;TIGAR;MGMT;XRCC1;TIMELESS;SPIRE2
gsea,phosphate-containing compound metabolic process (GO:0006796),0.28104053575479065,1.1764701011645227,0.17573872472783825,0.33889400143581916,1.0,44/97,37.47%,ALDOA;PGK1;PSPH;PPA1;NUDT5;DUSP12;BCKDK;DUSP5;GDE1;ACP6;ACYP1;AKT1;PLAA;PDXP;PPA2;AGPAT2;HDHD2;DUSP10;DUSP3;ISYNA1;NADK;PLA2G4F;IPPK;TIGAR;AGPAT1;CERKL;AGK;ALDOC;FRA10AC1;ACP2;PLBD1;DUSP4;G6PC3;GK;PLPP2;COQ8A;SPHK1;ENPP1;PLCB4;PXYLP1;ALPL;PLPP1;INPP5B;NUDT10
gsea,protein localization to membrane (GO:0072657),-0.2548821807806554,-1.1754727671920653,0.15384615384615385,0.3938559492433385,1.0,90/90,99.82%,FLNA;SPTBN1;ITGA4;MYO5A;JUP;RAPGEF2;NUP155;SEC16A;NLGN2;PACS2;ROCK2;TNIK;CLASP2;SYNE3;ROCK1;DENND4C;CDH1;GAK;AP3D1;C2CD5;PTCH1;PKP3;PKP2;NDC1;PACS1;TM9SF4;LRP6;SCRIB;SLMAP;FAM126B;NPC1;GAS6;HGS;DVL1;FAM126A;CPE;RAB32;DLG2;MAP7;TSPAN33;RAB34;EHD2;ATP1B1;MADCAM1;TSPAN32;NKD2;TNF;FLOT2;FGF13;SH3PXD2B;ARL5B;RDX;ITGB7;RAB3D;PICK1;ANK1;CACNB3;TSPAN15;RAB38;PACSIN1;FLOT1;LIN7A;RAMP2;MYADM;RAMP1;ZDHHC15;PLEKHF1;CD81;RFTN1;TTC7B;RAP2A;BID;EHD3;RAMP3;AP4M1;RAB13;ARL5C;TSPAN5;NUP54;EHD4;SAV1;TNFRSF1A;ZDHHC2;ACTN2;TESC;PDZD11;EZR;BSG;TMED2;S100A10
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.38679358262973107,1.172948412266505,0.2895238095238095,0.3435030214339199,1.0,9/31,27.10%,CENPA;STMN1;AURKB;RHOC;RTKN;NUSAP1;RACGAP1;PLK1;SPIRE2
gsea,hippo signaling (GO:0035329),0.4376294295297643,1.1718548639731012,0.27450980392156865,0.3447579587612814,1.0,5/15,35.12%,YWHAE;CASP3;SAV1;WWTR1;DVL2
gsea,positive regulation of JNK cascade (GO:0046330),-0.306224596368185,-1.1715192459251191,0.195,0.3991764523888599,1.0,19/39,36.61%,TAOK2;TAOK1;PTK2B;MAP3K5;TRAF3;RASGRP1;MAP3K11;MINK1;TRAF1;RIPK1;HIPK2;NCF1;SH3RF1;MTURN;F2RL1;DAB2IP;UNC5CL;RASSF2;MAPK8IP1
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.29878274483068995,1.1714402048275907,0.22375690607734808,0.3449204747150666,1.0,30/69,35.82%,MIF;PHB2;CCL3;HMGB1;XCL1;CCL4;PHB;CCR7;SCIMP;CCL1;ICAM1;PDGFA;GLIPR2;APP;HRAS;RAMP3;GPR183;CCR1;CCL8;GCNT2;CD36;CX3CL1;CCL25;CD74;TNFSF11;FGF2;GPR55;MFHAS1;CCL7;CCL2
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3399201308393075,1.1691826945792632,0.21859706362153344,0.3477628423399337,1.0,10/36,35.68%,SUMO2;RACK1;HSPBP1;RAD23A;PLK1;NUB1;BAG2;DAB2;STUB1;CBFA2T3
gsea,regulation of insulin secretion (GO:0050796),-0.2885277110525564,-1.1690542439180795,0.18339100346020762,0.40194316808654484,1.0,18/38,40.96%,ITPR3;ITPR1;NLGN2;ITPR2;IRS2;ACSL4;PRKCA;CACNA1A;SOX4;ARNTL;CLOCK;CACNA2D2;CCL5;REST;DPP4;CDK16;SYT7;TNF
gsea,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3797546410592187,-1.168658575306492,0.25471698113207547,0.4012353637138366,1.0,11/18,29.35%,STAT3;JAK2;CLCF1;STAT6;STAT5B;CTR9;STAT5A;STAT2;STAT1;STAMBP;SOCS6
gsea,regulation of protein modification process (GO:0031399),0.3382299950487568,1.1672603456056116,0.25542570951585974,0.35009213378193693,1.0,11/31,42.08%,PIN1;SOCS1;HPF1;IFNG;ATG10;RABL3;HSPB1;ATG7;PUM3;FN1;PLXNB2
gsea,unsaturated fatty acid metabolic process (GO:0033559),0.41676941541125856,1.1659636729569762,0.2547307132459971,0.35146770711262704,1.0,9/16,43.78%,GPX1;EPHX1;ABCD1;PNPLA8;FADS3;DECR2;ACOX1;PLA2G4A;ELOVL2
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.30804907906675194,1.164759068418702,0.22002820874471085,0.3527685690086565,1.0,19/59,33.35%,MANF;STMN1;PRMT1;HMGB1;CCR7;GPM6B;PLEK;BLOC1S2;KIFAP3;DOCK7;APP;TPM1;RAB13;HDGFL3;RYK;CEP78;PTPRM;UNC5A;ARFIP2
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3199410444491687,1.164703990208479,0.23564064801178203,0.352360746651741,1.0,24/50,43.49%,UBB;RPS27A;LPXN;DUSP22;SLC33A1;LRRC32;NRROS;GCNT2;PDCD4;HFE;ENG;BAMBI;FOS;STUB1;APPL2;SMAD5;ID1;PRKCZ;ACVRL1;EID2;SMAD1;INHBA;RGMB;TGFB2
gsea,histone methylation (GO:0016571),0.392787315049907,1.1621196124459918,0.2746212121212121,0.3556950801295542,1.0,9/18,32.51%,PRMT1;EZH2;FBL;SMYD3;N6AMT1;PRMT5;SETD6;SUV39H2;PRMT6
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",0.41101053275134075,1.1614540451530073,0.31262939958592134,0.356161800373759,1.0,8/18,28.21%,SF3B4;SNRNP40;DBR1;SF3A3;GEMIN2;TXNL4A;SRSF10;PRPF3
gsea,negative regulation of metabolic process (GO:0009892),-0.3442839389629722,-1.161314878889101,0.23511904761904762,0.4119536399807328,1.0,9/22,31.19%,NOTCH1;WNT10B;ATF4;IL18R1;TFE3;TLE3;ARNTL;ADAM17;RB1
gsea,B cell differentiation (GO:0030183),0.3438867936403231,1.1599433809762516,0.2596439169139466,0.35786339213230356,1.0,16/30,47.94%,SLC25A5;RABL3;TCF3;HHEX;IL10;VCAM1;KLF6;HDAC9;DCAF1;IRF2BP2;CD79A;NFAM1;FLT3;LYL1;BLNK;TPD52
gsea,regulation of signal transduction (GO:0009966),0.30916958358122576,1.1591454755712993,0.2342931937172775,0.3585179486528517,1.0,23/72,34.38%,PPIA;PLSCR1;IGFBP7;NUP62;BST1;OVOL2;SP100;KCTD8;ELF1;NCK2;CD63;RGS2;RGS16;CASTOR1;APP;TMEM237;PRNP;DHRS3;CD36;CX3CL1;RORA;GNG4;WWTR1
gsea,fatty acid biosynthetic process (GO:0006633),0.3635242237748779,1.1589873615428827,0.25176803394625175,0.35822662622697937,1.0,12/26,40.84%,NDUFAB1;HACD2;MCAT;XBP1;HACD1;OXSM;ABCD1;PTGS2;HACD4;FADS3;DECR2;LIAS
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.30945624177328723,1.1587608291204856,0.22289156626506024,0.35809661647113533,1.0,23/47,41.08%,POLR2C;GTF2E2;POLR2H;INTS11;TBP;POLR2L;NCBP2;POLR2E;GTF2F2;NCBP1;CDK7;TAF9;INTS4;CCNK;POLR2F;INTS10;POLR2B;INTS14;INTS5;INTS13;RPRD1B;GTF2E1;INTS3
gsea,liver development (GO:0001889),0.3641650809963147,1.1569445939201437,0.2655935613682093,0.3602667778144191,1.0,7/18,30.74%,CEBPB;CITED2;ANXA1;GFER;XBP1;CCDC40;AURKA
gsea,cell chemotaxis (GO:0060326),0.37243037207918506,1.1530952210425458,0.2507163323782235,0.36553235352887103,1.0,18/30,39.34%,HMGB2;CCR7;CXCR6;CCRL2;NR4A1;CCR8;RAB13;CXCR3;CCR1;CX3CL1;CCL25;LEF1;EGR3;CCR2;VEGFA;CCR4;CCR6;CCR9
gsea,regulation of carbohydrate catabolic process (GO:0043470),0.35661291257584216,1.1525620570595523,0.28051391862955033,0.3658488788659478,1.0,13/30,24.54%,PGAM1;EIF6;AAAS;NUP62;NUP43;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;NUP54;NUP35;NUP85
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.35206657434283617,-1.1524047041767604,0.25183374083129584,0.42574535014043857,1.0,17/22,38.02%,DICER1;TAOK2;TAOK1;MINK1;NCKAP1;TNIK;SRGAP2;KIF20B;ANKRD27;CTTN;ALS2;SHTN1;DAB2IP;PAK1;MAP4K4;BMP7;LRRK2
gsea,activation of protein kinase activity (GO:0032147),0.2807626669162055,1.152114370141748,0.23529411764705882,0.36601731728933506,1.0,24/54,56.86%,PPIA;PHB2;PHB;AKT1;CD86;TPX2;STRADA;PARK7;RIPK3;ADCY6;PINK1;VEGFA;TRAF2;SLC11A1;NTRK3;PRR5;TGFB2;MLST8;IGF1;ADRA2A;STK3;MTOR;AXIN1;CCDC88A
gsea,positive regulation of cell adhesion (GO:0045785),0.34251152605108415,1.151859611812079,0.23628691983122363,0.36586962556091945,1.0,15/35,38.72%,C1QBP;CITED2;RSU1;CCR7;TNFRSF18;TPM1;ARL2;RET;P4HB;SYK;LIF;TGM2;VEGFA;FOXC2;FBLN2
gsea,cell morphogenesis involved in differentiation (GO:0000904),-0.32618014125037753,-1.151715124914456,0.2481012658227848,0.4255130098302769,1.0,14/26,31.81%,ITGA4;ITGB3;PEAK1;ATF4;LAMC1;NRP1;SRGAP2;UNK;KIF14;SPI1;MEF2C;ATRNL1;RB1;ABI2
gsea,protein dephosphorylation (GO:0006470),0.2888484671220473,1.1515835445509248,0.23773584905660378,0.36574397753587234,1.0,26/63,40.20%,PPP2CB;PPM1G;DUSP12;DUSP5;UBLCP1;DUSP1;DUSP2;DUSP22;PDXP;PPP1CB;PPP5C;DUSP10;DUSP3;DUSP7;TIMM50;PDP1;DUSP6;DUSP4;PPP4R1;PPP1R15A;PTPRM;PPM1M;PTPN6;RPRD1B;CTDNEP1;DUSP18
gsea,regulation of cation channel activity (GO:2001257),-0.2945651612125995,-1.1507295845498455,0.21532846715328466,0.4258359093581591,1.0,14/29,36.59%,AHNAK;PTK2B;NLGN2;MINK1;CAMK2D;SLMAP;HOMER1;SELENON;JPH4;MEF2C;DLG2;ITGB1;NEFL;NOS1
gsea,regulation of purine nucleotide metabolic process (GO:1900542),0.3541525113942228,1.1506860781059287,0.27213822894168466,0.3665830906899269,1.0,13/31,24.54%,PGAM1;EIF6;AAAS;NUP62;NUP43;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;NUP54;NUP35;NUP85
gsea,regulation of cell morphogenesis (GO:0022604),-0.3575634632368321,-1.1505042287078626,0.25,0.4248140393477078,1.0,12/19,33.09%,MACF1;PHIP;PDZD8;BCL9L;CAMSAP1;LARP4;MOV10;ZMYM4;STRIP1;MYO9A;CD44;SH3D19
gsea,regulation of monocyte chemotaxis (GO:0090025),0.40771639394966414,1.1501507151107189,0.2822966507177033,0.36689288181139246,1.0,6/16,24.77%,HMGB1;DUSP1;CCL1;CXCL10;CREB3;CCR1
gsea,regulation of cell-cell adhesion (GO:0022407),-0.3891982502332431,-1.1500006067499955,0.26631853785900783,0.42422579429822366,1.0,8/17,27.04%,B4GALNT2;SMAD7;MINK1;NF2;CDH1;CEACAM1;ADAM8;FUT7
gsea,cellular response to type I interferon (GO:0071357),0.36631089808412487,1.1482388300838777,0.2837301587301587,0.36875612176917616,1.0,16/31,40.82%,IFI27;BST2;SAMHD1;IRF5;SP100;IRF8;IFNAR2;IRF9;IRF2;IRF1;ISG15;OAS3;IRF7;XAF1;EGR1;GBP2
gsea,type I interferon signaling pathway (GO:0060337),0.36631089808412487,1.1482388300838777,0.2837301587301587,0.36875612176917616,1.0,16/31,40.82%,IFI27;BST2;SAMHD1;IRF5;SP100;IRF8;IFNAR2;IRF9;IRF2;IRF1;ISG15;OAS3;IRF7;XAF1;EGR1;GBP2
gsea,snRNA transcription (GO:0009301),0.3060319775168572,1.1482181753922438,0.23541247484909456,0.36828361893152745,1.0,23/48,41.08%,POLR2C;GTF2E2;POLR2H;INTS11;TBP;POLR2L;NCBP2;POLR2E;GTF2F2;NCBP1;CDK7;TAF9;INTS4;CCNK;POLR2F;INTS10;POLR2B;INTS14;INTS5;INTS13;RPRD1B;GTF2E1;INTS3
gsea,cellular transition metal ion homeostasis (GO:0046916),0.3296881678199857,1.1473920339537067,0.27140255009107467,0.3689602003785057,1.0,22/36,43.60%,CCDC115;GLRX3;HMOX2;NUBP1;FXN;SLC31A1;SLC39A6;COX19;APP;ACO1;PRNP;MYC;TMEM199;HFE;SLC39A4;SLC11A1;ANKRD9;SLC39A7;FLVCR1;CUL1;HMOX1;FRRS1
gsea,cholesterol biosynthetic process (GO:0006695),0.3974691304250352,1.1458321109519043,0.288135593220339,0.37077499660036906,1.0,14/22,38.96%,SC5D;FDFT1;ACAT2;MSMO1;IDI1;FDPS;MVK;HSD17B7;DHCR7;IDI2;TM7SF2;PMVK;NSDHL;INSIG1
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",0.413549770979722,1.1457738448954506,0.28378378378378377,0.3703444562279361,1.0,6/17,26.20%,RBBP4;RBBP7;EZH2;PPHLN1;EED;SUZ12
gsea,protein localization to cell periphery (GO:1990778),0.290611541764268,1.145204519749064,0.2289348171701113,0.370755981275976,1.0,27/64,43.79%,S100A10;TMED2;BSG;EZR;PDZD11;TESC;ACTN2;ZDHHC2;TNFRSF1A;EHD4;TSPAN5;RAB13;AP4M1;RAMP3;EHD3;RAP2A;TTC7B;CD81;PLEKHF1;RAMP1;MYADM;RAMP2;LIN7A;FLOT1;PACSIN1;TSPAN15;CACNB3
gsea,positive regulation of neuron apoptotic process (GO:0043525),0.4031463398235887,1.1438164958424621,0.30887372013651876,0.37238710878824743,1.0,7/15,43.49%,BAX;CCL3;CTNNB1;PRNP;GRN;NUPR1;TGFB2
gsea,cellular response to insulin stimulus (GO:0032869),-0.2721576385489191,-1.1436467230954677,0.21782178217821782,0.4334094666681675,1.0,31/61,35.68%,IDE;MYO5A;PHIP;SLC39A14;LPIN2;TCIRG1;PRKDC;PIK3C2A;IRS2;DENND4C;FOXO1;C2CD5;GSK3B;SOS1;KAT2B;CEACAM1;PDE3B;ATP6V0A2;RHOQ;HDAC5;SLC27A1;SH2B2;PDPK1;TBC1D4;BCAR1;CPEB2;LPIN1;TRIB3;FOXO4;SORBS1;OTOP1
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),0.36358351580830733,1.1433660063172024,0.26604068857589985,0.37253445961402615,1.0,14/30,29.86%,IFI30;IFNG;IRF5;SP100;IRF8;IRF9;ICAM1;IRF2;CIITA;IRF1;PTAFR;VCAM1;HCK;OAS3
gsea,regulation of glycolytic process (GO:0006110),0.3149036159179413,1.141606344636458,0.2608695652173913,0.3747590281310475,1.0,20/44,37.85%,PGAM1;EIF6;IFNG;AAAS;NUP62;NUP43;NUP37;PRKAG2;SEH1L;RAE1;SLC2A6;NUP54;NUP35;APP;TIGAR;NUP85;NUP88;ENTPD5;CBFA2T3;NUPR1
gsea,cellular response to reactive oxygen species (GO:0034614),0.307101651230055,1.1413337530539673,0.26559714795008915,0.3747039090273141,1.0,13/36,39.70%,PRDX3;PPIF;ANXA1;FXN;AKT1;RELA;TPM1;PARK7;RIPK3;FOS;SIRPA;NFE2L2;MMP9
gsea,positive regulation of signaling (GO:0023056),0.3916794852748632,1.137443358557617,0.26476190476190475,0.38021304849665005,1.0,6/15,41.37%,ANXA2;KCTD13;RAMP3;WLS;INPP5F;EDN1
gsea,protein secretion (GO:0009306),0.35023887694918987,1.1372843601287452,0.28390596745027125,0.37995387742185127,1.0,13/21,46.77%,PDIA4;ANXA1;TVP23B;ARL4D;RAB13;PARK7;WLS;MIA2;COPG2;NAGPA;CAMK2G;CANX;ABCA1
gsea,positive regulation of protein kinase activity (GO:0045860),-0.26469000989554275,-1.1363313484953672,0.2517985611510791,0.4447600608260564,1.0,74/74,99.17%,DDX3X;NEDD9;TAOK2;TAOK1;PTK2B;CALCA;ITGB3;RAPGEF2;CENPE;RPTOR;MINK1;TNIK;TELO2;LTF;BORA;PAK6;LRP8;KIF14;PDGFB;CD4;GAS6;SLC27A1;CCL5;ALS2;ECT2;XRCC6;DAB2IP;CSF1;CSF1R;PAK1;RASSF2;RALB;CLSPN;MAP4K4;ADRB2;PAK4;SNX9;ETAA1;TNF;CDKN1A;XRCC5;CCDC88A;CCN1;AXIN1;HSP90AA1;STK3;ADRA2A;IL23A;TGFB2;DAXX;INCENP;EGR1;SLC11A1;CAMK1;CASS4;VEGFA;RIPK3;PRNP;NAB2;PIH1D1;STRADA;TRAF4;TPX2;MRNIP;HSP90AB1;MAP2K3;PRKAG2;EZH2;MMD;CCR7;LCP2;DUSP19;IFNG;CALM2
gsea,chromosome condensation (GO:0030261),0.4122885236785573,1.1359045407721042,0.3392857142857143,0.3814367384192985,1.0,9/26,23.16%,BANF1;CDK1;SET;CCNB1;NCAPH;NUSAP1;NCAPG;PLK1;SMC2
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.3515852009011497,1.1350741312368646,0.2655786350148368,0.3822755356787505,1.0,19/37,33.58%,MIF;TNFRSF4;PDCD1LG2;ANXA1;BST1;CD320;CD86;NCK2;TNFSF4;CD38;IL21;CD70;GPR183;CD40LG;VCAM1;IL1B;CD74;CD81;CD40
gsea,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3101408470775243,-1.1340289641907324,0.2613240418118467,0.4475599530951454,1.0,11/25,31.74%,DICER1;NLRC3;TNFAIP3;VSIR;LTF;SYT11;RARA;GAS6;MC1R;CD274;HAVCR2
gsea,cellular response to cytokine stimulus (GO:0071345),0.2609346924283656,1.1312715970587823,0.21671018276762402,0.38761787403530634,1.0,114/236,45.52%,UBB;RPS27A;PLP2;VIM;JUNB;YBX3;GAPDH;BIRC5;SOCS1;CCL3;XCL1;CASP3;CCL4;PHB;CCR7;ANXA1;HSPA8;IRF5;ZFP36L1;DUSP1;HAX1;HTRA2;SOCS3;AKT1;ZFP36;IRF8;CD86;ITGAX;CCL1;IL12RB2;IFNAR2;ST3GAL6;OSM;RELA;CASP1;SHMT1;ICAM1;GSDME;MAOA;TNFRSF1A;IL2RA;SLA;XBP1;CSF2RA;CXCL10;HYAL2;TCF7;CCR1;LRCH1;IL10;TLR4;IRAK3;GBP3;S1PR1;CCL8;MYC;IRF1;MUC1;PTAFR;VCAM1;GRB10;IL1R2;CD36;IL1B;TWIST1;CX3CL1;HCK;RORA;BATF;STK39;SYK;ZC3H12A;CCL25;LEF1;LIF;TNFSF11;GBP6;CACTIN;FGF2;CD40;FOS;CCR2;VEGFA;CCL7;PTGS2;CCL2;CTSG;SIRPA;AXL;ACOD1;IL2;TIMP1;PTPN6;FN1;NFE2L2;IL1RN;CEBPD;CSF2;MMP9;CXCL2;PID1;EGR1;GBP2;PF4;PNPT1;HMOX1;FLT3;F3;IL23A;PIK3R1;IL16;IL13RA1;TLR2;NOS2
gsea,collagen fibril organization (GO:0030199),-0.29552407123963764,-1.1303666282366636,0.2388888888888889,0.4526215924077699,1.0,13/32,39.25%,PLEC;ADAMTS14;NF1;COL6A3;P4HA1;ITGB4;PLOD2;ITGA6;CD151;PLOD1;COLGALT1;PLOD3;COL16A1
gsea,response to steroid hormone (GO:0048545),-0.3339704193267189,-1.1303169883821131,0.2993827160493827,0.45125845467028136,1.0,8/17,34.28%,ABCA2;MED1;NR3C1;TGFB3;AR;ATP1A1;PAQR7;YAP1
gsea,regulation of autophagy (GO:0010506),0.25344498572568996,1.129952065953095,0.23316912972085385,0.389173142330678,1.0,112/112,99.53%,EEF1A1;VDAC1;SNX5;GAPDH;DAP;HMGB1;EIF4E;IFNG;DAPL1;CASP3;HAX1;PRKAG2;HTRA2;AKT1;UFL1;RAB39B;HSPB1;KAT8;PLK2;C9ORF72;IL10;PIM2;ZC3H12A;PLEKHF1;DRAM1;PINK1;SH3BP4;BNIP3;VPS35;ATP6V0E2;CPTP;NUPR1;WDR41;MET;MLST8;PRKAA1;ATM;MEFV;DAPK1;DDIT3;MTOR;TLK2;PIK3R2;TRIM8;UCHL1;KEAP1;TRIM21;TBC1D14;USP33;PIK3CB;RNF152;LRRK2;MT3;DAPK2;TRIM65;SVIP;GPR137B;RASIP1;CSNK2A2;TRIB3;BCL2;WDR6;ZKSCAN3;UBQLN1;USP10;IL10RA;HDAC6;KDM4A;GOLGA2;BOK;TRIM5;RRAGB;FOXK2;ATF6;MTMR4;MID2;ULK1;KLHL22;EXOC8;MTDH;ATP6V0A2;TAB3;FOXO3;TRIM14;SMCR8;OPTN;SLC38A9;MAPK8;PIP4K2B;WDR24;GSK3B;EIF4G1;ABL1;FOXO1;FBXW7;ROCK1;PIK3C2A;EIF4G2;USP36;DEPDC5;ERN1;TFEB;RPTOR;MTMR3;ATP13A2;EXOC4;ITPR1;NEDD4;SREBF2;EIF4G3;EP300;STAT3
gsea,positive regulation of cellular metabolic process (GO:0031325),0.30073137303589514,1.1294513978329697,0.2754098360655738,0.38937716698660074,1.0,22/49,44.94%,ANXA2;PRELID1;CDK1;IFNG;AKT1;CCNB1;CD63;AGPAT1;RAMP3;NFKBIA;GADD45A;ZC3H12A;NR1H3;VEGFA;CBR1;ACOD1;INPP5F;PID1;KLF4;INHBA;PPARG;THBS1
gsea,regulation of MAPK cascade (GO:0043408),-0.26055518438616887,-1.1276305669882825,0.21030042918454936,0.454571377330393,1.0,70/70,96.16%,ABCA7;TAOK2;TAOK1;PTPRJ;RASGRP1;ROCK2;MINK1;KSR1;TNIK;NF1;PLCG2;ROCK1;TMEM106A;PAK6;CEACAM1;DAG1;F2R;PDGFB;CD4;PHLPP1;TRIM5;ARHGEF5;TGFBR3;DHX33;KIT;DAB2IP;PAK1;FLT1;LYN;MAP4K4;ADRB2;PAK4;WDR54;WWC1;SPRED1;BCAR3;SHC1;CCN1;PIK3R2;STK3;ADRA2A;IGF1;FLT3;NTRK3;CAV2;FN1;PTPN6;FAM83D;FGF2;LIF;CD74;SYK;RYK;CX3CL1;IL1B;RET;LBH;JCAD;HRAS;FAS;PDGFA;GSDME;DUSP3;OSM;MYDGF;DUSP1;APIP;DUSP19;HMGB1;PEBP1
gsea,establishment of mitotic spindle orientation (GO:0000132),0.40924515463274597,1.1275254834001982,0.3054545454545455,0.3919152474694308,1.0,7/17,29.58%,CENPA;MAD2L1;NSFL1C;UBXN2B;PLK1;NDE1;SAPCD2
gsea,regulation of DNA replication (GO:0006275),-0.34382090896807965,-1.127386685422686,0.3019271948608137,0.45359597057270473,1.0,16/35,40.40%,ANKRD17;PDS5A;EHMT2;RBBP6;ZBTB38;DHX9;CDAN1;ATR;USP37;FAF1;BRPF3;CTC1;BLM;TSPYL2;ATAD5;KAT7
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3287087126487764,1.1272316468167831,0.3305785123966942,0.391846641009993,1.0,43/100,33.15%,RAN;CENPA;STMN1;BCCIP;BIRC5;AURKB;BUB3;MAD2L1;NUDC;TACC3;NUP43;SPC24;NUP37;CDC20;RCC1;SKA1;SEH1L;ZWINT;CENPU;CCNB1;CENPQ;BUB1;DYNLL2;CDCA8;NUSAP1;CENPK;PMF1;PLK1;ITGB3BP;NDE1;CENPN;CENPH;NUF2;NUP85;PLK2;SPC25;CENPT;AURKA;CENPI;SGO1;DSN1;CENPM;CENPP
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.36374538990258354,1.126894542827546,0.2806026365348399,0.391844101041557,1.0,8/21,35.26%,BAX;CEBPB;BAK1;CHAC1;DNAJC10;PPP1R15A;BBC3;TRAF2
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2882231395952192,-1.1263891716466057,0.2713864306784661,0.45401617110550574,1.0,14/38,32.85%,HIP1R;CBL;HIP1;PTPRJ;SPRY2;ARAP1;CEACAM1;DGKD;HGS;ITGA1;RHBDF1;DAB2IP;RHBDF2;STAM2
gsea,endothelial cell migration (GO:0043542),-0.3384533311677965,-1.1257585695498347,0.271461716937355,0.4537744484166709,1.0,20/20,97.95%,MYH9;PIK3CA;PLXND1;NRP1;ABL1;STAT1;DPP4;FSTL1;ADGRA2;ID1;LGALS8;LOXL2;VEGFA;EGR3;PTP4A3;RAB13;TNFSF12;NR4A1;GIPC1;LPXN
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.37334543701622025,-1.1257067536055687,0.30092592592592593,0.4524186886687135,1.0,20/20,93.61%,SMARCA4;UBTF;NCL;EIF2AK3;ATF4;DHX33;PHF8;DDX11;HEATR1;MTOR;WDR43;PWP1;UTP15;RASL11A;NOL11;PIH1D1;IPPK;WDR75;LYAR;SMARCB1
gsea,positive regulation of defense response (GO:0031349),0.3184975895672487,1.125211672275623,0.2795549374130737,0.39388563363555273,1.0,25/52,34.36%,PLSCR1;CCL3;IFNG;NFKBIZ;ZBP1;CCL1;TNFSF4;OSM;TNFRSF1A;APP;IL21;HYAL2;MGST2;NINJ1;TLR7;NFKBIA;TLR4;SLC15A4;PDCD4;IL1B;CX3CL1;GRN;POLR3D;CCN4;CCR2
gsea,sensory perception of mechanical stimulus (GO:0050954),0.3338071467519521,1.1247319421853683,0.2895174708818636,0.3940864330143644,1.0,14/27,44.68%,BIRC5;TIMM8B;TIMM10;GSDME;USH1C;CLIC5;MYO3B;TPRN;TIMM9;TMIE;COL11A1;ALDH7A1;PAX3;COL1A1
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.23885936704380087,-1.1245595670392454,0.20600858369098712,0.45320578413183277,1.0,45/88,41.15%,NOTCH1;SMAD7;USF3;CORO1C;WNT10B;ATP2B4;ROCK2;BRCA2;ATF4;ROCK1;IL18R1;GSK3B;PTCH1;CHSY1;PTPN23;SPRY2;TFE3;SYT11;SPRED2;WNT11;ALPK2;F2R;TLE3;TWSG1;GAS6;IL13;ARNTL;ADAM17;SPI1;ASB1;RPS6KA5;SLAMF8;MEF2C;GATA3;RB1;DAB2IP;CALR;GPNMB;RAB11FIP1;ARRDC3;SRF;SPRED3;WWC1;TNF;SPRED1
gsea,positive regulation of endocytosis (GO:0045807),-0.33477467819480405,-1.124464401836534,0.3106060606060606,0.45192883246787036,1.0,12/22,35.22%,CBL;HIP1;ANKFY1;ANO6;CLN3;BICD1;DLL1;SMPD1;F2RL1;APOE;SERPINE1;CD151
gsea,monocarboxylic acid transport (GO:0015718),-0.3412381917919839,-1.1242453637561793,0.2796610169491525,0.450896145388165,1.0,12/20,33.35%,NCOA1;SLC16A1;ABCC4;NCOA2;SLCO3A1;CEACAM1;SLC16A6;ABCG2;SLC6A12;SLC27A1;SLCO2A1;ABCB4
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2692610210151248,-1.1240782568181191,0.25,0.4497391034478208,1.0,16/42,36.13%,MYH9;CALCA;PLCG1;PLCG2;ADRB1;CREB1;CALCRL;PRKAR2A;VIPR2;ADORA2B;ADAM17;MC1R;PRKAR2B;RHBDF2;FURIN;LYN
gsea,regulation of cardiac muscle contraction (GO:0055117),0.3797567664340892,1.1229185539127824,0.33437990580847726,0.3964624692968267,1.0,6/16,46.50%,CALM2;RGS2;ZC3H12A;CHGA;PLN;RNF207
gsea,actin polymerization or depolymerization (GO:0008154),0.3460469420090987,1.1222772020773863,0.29646017699115046,0.3969362821974148,1.0,14/29,47.84%,CFL1;CAPG;EVL;MSRB2;DSTN;SPIRE2;WASHC5;VIL1;MICAL3;CORO7;GHSR;PSTPIP2;MICAL1;CATIP
gsea,cellular response to amino acid starvation (GO:0034198),-0.2996473164907091,-1.1216849383126466,0.26490066225165565,0.45266102246408846,1.0,19/35,38.07%,MAP3K5;EIF2AK3;RPTOR;TFEB;GCN1;DEPDC5;TCIRG1;ATF4;WDR24;MAPK8;SLC38A9;IMPACT;RRAGB;EIF2AK2;EIF2AK4;ITFG2;SESN1;SESN3;RNF152
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3488809300895874,-1.1216825555782008,0.27037037037037037,0.4512508635156022,1.0,9/19,36.13%,PTPRS;OTUD4;TNFAIP3;GRAMD4;F2RL1;RAB7B;DAB2IP;LRRC14;LYN
gsea,regulation of posttranscriptional gene silencing (GO:0060147),-0.3398073494788223,-1.1194848864287352,0.3055555555555556,0.4524027897831122,1.0,22/38,34.62%,NUP210;RANBP2;PUM2;TNRC6A;AGO1;NUP98;AGO2;NUP155;POLR2A;IPO8;EIF4G1;NUP188;NUP214;POM121;NDC1;NUP205;NUP133;NUP153;FMR1;NUP93;NUP160;NUP107
gsea,regulation of gene silencing by RNA (GO:0060966),-0.3398073494788223,-1.1194848864287352,0.3055555555555556,0.4524027897831122,1.0,22/38,34.62%,NUP210;RANBP2;PUM2;TNRC6A;AGO1;NUP98;AGO2;NUP155;POLR2A;IPO8;EIF4G1;NUP188;NUP214;POM121;NDC1;NUP205;NUP133;NUP153;FMR1;NUP93;NUP160;NUP107
gsea,long-chain fatty acid transport (GO:0015909),0.38522405928716624,1.1194375369533411,0.3059581320450886,0.40076860608848774,1.0,6/17,32.40%,FABP5;PRKAG2;MID1IP1;CD36;MFSD2A;ABCD1
gsea,tRNA export from nucleus (GO:0006409),0.3598259631032603,1.1186757101738258,0.33476394849785407,0.40088808143848564,1.0,11/28,24.54%,RAN;SSB;AAAS;NUP62;NUP43;NUP37;SEH1L;RAE1;NUP54;NUP35;NUP85
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3598259631032603,1.1186757101738258,0.33476394849785407,0.40088808143848564,1.0,11/28,24.54%,RAN;SSB;AAAS;NUP62;NUP43;NUP37;SEH1L;RAE1;NUP54;NUP35;NUP85
gsea,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.328089702666632,1.1171350265625348,0.32318840579710145,0.40274444203216403,1.0,17/24,52.94%,GPR18;ACTN2;F2RL3;F2RL2;GNA15;GNA11;TGM2;GPR55;C3AR1;GPR174;HTR2A;P2RY6;PTH1R;ADRA2A;TRHR;C5AR1;GNA14
gsea,cellular response to radiation (GO:0071478),0.349666877836726,1.116953580870465,0.3247232472324723,0.4024700120113785,1.0,8/24,34.95%,EEF1D;RAD51;RHNO1;RAD1;FIGNL1;GADD45A;RAD51AP1;TRPM1
gsea,cholesterol metabolic process (GO:0008203),0.3269844208681413,1.116665748061947,0.2921535893155259,0.4023529159764094,1.0,17/35,38.96%,FDX1;FDFT1;ACAT2;MSMO1;IDI1;FDPS;MVK;HSD17B7;RXRA;DHCR7;IDI2;TM7SF2;CH25H;GBA2;PMVK;NSDHL;INSIG1
gsea,sensory perception of sound (GO:0007605),0.32453871491455527,1.1156984777483256,0.29853181076672103,0.40333090396948357,1.0,14/28,44.68%,BIRC5;TIMM8B;TIMM10;GSDME;USH1C;CLIC5;MYO3B;TPRN;TIMM9;TMIE;COL11A1;ALDH7A1;PAX3;COL1A1
gsea,autophagosome assembly (GO:0000045),-0.3848657621857834,-1.1129659888586938,0.3028953229398664,0.4625556267525854,1.0,10/16,32.72%,ATP2A2;ULK2;PACS2;ATG2A;AMBRA1;ULK1;MFN2;ATG2B;UBQLN1;RAB23
gsea,protein-containing complex subunit organization (GO:0043933),0.2775794878303375,1.1127509930198727,0.27895595432300163,0.4074241783798563,1.0,23/58,36.79%,CAPG;LPXN;CAPZA2;PPIH;CHCHD10;SEH1L;NIFK;TSPAN4;KIFAP3;ST13;NDUFAF1;NUP54;FAS;NUP35;PPID;TFAP4;SPG7;HFE;CD74;CD40;VIL1;TRAF2;LIN7A
gsea,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3668395084259952,-1.110579511675134,0.292817679558011,0.4654470916242046,1.0,7/15,26.70%,GLYR1;BRCA1;ARRB1;SOX4;DIP2A;RPS6KA5;PAXIP1
gsea,Notch signaling pathway (GO:0007219),-0.32387124509089776,-1.1101770825332788,0.26843657817109146,0.4647234507323138,1.0,14/26,26.45%,EP300;CREBBP;NOTCH1;MIB1;PLXND1;NOTCH2;KAT2B;JAG2;POFUT1;MAML2;DTX1;STAT1;ADAM17;DLL1
gsea,negative regulation of cell death (GO:0060548),0.3182145780336303,1.1098539574593789,0.3073089700996678,0.4114933659371659,1.0,15/38,35.26%,TMEM109;SRSF6;NUP62;HTRA2;AKT1;PSMC5;TIGAR;PARK7;CHGA;PINK1;FGF2;BNIP3;VPS35;CCN4;TRAF2
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34941432198152295,1.1093641733276436,0.3476764199655766,0.4117529230379644,1.0,8/22,56.50%,CDK4;CDKN2C;CDKN2D;CCL2;BRD7;KLF4;KANK2;SUSD2
gsea,response to peptide hormone (GO:0043434),0.3334019763079746,1.1090349433979356,0.3202479338842975,0.4117109283697355,1.0,9/26,42.31%,EIF6;EIF2B1;ANXA1;ZFP36L1;ZBED3;AKT1;XBP1;CRY1;EIF2B3
gsea,protein-containing complex assembly (GO:0065003),-0.2354142331669959,-1.1089759583712469,0.23310810810810811,0.4653800728284496,1.0,134/134,99.68%,KMT2A;KMT2D;PPP6R3;PPP6R1;EP300;TRRAP;MDN1;CREBBP;PICALM;SMARCA4;PTK2B;CDC73;MDM4;SEC16A;DHX9;ANO6;TUBGCP4;SEC24A;PDE4DIP;BCL9L;LAMC1;CUL3;ANKRD28;OPA1;SEC31A;FANCC;GSK3B;GEMIN5;CAND1;TRAPPC9;TRAF1;FANCA;SLC9A1;RIPK1;TLE4;TLE3;AFG3L2;TIAM1;LLGL1;BOK;RBBP5;GOLGA2;NSF;USO1;WIPF1;PML;SEC23IP;BLM;KNTC1;PLEKHA7;TUBGCP2;TSPAN33;YAP1;MITF;LRRK2;KPNA3;COL16A1;IKBKG;SNX9;TNF;PYGO2;CD2AP;SH3PXD2B;AXIN1;ZW10;AFDN;MDM2;ZNHIT6;SEC23A;DNAJB12;MATN1;SLC2A1;MEFV;SHANK1;REPS2;COL7A1;AREG;DMTN;SEC24D;HSF1;CUL1;TCF7L2;FN1;TGFA;FARP2;LIN7A;TRAF2;VIL1;CD40;TLE1;DNAJB14;LEF1;CD74;HFE;ZC3H12A;MCU;RUVBL1;LEO1;CX3CL1;SPG7;MYC;CTSZ;TCF7;TFAP4;CNIH2;HGSNAT;MEN1;MCFD2;USH1C;PPID;FAS;NDUFAF1;TNFRSF1A;ST13;AXIN2;KIFAP3;FADD;TSPAN4;NIFK;ASH2L;LMAN1;SAMM50;CTNNB1;CHCHD10;PDZD11;WDCP;CDC123;PPIH;CAPZA2;STOML2;LPXN;HDAC1;CAPG;TMED2
gsea,regulation of intracellular transport (GO:0032386),-0.3382530299827604,-1.1087398473260661,0.3074626865671642,0.4644421966685405,1.0,21/21,93.53%,DYNC1H1;ATP13A2;MAP2;NUMA1;NUP214;SPAG5;LCP1;LRRK2;WWC1;NEFH;INPP5F;HAP1;CRYAA;REEP6;TTC21B;CAPN10;RINT1;CRYAB;ATPSCKMT;LAMP1;AAAS
gsea,response to interferon-beta (GO:0035456),0.39469420831240687,1.1085923245642366,0.3169811320754717,0.4119577879783556,1.0,8/15,43.03%,PLSCR1;BST2;HTRA2;IFNAR2;IRF1;ACOD1;XAF1;PNPT1
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.26689047493123674,1.107962800741547,0.2992565055762082,0.41242209910038136,1.0,29/65,51.19%,TMED2;KDELR2;CAPZA2;CNIH4;BCAP29;LMAN2;VAMP7;ERGIC1;LMAN1;COPB2;DYNLL2;MCFD2;CNIH2;RANGRF;CTSZ;SPTA1;ACTR1A;TMED1;TGFA;MIA2;COPG2;COG7;SEC24D;AREG;COL7A1;ANK1;LMAN1L;SEC23A;PROZ
gsea,neuron projection development (GO:0031175),0.2762023680088554,1.1075701873257677,0.273121387283237,0.41247148599088246,1.0,26/75,56.72%,UBB;MANF;STMN1;PRMT1;HMGB1;KLK8;GPM6B;BLOC1S2;SGK1;DOCK7;APP;USH1C;RAB13;HDGFL3;RYK;PTPRM;UNC5A;PACSIN1;ZPR1;IFT88;VASH2;SHANK1;TSKU;FLRT3;NEFH;DCLK1
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3373063201968108,1.107142640155983,0.296998420221169,0.412662355796324,1.0,14/27,39.70%,BAX;PPIF;RACK1;HERPUD1;GSDME;PTPMT1;URI1;BID;P4HB;PINK1;BBC3;NUPR1;NOC2L;MMP9
gsea,response to glucose (GO:0009749),0.3385729937169508,1.106841058809026,0.3344103392568659,0.41258299297910117,1.0,10/22,48.34%,RACK1;EIF2B1;SELENOS;ZBED3;XBP1;TCF7L2;EIF2B3;PFKL;THBS1;PRKAA1
gsea,non-motile cilium assembly (GO:1905515),-0.3545510674366889,-1.1065679377024844,0.31106471816283926,0.467031455907056,1.0,10/19,36.21%,CEP250;DCTN1;TOGARAM1;C2CD3;PIBF1;PCM1;CEP89;CEP290;GORAB;RPGRIP1
gsea,COPII-coated vesicle budding (GO:0090114),-0.32330292409555705,-1.1062686709058,0.3090507726269316,0.46614737638537895,1.0,14/25,28.58%,PPP6R3;PPP6R1;SEC16A;SEC24A;CUL3;ANKRD28;MIA3;SEC31A;TRAPPC9;GOLGA2;NSF;SCAP;USO1;SEC23IP
gsea,cellular response to organic cyclic compound (GO:0071407),-0.25483088050220576,-1.1053029542859591,0.23624595469255663,0.4665320237445774,1.0,63/63,99.09%,LARP1;RAPGEF1;JUP;NR4A3;NCOA3;RAPGEF2;CIB2;DIAPH1;TAF1;ROCK2;SSH1;MED1;CDH1;BRCA1;NR3C1;IMPACT;TIPARP;NRIP1;PDGFB;CCL5;SPP1;CTNNA1;AR;MEF2C;ATP1A1;BLM;FES;ABCB4;SPIDR;LRRK2;TNF;P2RX4;AHR;HSP90B1;P2RY6;GABRB1;DMTN;EGR1;INSIG1;ATP1A2;CCL2;ATP1A3;ADCY6;TGM2;ZC3H12A;RORA;MGARP;IL1B;URI1;RAMP3;CCDC62;RUVBL2;NCOA4;PDXP;TFPI;RAD51;CASP7;CTNNB1;ZFP36L1;CASP3;CCL3;EZR;ACTB
gsea,mRNA modification (GO:0016556),0.36044091080976226,1.1052144204503582,0.29980276134122286,0.4145816900935469,1.0,10/18,35.88%,TRMT6;PUS1;TRMT61B;TRMT10C;NSUN2;PUS7;TRUB1;TRMT61A;DKC1;METTL3
gsea,negative regulation of secretion by cell (GO:1903531),0.40244588524824704,1.104422332483114,0.33706293706293705,0.4152925575379325,1.0,6/16,32.10%,VAMP8;ANXA1;OSM;TNFRSF1A;CHGA;LIF
gsea,regulation of protein-containing complex assembly (GO:0043254),-0.26143081367366217,-1.1035861708993864,0.2968299711815562,0.4680683400828642,1.0,67/67,98.12%,EP300;DDX3X;BCL2L11;VCP;HCFC1;ATF7IP;TFRC;HSPA5;NCLN;AIDA;HJURP;TFIP11;SLF2;ICE1;GSK3B;LATS1;IMPACT;FAF1;GNL3L;PTPN11;ULK1;SLF1;MPP7;EIF2AK2;HDAC6;RB1;APOE;DAB2IP;GSN;SPIDR;SVIP;RALB;FNIP1;TNF;HSP90AA1;ABCA1;BIK;INSM1;HSF1;PRKCZ;SELP;TRAF3IP1;NAPB;FARP2;TRAF2;VEGFA;PINK1;SYK;AJUBA;HCK;CD36;BID;PARK7;PIH1D1;PEX5;CRYAB;LGALS3;CDT1;CDC42EP2;TMC8;MTLN;HSPA8;RHOC;IFNG;BAK1;RACK1;BAX
gsea,negative regulation of angiogenesis (GO:0016525),0.2980739697817987,1.1028230131309167,0.29806259314456035,0.4173013671722118,1.0,17/42,44.94%,PGK1;RGCC;CD160;CTNNB1;KLF2;EPN2;CXCL10;HHEX;PTPRM;CCR2;FOXJ2;CREB3L1;PF4;KLF4;PPARG;TGFB2;THBS1
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3402859217054975,1.1024512846026766,0.3315972222222222,0.41737300532469473,1.0,22/22,99.28%,CDK4;CDKN2C;CDKN2D;CCL2;BRD7;KLF4;KANK2;CDKN1A;CDKN2A;PRMT2;RBL1;WEE1;GPNMB;RB1;DCUN1D3;PLK3;JADE1;CDKN2B;E2F7;CDC73;RBL2;CDK6
gsea,circulatory system development (GO:0072359),0.2970535403085721,1.1006733656641607,0.306970509383378,0.4195505819408663,1.0,25/52,56.01%,CRIP1;CACYBP;ID2;CITED2;PDLIM1;ZDHHC16;UTY;DVL2;RAMP2;FOXC2;HDAC9;FN1;PDLIM4;ACVRL1;NTRK3;TGFB2;PDLIM7;HEG1;SMYD4;WDR11;FLRT3;SMG9;NXN;MTHFD1;SH3PXD2B
gsea,positive regulation of cytokine production involved in immune response (GO:0002720),0.3837132410519917,1.1006153178872096,0.35168738898756663,0.419086749360038,1.0,6/15,35.26%,XCL1;CD160;SCIMP;TNFSF4;CD226;TRAF2
gsea,neurogenesis (GO:0022008),-0.3373030363662598,-1.1004424748233081,0.32926829268292684,0.472290003938998,1.0,9/19,33.04%,CDK6;CIT;CDK5RAP2;WDR62;THOC2;CXCR4;TRAK1;ERCC6;METTL14
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.342588436469882,1.1004145030713548,0.3144927536231884,0.4188307205064216,1.0,13/31,37.49%,TMSB4X;HMGB1;ANXA1;AKT1;MAP2K3;HSPB1;JCAD;FGF2;CD40;VEGFA;PTGS2;FOXC2;HDAC9
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2698573081471977,-1.1000696030252166,0.2770083102493075,0.4715782024596364,1.0,52/52,96.70%,TAOK2;MID1;TAOK1;PTK2B;MAP3K5;TRAF3;RASGRP1;MAP3K11;MINK1;XDH;MAP3K4;TRAF1;RIPK1;SEMA4C;HIPK2;NCF1;SH3RF1;EIF2AK2;SPI1;MTURN;F2RL1;DAB2IP;UNC5CL;RASSF2;MAPK8IP1;AXIN1;SLAMF1;FZD7;TGFB2;LTBR;TRAF5;FCGR2B;TRAF2;MFHAS1;RELL1;VEGFA;SPHK1;ZC3H12A;GADD45G;GADD45A;IL1B;HRAS;PJA2;APP;TRAF4;GADD45B;DUSP22;SCIMP;CCR7;DUSP19;HMGB1;PRMT1
gsea,negative regulation of defense response (GO:0031348),0.31405162926983116,1.0990912308727578,0.30364372469635625,0.4203659468973142,1.0,23/38,42.99%,C1QBP;LYAR;SELENOS;TNFRSF1A;TRAFD1;MVK;NLRP3;IL10;SMPDL3B;IRAK3;RORA;CACTIN;NR1H3;VPS35;MFHAS1;METRNL;SIRPA;TNFAIP8L2;ACOD1;GHSR;TRAF3IP1;KLF4;PPARG
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),0.35687844810821945,1.0976323078090984,0.32323232323232326,0.4222098855525728,1.0,9/19,28.24%,DUSP5;DUSP1;DUSP2;DUSP22;DUSP10;DUSP3;DUSP7;DUSP6;DUSP4
gsea,response to retinoic acid (GO:0032526),-0.30482578021220663,-1.0975268530603908,0.28205128205128205,0.47482484576845246,1.0,12/24,36.13%,SETX;PTK2B;ASXL1;WNT10B;CREB1;WNT3;WNT11;RARA;RARG;ADNP2;RORB;LYN
gsea,amino acid transport (GO:0006865),-0.33617312560449814,-1.0967513361913634,0.32116788321167883,0.4748227026817272,1.0,10/20,31.06%,SLC38A2;SLC7A1;SLC38A9;SLC7A5;SLC6A12;SLC7A6;SLC38A6;SLC38A1;SLC1A4;SLC25A45
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.29232395168800085,-1.096633790428453,0.358974358974359,0.47362426373310346,1.0,15/34,37.18%,B4GALT5;CHST2;CHST11;UST;DSEL;CHSY1;CHPF2;ABCC5;SDC3;ST3GAL3;CHST15;SDC1;XYLT1;HS2ST1;CHPF
gsea,positive regulation of protein polymerization (GO:0032273),0.3317081192078229,1.0958609184120955,0.3333333333333333,0.42453547067241626,1.0,12/32,32.81%,PFN1;DRG1;CCR7;EVL;NCK2;CDC42EP2;PFN2;ARL2;TPPP3;HCK;CDC42EP3;PINK1
gsea,innate immune response (GO:0045087),0.26315198015215147,1.0951626280089557,0.30434782608695654,0.4250828958590551,1.0,48/107,39.01%,PHB2;PPP1R14B;SERINC3;CAPZA2;CORO1A;IFI27;HMGB1;BST2;SHMT2;PGLYRP1;PHB;IRF5;SP100;GCH1;RELA;RIPK2;TRIM28;SLA;PGLYRP2;TKFC;NRROS;APP;NUB1;FCER1G;PJA2;CXCL10;CIITA;NCF2;TLR4;SRPK1;CYBB;ISG15;CLPB;HCK;SYK;CHGA;CD74;TIFA;CLEC4E;TTC4;CD40;MFHAS1;CXCL16;TRIM35;RNASE6;SLC11A1;IRF7;FGR
gsea,cellular response to light stimulus (GO:0071482),0.30465623047594237,1.094712092775386,0.33268858800773693,0.4252226871386038,1.0,17/36,49.49%,NPM1;EIF2S1;AURKB;BAK1;RHNO1;RUVBL2;MYC;PCNA;TRPM1;POLD1;METTL3;GNGT1;NOC2L;PARP1;GNAT1;PDE6A;MAPK13
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3265314656157892,-1.0937394204298503,0.3319919517102616,0.4773842665699741,1.0,13/33,34.59%,RIF1;SETD2;RTEL1;ARID2;POLQ;SMCHD1;ACTR2;UBQLN4;MMS19;SIRT6;WRAP53;ERCC6;SPIDR
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.34543166433685923,1.0935254360858615,0.3315696649029982,0.42654766517542003,1.0,13/22,41.02%,HSPB11;IFT57;IFT27;KIFAP3;DYNLL2;TTC21B;CLUAP1;IFT81;IFT43;TRAF3IP1;KIF3A;IFT74;IFT88
gsea,signal transduction by p53 class mediator (GO:0072331),0.35236074275448753,1.0934458761410604,0.3314285714285714,0.42614545592761466,1.0,7/18,54.87%,HINT1;BCL3;BATF;NDRG1;NBN;PDK2;SESN2
gsea,extracellular structure organization (GO:0043062),-0.23361504113951584,-1.0927194121511001,0.2925170068027211,0.47783502707572323,1.0,34/69,41.98%,ITGAM;ITGA4;ADAMTS14;ITGB3;ITGA3;JAM2;NF1;LAMC1;CDH1;ITGB8;COL6A3;DAG1;NID1;PDGFB;ITGA1;NDNF;SPOCK2;SPP1;ITGB4;CD44;ITGB1;NPNT;SERPINE1;ITGA6;FURIN;MADCAM1;ADAMTS6;TEX14;COL16A1;ADAM19;ITGA5;ITGAE;TGFBI;APLP1
gsea,neuron development (GO:0048666),-0.25979762099542486,-1.0921581211574267,0.27672955974842767,0.4774950890796891,1.0,36/60,39.80%,WNK1;B4GALT5;RUNX3;PPP1R9B;NEDD4;RAPGEF2;FRY;MAP2;ROCK1;GSK3B;CAMSAP1;BTG2;THOC2;UNK;BICDL1;MAP4;TBC1D23;ULK1;NPY;CDNF;RASGRF1;MEF2C;ATCAY;RB1;ERCC6;APOE;RUNX1;BLOC1S5;GPRIN3;LYN;MICALL1;NCDN;PBX3;TMEM108;CDK16;SRF
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.36943356411495337,-1.0918584241342868,0.34513274336283184,0.4766896197071907,1.0,9/16,34.83%,PPP6R3;PPP6R1;HTT;PPP6R2;TSC1;GSK3B;CRY2;ITGA1;MASTL
gsea,muscle contraction (GO:0006936),0.312193907219245,1.090932746499356,0.34045584045584043,0.4296206379563713,1.0,11/38,30.14%,ALDOA;VIM;ACTN2;TPM4;MYL6B;TPM3;CRYAB;TPM1;MYOM1;TNNT1;SORBS3
gsea,regulation of protein localization to cell surface (GO:2000008),-0.35473447506835454,-1.0902657390548163,0.312807881773399,0.478192804454991,1.0,17/17,91.57%,ABCA2;ABCA7;PICALM;KCNAB2;TM9SF4;TYROBP;TNF;MAP1A;GBF1;GPD1L;HFE;RANGRF;HSP90AB1;GPM6B;ACTN2;CTNNB1;TAX1BP3
gsea,ephrin receptor signaling pathway (GO:0048013),0.33187798015093956,1.0890307537060215,0.3333333333333333,0.4322243597562549,1.0,11/28,55.10%,ACTG1;ACTB;PSEN2;NCK2;HRAS;GRIN1;EPHA3;MMP9;ANKS1B;DNM1;EFNB2
gsea,supramolecular fiber organization (GO:0097435),0.242435328692137,1.0873208633514921,0.31432360742705573,0.43448481569542474,1.0,71/149,54.46%,UBB;RPS27A;ALDOA;VIM;STMN1;PIN1;CST3;CORO1A;RHOC;SH3BP1;TPM4;ZBED3;HSP90AB1;EVL;UBE2L6;LAMC2;CRTAP;MARCKSL1;TRIOBP;CDC42EP2;TPM3;TSPAN5;FIGNL1;APP;NCKAP5L;TPM1;MYO1C;ELMO1;RUFY3;RIPK3;TPPP3;SPTA1;ACTN1;CD36;P4HB;MFGE8;HDGFL3;COL27A1;P3H2;COL5A3;CORO7;P3H1;HOOK2;COL11A1;P4HA2;LOXL2;COL12A1;LOXL4;SERPINH1;KATNB1;TSPAN15;MYO1B;TGFB2;DST;COL1A1;FAT1;GGA2;GGA3;COL7A1;ARHGAP25;MYO5B;TMOD4;RHOBTB3;FBLN5;RND3;COL4A4;ARHGAP12;COL17A1;TCHH;MDM2;CENPJ
gsea,external encapsulating structure organization (GO:0045229),-0.23451027127563198,-1.0871808375883412,0.28187919463087246,0.4826999008650555,1.0,33/68,41.98%,ITGAM;ITGA4;ADAMTS14;ITGB3;ITGA3;JAM2;NF1;LAMC1;CDH1;ITGB8;COL6A3;DAG1;NID1;PDGFB;ITGA1;NDNF;SPOCK2;SPP1;ITGB4;CD44;ITGB1;NPNT;SERPINE1;ITGA6;FURIN;MADCAM1;ADAMTS6;COL16A1;ADAM19;ITGA5;ITGAE;TGFBI;APLP1
gsea,organelle disassembly (GO:1903008),0.3417540913446506,1.0871092297330809,0.3474747474747475,0.4342696308972444,1.0,8/21,29.23%,CDK1;DENR;VRK1;EIF2D;MRRF;UFL1;DYRK3;RETREG1
gsea,positive regulation of innate immune response (GO:0045089),0.37681946899581853,1.086976118295397,0.3690248565965583,0.4339326588114802,1.0,5/15,30.75%,PLSCR1;ZBP1;FADD;SLC15A4;POLR3D
gsea,positive regulation of inflammatory response (GO:0050729),0.3298083392893753,1.0868851551667014,0.3363994743758213,0.4335425611983438,1.0,28/49,37.85%,CCL3;VAMP8;IFNG;VAMP7;NFKBIZ;ZBP1;CCL1;TNFSF4;OSM;TNFRSF1A;APP;IL21;HYAL2;MGST2;NINJ1;TLR7;NFKBIA;TLR4;PDCD4;IL1B;CX3CL1;GRN;CD81;CCN4;CCR2;C2CD4B;IL2;NUPR1
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.290974320247961,-1.086627574543776,0.2956989247311828,0.4822648485547846,1.0,22/38,38.81%,MYO10;NR4A3;PIK3CA;MYO1G;NCKAP1;PLCG1;ACTR2;PLCG2;ABL1;LIMK1;VAV2;CYFIP1;NCKIPSD;ELMO2;PLD2;WIPF1;PRKCE;PAK1;LYN;VAV3;PIK3CB;BAIAP2
gsea,vesicle coating (GO:0006901),-0.32556124171967893,-1.0843801891152167,0.32589285714285715,0.4822977347059857,1.0,12/22,28.58%,PPP6R3;PPP6R1;SEC16A;SEC24A;CUL3;ANKRD28;SEC31A;TRAPPC9;GOLGA2;NSF;USO1;SEC23IP
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.32556124171967893,-1.0843801891152167,0.32589285714285715,0.4822977347059857,1.0,12/22,28.58%,PPP6R3;PPP6R1;SEC16A;SEC24A;CUL3;ANKRD28;SEC31A;TRAPPC9;GOLGA2;NSF;USO1;SEC23IP
gsea,COPII vesicle coating (GO:0048208),-0.32556124171967893,-1.0843801891152167,0.32589285714285715,0.4822977347059857,1.0,12/22,28.58%,PPP6R3;PPP6R1;SEC16A;SEC24A;CUL3;ANKRD28;SEC31A;TRAPPC9;GOLGA2;NSF;USO1;SEC23IP
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.2674404838590789,-1.0806935664563857,0.30656934306569344,0.4876205346318283,1.0,47/47,96.74%,SFN;ITGAM;SPTBN1;ITGA3;SLC5A3;ATP2B4;ZDHHC5;YWHAG;ZDHHC8;C2CD5;KIF5B;MAPK8;PTPN9;PDPK1;PRKCE;BCL2;ITGB1;CNPY4;AKAP5;SORBS1;PMAIP1;NKD2;CLIP3;TNF;PRKCI;PIK3R1;TCAF1;LRP1;PLS1;EPHA3;NMT1;BBC3;CD81;PRNP;BID;MYO1C;RANGRF;RAMP3;HRAS;LGALS3;TFDP2;E2F1;AKT1;IFNG;GZMB;YWHAE;TFDP1
gsea,endocytic recycling (GO:0032456),-0.3601746178325988,-1.0798674421265935,0.33962264150943394,0.48779944913027196,1.0,7/17,36.27%,ANKRD50;LMTK2;RAB11FIP4;PTPN23;ANKRD27;EHD2;MICALL1
gsea,negative regulation of inflammatory response (GO:0050728),-0.2322981616495511,-1.0796178350654213,0.30677290836653387,0.4868612394909466,1.0,28/73,41.05%,MYH9;CALCA;FEM1A;NLRC3;TNFAIP3;PLCG1;PLCG2;ADRB1;CREB1;CALCRL;AOAH;PRKAR2A;IL13;VIPR2;ADORA2B;ADAM17;MC1R;SLAMF8;MAPK7;GATA3;PRKAR2B;RB1;APOE;RHBDF2;FURIN;LYN;ADRB2;CD200R1
gsea,heart development (GO:0007507),0.2791345896620304,1.077827661968693,0.33016304347826086,0.4476333879998054,1.0,27/57,56.01%,CRIP1;CACYBP;ID2;CITED2;PDLIM1;ZDHHC16;UTY;VEGFA;DVL2;RAMP2;FOXC2;HDAC9;FN1;PDLIM4;ACVRL1;NTRK3;TGFB2;PDLIM7;APLN;HEG1;TBX2;SMYD4;WDR11;FLRT3;SMG9;MTHFD1;SH3PXD2B
gsea,phospholipid transport (GO:0015914),0.3237506875669136,1.0763462700364899,0.37105751391465674,0.4495182533983389,1.0,25/25,98.98%,PRELID3B;PRELID1;PRELID2;MFSD2A;CPTP;SCARB1;PRELID3A;PCTP;ABCA1;PITPNB;PLTP;ABCG1;OSBPL2;ABCB4;OSBPL5;APOE;ATP8A1;LDLR;ABCC1;ATP8B4;ATP11C;ATP11A;ATP10A;ATP8B2;ABCA7
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3713983163055047,1.0762999786521164,0.3538732394366197,0.44902062906107504,1.0,8/18,38.39%,RGCC;TFDP1;CCND3;ANXA1;AKT1;MTBP;UBE2E2;CDC6
gsea,cellular response to peptide (GO:1901653),0.3471883673334114,1.075895388330078,0.36222509702457956,0.449119350053875,1.0,15/28,38.38%,VIM;ZFP36L1;ICAM1;RIPK2;APP;XBP1;TIMELESS;PRNP;TLR4;VCAM1;CD36;GRIN1;ATP1A3;FCGR2B;LRP1
gsea,regulation of histone acetylation (GO:0035065),-0.3360913620371459,-1.0757263210722503,0.3634085213032581,0.49249651795955723,1.0,9/21,26.70%,KMT2A;GLYR1;BRCA1;IWS1;ARRB1;HDAC5;SPI1;RPS6KA5;PAXIP1
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2899817178913465,1.0750734020395123,0.35093696763202725,0.44987566935033313,1.0,21/45,37.99%,SOCS1;RACK1;IFNG;SOCS3;HSP90AB1;ELF1;ZBP1;IFNAR2;AGPAT2;FADD;TNFRSF1A;AGPAT1;IRAK3;BIRC3;USP18;SYK;CD74;SPHK1;TRAF2;AXL;PTPN6
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.31058575178510184,1.0749422015977217,0.3632075471698113,0.44951483654391405,1.0,13/38,37.16%,TMSB4X;DAP;NFKBIB;UFL1;NLRP3;IL10;NFKBIA;IRAK3;SETD6;ZC3H12A;GFI1;CACTIN;ACOD1
gsea,retinoid metabolic process (GO:0001523),0.356818502640947,1.0702155359534642,0.3723958333333333,0.45675592364254886,1.0,13/23,38.38%,ADH4;SCPEP1;DHRS9;UGT1A9;ALDH1A3;AKR1B10;RDH11;DHRS3;BCO1;DHRS13;CYP2S1;GPC1;LRP1
gsea,positive regulation of cellular protein localization (GO:1903829),-0.28615916813289655,-1.0701032548391443,0.33418367346938777,0.5015808207359802,1.0,19/39,40.96%,ABCA7;CEP250;TFRC;SLC5A3;EIF2AK3;NUMA1;GSK3B;TM9SF4;SYT11;GNL3L;GNL3;BICD1;TYROBP;TRAPPC12;YAP1;GPR137B;DTX3L;KAT7;TNF
gsea,regulation of epithelial cell migration (GO:0010632),0.3095769358224592,1.0699340636924692,0.3607142857142857,0.45663762236846833,1.0,9/28,25.33%,PFN1;IFNG;EVL;DUSP10;GLIPR2;GLUL;PFN2;CTSH;ARSB
gsea,positive regulation of myeloid cell differentiation (GO:0045639),0.35262615497323696,1.0681556928081117,0.350253807106599,0.4590702916326734,1.0,21/21,99.53%,PRMT1;PITHD1;HMGB2;TESC;INHBA;SCIN;HSPA1B;HIF1A;FES;RAB7B;MTURN;HSPA1A;STAT1;ABCB10;FOXO3;STAT5B;MED1;PRKDC;ARNT;ETS1;STAT3
gsea,positive regulation of kinase activity (GO:0033674),0.28050472592932824,1.0678783651502968,0.3652312599681021,0.4589521724800162,1.0,19/41,43.44%,DUSP19;LCP2;CCR7;MMD;PRKAG2;MAP2K3;MRNIP;TRAF4;TIGAR;RET;RYK;LMO4;CD74;AXL;EPHA3;NBN;NTRK3;DAXX;FLT3
gsea,negative regulation of T cell proliferation (GO:0042130),0.3583546212259197,1.0676793921228476,0.38943894389438943,0.45868584392132244,1.0,6/18,25.76%,CEBPB;PDCD1LG2;CD86;IL4I1;IL10;PRNP
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2615716410453706,-1.0676406667018703,0.3568627450980392,0.5047329808741822,1.0,37/37,85.42%,ADGRG1;CALCA;RAPGEF2;ADGRL1;ADRB1;CALCRL;MC1R;CXCL9;ADGRL2;S1PR2;GPR65;ADGRG3;ADRB2;PTGER4;ADRA2A;PTH1R;ABCA1;GPR3;ADGRE1;ADGRG5;TSHR;PF4;CALCB;GLP1R;RAMP2;RAMP1;ADCY6;LPAR3;ADM;PTGER2;S1PR1;ADGRE5;RAMP3;CXCL10;S1PR4;TBXA2R;ADORA2A
gsea,positive regulation of macromolecule metabolic process (GO:0010604),-0.21136968024269845,-1.0673703822190757,0.2773722627737226,0.5038683582603778,1.0,164/164,99.57%,STAT3;SLC38A2;ETS1;DDX3X;HCFC1;TNRC6A;ATF7IP;SP1;NOTCH1;AGO1;UBR5;AGO2;MAZ;ATP13A2;RAB27A;TFRC;AHI1;EIF2AK3;ROCK2;ATF4;PLCG2;ROCK1;DNMT1;SETDB1;TTN;MED1;VSIR;BRCA1;FUBP3;GSK3B;ITGB8;PKP3;MAPK8;SPRY2;TASOR;WNT3;MOV10;ARRB1;SCRIB;WNT11;TERF2;FAM98A;MED23;PIK3CD;PDGFB;SMAD3;ECE1;TBC1D5;GAS6;DDX58;IL13;HGS;FMR1;TMEM119;CELF1;RESF1;AMH;TYROBP;NSF;HSPA1A;HINFP;PPM1F;MAPK7;AR;MEF2C;SFRP4;IL33;CSF1;GSN;YAP1;MITF;LGALS7;HIF1A;BMP7;FAM98B;MT3;TADA3;DTX3L;PIK3CB;SETDB2;ADAM19;CTCF;OLFM1;TNF;HSPA1B;ATF2;RDX;SCYL2;AFDN;MTOR;PICK1;ATM;IGF1;ACTA2;VSTM2A;PRKAA1;NOS1AP;RNF207;WNT6;TLR2;F3;INHBA;KLF4;SMAD1;NTRK3;PF4;EGR1;ZPR1;DNMT3B;PID1;INPP5F;CSF2;NFE2L2;FN1;SLC11A1;GABPA;RAMP2;VEGFA;VPS35;DLL4;TLE1;FGF2;LEF1;CD74;HFE;ZC3H12A;TWIST1;IL1B;CD36;MYC;TLR4;VDR;PPHLN1;CTSH;PARK7;FUBP1;RAMP3;CAMK2N1;CALCOCO1;OSR2;MYOM1;DNAJA4;RPL5;APP;TRIM28;CD63;E2F1;KLF2;ITGAX;AKT1;HMGN5;OVOL2;TESC;PHB;IFNG;CITED2;CCL3;EZR;RGCC;ID2;SERPINB9;PLSCR1;ANXA2;ACTG1
gsea,protein N-linked glycosylation via asparagine (GO:0018279),0.39312774514341053,1.067239116523296,0.3674911660777385,0.45824044358687266,1.0,7/15,29.14%,DDOST;RPN2;STT3A;LMAN1;MCFD2;DERL3;RPN1
gsea,peptidyl-asparagine modification (GO:0018196),0.39312774514341053,1.067239116523296,0.3674911660777385,0.45824044358687266,1.0,7/15,29.14%,DDOST;RPN2;STT3A;LMAN1;MCFD2;DERL3;RPN1
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.32630119343486275,1.066294703786605,0.3476923076923077,0.4591889041636135,1.0,13/27,37.85%,BAX;RACK1;FADD;TNFSF12;GSDME;FAS;HYAL2;WWOX;BID;BBC3;TRAF2;LTBR;NUPR1
gsea,positive regulation of angiogenesis (GO:0045766),-0.2420606379414857,-1.0650394671720338,0.3169642857142857,0.5066718443591945,1.0,28/60,41.37%,ETS1;HIPK1;SP1;JUP;AGO2;PLCG1;BRCA1;ITGB8;PRKD2;PRKCA;MTDH;PIK3CD;HIPK2;PDPK1;DLL1;SIRT6;ITGB1;TJP1;SERPINE1;RUNX1;CCR3;SIRT1;FLT1;HIF1A;PAK4;ITGA5;HK2;RHOB
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.28743357448471235,-1.0649875792457442,0.35129310344827586,0.5053377051244059,1.0,32/32,88.93%,BIRC6;MADD;HTT;PHIP;TRAF1;RIPK1;SH3RF1;ACVR1;TNFRSF10B;AR;PML;FEM1B;TNFSF10;ITGA6;TNF;IGF1;THBS1;TCF7L2;LTBR;TRAF2;BID;PARK7;WWOX;HYAL2;LGALS3;FAS;TNFSF12;FADD;TMC8;RELA;PSME3;SP100
gsea,regulation of protein import into nucleus (GO:0042306),0.34943978581804935,1.0649866120114668,0.3736654804270463,0.4607803978362102,1.0,8/20,50.75%,RAN;IFNG;TRIM28;HYAL2;ZC3H12A;ZPR1;PIK3R1;MAVS
gsea,organic substance transport (GO:0071702),-0.2579062238385639,-1.0637065831987702,0.35147392290249435,0.5063420972567103,1.0,23/50,37.08%,MYH9;ABCA2;ABCA7;CHKA;CENPF;MIA3;ARRDC4;NDC1;ABCG2;CALCRL;LMAN2L;RCN3;ABCB9;DISP1;ATP8A1;ABCB6;CEP290;RUFY1;SLCO2A1;SCAMP1;TCN2;ABCG1;PLEKHA8
gsea,cellular response to growth factor stimulus (GO:0071363),0.27466240318362456,1.0635735084763824,0.34985835694050993,0.4626366039824303,1.0,34/73,42.11%,EEF1A1;RACK1;XCL1;ANXA1;ZFP36L1;CTNNB1;HTRA2;OVOL2;DUSP22;AKT1;MAP2K3;ZFP36;RELA;NR4A1;DUSP3;HSPB1;CPNE3;KNSTRN;HYAL2;WWOX;URI1;WNT10A;EGR3;SPHK1;DLL4;VIL1;VEGFA;RAMP2;CCL2;APPL2;ACVRL1;ZPR1;NTRK3;KLF4
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.29449733220833646,1.0627933440106652,0.35201149425287354,0.4633326652688848,1.0,20/47,43.44%,CALM2;RGCC;CCND3;IFNG;EZH2;AKT1;PDGFA;PIH1D1;HRAS;IL1B;TNFSF11;FGF2;CD40;VEGFA;CAMK1;PIK3R6;INCENP;EDN1;PSRC1;FLT3
gsea,histone deacetylation (GO:0016575),0.31304976552645203,1.0621972066037277,0.3701067615658363,0.46375756822199676,1.0,8/28,37.49%,HDAC1;HDAC2;PHB;MORF4L2;SFPQ;MTA1;MTA2;HDAC9
gsea,regulation of translational initiation (GO:0006446),0.3074522757468836,1.0599820405885314,0.3607843137254902,0.46703728387031246,1.0,13/34,53.83%,NPM1;CEBPB;CDC123;MIF4GD;EIF4EBP1;EIF5;NCBP2;NCBP1;NCK2;DDX1;HSPB1;ATF3;MTIF2
gsea,post-Golgi vesicle-mediated transport (GO:0006892),-0.29251741330503095,-1.0599611668593387,0.3604060913705584,0.5120622477443681,1.0,21/36,34.20%,GOLGB1;MYO5A;CLTC;EXOC4;AP1G1;AP1B1;VPS13C;DOP1B;ARFGEF2;ARRB1;EXOC2;EXOC8;AP4E1;HGS;LLGL1;KLHL20;OSBPL5;SCAMP1;EXOC6B;SH3D19;KIF16B
gsea,ERAD pathway (GO:0036503),-0.2797083537655642,-1.0589657802722865,0.3620309050772627,0.5125982292854443,1.0,22/45,29.59%,VCP;MAN1B1;UGGT1;USP19;HSPA5;UBE4B;TRIM25;ECPAS;YOD1;UBE4A;STT3B;POMT2;RCN3;ERLIN2;FOXRED2;NPLOC4;CCDC47;SYVN1;FBXO44;RHBDD1;SGTB;UBQLN1
gsea,very long-chain fatty acid metabolic process (GO:0000038),0.35289507618204596,1.058729450918654,0.3953846153846154,0.4684913198291131,1.0,9/16,46.11%,HACD2;PEX2;HACD1;ABCD1;HACD4;ACSL6;ACOX1;ELOVL2;ACOT4
gsea,regulation of intracellular signal transduction (GO:1902531),0.22296330774028045,1.0585076980806472,0.3333333333333333,0.46829805889646153,1.0,104/234,55.77%,TMSB4X;RPA3;RBBP4;HDAC1;PIN1;RBBP7;DDIT4;RFC5;CDK1;AURKB;EZR;RFC4;HDAC2;RPA2;CDK2;RHOC;RPF2;BST1;TBP;PRKAG2;AKT1;RFC3;RELA;BCL3;UFL1;SGK1;TPX2;RHNO1;RAD1;PRMT5;CCNG1;DEPDC1B;TAF9;TRAF4;ARHGAP20;RACGAP1;EXO1;PTPMT1;HSPB1;CASTOR1;TRIP10;TAF15;RPL5;MTA2;PJA2;RAD17;NFKBIA;LBH;SLC15A4;RMI2;MAP2K6;BIRC3;IL1B;AURKA;ARHGEF9;USP2;SSRP1;MBD3;TNFSF11;FAM13A;ENTPD5;FAM83D;VEGFA;TRAF2;IER3;INPP5B;TRAF5;CPNE1;RRS1;DNA2;NOC2L;NBN;BRD7;NOP2;NTRK3;DAXX;PRR5;HUS1;RFC2;ARHGDIG;ARHGAP19;ARHGAP25;ARHGEF19;MLST8;PRKAA1;ATM;ARHGAP22;ARHGEF26;BRIP1;NEK8;DIPK2A;MAPKAPK5;SGMS1;STK3;TAGAP;ARHGAP12;PLEKHG2;MDM2;MTOR;CHEK1;SMYD2;TAF5;PIK3R2;NET1
gsea,glycolipid metabolic process (GO:0006664),-0.32800048173653873,-1.057697210428109,0.37598425196850394,0.5136876941473353,1.0,10/22,36.46%,ABCA2;CERK;SMPD4;ST6GALNAC3;GALC;PGAP1;SMPD1;ST6GALNAC4;NAGA;PGAP3
gsea,mitotic nuclear division (GO:0140014),0.32354900911975865,1.0565537028541323,0.39250493096646943,0.47094911424966196,1.0,21/54,34.67%,RAN;BCCIP;UBE2S;AAAS;UBE2C;NUP62;ZWINT;TPX2;ABRAXAS1;CDCA8;NUSAP1;CENPK;PLK1;KNSTRN;NDE1;SMC3;EPS8;SGO1;DSN1;KIFC1;TUBG1
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3107754791502316,1.0556650830035041,0.37282780410742494,0.4719608920518046,1.0,36/36,99.85%,ACTG1;ACTB;HSP90AB1;MYO1C;ELMO1;WIPF3;HCK;SYK;FCGR2B;FGR;PIK3R1;DOCK1;HSP90AA1;PIK3R2;PLA2G6;BAIAP2;PIK3CB;VAV3;LYN;PAK1;PRKCE;WIPF1;PLD2;ELMO2;NCKIPSD;CYFIP1;VAV2;LIMK1;ABL1;PLCG2;ACTR2;PLCG1;NCKAP1;MYO1G;PIK3CA;MYO10
gsea,negative regulation of GTPase activity (GO:0034260),-0.35132313480977917,-1.0541928403173748,0.3954022988505747,0.5189214590151059,1.0,16/16,99.68%,WNK1;ARFGEF1;BCAS3;RCC2;CPEB2;DAB2IP;GPSM1;LRRK2;RDX;RASA4;SH3BP4;RRP1B;LRCH1;HRAS;ARL2;TMED2
gsea,regulation of phagocytosis (GO:0050764),0.37806804732881427,1.052443202361908,0.40759493670886077,0.4767842346242312,1.0,17/28,39.01%,PLSCR1;RACK1;IFNG;LYAR;LMAN2;FCER1G;TUB;IL1B;HCK;SYK;TGM2;SPHK1;FCGR2B;SIRPA;SLC11A1;SCARB1;FGR
gsea,negative regulation of tumor necrosis factor production (GO:0032720),-0.29034448693585446,-1.0518658468925335,0.3920863309352518,0.5216522086815862,1.0,9/23,31.74%,DICER1;NLRC3;TNFAIP3;VSIR;SYT11;RARA;GAS6;MC1R;HAVCR2
gsea,adherens junction organization (GO:0034332),-0.32446835271118196,-1.0513590120690823,0.3413793103448276,0.521111926240825,1.0,9/17,31.70%,CDH17;JUP;SMAD7;PIP5K1C;CDH1;VCL;CTNNA1;PVR;TJP1
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.3075191466833057,1.0513120597800116,0.3707692307692308,0.47800241733882787,1.0,16/33,45.79%,S100A10;C1QBP;RSU1;CCR7;TRIOBP;ARL2;CD36;P4HB;CX3CL1;CCL25;MYADM;CASS4;FN1;FBLN2;DMTN;DOCK1
gsea,negative regulation of smooth muscle cell proliferation (GO:0048662),0.36374048195085007,1.0509532264567856,0.39565943238731216,0.4779910816534583,1.0,5/15,26.99%,SOD2;IFNG;TPM1;IL10;PDCD4
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.30636695652538337,1.050600044700776,0.394856278366112,0.4779578011306308,1.0,18/39,45.10%,MIF;CCL3;HMGB1;IFNG;FRMD8;CD14;FADD;HSPB1;APP;TLR4;TWIST1;OAS3;SYK;CCR2;PF4;IL23A;THBS1;TLR2
gsea,regulation of protein localization to nucleus (GO:1900180),0.3229989830678828,1.049945913896547,0.3818493150684932,0.4784663881002483,1.0,11/27,34.83%,PIN1;CDK1;SUMO3;AKT1;GLUL;PLK1;PARK7;PARP9;LIF;WWTR1;MFHAS1
gsea,regulation of epidermal cell differentiation (GO:0045604),-0.33813148730465936,-1.0496096961116497,0.371571072319202,0.5229961349610911,1.0,7/16,34.89%,SFN;ROCK2;ROCK1;DLL1;SFRP4;RUNX1;KDF1
gsea,protein polymerization (GO:0051258),0.3293758181974096,1.0495032046976587,0.38731218697829717,0.47859973346739054,1.0,11/24,34.79%,PIN1;UBE2S;UBE2C;MSRB2;MID1IP1;SPIRE2;TPPP3;HDGFL3;WASHC5;VIL1;CORO7
gsea,regulation of cell migration (GO:0030334),-0.20428003641241915,-1.0487004944931415,0.2875,0.5233149775624405,1.0,185/185,99.96%,MACF1;FLNA;STAT3;NEDD9;SPATA13;PTK2B;SRGAP3;IFITM1;NOTCH1;SMAD7;MAZ;SUN2;PLXND1;PTPRJ;ARID2;CORO1C;SLK;SCAI;CARMIL2;ROCK2;SEMA6D;MINK1;HSPA5;NF1;ROCK1;NF2;MIA3;SRGAP2;VSIR;CDH1;ABI3;RCC2;ZMYND8;PRKCA;VCL;SPRY2;SYNE2;FOXO3;MGAT5;CEACAM1;WNT11;DAG1;F2R;AIF1;KIF14;SEMA4C;PLXNA1;RAP2C;PIK3CD;PDGFB;ADAM9;TIAM1;ACTN4;SEMA4B;DDX58;PRR5L;CLN3;SEMA7A;ADAM17;ACVR1;CLIC4;TBCCD1;CCL5;OSGIN1;BCAR1;PPM1F;KIF2A;F2RL1;KIT;LIMCH1;ITGB1;TJP1;PTPRK;SERPINE2;SERPINE1;GPNMB;CSF1;ITGA6;CSF1R;PAK1;FLT1;CD151;MITF;HACE1;AMOTL2;MAP4K4;TTBK2;ADGRG3;PLAU;GRB7;RHOB;DLC1;MMP14;CCN1;ELP3;FUZ;RDX;AFDN;DLG5;ELP6;ENPP2;RIPOR1;PLXNC1;HBEGF;AMOT;GTSE1;ADRA2A;ATM;IGF1;THBS1;COL1A1;SMIM22;F3;AMOTL1;TCAF1;CCAR1;PLXNB2;NTRK3;EDN1;ACVRL1;MMP9;FGR;APPL2;CASS4;CXCL16;CCL7;MYADM;PECAM1;RAP2B;DAB2;VEGFA;SEMA4A;IGSF10;PLET1;TMSB15A;VIL1;SPHK1;ARHGEF39;FGF2;ENG;LEF1;LGR6;CD74;NEXN;LMO4;SINHCAF;GRN;CX3CL1;IL1B;RET;GCNT2;RAP2A;RUFY3;LMNA;ARSB;CTSH;MCTP1;CCR1;MYO1C;HRAS;CPNE3;FAM110C;TPM1;XBP1;PDGFA;DUSP3;DUSP10;SGK1;ITGAX;LAMC2;AKT1;DUSP22;GTPBP4;ANXA1;RHOC;CITED2;ELP5;BST2;CCL3;RACK1;SOD2;TMSB10;MIF;ACTG1;TMSB4X
gsea,regulation of angiogenesis (GO:0045765),-0.2247889079699565,-1.0464467370192891,0.3648068669527897,0.5261338717588345,1.0,95/95,98.75%,ETS1;HIPK1;SP1;JUP;AGO1;AGO2;PLXND1;TNFAIP3;ATP2B4;ROCK2;PLCG1;NF1;ROCK1;BRCA1;CEMIP2;ITGB8;PRKD2;PRKCA;SPRY2;CEACAM1;PDE3B;MTDH;VASH1;GTF2I;PIK3CD;HIPK2;HGS;STAT1;PDPK1;PML;ITGB1;DAB2IP;SERPINE1;RUNX1;GPNMB;FOXO4;CCR3;SIRT1;FLT1;HIF1A;SERPINF1;PAK4;HK2;SPRED1;RHOB;ALOX5;STAB1;ATF2;SPARC;AMOT;ADGRA2;PGF;THBS1;VASH2;F3;TGFB2;HMOX1;PPARG;KLF4;PF4;PRKCB;PIK3R6;FOXJ2;RAMP2;VEGFA;ECM1;CCR2;CD40;SPHK1;FGF2;ANGPTL4;PTPRM;ZC3H12A;GRN;CXCL13;TWIST1;IL1B;CTSH;HHEX;ANXA3;NINJ1;CXCL10;VEGFB;XBP1;HSPB1;GLUL;TNFSF12;ITGAX;MYDGF;EGLN1;SP100;CTNNB1;CD160;RGCC;PGK1
gsea,nitrogen compound transport (GO:0071705),-0.24273342740460085,-1.0446061699199092,0.35280898876404493,0.5281686691885075,1.0,29/59,36.32%,MYH9;SLC38A2;SLC7A1;CENPF;MIA3;ARRDC4;SLC44A1;NDC1;ABCC1;SLC12A2;ABCG2;CALCRL;LMAN2L;RCN3;LRRC8D;SLC7A5;SLC6A12;SLC7A6;SLC38A1;SLC15A3;ABCB6;CEP290;SLC1A4;SEC14L1;RUFY1;SLC25A45;SCAMP1;TCN2;SLC15A2
gsea,cellular response to chemokine (GO:1990869),-0.28610463260508434,-1.0439930006460623,0.36454849498327757,0.5279038108780426,1.0,31/31,95.70%,WNK1;DOCK8;PTK2B;SLC12A2;OXSR1;CCL5;CXCL9;SH2B3;GPR35;CCL17;RIPOR2;CCL22;PF4;CXCL2;CCL2;CCL7;CCR2;CCL25;ZC3H12A;STK39;CXCL13;CX3CL1;CCL8;LRCH1;CCR1;CXCL10;CCL1;DUSP1;CCL4;XCL1;CCL3
gsea,protein catabolic process (GO:0030163),-0.29017246198125174,-1.0438976957513975,0.3612565445026178,0.5266360438772151,1.0,21/32,38.18%,CTSD;IDE;VCP;OGA;DDB1;CEACAM1;RIPK1;STT3B;TRIM24;CTRL;DENND3;DDI2;FBXO44;CLPX;SOCS6;APOE;CLN6;DAB2IP;CHEK2;PMAIP1;NCCRP1
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.30380737151909565,1.0419517663965108,0.3867924528301887,0.4907211821394179,1.0,37/37,99.85%,ACTG1;ACTB;HSP90AB1;FCER1G;MYO1C;ELMO1;WIPF3;HCK;SYK;FCGR2B;FGR;PIK3R1;DOCK1;HSP90AA1;PIK3R2;PLA2G6;BAIAP2;PIK3CB;VAV3;LYN;PAK1;PRKCE;WIPF1;PLD2;ELMO2;NCKIPSD;CYFIP1;VAV2;LIMK1;ABL1;PLCG2;ACTR2;PLCG1;NCKAP1;MYO1G;PIK3CA;MYO10
gsea,RNA methylation (GO:0001510),0.28005704277680316,1.0401376561500049,0.38144329896907214,0.49310622759036443,1.0,23/45,43.21%,BUD23;FBL;TRMT6;METTL5;TRDMT1;DIMT1;TRMT61B;TYW3;TRMT10C;NSUN2;TFB1M;MTERF4;TRMT5;TRMO;TRMT61A;METTL1;METTL3;FTSJ1;MTO1;GTPBP3;NOP2;LCMT2;TRMT44
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2487610450202507,1.0382182007965302,0.3825396825396825,0.49582117058313024,1.0,43/105,40.37%,UBE2N;LITAF;GAPDH;LGALS1;EEF1D;BST2;RHOC;CCR7;NUP62;S100A4;PPP5C;RELA;CASP1;UFL1;FADD;RIPK2;TNFRSF1A;DDX1;TRAF4;TSPAN6;HSPB1;TERF2IP;PLK2;PIM2;BIRC3;IL1B;CX3CL1;RORA;WLS;ZC3H12A;CD74;PINK1;CACTIN;TLE1;TIFA;CD40;ECM1;TRAF2;TRAF5;CPNE1;LTBR;TMEM101;PRKCB
gsea,cholesterol homeostasis (GO:0042632),0.3482079506515246,1.0374860463075575,0.4097902097902098,0.4964587600222254,1.0,8/22,38.96%,CNBP;TMEM97;XBP1;RORA;NR1H3;HDAC9;SCARB1;INSIG1
gsea,positive regulation of protein import into nucleus (GO:0042307),0.3540198565769013,1.0368699113432651,0.3978685612788632,0.4968115899487661,1.0,8/18,50.75%,RAN;IFNG;TRIM28;HYAL2;ZC3H12A;ZPR1;PIK3R1;MAVS
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.32307256969643416,-1.0360289144323553,0.357487922705314,0.54012209804045,1.0,17/17,92.51%,HDAC7;NOTCH1;PIK3C2A;MAP3K3;HDAC5;THBS1;HMOX1;KLF4;HDAC9;FOXC2;PTGS2;VEGFA;DLL4;FGF2;JCAD;TBXA2R;ANXA1
gsea,cellular response to oxygen-containing compound (GO:1901701),0.24690248109376212,1.0345500248783888,0.3870558375634518,0.5001919567003885,1.0,66/137,46.38%,ACTB;PRDX3;VIM;EZR;HMGB1;PDCD1LG2;CDK2;HMGB2;TESC;ZFP36L1;SELENOS;CD14;NFKBIB;HTRA2;CD68;AKT1;PLAA;PDXP;ZFP36;CD86;TNFSF4;RELA;CASP1;SHMT1;GUCY1B1;XBP1;TPM1;RUVBL2;CCDC62;CXCL10;RAMP3;NLRP3;IL10;TLR4;PDCD4;RET;IL1B;CXCL13;RORA;ZC3H12A;GFI1;TGM2;ADCY6;CACTIN;SH3BP4;NR1H3;FOS;CCL2;CTSG;SIRPA;AXL;EPHA3;ACOD1;INSIG1;CD180;MMP9;CXCL2;PID1;EGR1;PF4;TSHR;DMTN;TLR2;WNT6;FZD7;P2RY6
gsea,negative regulation of cellular catabolic process (GO:0031330),0.2960193614556711,1.0337841075441188,0.40634920634920635,0.5009278036753367,1.0,14/35,54.43%,CST3;DAP;EIF4E;DAPL1;AKT1;IL10;MFSD2A;CPTP;NUPR1;TIMP1;MET;MTOR;PTPN3;TLK2
gsea,negative regulation of organelle assembly (GO:1902116),-0.3024622947934657,-1.0334542770917021,0.38588235294117645,0.5437396377198992,1.0,12/22,38.02%,CDK5RAP2;BRCA1;KAT2B;SMCR8;CEP97;EVI5L;CCP110;KAT2A;PHF23;YAP1;TCHP;LRRK2
gsea,positive regulation of protein import (GO:1904591),0.3480116794882556,1.032660892217208,0.4090121317157712,0.5022193899161692,1.0,8/19,50.75%,RAN;IFNG;TRIM28;HYAL2;ZC3H12A;ZPR1;PIK3R1;MAVS
gsea,anterograde axonal transport (GO:0008089),0.3273054486793718,1.0315227676025043,0.4056761268781302,0.5035755700201122,1.0,8/21,45.35%,AP3S1;BLOC1S2;AP3M1;HSPB1;MGARP;HAP1;KIF3A;KIF1A
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3500500887181456,1.030084820070698,0.39444444444444443,0.505511689038299,1.0,8/17,31.63%,UCHL5;GIPC1;HSP90AB1;TAF9;BAG5;RPL5;PARK7;HFE
gsea,cellular protein catabolic process (GO:0044257),-0.298879342896166,-1.0296166256047634,0.4095022624434389,0.5494648452945486,1.0,16/29,36.79%,AP2A2;IDE;AP2B1;MALT1;CLTC;TCIRG1;YME1L1;RIPK1;CAPN2;DENND3;LONP1;CLPX;DAB2IP;CLPP;CHEK2;LGMN
gsea,positive regulation of immune response (GO:0050778),0.2982424366919907,1.0294238094360273,0.43086816720257237,0.5060604259309526,1.0,19/35,44.48%,PLSCR1;IFNG;CCR7;TNFSF4;FADD;XBP1;NLRP3;IL10;SLC15A4;GRN;CD226;POLR3D;CD74;CD81;FCGR2B;IL2;TGFB2;POLR3G;IL23A
gsea,negative regulation of transport (GO:0051051),0.40569576213479075,1.0290530333865406,0.41132075471698115,0.5060624524872004,1.0,13/19,36.61%,PLSCR1;RACK1;BST2;YRDC;LGALS3;CRYAB;MCTP1;TRAT1;NR1H3;CRYAA;FCGR2B;SIRPA;EPHA3
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.25582060520207855,-1.0275359997557145,0.3942857142857143,0.5519011487659605,1.0,41/41,99.12%,TNK2;PTK2B;ITGB3;PTPRJ;JAK2;TEC;PLCG2;NRP1;ABL1;CD80;LRP8;PTPN11;ARHGEF2;RAP2C;PDGFB;IL22RA2;ACVR1;CD44;IL3;ITGA5;ENPP2;IGF1;IL23A;DMTN;PRKCZ;PTPN6;PECAM1;RAP2B;VEGFA;LIF;CD81;CD74;PRNP;BANK1;APP;RIPK2;PDGFA;OSM;BST1;HAX1;MIF
gsea,T cell activation (GO:0042110),0.30894464315299364,1.0275178543778818,0.43617021276595747,0.5080680544252323,1.0,14/35,43.75%,DDOST;TNFRSF4;CCR7;HSPD1;NCK2;TNFSF4;TNFSF14;CD74;JAML;DLL4;IL2;CRTAM;ADA;CD7
gsea,import into cell (GO:0098657),-0.3188023168961732,-1.02745362731279,0.42152466367713004,0.5505928619030966,1.0,9/18,28.07%,SLC7A1;SLC5A3;SLC39A14;SLC12A6;LRRC8D;SLC7A5;SLC38A1;SLC27A1;IL10RA
gsea,protein autoubiquitination (GO:0051865),-0.32034188886020554,-1.0271100248268943,0.42209072978303747,0.549770109026765,1.0,14/22,39.52%,RNF213;CUL3;KLHL24;BRCA1;RNF157;SH3RF1;RNF19B;RNF8;RAD18;UHRF1;NFX1;DTX3L;ERCC8;TRIM21
gsea,sterol homeostasis (GO:0055092),0.33870539051011916,1.026508093090088,0.41818181818181815,0.5091220852413957,1.0,9/23,38.96%,CNBP;TMEM97;XBP1;RORA;ABCD1;NR1H3;HDAC9;SCARB1;INSIG1
gsea,regulation of actin filament polymerization (GO:0030833),0.31646924600704296,1.0253282774751966,0.4333821376281113,0.5105582452833414,1.0,13/30,36.00%,PFN1;CCR7;HAX1;EVL;NCK2;CDC42EP2;PFN2;HCK;CDC42EP3;WASHC5;VIL1;MYADM;GBA2
gsea,monocarboxylic acid biosynthetic process (GO:0072330),0.35939390703388363,1.024196022663805,0.42799461641991926,0.511923761479681,1.0,10/23,35.10%,NDUFAB1;GATM;MCAT;ALDH1A3;XBP1;HSD17B10;PARK7;OSBPL9;OXSM;CH25H
gsea,positive regulation of cytokinesis (GO:0032467),-0.35710334996904297,-1.0236860070911349,0.4292237442922374,0.5533982465291576,1.0,10/19,31.56%,PKP4;CIT;SVIL;CDC14A;CUL3;KIF14;KIF20B;CSPP1;PRKCE;ECT2
gsea,positive regulation of cell division (GO:0051781),-0.35710334996904297,-1.0236860070911349,0.4292237442922374,0.5533982465291576,1.0,10/19,31.56%,PKP4;CIT;SVIL;CDC14A;CUL3;KIF14;KIF20B;CSPP1;PRKCE;ECT2
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.26740516198373365,1.0218587281330382,0.421259842519685,0.5153322103386911,1.0,33/88,42.14%,TUBA1A;CCNB2;TUBB4B;CDK1;YWHAE;CDK2;TUBA4A;HAUS1;HAUS4;CCNA2;HAUS8;MELK;PPP1CB;CCNB1;CDK7;PHLDA1;USH1C;PLK1;NDE1;HAUS2;NEK2;CEP41;ACTR1A;FBXL15;AURKA;AJUBA;HAUS6;CEP78;TUBG1;HAUS7;CUL1;CEP72;NEDD1
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2751765881535494,-1.0207450612740332,0.38377192982456143,0.5577638213910673,1.0,38/38,99.83%,HUWE1;RASD2;SMAD7;MALT1;HDAC4;CUL3;BIRC2;FBXW7;BRCA1;FANCI;GNL3;DCUN1D3;PAXIP1;UBQLN1;TNIP1;PHF23;TANK;LRRK2;PIAS4;AXIN1;WDR48;SPRTN;CENPS;PIAS3;DCUN1D2;STUB1;SPHK1;PINK1;ZC3H12A;TBC1D7;BIRC3;CRY1;SAE1;RIPK2;DCUN1D1;HSPBP1;UBA2;UBB
gsea,mitotic cytokinesis (GO:0000281),0.3373828427575015,1.01993815849213,0.42314990512333966,0.5180221448621406,1.0,7/29,20.14%,CENPA;STMN1;RHOC;RTKN;NUSAP1;RACGAP1;PLK1
gsea,posttranscriptional regulation of gene expression (GO:0010608),0.3042162188629852,1.0199349858717761,0.40709459459459457,0.5174047145840214,1.0,16/32,57.06%,RPL10;EIF4E;EIF2A;METAP1;APP;GCNT2;PARP9;PUM3;TCOF1;NANOS3;MAPKAPK5;RBM4B;ZC3H10;METTL16;ATG14;NANOS1
gsea,positive regulation of interferon-gamma production (GO:0032729),0.3375361729898722,1.0159065328454475,0.4418262150220913,0.5238986534703538,1.0,15/26,38.90%,HSPD1;CD14;SLAMF6;IL12RB2;TNFSF4;FADD;IL21;TLR7;TLR4;ISG15;IL1B;CD226;CCR2;SLC11A1;CRTAM
gsea,"DNA-templated transcription, initiation (GO:0006352)",-0.23007050855369152,-1.0152121081257754,0.40350877192982454,0.5665440986561874,1.0,86/86,98.42%,NCOR2;HDAC7;CREBBP;GTF3C1;UBTF;NR4A3;NOTCH1;TBL1XR1;MAZ;TAF1;TAF1D;GTF2A1;POLR2A;NCOA6;POLR1A;NOTCH2;MED1;POLRMT;NR3C1;GTF2F1;E2F3;KAT2B;TAF2;E2F2;MED23;MAML2;TAF4B;RARA;HDAC5;AR;RARG;NR5A2;TAF6;RORB;TBL1X;TAF1A;YAP1;POLR1B;TAF3;RRN3;SMARCA5;HDAC10;TAF5;ESRRA;PPARG;CAVIN1;GTF2E1;MAML3;HDAC9;WWTR1;NR1H3;GTF2H1;BRF2;NR2F6;MED7;ERCC2;RORA;THRB;POLR2B;GTF2H4;VDR;POLR2F;GTF2H2;NR2C2AP;RXRA;NR4A2;TAF15;TFB1M;POLR1C;TAF9;CDK7;ERCC3;NR4A1;GTF2F2;GTF2H3;POLR1E;POLR2E;POLR2L;TBP;TFAM;POLR3H;POLR2H;TAF1B;GTF2E2;POLR2C;HDAC1
gsea,cell cycle G2/M phase transition (GO:0044839),0.2661132925741377,1.0141082786649378,0.4316831683168317,0.5262708117051759,1.0,33/88,42.14%,TUBA1A;CCNB2;TUBB4B;CDK1;YWHAE;CDK2;TUBA4A;HAUS1;HAUS4;CCNA2;HAUS8;MELK;PPP1CB;CCNB1;CDK7;PHLDA1;USH1C;PLK1;NDE1;HAUS2;NEK2;CEP41;ACTR1A;FBXL15;AURKA;AJUBA;HAUS6;CEP78;TUBG1;HAUS7;CUL1;CEP72;NEDD1
gsea,negative regulation of intracellular signal transduction (GO:1902532),0.237112375806181,1.0139766718203491,0.42857142857142855,0.5258657692863097,1.0,45/102,53.95%,TMSB4X;DDIT4;PPIF;PEBP1;RACK1;DUSP1;SH3BP1;HERPUD1;AKT1;MAP2K3;PLEK;RELA;DUSP3;TSPAN6;BANK1;HYAL2;URI1;NLRP3;TWIST1;RORA;TBC1D7;AJUBA;ZC3H12A;PINK1;CACTIN;TLE1;SH3BP4;NPRL3;MYADM;CPNE1;NOC2L;MMP9;PIK3IP1;PLAUR;GPD1L;THBS1;ARHGAP25;PRKAA1;PHLPP2;MAPKAPK5;DLG5;DDIT3;ARHGAP12;TNFAIP8L1;MDM2
gsea,establishment of spindle orientation (GO:0051294),0.34661576757914525,1.0138971281576217,0.4151624548736462,0.5253764413822403,1.0,7/20,29.58%,CENPA;MAD2L1;NSFL1C;UBXN2B;PLK1;NDE1;SAPCD2
gsea,negative regulation of type I interferon production (GO:0032480),-0.3080127992561857,-1.0127729732191009,0.43358395989974935,0.5700042316271501,1.0,10/22,31.74%,YY1;PTPRS;NLRC3;TNFAIP3;TRIM25;IKBKE;DDX58;NPLOC4;DHX58;HAVCR2
gsea,myeloid leukocyte differentiation (GO:0002573),0.29729935198493607,1.012419082475749,0.4442836468885673,0.5273085419302159,1.0,21/39,43.71%,CDK4;CDK2;IFNG;CCR7;E2F1;THOC5;RXRA;GPR183;BATF;LEF1;TNFSF11;VEGFA;CBFA2T3;FARP2;CSF2;FOXP1;MMP9;PARP1;PPARG;BATF2;DEK
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2900498289278279,1.0121352220227315,0.4568835098335855,0.5271322912331567,1.0,19/41,45.10%,MIF;CCL3;HMGB1;IFNG;FRMD8;CD14;CD86;FADD;HSPB1;APP;TLR4;TWIST1;OAS3;SYK;CCR2;PF4;IL23A;THBS1;TLR2
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.27497067834828914,1.0120165630214142,0.44788273615635177,0.5267108995355415,1.0,19/41,56.86%,PFN1;CCR7;RALA;CDC42EP2;HRAS;EPS8;CDC42EP3;BBS4;WNT1;FNBP1L;PIK3R1;CDC42EP1;ANLN;RIPOR2;DEF8;FSCN1;FUZ;EPS8L1;CCDC88A
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.25564337667418624,-1.0112997712317775,0.4321266968325792,0.5714963968929695,1.0,21/41,34.04%,BIRC6;DDX3X;HTT;PHIP;TNFAIP3;BRCA1;GSK3B;RIPK1;ARHGEF2;EYA3;SH3RF1;ACVR1;TNFRSF10B;HSPA1A;MAPK7;AR;BCL2L1;BCL2;TNFSF10;SERPINE1;ITGA6
gsea,mitotic spindle organization (GO:0007052),0.2819408627173963,1.0107495147268906,0.428,0.52835475145395,1.0,55/118,44.50%,RAN;CENPA;STMN1;BCCIP;BIRC5;AURKB;BUB3;MAD2L1;NUDC;AAAS;NUP43;SPC24;NUP37;CDC20;RCC1;SKA1;SEH1L;ZWINT;CENPU;CCNB1;CENPQ;BUB1;TPX2;DYNLL2;ABRAXAS1;CDCA8;CENPK;PMF1;PLK1;ITGB3BP;NDE1;SMC3;CENPN;CENPH;NUF2;NUP85;PLK2;SPC25;CENPT;AURKA;CENPI;SGO1;DSN1;CENPM;CENPP;KIFC1;TUBG1;INTS13;TTK;INCENP;KIF23;CENPL;CENPS;RMDN1;WRAP73
gsea,response to lipid (GO:0033993),-0.24474842958899926,-1.0105077725054774,0.42955326460481097,0.5714359149942984,1.0,46/46,98.39%,STAT3;ABCA2;RPS6KA3;ERBIN;ASXL1;JAK2;FOXO1;STAT5B;FOXO3;F2R;MAPKAPK2;RARA;ADAM17;SPP1;RARG;TRIB1;PAQR7;NOCT;ABCG1;NOS1;SOCS2;PCK2;NOS2;SLPI;PPARG;AQP3;FOXA1;LIAS;SELP;FOXP1;SLC11A1;ALPL;MAPKAPK3;IL1B;CD36;IRAK3;TLR4;CTSH;RXRA;GCH1;HNRNPA0;CDKN2D;CTNNB1;ANXA1;HMGB2;PRDX3
gsea,regulation of fat cell differentiation (GO:0045598),0.2938957712496647,1.0059005835958483,0.4464555052790347,0.5360965929074814,1.0,15/38,42.99%,ID2;CEBPB;ZFP36L1;AKT1;ZFP36;TMEM64;E2F1;XBP1;RORA;ZBTB16;ZC3H12A;ENPP1;WWTR1;WNT1;PPARG
gsea,negative regulation of response to stimulus (GO:0048585),-0.28243415514120984,-1.0046781379293515,0.41414141414141414,0.581200263954743,1.0,13/26,36.13%,TLE5;CDK6;VPS13C;MAP3K3;TERF2;SOCS5;ACVR1;MAPK7;ZKSCAN3;SH2B3;SIRT1;RBL1;LYN
gsea,response to molecule of bacterial origin (GO:0002237),0.31787271758863794,1.0035114661081634,0.47619047619047616,0.5395598346983113,1.0,18/30,40.84%,PRDX3;HMGB2;IRF5;CD14;HNRNPA0;GCH1;IL10;TLR4;IRAK3;IL1B;MAPKAPK3;FCGR2B;ACOD1;SLC11A1;FOXP1;CXCL2;SELP;LIAS
gsea,spindle assembly (GO:0051225),-0.28092116166295733,-1.002451090757845,0.4263261296660118,0.5841340622175081,1.0,23/46,35.11%,FLNA;CLASP1;CEP192;STAG1;TOGARAM1;NUMA1;TUBGCP4;CLASP2;KPNB1;TUBGCP6;PIBF1;MAP9;TUBGCP3;INO80;HAUS3;KIF3B;SMC1A;GOLGA2;KIF11;KIF2A;TUBGCP2;STAG2;CHEK2
gsea,regulation of cellular protein localization (GO:1903827),-0.29910714238406255,-1.0017160701265928,0.4298850574712644,0.5840195462030727,1.0,15/27,37.30%,ABCA2;VCP;ATP13A2;SETD2;MAP2;KCNAB2;DVL3;TRIM46;CCDC66;DVL1;PPM1F;SPIDR;RALB;LCP1;CSNK1E
gsea,response to light stimulus (GO:0009416),0.29360457769958254,1.0002643346399565,0.463768115942029,0.5446344474224507,1.0,13/32,35.04%,PCLAF;COPS3;CDKN2D;ERCC3;FECH;USP1;MEN1;GTF2H2;CRY1;DCT;ERCC2;TRPM1;POLD1
gsea,positive regulation of cell death (GO:0010942),0.2919488838576755,0.9996454836607696,0.450920245398773,0.5450405588128122,1.0,18/35,41.63%,EIF2S1;DDIT4;IFNG;PHB;AXIN2;RIPK2;RAMP3;PRNP;PRR7;CD36;ZC3H12A;BNIP3;FOS;FCGR2B;SLC6A13;LRP1;EGR1;DAXX
gsea,negative regulation of protein ubiquitination (GO:0031397),0.29880649894638817,0.9995765849040248,0.4764595103578154,0.5445139404218394,1.0,14/28,29.84%,DNAJA1;GTPBP4;U2AF2;AKT1;UFL1;BAG5;FBXO5;PRMT3;PARK7;CRY1;ISG15;PRR7;PINX1;BAG2
gsea,positive regulation of intracellular signal transduction (GO:1902533),0.21950019041758986,0.9994551229611583,0.4431818181818182,0.5440965109725288,1.0,108/233,47.44%,UBE2N;MIF;C1QBP;BAX;PHB2;LITAF;GAPDH;LGALS1;EEF1D;RACK1;CCL3;HMGB1;BST2;RHOC;DUSP19;CCL4;PHB;CCR7;NUP62;HAX1;S100A4;CD14;HSP90AB1;SEH1L;CD86;MYDGF;PPP5C;OSM;RELA;CASP1;FADD;GSDME;PDGFA;RIPK2;TNFRSF1A;DDX1;TSPAN6;APP;FAM110C;ICOS;HRAS;RAMP3;PTP4A3;TERF2IP;PARK7;PLK2;PIM2;TLR7;JCAD;BID;TLR4;GCNT2;PDCD4;EPOR;RET;BIRC3;IL1B;CX3CL1;TNFSF14;WLS;RYK;PIK3AP1;CD74;TRAT1;ENG;LIF;TNFSF11;TGM2;PINK1;FGF2;SPHK1;TIFA;BBC3;CD40;ECM1;VEGFA;MFHAS1;TRAF2;AXL;CASS4;TRAF5;CPNE1;LTBR;TGFA;NUPR1;PTPN6;FN1;FGR;SELP;TMEM101;PRKCB;TCF7L2;CAV2;NTRK3;HMOX1;FLT3;TGFB2;F3;IL23A;PIK3R1;AREG;THBS1;TLR2;MET;ZDHHC13;FFAR4;NOS1AP;MLST8
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.253338493840316,-0.9992177039436189,0.42718446601941745,0.587441169113054,1.0,36/36,97.70%,ITGAM;CDH17;DSCAM;PTPRS;ADGRL1;CDH1;CEACAM1;ACVR1;DSG2;PVR;ITGB1;CDH23;PALLD;L1CAM;MPZL2;FLRT3;MMP24;CADM1;TGFB2;PLXNB2;SELP;CRTAM;PECAM1;JAML;NECTIN4;PTPRM;NEXN;VCAM1;MILR1;ALCAM;NECTIN2;SELL;CLDN10;ICAM1;EMB;BSG
gsea,positive regulation of endothelial cell migration (GO:0010595),-0.2512149694907773,-0.9984471099721949,0.4161676646706587,0.5875192841944361,1.0,28/47,41.43%,ETS1;PTK2B;SP1;ITGB3;ROCK2;PLCG1;BCAS3;NRP1;ABL1;PIK3CG;PRKD2;PRKCA;STAT5A;PIK3CD;PDGFB;ADAM17;PDPK1;BCAR1;RIN2;GATA3;CALR;NUS1;SIRT1;HIF1A;LGMN;PIK3CB;RHOB;P2RX4
gsea,positive regulation of autophagy (GO:0010508),-0.2476625862034192,-0.9966463311575685,0.48699763593380613,0.5895159265504137,1.0,30/50,39.52%,LARP1;HTT;TFEB;PIK3C2A;ROCK1;FOXO1;GSK3B;TSC2;OPTN;TRIM14;FOXO3;MTDH;ULK1;MID2;ATF6;PLK3;TRIM5;EIF2AK4;MAP3K7;SESN1;SESN3;CAMKK2;SIRT1;SVIP;TRIM65;GPSM1;LRRK2;RNF152;PIK3CB;TRIM21
gsea,regulation of glucose import (GO:0046324),0.3298015334842229,0.9955122695092917,0.45694200351493847,0.5504736215829816,1.0,9/16,44.61%,SELENOS;PRKAG2;AKT1;CAPN10;GRB10;ENPP1;APPL2;PID1;PIK3R1
gsea,cellular response to DNA damage stimulus (GO:0006974),0.217316439797069,0.9944104328633692,0.4681238615664845,0.5517048194523357,1.0,112/245,56.29%,CRIP1;NPM1;CTLA4;BAX;PCLAF;RFC5;CDK1;RFC4;NSMCE4A;HPF1;CBX1;FEN1;BAK1;OARD1;FANCL;SAMHD1;APEX1;ASF1A;TDP1;UBE2T;NUDT1;RAD51;HTRA2;ALKBH7;RFC3;GTF2H3;HIC1;ZDHHC16;ASH2L;BCL3;UNG;UFL1;MRNIP;E2F1;ERCC3;MCM7;RAD1;MUS81;TRIM28;TRAIP;POLE2;TAF9;APTX;EXO1;RAD51D;POLE3;CCNK;MEN1;TIGAR;MGMT;TIMELESS;RAD17;RAD51C;PARK7;PARP3;BID;PARP2;GTF2H4;CRY1;MYC;CHCHD6;RMI2;CHD1L;OGG1;CUL4B;MAP2K6;GADD45A;RPAIN;UBE2E2;SIRT4;BATF;FANCG;RAD51AP1;PPP1R15A;ZC3H12A;GTF2H1;AKTIP;POLD1;METTL3;FANCF;WNT1;IRF7;SMC6;NBN;FOXP1;INTS3;PARP1;CENPS;HUS1;RFC2;SPRTN;NEK4;DDB2;POLH;ATM;LIG1;GNL1;IGHMBP2;MSH3;BCL6;DDIT3;CCND1;MCM8;CGAS;CHEK1;TLK2;SUV39H1;BACH1;ATF2;WDR48;FBH1;ZRANB3
gsea,regulation of bone mineralization (GO:0030500),-0.28454927767584115,-0.9935126947267965,0.49079754601226994,0.5941801825307637,1.0,23/23,95.70%,PTK2B;BMP2K;BCOR;ANO6;TGFB3;TMEM119;ACVR1;MEF2C;BMP7;ALOX5;CCN1;SLC8A1;WNT4;TXLNG;ECM1;ENPP1;TWIST1;ISG15;S1PR1;CCR1;OSR2;GPM6B;CCL3
gsea,regulation of p38MAPK cascade (GO:1900744),0.3326055351321233,0.9916144819730051,0.4816053511705686,0.5558935981178472,1.0,14/23,34.83%,PRMT1;EZR;DUSP1;GADD45B;DUSP10;PJA2;IL1B;GADD45A;GADD45G;ZC3H12A;SPHK1;VEGFA;RELL1;MFHAS1
gsea,regulation of chromosome organization (GO:0033044),0.3491980662216292,0.9915306647664791,0.4777327935222672,0.5553887298683383,1.0,7/15,27.44%,HNRNPD;CENPV;BUB1;CDT1;TERF2IP;MYC;RMI2
gsea,positive regulation of cell differentiation (GO:0045597),0.2407956993804497,0.9902719789894653,0.4828897338403042,0.5569801221921342,1.0,50/96,49.60%,ID2;RGCC;CEBPB;PA2G4;MMD;ZFP36L1;EZH2;CTNNB1;AKT1;HSP90AB1;ZFP36;TMEM64;BOC;AXIN2;GLIPR2;TCF3;XBP1;FBXO5;XKR8;GCNT2;CD36;IL1B;TWIST1;NRCAM;ZBTB16;ZC3H12A;LEF1;BAMBI;CCN4;WWTR1;DAB2;GPC1;CAMK1;CPNE1;CSF2;LOXL2;ACVRL1;PF4;PPARG;INSM1;TGFB2;COL1A1;ASB4;FFAR4;HOXB4;TCF15;IGF1;WNT4;MSR1;RIPOR2
gsea,regulation of T cell activation (GO:0050863),0.32173922925728426,0.9881731514485951,0.49203821656050956,0.5600303725791659,1.0,15/24,38.90%,TBX21;PRELID1;HSPD1;SIT1;DUSP3;LGALS3;IL4I1;TNFSF9;TNFSF11;CCR2;CCL2;METTL3;SIRPA;TNFAIP8L2;CRTAM
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.34650289177928584,0.9873397917004678,0.48628884826325414,0.5609049753054576,1.0,8/16,44.15%,PDIA3;IFI30;TAP2;FCER1G;TAPBPL;HFE;SEC24D;CANX
gsea,response to insulin (GO:0032868),0.26821759228540726,0.9851204449623316,0.4688026981450253,0.564199041650028,1.0,17/44,44.61%,EIF6;GOT1;ZFP36L1;PKM;SELENOS;ZBED3;AKT1;SLC25A33;XBP1;RAB13;CAPN10;ENPP1;HDAC9;INSIG1;PARP1;PPARG;PIK3R1
gsea,secondary alcohol biosynthetic process (GO:1902653),0.34441443009003553,0.9830198075898273,0.4821092278719397,0.5672053544943784,1.0,13/21,38.96%,FDFT1;ACAT2;MSMO1;IDI1;FDPS;MVK;HSD17B7;DHCR7;IDI2;TM7SF2;PMVK;NSDHL;INSIG1
gsea,mRNA polyadenylation (GO:0006378),-0.342644728643531,-0.9825332969252751,0.48106904231625836,0.6129368060329118,1.0,8/15,33.05%,TENT4B;CDC73;SYMPK;PCF11;PABPC1;CSTF3;AHCYL1;CPSF1
gsea,RNA polyadenylation (GO:0043631),-0.342644728643531,-0.9825332969252751,0.48106904231625836,0.6129368060329118,1.0,8/15,33.05%,TENT4B;CDC73;SYMPK;PCF11;PABPC1;CSTF3;AHCYL1;CPSF1
gsea,cortical cytoskeleton organization (GO:0030865),0.3178384957230704,0.9812174708494406,0.482078853046595,0.5697388902547101,1.0,9/20,50.25%,EZR;RHOC;PLEK;RAB13;FMNL2;PPP2R3C;FMNL3;RHOBTB3;RND3
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.32104430279902657,-0.9810055569092772,0.4772727272727273,0.6145884574359856,1.0,10/19,32.49%,XPO1;PTK2B;TAF1;FBXW7;LATS1;UBQLN4;TRIM39;HIPK2;PML;CSNK2A2
gsea,endoplasmic reticulum organization (GO:0007029),0.2935797239142083,0.9808271311318216,0.4918300653594771,0.5697794126353796,1.0,14/33,43.09%,SERP1;REEP4;TMEM33;LMAN2;ZBED3;LMAN1;RTN3;GET4;APP;PRNP;REEP2;REEP6;CAV2;HMOX1
gsea,regulation of mitochondrion organization (GO:0010821),0.29481124489030014,0.9796653265409169,0.4835589941972921,0.5710723142937606,1.0,11/24,50.51%,VDAC1;PARL;HAX1;HTRA2;PISD;MGARP;PRMT6;PINK1;VPS35;PID1;OMA1
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),0.33545914744912786,0.9794681177839634,0.49008498583569404,0.5707443089468746,1.0,13/25,42.11%,ASS1;IFNG;AKT1;HSP90AB1;KLF2;TLR4;CD36;IL1B;ZC3H12A;PTGS2;SIRPA;EDN1;KLF4
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.2204301644360518,0.9780307623716726,0.4900990099009901,0.5727413689205383,1.0,39/70,51.10%,NMRAL1;HACD2;ASS1;GSTO1;NANP;CHPT1;ST3GAL4;GCH1;ALAS1;TYW5;GSTM1;HACD1;MGST2;MGST3;PLPP2;GSTK1;MFSD2A;SPHK1;GSTM5;GSTT1;HACD4;PLPP1;GSTZ1;PCTP;ALDH3B1;LCMT2;INHBA;GPHN;PLA2G4A;ELOVL2;ARG1;SLC25A2;LPCAT2;ACHE;FA2H;MGST1;TYW1;INHA;SGMS1
gsea,TOR signaling (GO:0031929),0.3177991026485046,0.9772878560265197,0.4877126654064272,0.5734041972258407,1.0,9/18,47.44%,TIPRL;EIF4EBP1;RPS6;AKT1;RHEBL1;PINK1;NPRL3;PRR5;MLST8
gsea,carboxylic acid transport (GO:0046942),-0.29139047331985585,-0.9764090680148403,0.5,0.6221085262977645,1.0,12/26,29.53%,SLC38A2;SLC7A1;SLC16A1;SLC16A6;SLC23A2;SLC7A5;SLC6A12;CLN3;SLC7A6;SLC38A6;SLC38A1;SLC1A4
gsea,regulation of smoothened signaling pathway (GO:0008589),0.30625050153001854,0.976013810688671,0.45611015490533563,0.5750175876362743,1.0,13/21,56.38%,RACK1;UCHL5;PDCL;TEDC1;RORA;KCTD21;IFT81;PTCH2;DLG5;WDR11;FUZ;TEDC2;GAS8
gsea,protein-containing complex disassembly (GO:0032984),0.3017584797567264,0.97542375253679,0.48134328358208955,0.5754400960942172,1.0,10/23,40.42%,VAMP8;HSPA8;CTNNB1;VAMP7;PYM1;MYC;DVL2;WNT1;VPS33A;FRAT2
gsea,positive regulation of cellular component organization (GO:0051130),0.2512558056208271,0.9745322326501711,0.5135135135135135,0.576381037398281,1.0,27/59,43.49%,BAX;RACK1;BAK1;IFNG;RHOC;GPX1;MTLN;CDC20;LMAN1;CDC42EP2;CDT1;LGALS3;PIH1D1;ADD1;PARK7;BID;PPP1R15A;AJUBA;SYK;BNIP3;VEGFA;DAB2;CAMK1;FLOT1;LRP1;BIK;TGFB2
gsea,response to peptide (GO:1901652),-0.29365199139648546,-0.9735941144291829,0.5064935064935064,0.6263660555867256,1.0,11/20,35.21%,STAT3;ERBIN;STAT6;STAT5B;EIF2B5;STAT5A;CACNA1A;STAT2;STAT1;EIF2B4;STAT4
gsea,mitotic spindle assembly (GO:0090307),-0.31254516121300796,-0.9735189842234124,0.49361702127659574,0.6249324650347913,1.0,16/31,35.11%,FLNA;CLASP1;CEP192;STAG1;TOGARAM1;CLASP2;KPNB1;PIBF1;MAP9;KIF3B;SMC1A;GOLGA2;KIF11;KIF2A;STAG2;CHEK2
gsea,mitotic sister chromatid segregation (GO:0000070),0.29645407316503464,0.9734367833483845,0.46601941747572817,0.5776133190926703,1.0,29/70,44.50%,RAN;CDK1;NUDC;SET;NUP62;SEH1L;ZWINT;CCNB1;CDC23;NCAPH;CDCA8;NUSAP1;KIF22;CENPK;NCAPG;PLK1;KNSTRN;SMC2;PINX1;SGO1;DSN1;KIFC1;TUBG1;NAA50;RRS1;CDCA5;KIF23;PSRC1;WRAP73
gsea,mitotic metaphase plate congression (GO:0007080),0.3141773437209848,0.9734079944638643,0.49007936507936506,0.5770039357708197,1.0,15/30,43.99%,NUDC;NUP62;SEH1L;CCNB1;CDC23;CDCA8;CDT1;KIF22;NUF2;PINX1;KIFC1;RRS1;CDCA5;PSRC1;RMDN1
gsea,sister chromatid segregation (GO:0000819),0.33629336305965774,0.9732411402580677,0.4774066797642436,0.5766451343111016,1.0,11/29,34.67%,RAN;ZWINT;CDCA8;NUSAP1;CENPK;PLK1;KNSTRN;SGO1;DSN1;KIFC1;TUBG1
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.27456790735538433,-0.9732282977540901,0.4958904109589041,0.6239698323358824,1.0,8/20,28.22%,NR4A3;ERN1;DNMT1;JUN;TGFB3;PDGFB;MFN2;MEF2C
gsea,snRNA processing (GO:0016180),-0.3395269557264853,-0.9719077081065544,0.4930966469428008,0.6250851116736127,1.0,7/15,40.59%,INTS1;INTS7;INTS6;INTS2;INTS6L;INTS9;INTS8
gsea,fat cell differentiation (GO:0045444),-0.2614709873326482,-0.9712617178915306,0.5170603674540682,0.624839985825812,1.0,27/27,88.47%,EP300;NR4A3;FOXO1;MED1;EGR2;ERAP1;PRDM16;SIRT1;CTBP2;CLIP3;MKKS;ATF5;FFAR4;PPARG;KLF4;SOX8;MAFB;TCF7L2;PID1;BBS4;METRNL;TMEM120B;TMEM120A;NR4A2;NR4A1;SDF4;CBY1
gsea,cation transport (GO:0006812),-0.24203247165468708,-0.9710617811945339,0.49429657794676807,0.6236484314188241,1.0,15/35,37.58%,SLC7A1;PIEZO1;KCNN4;ANO6;SLC12A2;ANO10;CLN3;SLC7A6;KCNJ10;SLC12A3;KCNC1;SLC39A1;ATP1B1;KCNK5;SLC41A1
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.26689162065749816,-0.9706930228212125,0.46304347826086956,0.6227821042803509,1.0,17/37,29.59%,VCP;MAN1B1;USP19;HSPA5;UBE4B;TRIM25;ECPAS;YOD1;UBE4A;STT3B;ERLIN2;FOXRED2;NPLOC4;SYVN1;FBXO44;SGTB;UBQLN1
gsea,calcium-mediated signaling (GO:0019722),-0.23310897525502,-0.9705560095644462,0.5533980582524272,0.6214600809675349,1.0,52/52,95.70%,PPP1R9B;ATP2A2;PTPRJ;EIF2AK3;PLCG1;MCTP2;PLCG2;ADGRL1;RCAN3;SLC9A1;NUDT4;PLA2G4B;CXCR4;PDPK1;KSR2;CAMKK2;TNNI3;CCR3;ATP1B1;CX3CR1;LRRK2;CXCR5;P2RX4;PPP3CB;SLC8A1;BTK;CCR5;PRKAA1;DMTN;EDNRB;EDN1;SELP;CCR9;CCR6;CCR4;CCR2;SPHK1;TNFSF11;MCU;VCAM1;PRNP;MCTP1;CCR1;CXCR3;CCR8;STIMATE;RCAN1;CCRL2;LAT2;CXCR6;CCR7;CCL3
gsea,microtubule polymerization (GO:0046785),-0.3265077091992349,-0.9701877238666382,0.4601366742596811,0.620659568941171,1.0,9/18,34.21%,CLASP1;TUBGCP4;CLASP2;TUBGCP6;CKAP5;TUBGCP3;GOLGA2;TUBGCP2;MAP7D3
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2629709068617258,-0.9699610344217438,0.5043103448275862,0.6195896319689912,1.0,20/35,32.89%,DCTN1;ANKFY1;CLTC;GCC2;STX16;DENND5A;RGP1;UBE2O;ERC1;TBC1D23;TMEM87A;RBSN;TBC1D5;SGSM2;HEATR5A;HEATR5B;BAIAP3;TBC1D10B;RAB7B;PIKFYVE
gsea,inorganic cation transmembrane transport (GO:0098662),-0.21063845375748844,-0.968376792749946,0.5240384615384616,0.6211426999396936,1.0,35/71,39.02%,ATP2A2;KCNN4;SLC39A14;ANO6;ATP2B4;SLC9A8;KCNAB2;ATP2A3;SLC30A4;SLC12A2;SLC9A1;KCNJ14;TRPC1;GAS6;CACNA1A;SLC4A8;SLC6A12;KCNJ10;ABCB7;SLC39A13;SLC12A3;ATP1A1;TRPV2;KCNC1;KCNK10;SLC39A3;SLC39A1;ATP1B1;OTOP1;SCN1B;KCNK5;SLC30A1;ABCB8;SLC41A1;MCOLN2
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.3536777476624669,0.9679548712123067,0.5087719298245614,0.5852457441536432,1.0,10/15,38.63%,IMPDH2;ADSL;GUCY1B1;PPCS;DCAKD;GMPS;ADCY6;IMPDH1;NPPC;AMPD2
gsea,lymphocyte proliferation (GO:0046651),0.34597875972848025,0.9677146234395183,0.5192878338278932,0.5850038447347463,1.0,8/16,33.58%,TNFRSF4;HSPD1;HELLS;CD70;CD40LG;IL10;TNFSF14;CD40
gsea,protein localization to chromosome (GO:0034502),0.3072055975682617,0.9648290240836478,0.518,0.5893562688927034,1.0,7/22,28.78%,CENPA;RPA2;MRNIP;PLK1;TERF2IP;PARP3;PINX1
gsea,fatty acid derivative biosynthetic process (GO:1901570),-0.29763198091755305,-0.9628663244700693,0.4856396866840731,0.6307485390149541,1.0,16/16,91.60%,FASN;ACACA;ACLY;GCDH;FAR1;CBR4;ALOX5;GGTA1;LTC4S;SLC25A1;AWAT2;AACS;ALOX5AP;BDH1;BDH2;PPT2
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2707359713534003,-0.9625239813910276,0.511400651465798,0.6299289240503386,1.0,27/27,93.64%,STAT3;PARP14;JAK2;IL6ST;CLCF1;PIBF1;CCL5;KIT;IL3;CSF1R;LYN;TNF;IGF1;IL23A;FLT3;CSF2;IL2;VEGFA;CD40;LIF;PARP9;IL21;TNFRSF1A;OSM;SOCS3;TNFRSF18;IFNG
gsea,regulation of interleukin-10 production (GO:0032653),0.3172947448087846,0.9602310015982138,0.49926144756277696,0.5968386332576716,1.0,13/25,46.34%,HMGB1;XCL1;PDCD1LG2;HSPD1;TNFSF4;CD40LG;TLR4;ISG15;SYK;FCGR2B;PRKCZ;IL23A;TNFRSF21
gsea,protein transport (GO:0015031),-0.19329712623506992,-0.9600369309268831,0.5414201183431953,0.6332334723326652,1.0,144/144,99.68%,MYH9;MACF1;GOLGA4;SPTBN1;CLTC;TBC1D8B;LMTK2;HERC2;TFRC;GCC2;TCIRG1;STX16;TBC1D13;CENPF;TBC1D22B;RAB3GAP2;MIA3;AP3D1;SEC31A;ARRDC4;TANGO6;OPTN;NDC1;TBCK;ATP6V0A2;DNAJC27;EVI5L;STX19;ARHGEF2;CALCRL;LMAN2L;RCN3;TBC1D5;ARFGAP3;TRIM23;SGSM2;AP3B1;KIF3B;TBC1D4;NSF;TBC1D8;USO1;HDAC6;RAB32;CTTN;TBC1D1;IL10RA;ARCN1;SEC23IP;CEP290;TBC1D25;TBC1D10B;RUFY1;APOE;SCAMP1;RAB23;MYO6;RAB34;ABCG1;COPG1;REP15;TBC1D14;ARRDC3;STXBP3;RPGR;STX17;SNX9;VPS45;STX2;RAB6B;COPA;COPZ2;TICAM2;RAB20;ARL5B;SNX27;PREPL;HSP90B1;USP6NL;WDR11;VPS33B;RAB3D;PICK1;SIL1;SCG5;TBC1D30;ATP6V1G3;TBC1D9;RAB5B;ABCA1;GGA3;GGA2;IFT22;CANX;RABGAP1;PPARG;SCFD2;UNC93B1;COG7;SNX13;PRKCB;COPG2;KIF3A;RAB38;VPS33A;LRP1;MIA2;NAPB;RAMP2;RAMP1;ATP6V0E2;VPS35;ARFIP2;SGSM3;CMTM6;ARL4C;GRTP1;CD74;HFE;TMED1;WLS;ARL11;CD36;STX11;RAMP3;AP4M1;VAMP5;TXNIP;RAB13;ARL5C;EVI5;RABL3;COPB2;EIF2D;ARL4D;IFT27;TVP23B;SCAMP4;PDIA4;ARL1;ADPRH;HIKESHI;NPM1;TMED2
gsea,protein lipidation (GO:0006497),0.2926766538689303,0.9595494813429545,0.5191956124314442,0.5973708838810898,1.0,11/27,34.99%,PIGF;ATG10;ZDHHC16;ZDHHC2;PGAP2;GLUL;ATG7;ZDHHC6;ZDHHC12;ZDHHC15;PIGH
gsea,negative regulation of cell cycle (GO:0045786),0.26506699833894004,0.9593188829483911,0.5092748735244519,0.5970626013854458,1.0,17/39,37.85%,MAD2L1;GMNN;DUSP1;HTRA2;CDK5RAP1;NR4A1;PLK1;MEN1;CAMK2N1;TFAP4;HHEX;IL10;PDCD4;NUDT6;NPPC;TRIM35;NUPR1
gsea,epithelial to mesenchymal transition (GO:0001837),0.2795079188155452,0.9590168255592554,0.5078809106830122,0.5968798863666896,1.0,11/23,52.81%,HNRNPAB;CTNNB1;S100A4;TRIM28;LEF1;ENG;FAM83D;LOXL2;TGFB2;WNT4;DLG5
gsea,positive regulation of DNA recombination (GO:0045911),-0.314019620961682,-0.9581280670642135,0.49272349272349275,0.6355643816057103,1.0,11/21,32.05%,RIF1;TFRC;ARID2;ACTR2;KMT5C;MMS19;KMT5B;PAXIP1;WRAP53;ERCC6;ZCWPW1
gsea,Rho protein signal transduction (GO:0007266),-0.2743580231513897,-0.9580794208752176,0.49295774647887325,0.6341145157978657,1.0,24/24,99.63%,MYO9B;ADGRG1;ARHGDIA;ROCK2;ROCK1;LIMK1;ARHGEF11;ARHGAP5;SHTN1;ARHGEF3;RHOB;EPS8L1;RIPOR1;CNKSR1;ADRA2A;ARHGDIG;CDC42EP1;PHACTR4;CDC42EP3;EPS8;CDC42EP2;RTKN;TAX1BP3;CFL1
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.32660193712385577,0.9575594125967578,0.5268505079825835,0.598687977552404,1.0,14/24,33.04%,PHB2;PHB;CD14;CD86;RELA;APP;PTP4A3;TERF2IP;TLR7;TLR4;PDCD4;IL1B;TNFSF14;SPHK1
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.25282797879156127,-0.9567515170797224,0.524390243902439,0.6351757969883512,1.0,41/41,99.09%,PICALM;SPTBN1;ITGA3;CLTC;PPFIA1;ATP2B4;ZDHHC5;ZDHHC8;ABI3;KIF5B;RHOQ;PTPN9;CLN3;PDPK1;AR;BCL2L1;PRKCE;ITGB1;CNPY4;AKAP5;SORBS1;NKD2;CLIP3;TNF;MMP14;PRKCI;PIK3R1;PID1;LRP1;PLS1;EPHA3;DAB2;RANGRF;RAMP3;LGALS3;TMBIM1;ZDHHC2;AKT1;IFNG;VAMP8;ACTB
gsea,mitotic chromosome condensation (GO:0007076),0.3489729658070568,0.9558703974292682,0.5,0.6009088750739903,1.0,8/22,23.16%,CDK1;SET;CCNB1;NCAPH;NUSAP1;NCAPG;PLK1;SMC2
gsea,regulation of JUN kinase activity (GO:0043506),-0.2957575758227685,-0.9555543600518676,0.5285087719298246,0.6359638376931983,1.0,12/19,40.96%,MAP3K5;HIPK3;MAP3K11;AIDA;MAP3K4;DVL3;ARHGEF5;MAP3K7;DAB2IP;PAK1;MAPK8IP1;TNF
gsea,ciliary basal body-plasma membrane docking (GO:0097711),-0.2561262114094196,-0.9551196810546588,0.5232323232323233,0.6353116542458568,1.0,35/67,42.11%,DYNC1H1;CEP250;CLASP1;DCTN1;CNTRL;AHI1;CEP192;ALMS1;CDK5RAP2;C2CD3;PCNT;CKAP5;CEP152;YWHAG;CEP162;DYNC1I2;PCM1;CEP97;CEP135;CEP164;HAUS3;SDCCAG8;CCP110;CEP83;CEP89;SCLT1;CEP290;RAB3IP;PRKAR2B;CEP76;ODF2;TTBK2;CSNK1E;KIF24;RPGRIP1L
gsea,oligosaccharide metabolic process (GO:0009311),-0.2952140905461624,-0.9540761524825907,0.5233415233415234,0.6358914242979973,1.0,10/20,34.49%,B4GALNT2;MAN1B1;ST8SIA4;ST6GALNAC3;ST3GAL3;FUT8;FUT7;MAN2C1;ST6GALNAC4;NAGA
gsea,regulation of protein metabolic process (GO:0051246),0.2939368012015501,0.9536754482909605,0.5307971014492754,0.6041950681033168,1.0,12/25,43.37%,ODC1;PARL;GSAP;HSP90AB1;ZDHHC2;KLF2;APP;FAM83D;VPS35;TMEM9;KLF4;PLAUR
gsea,negative regulation of hydrolase activity (GO:0051346),0.29026799895616484,0.9536378933147094,0.5375,0.6035573466956536,1.0,12/29,34.45%,TMED2;CST3;EGLN1;ARL2;PPP1R35;HRAS;URI1;LRCH1;NEIL1;RRP1B;SH3BP4;ECM1
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.32842825338880444,0.9530270493731157,0.5228758169934641,0.603978875897676,1.0,16/23,44.68%,RGCC;EZH2;CTNNB1;AXIN2;GLIPR2;GCNT2;IL1B;TWIST1;LEF1;BAMBI;WWTR1;DAB2;LOXL2;TCF7L2;TGFB2;COL1A1
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3107601660409195,-0.9521722992998952,0.51340206185567,0.6382002775706629,1.0,10/17,39.92%,CLASP1;TAOK1;DYRK1A;MAP2;CLASP2;CAMSAP1;ARHGEF2;CAMSAP2;TTBK2;CLIP3
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),0.33351924383064335,0.9509891978374616,0.5322896281800391,0.6068517494926348,1.0,8/16,40.90%,STMN1;FKBP4;SKA1;ARL2;SKA3;GAS2L1;GBA2;PRUNE1
gsea,response to interleukin-1 (GO:0070555),0.29356195872078267,0.949567371101654,0.5679012345679012,0.6087524366371512,1.0,22/39,37.16%,CCL3;XCL1;CCL4;ANXA1;CCL1;RELA;TAF9;APP;HYAL2;IRAK3;GBP3;CCL8;IL1B;CX3CL1;ZC3H12A;CCL25;CACTIN;CD40;CCL7;CCL2;SIRPA;ACOD1
gsea,positive regulation of synaptic transmission (GO:0050806),-0.2888755992048895,-0.9486207088543431,0.521865889212828,0.643665808907441,1.0,20/20,89.40%,PTK2B;CLSTN1;NLGN2;FMR1;EIF2AK4;BAIAP3;AKAP5;LGMN;TNF;ARC;PRKCZ;FLOT1;HAP1;CCL2;CCR2;ZDHHC12;PLK2;APP;ZDHHC2;KCTD13
gsea,regulation of nitric-oxide synthase activity (GO:0050999),0.31975115581854113,0.9482371822977761,0.5264847512038523,0.6103824158656799,1.0,7/20,37.69%,DHFR;AKT1;GCH1;SPR;S100A1;IL1B;SCARB1
gsea,acyl-CoA metabolic process (GO:0006637),0.30795335538479385,0.9480296889747876,0.5128205128205128,0.6100414253624226,1.0,9/15,51.89%,DBI;MCEE;OXSM;DLST;SUCLG2;ACSL6;ACOT4;ACSF2;ACOT1
gsea,positive regulation of MAPK cascade (GO:0043410),0.22534267195907326,0.947441383863956,0.5800756620428752,0.610405347046017,1.0,55/110,50.09%,MIF;PHB2;CCL3;HMGB1;XCL1;DUSP19;CCL4;PHB;CCR7;EZH2;SCIMP;MYDGF;CCL1;OSM;ICAM1;GSDME;PDGFA;GLIPR2;APP;HRAS;RAMP3;GPR183;CCR1;JCAD;CCL8;GCNT2;RET;CD36;CX3CL1;RYK;CCL25;CD74;LIF;TNFSF11;FGF2;CD40;GPR55;VEGFA;MFHAS1;CCL7;CCL2;PIK3R6;PRKCZ;EDN1;CAV2;NTRK3;FLT3;TGFB2;HTR2A;P2RY6;FFAR4;IGF1;CCL22;SLAMF1;ADRA2A
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.2911181651624027,0.9464101187970286,0.5376344086021505,0.6115913162843915,1.0,9/26,25.62%,HDGF;SERP1;PDIA6;DNAJB11;MYDGF;SRPRB;XBP1;ADD1;LMNA
gsea,inorganic anion transport (GO:0015698),-0.2689630814209578,-0.9462057495438863,0.5228915662650603,0.6467474614745082,1.0,7/21,25.64%,XPR1;ANO6;ANO8;CLCN6;FXYD1;ANO10;CLIC4
gsea,negative regulation of T cell activation (GO:0050868),0.29885219800216695,0.9452131573696456,0.5502471169686985,0.6130347579685631,1.0,9/24,36.24%,CEBPB;PDCD1LG2;CD86;DUSP3;LGALS3;IL4I1;IL10;FCGR2B;TNFAIP8L2
gsea,negative regulation of DNA recombination (GO:0045910),-0.28095465556628074,-0.9447263560381848,0.5270833333333333,0.6480989128052503,1.0,31/31,97.00%,ATRX;RIF1;RTEL1;POLQ;SMCHD1;POLR2A;UBQLN4;TERF2;BLM;MSH2;TINF2;MSH6;HELB;FANCB;ZRANB3;FBH1;SHLD2;CGAS;PARPBP;MSH3;DAXX;RMI2;POLR2B;PARP3;TERF2IP;POLR2F;SHLD1;POLR2E;POLR2L;POLR2H;POLR2C
gsea,membrane protein proteolysis (GO:0033619),-0.2926207952759623,-0.943223195915484,0.5347721822541966,0.6496515723003973,1.0,14/21,41.40%,MYH9;TMPRSS6;DAG1;NFKB1;AFG3L2;ADAM9;ADAM17;RHBDD1;ERAP1;CLPP;ADAM19;SPPL2B;RBMX;NAPSA
gsea,regulation of innate immune response (GO:0045088),0.264145271161295,0.9402316893599064,0.5485611510791367,0.6211070594646806,1.0,20/38,39.01%,PLSCR1;SAMHD1;LYAR;HSP90AB1;IFNAR2;TKFC;TRAFD1;IRAK3;SLC15A4;IRF1;PARP9;BIRC3;USP18;POLR3D;CACTIN;FCGR2B;ACOD1;APPL2;PTPN6;FGR
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),0.3103720856022705,0.9393729081648173,0.5611650485436893,0.6219107799004701,1.0,9/19,46.35%,NHP2;CPSF3;RPP30;RNASEH1;LACTB2;TOE1;ZC3H12A;RNASE6;ZC3H12D
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2655914112832874,0.9382656563221183,0.5747126436781609,0.6230972178336153,1.0,31/53,44.00%,HMGB1;GPR18;CCR7;CXCR6;CCRL2;F2RL3;F2RL2;CCL1;GNA15;TBXA2R;S1PR4;CCR8;CXCR3;CCR1;CD36;PTGER2;CXCL13;LPAR3;GRIN1;GPR55;CCR2;TRPM1;GLP1R;CCR4;CCR6;CCR9;C3AR1;EDN1;GPR174;CACNB3;CACNA2D1
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.24174273340808114,-0.9374015895149467,0.57,0.6595975222764056,1.0,17/33,39.14%,PPP1R9B;SLC39A14;ROCK2;ROCK1;RGS12;GRK5;RNF157;USP20;RIC8B;MGRN1;SAG;NMT2;CCL5;SYP;TULP3;FNTB;USP33
gsea,regulation of viral entry into host cell (GO:0046596),0.34127586290703993,0.9371266908072422,0.5356521739130434,0.6244148544426961,1.0,6/16,31.68%,LGALS1;LY6E;CIITA;NECTIN2;P4HB;CD74
gsea,mesenchymal cell differentiation (GO:0048762),0.281218261557059,0.9369032469390332,0.5502645502645502,0.6241411301542265,1.0,11/22,52.81%,HNRNPAB;CTNNB1;S100A4;TRIM28;LEF1;ENG;FAM83D;LOXL2;TGFB2;WNT4;DLG5
gsea,gland development (GO:0048732),0.2811352403319767,0.9361755017229437,0.5667189952904239,0.6247505816314435,1.0,14/25,50.24%,EZR;CITED2;ANXA1;FADD;GFER;XBP1;RIPK3;SIX3;WNT10A;DKK3;FOXE1;MET;WNT4;LSR
gsea,generation of neurons (GO:0048699),0.22460709607182983,0.935929141292018,0.5659574468085107,0.624460885047719,1.0,31/65,50.13%,PIN1;BHLHE40;DDIT4;HMGB2;CASP3;CTNNB1;TUBB2A;DOCK7;NIF3L1;RACGAP1;NR4A2;BHLHE41;IL1B;CX3CL1;RYK;NRCAM;SIX3;WNT10A;WNT1;PRUNE1;PLXNB2;INSM1;TGFB2;FZD3;WNT6;FZD7;MET;BHLHA15;WNT2B;WNT4;NAV1
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.24401623602925215,-0.9354420043131768,0.5420875420875421,0.6619858744999785,1.0,12/25,35.46%,SLC39A14;ATP2B4;SLC12A2;SLC9A1;SLC12A6;KCNJ14;KCNJ10;SLC12A3;ATP1A1;TRPV2;SLC39A10;ATP1B1
gsea,ncRNA metabolic process (GO:0034660),0.30241675859137057,0.934100808269674,0.5776515151515151,0.6269755009151422,1.0,7/19,26.83%,RAN;DTD1;PRKRA;NIFK;DTD2;TARBP2;PIWIL2
gsea,positive regulation of biomineral tissue development (GO:0070169),0.31081718583829576,0.9337147644447006,0.551617873651772,0.6268830214900145,1.0,5/17,27.71%,CEBPB;GPM6B;FBXO5;OSR2;ISG15
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.2806709461648149,0.9327566610300516,0.5606508875739645,0.6279576747185917,1.0,11/32,40.58%,SOD2;NONO;SET;PARK7;CX3CL1;RETREG1;GRN;PINK1;FOXQ1;CCL2;ZPR1
gsea,response to gamma radiation (GO:0010332),0.31536512767084757,0.9327554421510019,0.5313028764805414,0.6272585287195869,1.0,5/19,26.87%,TMEM109;CRYAB;MEN1;HRAS;MYC
gsea,protein K63-linked deubiquitination (GO:0070536),0.31083022377041086,0.932303391047587,0.5487077534791253,0.6273334374519346,1.0,6/17,49.67%,PSMD14;SHMT2;BRCC3;ABRAXAS1;ATXN3;STAMBPL1
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.21720572279676012,-0.9320468519331958,0.6073619631901841,0.667124698331117,1.0,68/68,98.42%,NCOR2;HDAC7;CREBBP;NR4A3;NOTCH1;TBL1XR1;MAZ;TAF1;GTF2A1;POLR2A;NOTCH2;MED1;NR3C1;GTF2F1;E2F3;KAT2B;TAF2;E2F2;MED23;MAML2;TAF4B;RARA;HDAC5;AR;RARG;NR5A2;TAF6;RORB;TBL1X;YAP1;TAF3;HDAC10;TAF5;ESRRA;PPARG;GTF2E1;MAML3;HDAC9;WWTR1;NR1H3;GTF2H1;NR2F6;MED7;ERCC2;RORA;THRB;POLR2B;GTF2H4;VDR;POLR2F;GTF2H2;NR2C2AP;RXRA;NR4A2;TAF15;TAF9;CDK7;ERCC3;NR4A1;GTF2F2;GTF2H3;POLR2E;POLR2L;TBP;POLR2H;GTF2E2;POLR2C;HDAC1
gsea,regulation of JNK cascade (GO:0046328),-0.2328181749349351,-0.9303606848308121,0.5842391304347826,0.6688924898029667,1.0,52/52,95.09%,TAOK2;TAOK1;PTK2B;MAP3K5;TRAF3;RASGRP1;MAP3K11;MINK1;AIDA;TRAF1;RIPK1;HIPK2;PER1;NCF1;SH3RF1;PHLPP1;MTURN;TGFBR3;F2RL1;DAB2IP;UNC5CL;RASSF2;MAP4K4;MAPK8IP1;FKTN;AXIN1;SLAMF1;FZD7;LTBR;TRAF5;SIRPA;FCGR2B;TRAF2;MFHAS1;PINK1;GADD45G;GADD45A;IL1B;RAP2A;HRAS;PJA2;MEN1;APP;TRAF4;DUSP3;DUSP10;COPS5;GADD45B;DUSP22;CCR7;DUSP19;HMGB1
gsea,negative regulation of MAP kinase activity (GO:0043407),0.3042579165454483,0.9297835174056924,0.5672268907563025,0.6310050042971307,1.0,13/28,35.36%,DNAJA1;DUSP19;DUSP1;DUSP10;RGS2;DUSP7;HYAL2;IRAK3;PDCD4;IL1B;CD300A;SPRY4;SPRY1
gsea,negative regulation of response to external stimulus (GO:0032102),0.2604760878300852,0.9295959552383614,0.601572739187418,0.630646266853249,1.0,27/47,42.99%,C1QBP;LYAR;SELENOS;KLK8;DUSP3;TNFRSF1A;TRAFD1;MVK;NLRP3;IL10;SMPDL3B;IRAK3;RORA;CACTIN;FGF2;NR1H3;VPS35;MFHAS1;METRNL;SIRPA;TNFAIP8L2;ACOD1;GHSR;INPP5F;TRAF3IP1;KLF4;PPARG
gsea,skin development (GO:0043588),-0.24339306377786235,-0.9292997020285211,0.5650224215246636,0.669452177229107,1.0,31/31,98.11%,SFN;DHCR24;ITGA3;BCR;MED1;ADAM9;CLIC4;DLL1;ABCB6;ITGB4;DSP;ITGA6;KDF1;ERRFI1;RYR1;LSR;FA2H;MET;COL1A1;SPRR1A;EVPL;ASCL4;COL5A3;WNT10A;ST14;TXNIP;KRT10;PDGFA;ANXA1;CASP3;STMN1
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.2027310895445218,-0.9285097316963857,0.6238532110091743,0.6693930490597411,1.0,49/49,96.85%,RPS6KA3;EXOC4;NLGN2;MINK1;LRP6;PMP22;SLC12A6;HOMER1;NPY;UNC13B;CACNA1A;PRKAR2A;CHRNE;SPG11;DLG2;PRKAR2B;AKAP5;CAMKK2;MBP;SYN1;MYCBPAP;DRD4;HTR7;KCNMB1;GLRA1;NPTX1;HTR2A;SLC12A7;PDE7B;GABRB1;CACNA1B;CACNB3;SLC1A2;ATXN3;SLC12A5;SLC12A4;APBA3;KCNQ3;PNOC;CAMK1;HAP1;GRIN1;LPAR3;GABRR1;RAPSN;KCNMB4;PENK;GIPC1;NRGN
gsea,negative regulation of neuron death (GO:1901215),-0.23989616520827967,-0.9284358330026373,0.5817174515235457,0.6679574491703737,1.0,27/43,41.05%,PTK2B;ATP13A2;ATF4;RASA1;KDM2B;EIF4G1;CLCF1;GSK3B;TGFB3;F2R;KIF14;CLN3;ADAM8;NDNF;MEF2C;BCL2;APOE;GPNMB;CSF1;REST;MSH2;LGMN;MT3;LRRK2;LIG4;IKBKG;CD200R1
gsea,neuron projection extension (GO:1990138),-0.28657193018813315,-0.9283063777386328,0.5501113585746102,0.6666304764112178,1.0,10/20,38.19%,USP9X;ULK2;NRP1;IMPACT;CYFIP1;ULK1;EIF2AK4;SPG11;CDKL3;TMEM108
gsea,negative regulation of mRNA catabolic process (GO:1902373),0.3223678229541264,0.9282404766029402,0.5614035087719298,0.6323410256645435,1.0,7/17,23.31%,YBX1;FUS;TENT5A;E2F1;AXIN2;TAF15;THRAP3
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.21991001197061716,-0.9280834433089159,0.5945945945945946,0.665475875367551,1.0,65/65,99.12%,STAT3;DICER1;SPN;NLRC3;PTPRJ;RASGRP1;DHX9;TNFAIP3;JAK2;PLCG2;TMEM106A;VSIR;LTF;SYT11;ARFGEF2;RIPK1;PTPN11;ARHGEF2;MAPKAPK2;RARA;GAS6;DDX58;TYROBP;MC1R;LPL;HAVCR2;IL33;CX3CR1;SPHK2;C1QTNF4;IFIH1;MAVS;SLAMF1;IGF1;CIDEA;TLR2;THBS1;IL23A;PF4;FOXP1;PTPN6;GHSR;SIRPA;CCR2;CACTIN;ZC3H12A;SYK;OAS3;CX3CL1;TWIST1;IRAK3;TLR4;CD33;IL10;APP;HSPB1;FADD;ZFP36;CD14;SELENOS;FRMD8;IFNG;HMGB1;CCL3;MIF
gsea,protein localization to lysosome (GO:0061462),-0.30883718782414615,-0.9279812215715981,0.5523385300668151,0.6640984946446359,1.0,15/15,93.34%,NEDD4;ATP13A2;GCC2;ZFYVE16;HGS;RNF128;SNX16;GGA3;NAGPA;SH3BP4;CD81;AP4M1;NCOA4;AP3M1;M6PR
gsea,cilium organization (GO:0044782),-0.20324028830362115,-0.9269138476983126,0.5876777251184834,0.6647140621195902,1.0,46/92,41.92%,FLNA;CEP250;NOTCH1;EXOC4;AHI1;ACTR2;CDC14A;PCNT;DYNC2H1;CPLANE1;CEP162;RTTN;PTPN23;PIBF1;PCM1;ABCC4;WDR90;EXOC2;CCNO;EXOC8;CEP164;CCDC66;CCP110;ASAP1;KIF3B;HDAC6;CEP83;CEP89;SCLT1;CEP290;RAB3IP;NEK1;RAB23;SSX2IP;IFT80;GSN;EHD2;ODF2;MNS1;TTBK2;KIF24;RPGR;IQCG;SNX10;MKKS;ARL13B
gsea,mRNA splice site selection (GO:0006376),-0.31009651120592674,-0.9260496786535767,0.5321637426900585,0.6648162458785237,1.0,9/17,38.68%,CELF4;SETX;SFSWAP;PRPF39;SRSF1;CELF2;CELF1;LUC7L3;LUC7L
gsea,regulation of secretion by cell (GO:1903530),0.319326016979833,0.9247753548169612,0.5738161559888579,0.6376440119078036,1.0,8/20,36.27%,VAMP8;ANXA1;RALA;KCNMB4;RAB13;MCTP1;P3H1;HAP1
gsea,negative regulation of transferase activity (GO:0051348),0.3136945840110315,0.9242399474640771,0.5703125,0.6378845414803501,1.0,7/16,28.78%,PRDX3;ZFP36;BAG5;FBXO5;MEN1;PARK7;PINX1
gsea,response to cytokine (GO:0034097),0.2271687095559747,0.9240252081263058,0.578125,0.6375542558004621,1.0,37/84,51.32%,DDOST;PLSCR1;BST2;SHMT2;CASP3;CCR7;ANXA1;HAX1;SP100;IFNAR2;GCH1;RELA;CASP1;TAF9;APP;NUB1;CIITA;IRAK3;ISG15;IL1B;CD74;LEF1;SPHK1;CD40;MAPKAPK3;CXCL16;SLC11A1;TIMP1;PTPN6;XAF1;SELP;PID1;FLT3;KYNU;RELB;MEFV;LIFR
gsea,cellular response to glucose starvation (GO:0042149),-0.2669342443894718,-0.9239531717789392,0.5536842105263158,0.6673445643811818,1.0,14/26,38.17%,MTMR3;EIF2AK3;ATF4;HSPA5;SIK2;IMPACT;FOXO3;TBL2;ITFG2;MYBBP1A;RRP8;SESN1;SESN3;PMAIP1
gsea,response to ionizing radiation (GO:0010212),0.24940988476064496,0.9230466386261656,0.5731958762886598,0.6385559364616437,1.0,19/51,48.89%,EEF1D;ANXA1;RAD51;BRCC3;MRNIP;RHNO1;RAD1;ABRAXAS1;MTA1;FIGNL1;MEN1;IKBIP;MYC;GADD45A;RAD51AP1;INTS3;HUS1;PRKAA1;ATM
gsea,positive regulation of developmental process (GO:0051094),0.22706626355422724,0.9219546106148745,0.603448275862069,0.639672154628488,1.0,34/73,52.81%,CFL1;C1QBP;CEBPB;PA2G4;RALA;CDC20;ZBED3;HSP90AB1;KRT10;SHLD1;LLPH;XBP1;FBXO5;LMNA;ZDHHC6;MCU;ZBTB16;AURKA;PINK1;ZDHHC15;VIL1;BNIP3;VPS35;VEGFA;DVL2;CAMK1;PACSIN1;SOX8;INSM1;PHLDB2;SHANK1;ENPP2;SLC6A6;DLG5
gsea,regulation of double-strand break repair (GO:2000779),-0.2769243143259496,-0.9217270816042674,0.6022471910112359,0.6701278152661909,1.0,28/28,94.81%,UBR5;SETD2;RTEL1;ACTR2;FOXM1;SLF2;SLF1;SIRT6;WRAP53;PML;ZCWPW1;SPIDR;DDX11;SPIRE1;SHLD2;PPP4R2;CHEK1;DEK;RAD51AP1;TWIST1;SPIRE2;TERF2IP;TIMELESS;MGMT;FIGNL1;MRNIP;RAD51;RPA2
gsea,response to estrogen (GO:0043627),-0.30659755578796916,-0.9214629473011888,0.5676229508196722,0.6690698102413094,1.0,13/17,33.27%,KMT2D;EP300;BCAS3;BRCA1;TRIM25;TRIM24;RARA;RBBP5;AR;CITED4;PELP1;GATA3;ARID5A
gsea,negative regulation of Ras protein signal transduction (GO:0046580),-0.25178621687104613,-0.9207424753763996,0.5666666666666667,0.6689802302131471,1.0,22/22,98.11%,ITGA3;ARHGAP35;SCAI;CUL3;SPRY2;MFN2;STAMBP;DAB2IP;RASIP1;ARHGAP24;DLC1;SYNGAP1;RIPOR2;HEG1;MET;TGFB2;SPRY1;SPRY4;CCDC125;TNFAIP1;KCTD13;STMN1
gsea,negative regulation of protein secretion (GO:0050709),-0.28895668090298965,-0.9195973078733465,0.5857740585774058,0.6696777827657272,1.0,16/16,71.17%,F2R;RHBDF1;APOE;RHBDF2;REST;RAB11FIP1;HMGCR;CD200;RSAD2;DRD4;ADRA2A;MIDN;NR1H3;CHGA;SIRT4;IL1B
gsea,sulfur compound biosynthetic process (GO:0044272),0.25054663053981463,0.9169214171221184,0.5955414012738853,0.6477747888511456,1.0,26/43,49.31%,GSTO1;SLC35D2;GGCT;ST3GAL4;B4GALT4;ST3GAL6;B4GAT1;CHAC1;CHAC2;GSS;GSTM1;MGST2;B3GNT3;MAT2A;MGST3;GSTK1;GSTM5;GSTT1;CBS;GSTZ1;LIAS;CSGALNACT2;CHSY3;CTH;VCAN;MGST1
gsea,positive regulation of interleukin-2 production (GO:0032743),-0.2990165698102063,-0.9168686280201537,0.5597189695550351,0.6733663041064084,1.0,9/18,32.94%,SPTBN1;MALT1;PLCG2;CARD11;PRKD2;CD80;CD4;MAP3K7;RUNX1
gsea,regulation of protein autophosphorylation (GO:0031952),0.3101013177149022,0.9165473434068986,0.5612788632326821,0.6477391605563579,1.0,7/19,39.33%,CALM2;PDGFA;RAP2A;ENG;ENPP1;VEGFA;NBN
gsea,cilium assembly (GO:0060271),0.20403626441631034,0.9162340002139009,0.6206896551724138,0.6476105168739588,1.0,62/145,45.74%,TUBA1A;TUBB4B;CDK1;E2F4;YWHAE;TMEM107;RILPL2;TUBA4A;HAUS1;HAUS4;HSPB11;IFT57;TMEM138;TMEM80;IFT27;HAUS8;CFAP298;KIFAP3;PDE6D;LZTFL1;DYNLL2;RP2;TTC39C;EHD4;SPATA6;PLK1;CEP19;TMEM237;SPAG16;NDE1;HAUS2;EHD3;POC1B;NEK2;TMEM216;CEP41;TTC21B;B9D1;ACTR1A;CCDC40;HAUS6;CEP78;TCTN3;PTPDC1;TUBG1;CLUAP1;BBS4;CCDC28B;IQCB1;IFT81;IFT43;TRAF3IP1;KIF3A;HAUS7;IFT74;IFT88;CEP72;FNBP1L;NEDD1;LRGUK;IFT22;KIF27
gsea,negative regulation of cell motility (GO:2000146),0.2511532145033438,0.9147931274064843,0.6017699115044248,0.6494716835965353,1.0,19/48,42.87%,MIF;PIN1;BST2;CITED2;GTPBP4;DUSP22;DUSP10;DUSP3;TPM1;MCTP1;RAP2A;CX3CL1;SINHCAF;CD74;ENG;CCDC125;RAP2B;ACVRL1;TCAF1
gsea,cellular response to hormone stimulus (GO:0032870),-0.24382367596308577,-0.9134834395314223,0.6338461538461538,0.6782832964115038,1.0,39/39,97.94%,STAT3;NCOA1;NR4A3;NCOA3;BCAS3;BRD8;MED1;NR3C1;STAT5B;NCOA2;TRIM24;RARA;AR;MEF2C;ATP1A1;PELP1;ARID5A;SOCS2;RDX;KLF9;ADRA2A;ATP1A2;RAMP2;ATP1A3;RAMP1;GAS2L1;LMO2;MGARP;THRB;CTSH;URI1;RAMP3;XBP1;NCOA4;CTSL;TFPI;CTSS;ZFP36L1;SERPINB9
gsea,extracellular matrix organization (GO:0030198),-0.18636797159988105,-0.9132900262230347,0.6692307692307692,0.6771139363907444,1.0,105/105,98.71%,PLEC;ITGAM;TMPRSS6;ITGA4;ADAMTS14;ITGB3;ITGA3;JAM2;NF1;LAMC1;CDH1;ITGB8;COL6A3;DAG1;CAPN2;NID1;PDGFB;EXOC8;P4HA1;GAS6;ITGA1;ADAM8;NDNF;SPOCK2;SPP1;ITGB4;CD44;ITGB1;NPNT;PRSS2;SERPINE1;PLOD2;GSN;ITGA6;CD151;FURIN;LCP1;MADCAM1;ADAMTS6;PLOD1;COLGALT1;PLOD3;TIMP2;COL16A1;ADAM19;ITGA5;ITGAE;TGFBI;APLP1;MMP14;SH3PXD2B;ITGB7;SPARC;COL17A1;COL4A4;MMP24;FBLN5;MATN1;VCAN;ITGA10;COL7A1;CTSK;ITGA7;THBS1;COL1A1;DST;TGFB2;SERPINH1;ADAMTS20;LOXL4;COL12A1;LOXL2;MMP9;CREB3L1;P4HA2;COL11A1;FN1;TIMP1;FLOT1;CTSG;PECAM1;P3H1;GFOD2;ST7;COL5A3;FGF2;P3H2;COL27A1;SH3PXD2A;P4HB;VCAM1;SMOC1;APP;COLQ;CTSL;PDGFA;ICAM1;CRTAP;ITGAX;LAMC2;GPM6B;ICAM2;CTSS;BSG;CAPG
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2840049224971516,0.9130710552185511,0.55637707948244,0.6518249788177266,1.0,13/32,42.77%,ALYREF;TIPIN;RAD51;DONSON;MMS22L;TRAIP;TIMELESS;PCNA;POLD1;EME1;THOC1;TONSL;CENPS
gsea,negative regulation of ERBB signaling pathway (GO:1901185),-0.2733333439403529,-0.9128146826572195,0.6163069544364509,0.6764404513711472,1.0,8/22,36.79%,CBL;PTPRJ;SPRY2;HGS;ITGA1;DAB2IP;STAM2;LGMN
gsea,endoderm formation (GO:0001706),0.341067019093065,0.9125587603895178,0.587467362924282,0.652007256933552,1.0,11/16,46.26%,DUSP5;DUSP1;DUSP2;DUSP4;FN1;COL11A1;MMP9;COL12A1;INHBA;ITGA7;COL7A1
gsea,heart looping (GO:0001947),0.312101662988304,0.9121089706053883,0.5833333333333334,0.6513972683081781,1.0,15/15,96.42%,TBX21;CCDC40;ENG;BBS4;TBX2;MKKS;SRF;SETDB2;STIL;MEF2C;EOMES;DLL1;MICAL2;AHI1;NOTCH1
gsea,determination of heart left/right asymmetry (GO:0061371),0.312101662988304,0.9121089706053883,0.5833333333333334,0.6513972683081781,1.0,15/15,96.42%,TBX21;CCDC40;ENG;BBS4;TBX2;MKKS;SRF;SETDB2;STIL;MEF2C;EOMES;DLL1;MICAL2;AHI1;NOTCH1
gsea,cellular response to lipid (GO:0071396),0.23852440752498766,0.9113795387068785,0.6242496998799519,0.6519347421470248,1.0,52/100,40.86%,VIM;HMGB1;PDCD1LG2;HMGB2;TESC;SELENOS;CD14;NFKBIB;HTRA2;CD68;TFPI;PLAA;ZFP36;CD86;TNFSF4;RELA;CASP1;NCOA4;XBP1;RUVBL2;CCDC62;CXCL10;RAMP3;URI1;NLRP3;IL10;TLR4;PDCD4;RET;MAP4K1;IL1B;MGARP;CXCL13;RORA;ZC3H12A;GFI1;ADCY6;CACTIN;NR1H3;ATP1A3;CCL2;CTSG;SIRPA;AXL;EPHA3;ACOD1;ATP1A2;INSIG1;CD180;CXCL2;PID1;PF4
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3185758175689545,0.9109897579826469,0.5911764705882353,0.6518827189343115,1.0,10/18,44.94%,RGCC;HMGB1;TBXA2R;GADD45A;FGF2;DLL4;ACVRL1;KLF4;PPARG;THBS1
gsea,potassium ion transmembrane transport (GO:0071805),-0.23118720720782845,-0.9097239934976046,0.631578947368421,0.6808085290294484,1.0,15/31,37.35%,KCNN4;SLC9A8;KCNAB2;SLC12A2;SLC9A1;SLC12A6;KCNJ14;KCNJ10;SLC12A3;ATP1A1;KCNC1;KCNK10;ATP1B1;KCNK5;ABCB8
gsea,aminoglycan biosynthetic process (GO:0006023),0.3379536374220626,0.9096504793963645,0.5893129770992367,0.6534104975743508,1.0,6/15,35.66%,SLC35D2;B4GAT1;B3GNT3;GCNT2;PXYLP1;GPC1
gsea,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.2907286553637801,-0.9071378535016189,0.5994962216624685,0.684218005471485,1.0,7/16,35.20%,PTK2B;WDR81;AMBRA1;PDGFB;KIT;DAB2IP;FLT1
gsea,glycoprotein biosynthetic process (GO:0009101),0.25634964602485066,0.9060870263556189,0.6097972972972973,0.6589338228187952,1.0,18/36,51.80%,DDOST;SERP1;ST3GAL4;SERP2;ST3GAL6;ALG3;ST8SIA1;B3GNT3;ST3GAL5;GCNT2;MPI;COG7;CSGALNACT2;B3GALT6;B3GALNT2;IGF1;B3GALT4;B3GNT5
gsea,glial cell development (GO:0021782),-0.2946841163899556,-0.903176625190901,0.5594936708860759,0.6902747580532211,1.0,7/15,29.58%,CDK6;NF1;SOX10;EIF2B5;SOX4;DLL1;EIF2B4
gsea,positive regulation of interleukin-10 production (GO:0032733),0.32262896758204584,0.9027708818066524,0.5881458966565349,0.6640028812429731,1.0,8/17,31.01%,HMGB1;XCL1;HSPD1;TNFSF4;CD40LG;TLR4;ISG15;SYK
gsea,negative regulation of immune response (GO:0050777),-0.21108424946767312,-0.901917405516374,0.6858407079646017,0.6911641248539817,1.0,58/58,98.90%,MYH9;CALCA;NLRC3;TNFAIP3;PLCG1;PLCG2;ADRB1;CREB1;CALCRL;PRKAR2A;VIPR2;ADORA2B;ADAM17;SPI1;MC1R;DHX58;PRKAR2B;HAVCR2;RHBDF2;FURIN;LYN;TRIM21;ADRB2;FOXP3;CYSLTR2;PTGER4;GPR83;PTH1R;SCT;HTR7;CYSLTR1;TSHR;CALCB;TRAF3IP1;FGR;ACOD1;GLP1R;FCGR2B;RAMP2;RAMP1;CCR2;CACTIN;RLN3;ADCY6;SYK;ADM;HCK;CD300A;PTGER2;IRAK3;IL10;PLK2;RAMP3;TRAFD1;LGALS3;ADORA2A;LYAR;C1QBP
gsea,positive regulation of interleukin-1 production (GO:0032732),0.31972846735223703,0.9011204597653264,0.6107784431137725,0.6661115344909325,1.0,10/21,28.60%,CCL3;HMGB1;IFNG;CASP1;RIPK2;HSPB1;APP;NLRP3;TLR4;CD36
gsea,renal system development (GO:0072001),0.3067775379433413,0.9006969332145627,0.5993377483443708,0.6661447088369843,1.0,7/15,43.49%,HSPB11;IFT27;HYAL2;VEGFA;TRAF3IP1;IFT88;TGFB2
gsea,neurotransmitter transport (GO:0006836),-0.2616377672687898,-0.9006392221309659,0.6171003717472119,0.6920607651127667,1.0,24/24,93.00%,SLC38A2;GLS;PPFIA1;UNC13B;SLC17A8;DVL1;SLC38A1;PPFIA3;SYNJ1;NAAA;STXBP3;SYN1;SLC17A6;GLS2;SLC1A2;PPFIA4;ATP1A2;LIN7A;UNC13A;SLC32A1;GLUL;SLC29A1;HSPA8;PDZD11
gsea,positive regulation of DNA metabolic process (GO:0051054),0.254776683620825,0.9005871275707749,0.6061185468451242,0.6656368010035,1.0,13/39,39.33%,UBE2N;RGCC;HMGB1;RAD51;BRCC3;ABRAXAS1;TRIM28;TIGAR;PARP3;MYC;FGF2;PCNA;NBN
gsea,positive regulation of response to biotic stimulus (GO:0002833),-0.2727843360428206,-0.8940562919142282,0.6410256410256411,0.7031234817767241,1.0,13/22,35.16%,ANKRD17;PUM2;DHX9;PRKCA;AKIRIN2;USP15;POLR3F;ADAM8;CCL5;DDX60;DHX58;GBP5;POLR3B
gsea,negative regulation of endothelial cell migration (GO:0010596),0.3138486918766621,0.8936235988820593,0.6251768033946252,0.677255729226433,1.0,11/19,44.94%,RGCC;HMGB1;SP100;DNAJA4;GADD45A;PTPRM;FGF2;DLL4;ACVRL1;PPARG;THBS1
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.23503582931248293,-0.8913053856035372,0.6447761194029851,0.7066430814551136,1.0,32/32,95.98%,STAT3;PARP14;JAK2;IL6ST;NF2;CLCF1;PIBF1;IL22RA2;CCL5;KIT;SH2B3;IL3;CSF1R;LYN;TNF;IGF1;IL23A;FLT3;INPP5F;CSF2;IL2;VEGFA;CD40;LIF;PARP9;IL21;TNFRSF1A;OSM;SOCS3;TNFRSF18;IFNG;SOCS1
gsea,gonad development (GO:0008406),0.2821232458816352,0.8904285263289006,0.6252072968490879,0.6819074936597708,1.0,9/16,49.29%,UTF1;NCOA4;SOX8;INHBA;BIK;TGFB2;WNT2B;SOX15;WNT4
gsea,regulation of T cell proliferation (GO:0042129),0.2623447512874954,0.8902277415163333,0.6362339514978602,0.6814985091254404,1.0,16/36,30.36%,CEBPB;PDCD1LG2;ANXA1;CD86;NCK2;TNFSF4;LGALS3;IL21;IL4I1;CD70;CD40LG;IL10;RIPK3;VCAM1;IL1B;TNFSF9
gsea,regulation of organelle organization (GO:0033043),0.2554908554940518,0.8852818996737787,0.6460767946577629,0.6893087043950259,1.0,13/34,34.11%,ARL6IP1;EZR;PARL;TMEM33;CENPV;LMAN1;CDT1;PISD;EHD3;NEXN;PRMT6;PINK1;VPS35
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.30416112871709344,-0.8846033180785539,0.5711252653927813,0.7177767980135743,1.0,11/22,35.56%,TAOK2;TAOK1;TOPBP1;FOXN3;BRCA1;FZR1;TRIM39;DTL;BLM;TICRR;CLSPN
gsea,lymphocyte differentiation (GO:0030098),0.2471864648144496,0.8830284685683203,0.6585034013605442,0.6925931429952307,1.0,21/42,47.94%,SLC25A5;RABL3;TCF3;HHEX;IL10;VCAM1;KLF6;DLL4;AXL;IL2;HDAC9;NFIL3;DCAF1;CD79A;NFAM1;FLT3;LYL1;BLNK;LY6D;RELB;TPD52
gsea,hexose metabolic process (GO:0019318),0.3046318542857264,0.8824947749551287,0.6407407407407407,0.6927270457149056,1.0,7/18,50.51%,ALDOA;GALK1;SLC37A4;PGM1;ALDOC;FUOM;OMA1
gsea,establishment of mitotic spindle localization (GO:0040001),-0.3099256275522516,-0.88220425933242,0.5804347826086956,0.7208213153979136,1.0,22/22,98.20%,HTT;CLASP1;DCTN1;NUMA1;CLASP2;CDK5RAP2;KPNB1;GPSM2;ESPL1;SPDL1;ITGB1;INSC;ZW10;NDC80;SAPCD2;NDE1;PLK1;NUSAP1;UBXN2B;NSFL1C;MAD2L1;CENPA
gsea,positive regulation of p38MAPK cascade (GO:1900745),0.3271013455194077,0.8819593226797868,0.6121495327102804,0.692894217337591,1.0,11/16,34.83%,PRMT1;GADD45B;PJA2;IL1B;GADD45A;GADD45G;ZC3H12A;SPHK1;VEGFA;RELL1;MFHAS1
gsea,cellular response to peptide hormone stimulus (GO:0071375),-0.2218140966208169,-0.8792184758139604,0.6587301587301587,0.7249695311189216,1.0,49/49,95.12%,MYO5A;NR4A3;SLC39A14;LPIN2;PRKDC;IRS2;DENND4C;FOXO1;C2CD5;KAT2B;CEACAM1;PDE3B;NFKB1;RHOQ;PRKAR2A;HDAC5;PDPK1;TBC1D4;CPEB2;LPIN1;PRKAR2B;TRIB3;SORBS1;OTOP1;PIK3R2;PRKCI;CYSLTR2;PCK2;PIK3R1;PPARG;TSHR;PARP1;INSIG1;HDAC9;ENPP1;ADCY6;MGARP;CAPN10;RAB13;NR4A2;XBP1;SLC25A33;NR4A1;RELA;AKT1;SELENOS;PKM;ZFP36L1;GOT1
gsea,embryonic heart tube morphogenesis (GO:0003143),0.29895329086288264,0.8791145411113802,0.6176991150442478,0.6970584838109928,1.0,16/16,96.42%,TBX21;CCDC40;ENG;BBS4;TBX2;MKKS;SRF;SETDB2;STIL;MEF2C;EOMES;DLL1;ACVR1;MICAL2;AHI1;NOTCH1
gsea,potassium ion transport (GO:0006813),-0.22797125599344348,-0.8784887507933193,0.6653696498054474,0.724701413586886,1.0,10/23,37.35%,KCNN4;SLC9A8;KCNAB2;SLC9A1;KCNJ14;KCNJ10;KCNC1;KCNK10;KCNK5;ABCB8
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.30799350912437584,-0.8766633796880818,0.6101010101010101,0.7265536020321637,1.0,11/16,38.47%,TENT4B;NAT10;SLX4;GNL3L;TERF2;CTC1;XRN1;ERCC4;HNRNPU;PIF1;TINF2
gsea,regulation of protein tyrosine kinase activity (GO:0061097),-0.27851838375333904,-0.8765562729981768,0.6179775280898876,0.7251733220581322,1.0,7/15,34.66%,NEDD9;LRP8;RAP2C;PDGFB;GAS6;SH3BP5;CSF1R
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.2607430216044664,-0.8758427848298281,0.6716867469879518,0.7248530952729598,1.0,22/22,92.51%,PIK3CA;NOTCH1;ERN1;NRP1;PRKD2;SPRY2;MAPKAPK2;DAB2IP;NUS1;FLT1;PGF;RAMP2;VEGFA;DLL4;SPHK1;EGR3;VEGFB;HSPB1;NR4A1;RELA;MAP2K3;ANXA1
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.24571355104516585,-0.8731529729847536,0.64,0.7282333965486435,1.0,12/28,29.91%,MADD;HIPK1;TNFAIP3;BIRC2;TRAF1;RIPK1;GAS6;SPATA2;ADAM17;HSPA1A;CHUK;F2RL1
gsea,skeletal system development (GO:0001501),0.2554708603086183,0.8728222710251027,0.6734955185659411,0.7071646463263404,1.0,21/40,56.85%,PRDX1;VKORC1;HYAL2;WWOX;DYM;ZBTB16;TGM2;HAPLN4;P3H1;ALPL;WNT1;TCOF1;TGFB2;COL1A1;VCAN;IGF1;PTH1R;INHA;PTGER4;SH3PXD2B;MMP14
gsea,icosanoid metabolic process (GO:0006690),0.3208486309299693,0.8725581589510302,0.6707988980716253,0.7068701586354642,1.0,9/16,46.92%,GPX1;EPHX1;PON3;ALOX5AP;PTGS2;CYP2S1;PNPLA8;PLA2G4A;LTC4S
gsea,positive regulation of T cell activation (GO:0050870),-0.23798767173411892,-0.8697570805658049,0.6410256410256411,0.7328701387096799,1.0,33/33,94.37%,CCDC88B;DOCK8;SLC7A1;TFRC;IL6ST;ZMIZ1;CD80;AIF1;ZBTB1;CCL5;CD274;GATA3;FLOT2;IL23A;TNFRSF13C;SIRPA;CCL2;CCR2;TNFSF11;CD81;IL1B;VCAM1;CD40LG;CD70;XBP1;IL21;TNFSF4;NCK2;CD86;HSPD1;ANXA1;CCR7;PDCD1LG2
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.2586322190308725,-0.8683028714658381,0.6492307692307693,0.7340086630570211,1.0,10/17,34.28%,TNFAIP3;TNIP2;GAS6;IL13;NDNF;PDPK1;MAPK7;GATA3;SERPINE1;YAP1
gsea,positive regulation of growth (GO:0045927),-0.23422716078721373,-0.8680953399306993,0.6915422885572139,0.7327824205355953,1.0,35/35,92.53%,RPS6KA3;DDX3X;USP47;RPTOR;EIF4G2;EIF4G1;EXOSC2;KLHL22;SUPV3L1;INO80;ADAM17;PPM1F;BRAT1;BCL2;ADNP2;PRSS2;HDGFL2;DDX49;MMP14;TGFB2;ZPR1;IL2;CXCL16;SPHK1;MFSD2A;RFTN1;DNPH1;EXOSC4;SLC25A33;N6AMT1;NCBP1;AKT1;DERL2;FXN;EXOSC9
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2607350656009063,0.8661337709000893,0.6737451737451737,0.717152907070208,1.0,24/24,98.93%,GPX1;SP100;TMC8;FADD;ICAM1;TMBIM1;FAS;LGALS3;TRAF2;HMOX1;THBS1;PMAIP1;SERPINE1;TNFSF10;FEM1B;BCL2L1;TNFRSF10B;ARHGEF2;RIPK1;GSK3B;BRCA1;TNFAIP3;DDX3X;MADD
gsea,cellular response to hydrogen peroxide (GO:0070301),0.25239396498801714,0.8639213222457073,0.6593001841620626,0.7201324681362367,1.0,9/24,38.48%,PPIF;ANXA1;FXN;RELA;SIGMAR1;PARK7;RIPK3;SIRPA;NFE2L2
gsea,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2849437938838603,0.8609589567133829,0.6677316293929713,0.7243500129200813,1.0,12/20,45.52%,XCL1;CD160;LAMP1;SLAMF6;FADD;IL21;NECTIN2;CD226;CRTAM;IL23A;CADM1;NOS2
gsea,regulation of autophagosome assembly (GO:2000785),0.2794904560126092,0.8609558064204984,0.6453900709219859,0.7235804251268299,1.0,7/18,41.02%,ADPRH;TMEM39A;C9ORF72;PINK1;NPRL3;NUPR1;IFT88
gsea,positive regulation of neurogenesis (GO:0050769),0.2697420242071773,0.8604843661616239,0.670028818443804,0.7236086031674808,1.0,13/28,50.80%,NAP1L1;IFNG;CTNNB1;SS18L2;DCT;CX3CL1;TGM2;VEGFA;MAP6;SOX8;PLXNB2;FZD3;PLXNC1
gsea,negative regulation of signal transduction (GO:0009968),-0.1775431462173605,-0.8586538854086151,0.7982456140350878,0.7483537760738983,1.0,108/108,97.03%,CNOT1;VCP;NEDD4;ASXL1;MAZ;OTUD4;PTPRJ;TNFAIP3;XDH;FBXW7;LTF;PTCH1;PIP4K2B;TSC2;SPRY2;RNF157;SIGIRR;ARRB1;BTRC;MGRN1;HGS;SOCS5;ACVR1;HMGXB4;CCL5;DLL1;SMPD1;NLK;TRIB1;GATA3;SFRP4;BCL2;RB1;DAB2IP;CALR;CSNK2A2;FRZB;PALM;LRRC14;CX3CR1;TULP3;PTPRE;LYN;LGMN;SHISA2;LRRK2;PIK3CB;NKD2;TNF;GRB7;SULF2;RPGRIP1L;PTPN12;MMP14;NXN;TSKU;PTCH2;SLAMF1;SOX30;APLN;DLK2;THBS1;KANK2;TSPAN15;RITA1;PRKCB;PID1;PRKCZ;CREB3L1;LRP1;PHACTR4;DKK3;KCTD21;METTL3;GPC1;SPRY1;SPRY4;DLL4;TLE1;ENPP1;FGF2;CACTIN;NRARP;NFATC1;CX3CL1;IL1B;GRB10;CRY1;IRAK3;SMPDL3B;IL10;HHEX;WWOX;EGFL7;NR4A2;TMBIM1;RGS2;EPN2;CHAC1;HIC1;PLEK;AKT1;CBY1;TAX1BP3;EZH2;RACK1;SOCS1;DDIT4
gsea,glycosaminoglycan metabolic process (GO:0030203),0.2937681705769942,0.8563352102664137,0.6577708006279435,0.7299027293380896,1.0,7/19,35.66%,GUSB;SLC35D2;HGSNAT;HYAL2;GCNT2;PXYLP1;GPC1
gsea,regulation of cytokinesis (GO:0032465),-0.24969934627772114,-0.855656971465688,0.6353711790393013,0.752237067651089,1.0,45/45,99.17%,PKP4;BIRC6;SETD2;RAB11FIP4;CIT;SVIL;CDC14A;CUL3;AHCTF1;E2F7;ZFYVE26;KIF14;KIF20B;MAP9;KLHL9;CCP110;PLK3;CSPP1;BCL2L1;PRKCE;ECT2;KLHL21;KIF20A;CXCR5;E2F8;MAP10;PIK3R4;PRC1;PLK4;CDC25B;KIF23;CDC6;ZFYVE19;BBS4;AURKA;PLK2;PLK1;RACGAP1;PRPF40A;PDXP;GIPC1;CENPV;AURKB;PIN1;CALM2
gsea,regulation of protein kinase B signaling (GO:0051896),0.20615896206500148,0.853781323064878,0.7276657060518732,0.7335191484069065,1.0,44/84,52.84%,C1QBP;RACK1;CCL3;PHB;CCR7;HAX1;AKT1;HSP90AB1;CD86;MYDGF;OSM;PDGFA;FAM110C;BANK1;ICOS;HYAL2;RAMP3;PARK7;GCNT2;RET;CX3CL1;PIK3AP1;TRAT1;ENG;PINK1;FGF2;MFHAS1;AXL;CASS4;CPNE1;TGFA;TCF7L2;NTRK3;FLT3;F3;PIK3R1;AREG;THBS1;MET;BTC;HBEGF;PHLPP2;HSP90AA1;DDIT3
gsea,organic acid transport (GO:0015849),-0.22147505321087252,-0.8536342795965334,0.6763285024154589,0.7544268341768227,1.0,38/38,96.97%,SLC38A2;SLC7A1;NCOA1;SLC16A1;ABCC4;NCOA2;CEACAM1;SLC23A2;ABCG2;LRRC8D;SLC6A12;SLC7A6;SLC38A1;SLC27A1;SLC1A4;SLC25A45;SLC16A10;SLC25A10;ACSL1;SLC43A2;SLC6A6;SLC3A1;GOT2;SLC7A8;SLC27A3;SLC6A13;SLC25A30;MFSD2A;SLC25A32;SLC25A14;SLC1A5;STARD5;RXRA;SLC19A1;SLC13A3;SLC7A3;SLC3A2;SLC25A17
gsea,positive regulation of RNA metabolic process (GO:0051254),0.25917134956029647,0.8501542562938365,0.6755218216318786,0.738809758461287,1.0,15/28,44.61%,HNRNPLL;BUD23;WDR75;U2AF2;DIMT1;RELA;GRSF1;RIOK2;HRAS;DXO;IL1B;UTP15;ZPR1;PNPT1;PIK3R1
gsea,defense response to Gram-positive bacterium (GO:0050830),0.32514748557111367,0.8482078157973985,0.6711509715994021,0.7412411938927818,1.0,10/15,48.20%,HMGB2;PGLYRP1;PGLYRP2;CHGA;GBP6;RNASE6;FGR;GBP2;TLR2;MR1
gsea,regulation of interleukin-6 production (GO:0032675),-0.20661369564008514,-0.8453587695982601,0.7975206611570248,0.7677821893540018,1.0,58/58,95.09%,STAT3;IL17RA;NLRC3;DHX9;TNFAIP3;PLCG2;TMEM106A;SYT11;ARRB1;POU2AF1;F2R;AIF1;PTPN11;ARHGEF2;MAPKAPK2;GAS6;DDX58;TYROBP;LPL;F2RL1;RAB7B;IL33;SPHK2;POU2F2;C1QTNF4;TNF;CD200R1;MBP;IFIH1;CD200;MAVS;SLAMF1;MAPK13;NOS2;TLR2;IL16;PTPN6;GHSR;SIRPA;CD74;ZC3H12A;SYK;CX3CL1;TWIST1;IL1B;IRAK3;TLR4;TLR7;IL10;HYAL2;XBP1;APP;TNFSF4;SCIMP;SELENOS;HSPD1;IFNG;HMGB1
gsea,positive regulation of MAP kinase activity (GO:0043406),-0.2173928436182278,-0.8441215083164688,0.7304075235109718,0.7683732675006355,1.0,17/31,40.96%,MAP3K5;RASGRP1;MAP3K11;MAP3K4;PIK3CG;DVL3;PDGFB;ADAM8;ARHGEF5;MAP3K7;KIT;DAB2IP;PAK1;FLT1;PIK3R5;LRRK2;TNF
gsea,striated muscle contraction (GO:0006941),0.29387165737607857,0.8439009283343786,0.6946264744429882,0.7476623384826144,1.0,19/19,99.04%,ALDOA;TPM1;TNNT1;ATP1A2;SCN4B;TNNI2;SLC8A1;NOS1;SCN1B;ATP1B1;TNNI3;LMOD3;ARHGEF11;RCSD1;CCDC78;GAA;TTN;PIK3CA;GRK2
gsea,cellular protein localization (GO:0034613),0.18917066673649383,0.8403815403791777,0.8005952380952381,0.7526329701049309,1.0,66/131,56.38%,TMED2;NPM1;ADPRH;ARL1;PRPF19;COX18;CTNNB1;IFT27;ARL4D;EIF2D;AXIN2;COPB2;CD63;RABL3;EVI5;ARL5C;MESD;AP4M1;STX11;HHEX;RAP2A;ARL11;WLS;TMED1;CD74;GRTP1;ARL4C;SGSM3;ZDHHC15;ARFIP2;VPS35;BBS4;NAPB;RTP4;PACSIN1;VPS33A;RAB38;ID1;SNX13;COG7;UNC93B1;CEP68;SCFD2;RABGAP1;IFT22;GGA2;GGA3;RAB5B;TBC1D9;TBC1D30;SCG5;FBLN5;SIL1;AMOT;PICK1;VPS33B;PIGU;WDR11;USP6NL;SNX27;ARL5B;SH3PXD2B;RAB20;TICAM2;COPZ2;GAS8
gsea,positive regulation of T cell proliferation (GO:0042102),0.2706659368735312,0.8394032049364889,0.7004103967168263,0.7534332745985549,1.0,16/30,37.40%,HMGB1;PDCD1LG2;ANXA1;CD86;NCK2;TNFSF4;FADD;IL21;CD70;CD40LG;VCAM1;IL1B;TNFSF9;SYK;CCR2;IL2
gsea,chemokine-mediated signaling pathway (GO:0070098),-0.2420150532056376,-0.8389460634465195,0.7063197026022305,0.7758394339703013,1.0,26/26,95.70%,WNK1;PTK2B;RBM15;OXSR1;CCL5;CXCL9;SH2B3;GPR35;CCL17;CCL22;PF4;CXCL2;CCL2;CCL7;CCR2;CCL25;STK39;CXCL13;CX3CL1;CCL8;CCR1;CXCL10;CCL1;CCL4;XCL1;CCL3
gsea,signal transduction in response to DNA damage (GO:0042770),-0.23300507828351746,-0.837761706859766,0.6985138004246284,0.7762864752333142,1.0,36/36,95.25%,ATRX;MDM4;DOT1L;INTS7;ATR;ABL1;E2F7;RAD9A;CLOCK;PAXIP1;HINFP;USP10;ERCC6;MYO6;CHEK2;CLSPN;SESN2;CHEK1;MAP3K20;BRIP1;ATM;HUS1;NBN;WNT1;NDRG1;BATF;GADD45A;BID;RAD17;RAD1;RHNO1;E2F1;BCL3;DONSON;PRPF19;TIPRL
gsea,neuron migration (GO:0001764),-0.26378940164188314,-0.8373682258384626,0.685785536159601,0.775394292312232,1.0,9/18,38.53%,USP9X;RAPGEF2;NRP1;SH3RF1;SDCCAG8;NDNF;MEF2C;TUBGCP2;TUBB2B
gsea,lysosome organization (GO:0007040),-0.25171558107613723,-0.8371626414493821,0.7098121085594989,0.7740778456545846,1.0,10/21,38.02%,GNPTAB;HOOK3;TFEB;GAA;VPS18;CLN3;HOOK1;ZKSCAN3;CLN6;LRRK2
gsea,positive regulation of endothelial cell proliferation (GO:0001938),-0.2122742669261653,-0.8356364801300367,0.7320574162679426,0.7750119459131273,1.0,37/37,95.09%,SP1;ITGA4;ITGB3;PLCG1;ARNT;NRP1;PRKD2;PRKCA;STAT5A;PIK3CD;PDGFB;ADAM17;PDPK1;SIRT6;NRAS;SIRT1;HIF1A;PGF;APLN;VASH2;F3;HMOX1;NRP2;VEGFA;ECM1;FGF2;EGR3;NRARP;JCAD;EGFL7;VEGFB;TNFSF12;NR4A1;MYDGF;AKT1;HMGB2;HMGB1
gsea,positive regulation of interleukin-8 production (GO:0032757),0.26889674092217547,0.8335477523614526,0.7136752136752137,0.7624542450143758,1.0,11/26,31.68%,HMGB1;CD14;RELA;FADD;HYAL2;PARK7;TLR7;TLR4;IL1B;SYK;CD74
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2333148082637607,-0.8333602550021882,0.7432098765432099,0.7773011032613284,1.0,31/31,95.85%,SPTBN1;ITGA3;ATP2B4;ZDHHC5;ZDHHC8;KIF5B;CNST;PTPN9;CLN3;PDPK1;PRKCE;ITGB1;CNPY4;AKAP5;SORBS1;NKD2;CLIP3;TNF;PRKCI;ACSL3;PIK3R1;LRP1;PLS1;EPHA3;RANGRF;RAMP3;LGALS3;ZDHHC2;AKT1;IFNG;RACK1
gsea,negative regulation of neuron projection development (GO:0010977),0.2731248729828083,0.8330678719632152,0.6928213689482471,0.7624244977779945,1.0,7/19,32.60%,FKBP4;HDAC2;CRMP1;BAG5;RUFY3;GFI1;ADCY6
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.27177656254650684,-0.8310726850687142,0.7008032128514057,0.779820761754524,1.0,12/19,32.60%,NOTCH1;DOT1L;JAK2;NF2;OCIAD2;F2R;HGS;CCL5;IL10RA;NLK;KIT;SH2B3
gsea,defense response to bacterium (GO:0042742),-0.21421628434209655,-0.8294416118825622,0.8067632850241546,0.7808627723943495,1.0,42/42,95.02%,ANKRD17;SPN;LYST;DROSHA;LTF;OPTN;GBP7;CFP;GBP4;ADAM17;SLAMF8;MPEG1;SERPINE1;SHC1;PLA2G6;STAB1;MAVS;MR1;NOS2;SLPI;TLR2;IL23A;MPO;GBP2;SELP;FGR;SLC11A1;RNASE6;CTSG;GBP6;CHGA;SYK;OAS3;CXCL13;ISG15;TLR4;ANXA3;FCER1G;PGLYRP2;PGLYRP1;HMGB2;CEBPB
gsea,metal ion homeostasis (GO:0055065),-0.24887900471825236,-0.8257385857471514,0.7408637873754153,0.7854127968769707,1.0,9/16,37.04%,CIB2;SLC12A2;SLC12A6;FAM20A;SELENON;SLC12A3;CNNM2;TMTC2;MT3
gsea,mitotic G2/M transition checkpoint (GO:0044818),-0.2681843087342056,-0.823860486867509,0.6993603411513859,0.7869902899103262,1.0,29/29,96.57%,TAOK2;TAOK1;TOPBP1;FOXN3;NABP1;BRCA1;FZR1;TRIM39;DTL;BLM;TICRR;CLSPN;CDKN1A;CHEK1;ATM;HUS1;INTS3;ORC1;NBN;CDC6;RAD17;RINT1;PLK1;ABRAXAS1;MRNIP;BRCC3;DONSON;NAE1;CDK1
gsea,positive regulation of immune effector process (GO:0002699),-0.26181808275841084,-0.8233366469564402,0.7476340694006309,0.7861929183113314,1.0,18/18,93.64%,ANKRD17;PTPRJ;DDX60;DHX58;MYO18A;IL12RB1;MYB;IL23A;APPL2;IL2;CCR2;CD81;IL1B;IL10;XBP1;TNFSF4;PHB;IFNG
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),0.27629164354996355,0.8222137465938092,0.7065767284991569,0.7795077836832933,1.0,11/17,55.35%,HACD2;PPT2;ACSL5;HSD17B12;HACD1;ACSL6;ELOVL2;SLC25A1;ACSL1;ACSL3;ELOVL6
gsea,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.2992947170264218,0.8214092919998092,0.7149253731343284,0.7799592015079883,1.0,7/15,42.60%,HTRA2;AKT1;RET;IL1B;CSF2;PF4;INHBA
gsea,negative regulation of TOR signaling (GO:0032007),-0.248756831252499,-0.8203026771198524,0.7226277372262774,0.7897625514918525,1.0,12/23,38.69%,DEPDC5;TMEM127;TSC1;TSC2;UBR1;ARNTL;ITFG2;SESN1;SESN3;SIRT1;RNF152;FNIP1
gsea,regulation of lipid storage (GO:0010883),0.2717218022947824,0.8201633046730876,0.6586270871985158,0.7811640216217407,1.0,7/15,51.26%,HILPDA;ALKBH7;NFKBIA;MEST;ZC3H12A;VSTM2A;C3
gsea,cellular response to organic substance (GO:0071310),-0.19650181570703434,-0.818923890426614,0.8354037267080745,0.7903192942402988,1.0,31/56,40.96%,STAT3;NFAT5;NCOA1;NCOA3;IL18R1;MAPK8;STAT5B;PTPN23;SIGIRR;TIPARP;NCOA2;PTPN11;PTPN9;PDGFB;SMAD3;CXCR4;PTPN7;NDOR1;PTPN13;ACVR1;CCL5;HDAC6;KHSRP;MAPK7;CLEC3B;PTPN5;CSF1R;NOS1;LRRK2;SOCS2;TNF
gsea,regulation of mitotic spindle organization (GO:0060236),-0.2751563870565172,-0.8163835336206121,0.6989473684210527,0.792804360201914,1.0,11/21,35.00%,DYNC1H1;DCTN1;CLTC;NUMA1;BORA;CEP97;MAP9;GPSM2;HSPA1A;HNRNPU;EML3
gsea,negative regulation of cell projection organization (GO:0031345),0.27189255314338073,0.8132457314037618,0.7365079365079366,0.7913785484100646,1.0,7/18,32.60%,FKBP4;HDAC2;CRMP1;BAG5;PRNP;GFI1;ADCY6
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.26993864229232256,-0.8103370679432605,0.723404255319149,0.8009888563799027,1.0,9/16,38.17%,BCL2L11;EIF2AK3;OPA1;BOK;SYVN1;HSPA1A;BCL2L1;LRRK2;PMAIP1
gsea,negative regulation of innate immune response (GO:0045824),0.2830843437267753,0.8097424282263467,0.7145214521452146,0.795969705889849,1.0,11/19,37.16%,SAMHD1;LYAR;TRAFD1;IRAK3;ISG15;GRN;USP18;OAS3;CACTIN;METTL3;ACOD1
gsea,replication fork processing (GO:0031297),-0.263434888694831,-0.8073699861630264,0.7045951859956237,0.8041187353240165,1.0,29/29,98.67%,ATRX;RTEL1;BRCA2;RFWD3;ATR;FAM111A;FANCM;SMARCAL1;WRN;ZGRF1;BLM;GEN1;PRIMPOL;DDX11;ETAA1;ZRANB3;FBH1;NUCKS1;CENPS;DNA2;TONSL;THOC1;EME1;PCNA;TRAIP;MMS22L;RAD51;SAMHD1;ALYREF
gsea,positive regulation of cell motility (GO:2000147),0.20520258362246696,0.8066160615009604,0.8341463414634146,0.8000003742791628,1.0,54/104,52.58%,ACTG1;SOD2;RACK1;CCL3;ELP5;RHOC;CCR7;LAMC2;ITGAX;PDGFA;XBP1;FAM110C;CPNE3;HRAS;MYO1C;CCR1;CTSH;RUFY3;GCNT2;RET;IL1B;TWIST1;GRN;LGR6;LEF1;ARHGEF39;SPHK1;VIL1;PLET1;SEMA4A;VEGFA;DAB2;PECAM1;MYADM;CCL7;CXCL16;CASS4;FGR;MMP9;CAVIN1;EDN1;NTRK3;CCAR1;F3;SMIM22;COL1A1;THBS1;IGF1;ATM;ADRA2A;GTSE1;HBEGF;RIPOR1;ELP6
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.20159644830748466,0.8038218436434427,0.8307254623044097,0.8034022268682186,1.0,34/68,46.24%,C1QBP;CCL3;PHB;CCR7;HAX1;HSP90AB1;CD86;MYDGF;OSM;PDGFA;FAM110C;ICOS;RAMP3;PARK7;GCNT2;RET;CX3CL1;PIK3AP1;TRAT1;ENG;PINK1;FGF2;MFHAS1;AXL;CASS4;CPNE1;TGFA;TCF7L2;FLT3;F3;PIK3R1;AREG;THBS1;MET
gsea,phosphatidylcholine metabolic process (GO:0046470),0.23371626170001425,0.8024640329724382,0.7618320610687023,0.8047639842987975,1.0,15/30,47.05%,DBI;CHPT1;PLA2G12A;MBOAT2;ABHD4;PLA2G4F;MBOAT1;PLBD1;MFSD2A;NR1H3;PNPLA8;PCTP;PLA2G4A;LPCAT2;ACHE
gsea,response to calcium ion (GO:0051592),0.22096338572730082,0.8016050040029172,0.7774343122102009,0.8052333821755409,1.0,41/41,99.00%,CALM2;PPIF;RASGRP2;KCNMB4;CPNE3;ADD1;CPNE2;D2HGDH;ALOX5AP;SLC25A13;CPNE1;SYT4;AQP3;DMTN;THBS1;PRKAA1;KCNMB1;RASA4;RYR1;SYT7;LGMN;AHCYL1;ECT2;MEF2C;SMPD1;ALG2;CLIC4;CPNE9;CPNE7;SLC25A24;HOMER1;ADAM9;TRPC1;CAMK2D;SYT11;SEC31A;TTN;PLCG2;NEDD4;ITPR3;ITPKB
gsea,axonal transport (GO:0098930),0.2630710013070565,0.8013256955965296,0.7463175122749591,0.8048353535508066,1.0,20/20,99.56%,AP3S1;BLOC1S2;AP3M1;MGARP;HAP1;KIF3A;DST;KIF1A;TMEM108;HIF1A;BLOC1S5;NEFL;KIF1B;KIF3B;AP3B1;AP3M2;AP3D1;OPA1;DCTN1;DYNC1H1
gsea,positive regulation of cell-cell adhesion (GO:0022409),-0.24006481782643965,-0.8003130723567881,0.7890625,0.8136116130549671,1.0,22/22,93.83%,SMAD7;PIEZO1;DENND6A;PTPN23;CCL5;FUT7;CD44;TJP1;BMP7;ADAM19;TNF;AFDN;PLAUR;FOXA1;FLOT1;TNFSF11;CXCL13;CX3CL1;IL1B;GCNT2;IL10;CITED2
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2693484239874846,0.7992605231929941,0.7272727272727273,0.8071534260813512,1.0,9/21,37.34%,NOP9;DCAF13;UTP3;UTP4;TSR2;UTP6;RPP40;TBL3;RRS1
gsea,cation transmembrane transport (GO:0098655),-0.26599358096626047,-0.7957386000246521,0.7592592592592593,0.8191053693537356,1.0,15/15,91.52%,SLC7A1;ATP13A2;SLC7A5;SFXN2;ATP1B1;SLC25A19;KCNJ8;SLC36A4;SLC7A8;ATP1A2;TRPM1;SLC6A9;SFXN1;SLC7A3;SLC3A2
gsea,RNA biosynthetic process (GO:0032774),0.28053217467940567,0.7955320369082904,0.7357723577235772,0.8120524035232707,1.0,6/17,55.38%,SMN1;TBP;PRMT5;PRIM2;BRF2;TAF5
gsea,protein glycosylation (GO:0006486),0.19923349488431175,0.7934129774079743,0.8220757825370676,0.814469538827287,1.0,29/72,51.80%,DDOST;SERP1;RPN2;ST3GAL4;STT3A;SERP2;ST3GAL6;ALG3;B4GAT1;ST8SIA1;DPAGT1;MOGS;PGM3;B3GNT3;ST3GAL5;GCNT2;RPN1;DOLPP1;MPI;ALG6;POGLUT1;ENTPD5;EOGT;ALG8;COG7;B3GALNT2;B3GALT4;GFPT2;B3GNT5
gsea,negative regulation of catalytic activity (GO:0043086),-0.25954242127070437,-0.7894523721229854,0.7632743362831859,0.8270977103266798,1.0,8/15,37.04%,NOTCH1;CAND1;CLN3;CCAR2;HDAC6;SIRT1;NOS1;MT3
gsea,positive regulation of response to external stimulus (GO:0032103),0.21332453108011803,0.7872357389407992,0.8252427184466019,0.8229643102897123,1.0,34/66,45.10%,PLSCR1;CCL3;IFNG;NFKBIZ;SCIMP;ZBP1;CCL1;TNFSF4;OSM;TNFRSF1A;APP;IL21;HYAL2;MGST2;NINJ1;TLR7;NFKBIA;TLR4;SLC15A4;PDCD4;IL1B;CX3CL1;GRN;POLR3D;CCN4;CCR2;ACOD1;IL2;CD180;POLR3G;IL23A;IL16;THBS1;TLR2
gsea,negative regulation of endothelial cell proliferation (GO:0001937),0.29690663689789126,0.7856292457312405,0.7640156453715776,0.8245054182126846,1.0,8/16,53.55%,RGCC;PTPRM;DLL4;CCL2;CAV2;PPARG;THBS1;SPARC
gsea,positive regulation of T cell differentiation (GO:0045582),0.2749086480934631,0.7833166754829783,0.7779751332149201,0.8270721503830357,1.0,8/18,35.62%,SOCS1;TNFSF4;DUSP10;XBP1;IL4I1;TNFSF9;LEF1;TESPA1
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),-0.2007584401684075,-0.7826286807830687,0.8693693693693694,0.8356526014905211,1.0,37/37,96.87%,CLASP1;SMAD7;USF3;BCL9L;CLASP2;SPRY2;TGFB3;SPRED2;DAG1;SMAD3;TIAM1;GATA3;DAB2IP;SPRED3;OLFM1;SPRED1;MTOR;PHLDB2;COL1A1;TGFB2;FOXA1;LOXL2;EPHA3;SPRY1;DAB2;WWTR1;BAMBI;LEF1;TWIST1;IL1B;GCNT2;GLIPR2;AXIN2;OVOL2;CTNNB1;EZH2;RGCC
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2890054177787579,0.7825417005501634,0.7992565055762082,0.8273537306334064,1.0,9/19,44.85%,BSG;EMB;NECTIN2;NEXN;PTPRM;NECTIN4;PECAM1;PLXNB2;CADM1
gsea,stem cell differentiation (GO:0048863),0.25574027090552176,0.7763047606469047,0.78125,0.8357281845786345,1.0,8/17,48.23%,PSMD11;METTL5;UFL1;SETD6;BATF;MTF2;TGFB2;HOXB4
gsea,regulation of endothelial cell apoptotic process (GO:2000351),-0.21195455154202997,-0.7746318603635896,0.8132530120481928,0.8456565407104162,1.0,26/26,96.87%,ITGA4;TNFAIP3;ANO6;PLCG1;TNIP2;GAS6;IL13;NDNF;PDPK1;MAPK7;GATA3;SERPINE1;PAK4;TNF;PRKCI;THBS1;NFE2L2;CCL2;RAMP2;CD40;PDCD4;IL10;CD40LG;ICAM1;CD160;RGCC
gsea,cellular response to metal ion (GO:0071248),-0.1863930626923676,-0.7735123377452224,0.8754325259515571,0.8455028183959648,1.0,25/48,41.43%,ITPKB;ATP13A2;PLCG2;CDH1;JUN;MAPK8;SYT11;CAMK2D;SLC12A2;NCF1;SLC25A24;CPNE7;CPNE9;CLIC4;SMPD1;MEF2C;DLG2;CHUK;ECT2;LGMN;MT3;SLC41A1;LRRK2;SYT7;P2RX4
gsea,tRNA methylation (GO:0030488),0.2281986947240389,0.7735114615883697,0.7894736842105263,0.838632910421429,1.0,16/27,43.21%,TRDMT1;TRMT61B;TYW3;TRMT10C;NSUN2;TRMT1;HSD17B10;TRMT5;TRMO;TRMT61A;METTL1;FTSJ1;MTO1;GTPBP3;LCMT2;TRMT44
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),0.23603620577933354,0.7707170497422846,0.7990867579908676,0.8418116655482931,1.0,16/26,48.74%,ID2;PHB;AKT1;IL10;RBPMS2;CX3CL1;FGF2;CCN4;FOXJ2;FOXP1;MMP9;EDN1;HMOX1;THBS1;P2RY6;IGF1
gsea,establishment of protein localization to membrane (GO:0090150),-0.21958138139499966,-0.7690910115556908,0.8483412322274881,0.8501358682250658,1.0,28/28,94.36%,TAOK2;SYNE3;RAB3GAP2;ICMT;ZDHHC21;ZDHHC14;REEP1;NPC1;NCF1;RAB3IP;PIKFYVE;MICALL1;VPS37C;RAB3GAP1;PRKCI;ZDHHC24;AFDN;RTP4;CHM;ZDHHC15;ZDHHC12;RFTN1;ZDHHC6;BID;MYO1C;ZDHHC2;COX18;GORASP2
gsea,regulation of sprouting angiogenesis (GO:1903670),0.2630200033372435,0.7685389866649209,0.8,0.8439729927241394,1.0,11/20,44.94%,PKM;KLF2;EPN2;GLUL;S100A1;FGF2;VEGFA;CREB3L1;SMAD1;KLF4;THBS1
gsea,purinergic nucleotide receptor signaling pathway (GO:0035590),0.27206646817261554,0.7654530645578808,0.7667682926829268,0.8475433258964219,1.0,9/15,40.49%,HSP90AB1;CASP1;APP;TXNIP;NLRP3;IL1B;ENTPD5;CTSG;C3AR1
gsea,negative regulation of interleukin-6 production (GO:0032715),-0.23130352686454203,-0.7621816078363045,0.8625429553264605,0.8578138224281451,1.0,18/18,91.18%,NLRC3;TNFAIP3;SYT11;ARRB1;GAS6;TNF;CD200R1;CD200;SLAMF1;PTPN6;GHSR;SIRPA;ZC3H12A;CX3CL1;IRAK3;TLR4;IL10;SELENOS
gsea,phosphatidic acid metabolic process (GO:0046473),0.22301454549320243,0.7605882888259708,0.8014571948998178,0.8533121954891532,1.0,11/24,50.81%,AGPAT5;ACP6;PLA2G12A;AGPAT2;ABHD4;AGPAT1;GNPAT;DGKA;PLA2G4A;GPD1L;GPD1
gsea,regulation of toll-like receptor signaling pathway (GO:0034121),-0.25744265495363594,-0.7598221805098236,0.8212435233160622,0.8592300528338288,1.0,15/15,74.31%,OTUD4;BIRC2;LRRC14;FLOT2;TLR2;IRF7;APPL2;FLOT1;CACTIN;GFI1;BIRC3;CD36;IRF1;IRAK3;SMPDL3B
gsea,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2657656105631142,-0.7594812467531536,0.7610441767068273,0.8579294420942173,1.0,6/15,36.40%,EPAS1;ZMIZ1;HSPA1A;DCUN1D3;UBQLN1;HIF1A
gsea,cellular response to mechanical stimulus (GO:0071260),-0.2253460942777751,-0.7577100271405718,0.8896103896103896,0.8585373839872469,1.0,25/25,93.78%,MAP3K1;PIEZO1;MAP3K14;MAPK8;HABP4;SLC9A1;NFKB1;CASP8AP2;TNFRSF10B;CHEK1;PTGER4;LTBR;BNIP3;CD40;TNFSF14;GADD45A;IL1B;IRF1;TLR4;TLR7;FAS;TNFRSF1A;FADD;CASP1;BAK1
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24937085866700182,-0.756298506846312,0.7907949790794979,0.8586726917248725,1.0,10/18,32.86%,DDX3X;TNFAIP3;BRCA1;GSK3B;RIPK1;ARHGEF2;TNFRSF10B;BCL2L1;TNFSF10;SERPINE1
gsea,organophosphate biosynthetic process (GO:0090407),0.24955696216394319,0.7518015686815711,0.8193916349809885,0.8641535905833232,1.0,10/19,42.66%,AGPAT5;TKT;IPPK;MBOAT1;GNPAT;GK;PNPO;FGF2;PPIP5K2;GPHN
gsea,phosphatidic acid biosynthetic process (GO:0006654),0.22377459736905586,0.7517046345169279,0.8104089219330854,0.863377592330161,1.0,11/23,50.81%,AGPAT5;ACP6;PLA2G12A;AGPAT2;ABHD4;AGPAT1;GNPAT;DGKA;PLA2G4A;GPD1L;GPD1
gsea,positive regulation of interferon-beta production (GO:0032728),-0.22743491677181268,-0.7509553793699244,0.8273381294964028,0.8639923954735415,1.0,24/24,92.06%,DDX3X;DHX9;POLR3A;TRIM56;PTPN11;POLR3F;DDX58;DHX58;POLR3B;IFIH1;HSP90AA1;MAVS;TLR2;POLR3G;IRF7;FLOT1;POLR3D;OAS3;ISG15;IRF1;TLR4;TLR7;RIPK2;IRF5
gsea,regulation of cell cycle process (GO:0010564),-0.20921540932239174,-0.7502838765002149,0.8219780219780219,0.8631795826183107,1.0,64/64,99.17%,DYNC1H1;MKI67;BIRC6;CEP250;USP19;SETD2;RAB11FIP4;NUMA1;AHCTF1;ZFYVE26;SPAG5;BORA;TTL;CDC25C;CDKN2B;MAD1L1;KIF20B;MAP9;PKMYT1;KLHL9;E4F1;SND1;CCP110;PLK3;DCUN1D3;CUL7;BCL2L1;KIF11;ECT2;CSNK2A2;KLHL21;KIF20A;NUDT16;CHEK1;ATF5;PIK3R4;PRC1;PLK4;TXLNG;INSM1;CAV2;RPRD1B;BBS4;CEP85;DBF4;AURKA;SIX3;RMI2;NEK2;PLK2;KNSTRN;FBXO5;PLK1;RACGAP1;PRPF40A;PRMT5;BUB1;PDXP;RCC1;CTNNB1;AURKB;TIPIN;PIN1;CALM2
gsea,regulation of endothelial cell proliferation (GO:0001936),0.20321867652910566,0.7472179381611864,0.85383502170767,0.8683666642929584,1.0,21/39,47.28%,RGCC;HMGB2;AKT1;MYDGF;NR4A1;TNFSF12;VEGFB;EGFL7;PTPRM;NRARP;EGR3;FGF2;ECM1;VEGFA;NRP2;ACVRL1;CAV2;F3;VASH2;THBS1;PGF
gsea,negative regulation of DNA biosynthetic process (GO:2000279),0.24996760982974786,0.7383757864513777,0.8265895953757225,0.8787368557939251,1.0,6/17,49.20%,HNRNPA1;HNRNPC;MEN1;PINX1;ACVRL1;EXOSC10
gsea,actin filament bundle assembly (GO:0051017),0.26759857322236097,0.7349291631397128,0.8224043715846995,0.8822230954203122,1.0,10/20,45.51%,EZR;PDXP;USH1C;ADD1;EPS8;PLS1;PAWR;MYO1B;DMTN;MICAL1
gsea,regulation of supramolecular fiber organization (GO:1902903),0.261333862450979,0.7343914457575896,0.8235294117647058,0.8819843631955404,1.0,8/15,40.90%,GPX1;HSPA8;ARL2;AEBP1;PARK7;C9ORF72;GBA2;PRUNE1
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.27029236617756947,0.7329986735322119,0.8148148148148148,0.8827829810876803,1.0,9/19,28.60%,CCL3;IFNG;CASP1;RIPK2;HSPB1;APP;NLRP3;TLR4;CD36
gsea,kidney development (GO:0001822),0.24121108591867546,0.7298841817760824,0.85273492286115,0.8856356008503798,1.0,11/20,44.23%,HSPB11;IFT27;OSR2;HYAL2;CTSH;ZBTB16;VEGFA;TRAF3IP1;IFT88;TGFB2;KANK2
gsea,positive regulation of interleukin-6 production (GO:0032755),-0.19124718870109644,-0.7224593348198803,0.9314079422382672,0.8951397504797824,1.0,41/41,95.09%,STAT3;IL17RA;DHX9;PLCG2;TMEM106A;POU2AF1;F2R;AIF1;PTPN11;ARHGEF2;DDX58;TYROBP;LPL;F2RL1;RAB7B;IL33;SPHK2;POU2F2;C1QTNF4;TNF;MBP;IFIH1;MAVS;MAPK13;NOS2;TLR2;IL16;CD74;SYK;TWIST1;IL1B;TLR4;TLR7;HYAL2;XBP1;APP;TNFSF4;SCIMP;HSPD1;IFNG;HMGB1
gsea,chemical synaptic transmission (GO:0007268),-0.1472430309456319,-0.7139796993130249,0.9767441860465116,0.9026918162887444,1.0,68/68,96.85%,RPS6KA3;EXOC4;NLGN2;MINK1;LRP6;PMP22;FCHSD2;SLC12A6;ERC1;HOMER1;NPY;UNC13B;CACNA1A;PRKAR2A;SLC17A8;DVL1;CHRNE;PPFIA3;SPG11;DLG2;SLC1A4;PRKAR2B;AKAP5;APOE;CAMKK2;KIF1B;NAAA;STXBP3;MBP;SYN1;SLC17A6;MYCBPAP;DRD4;HTR7;KCNMB1;GLRA1;NPTX1;HTR2A;SLC12A7;PDE7B;GABRB1;CACNA1B;CACNB3;SLC1A2;ATXN3;SLC12A5;SLC12A4;PDLIM4;APBA3;KCNQ3;PNOC;NAPB;LIN7A;CAMK1;HAP1;NSG1;GRIN1;LPAR3;UNC13A;SLC32A1;GABRR1;RAPSN;KCNMB4;PENK;GIPC1;HSPA8;PDZD11;NRGN
gsea,bone development (GO:0060348),-0.23211129253664675,-0.7136095070547193,0.9044117647058824,0.9013352864454459,1.0,16/16,90.14%,SKI;LTF;LRP6;RPL13;SFRP4;PLS3;SULF2;SH3PXD2B;PTGER4;WNT1;P3H1;TGM2;MBTPS2;DYM;OSR2;VKORC1
gsea,sensory perception of light stimulus (GO:0050953),0.22262557221233586,0.7101216487704334,0.8947368421052632,0.9075094364328731,1.0,14/27,44.68%,OAT;RP2;RGS16;RABGGTB;USH1C;GPR179;DHRS3;SIX3;CRYZ;TRPM1;CRYAA;COL11A1;GNAT1;COL1A1
gsea,membrane lipid biosynthetic process (GO:0046467),0.21139591394643692,0.7088710055350312,0.8685524126455907,0.9079610720197783,1.0,15/25,55.35%,HACD2;ST3GAL4;HACD1;PLPP2;SPHK1;HACD4;PLPP1;ALDH3B1;ELOVL2;FA2H;SGMS1;B3GNT5;ALDH3A2;SCCPDH;ELOVL6
gsea,positive regulation of ossification (GO:0045778),-0.21376071603909347,-0.7087414340672085,0.8468468468468469,0.9046844146719246,1.0,7/16,36.66%,ANO6;TGFB3;PTPN11;TMEM119;ACVR1;MEF2C;BMP7
gsea,regulation of interleukin-1 beta production (GO:0032651),0.22317687843883385,0.7072317755010362,0.8603042876901799,0.908758262396298,1.0,18/33,40.59%,CCL3;IFNG;CCR7;CASP1;RIPK2;HSPB1;APP;NLRP3;CD33;TLR4;CD36;CX3CL1;ZC3H12A;SIRPA;CPTP;GHSR;FOXP1;EGR1
gsea,positive regulation of chemokine production (GO:0032722),0.25676769985444625,0.7069400447173986,0.8722580645161291,0.9081262026104104,1.0,15/28,45.10%,HMGB1;IFNG;TNFSF4;APP;TLR7;TLR4;IL1B;TWIST1;OAS3;SYK;CD74;AIRE;EGR1;HMOX1;TLR2
gsea,spermatid development (GO:0007286),-0.21769969885974602,-0.7031682409712091,0.8896551724137931,0.9086129148117875,1.0,8/15,41.79%,JAM2;CDYL;PRM2;DDX25;RNF8;YTHDC2;IQCG;MKKS
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.2444057847365424,0.70221545077099,0.8663101604278075,0.912178649666932,1.0,10/18,51.03%,PIN1;RBPMS;HFE;ENG;DAB2;ACVRL1;TTK;INHBA;TGFB2;INHA
gsea,second-messenger-mediated signaling (GO:0019932),0.20073812139416994,0.701355721772093,0.9131578947368421,0.91217180831741,1.0,22/48,45.52%,CCL3;CCR7;CXCR6;LAT2;CCRL2;RCAN1;GUCY1B1;CCR8;CXCR3;CCR1;MCTP1;CD36;MCU;TNFSF11;SPHK1;CCR2;CCR4;CCR6;CCR9;EDN1;EDNRB;NOS2
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.20037107108418972,0.7004914429422628,0.9170182841068917,0.9121547985946264,1.0,18/45,35.36%,DUSP1;AKT1;CDK5RAP1;RGS2;DUSP7;PLK1;MEN1;PKIG;HYAL2;TFAP4;HHEX;IRAK3;IL1B;GADD45A;CD300A;PKIB;SPRY4;SPRY1
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.19322563642121712,0.6986502333366256,0.9302325581395349,0.9130962470588061,1.0,27/52,43.67%,YWHAE;HMGB1;CCR7;CXCR6;CCRL2;CCL1;TBXA2R;S1PR4;CCR8;SLC35G1;CXCR3;CCR1;CD36;PTGER2;CXCL13;LPAR3;CCR2;GLP1R;ATP1A2;CCR4;CCR6;CCR9;CALCB;C3AR1;EDN1;CAV2;PLN
gsea,diterpenoid metabolic process (GO:0016101),0.25562447250493714,0.6942984500159987,0.8655692729766804,0.916419244327536,1.0,9/17,43.62%,ADH4;AKR1B10;RDH11;DHRS3;PECR;BCO1;GPC1;LRP1;AWAT2
gsea,protein ADP-ribosylation (GO:0006471),0.23328800209391778,0.6864681903404253,0.8758741258741258,0.9230448164534144,1.0,8/16,41.57%,HPF1;ART3;PARP3;PARP2;PARP9;SIRT4;PARP12;PARP1
gsea,blood circulation (GO:0008015),0.23976089647011842,0.677308183329488,0.909323116219668,0.9305921747695606,1.0,10/19,43.67%,GPX1;ADORA2A;SCPEP1;GUCY1B1;CXCL10;ADCY6;DLL4;ACVRL1;C3AR1;PLN
gsea,negative regulation of protein kinase B signaling (GO:0051898),-0.2169939927837991,-0.6749019670632661,0.914572864321608,0.9330560316394411,1.0,12/18,38.56%,PTPRJ;XDH;THEM4;TSC2;DAG1;PHLPP1;PLEKHA1;PHLDA3;TRIB3;SH2B3;SIRT1;PIK3CB
gsea,regulation of response to biotic stimulus (GO:0002831),-0.2030833505105021,-0.6471504153268285,0.9534246575342465,0.9527309222444811,1.0,19/19,93.18%,TRAF3;BIRC2;CD55;ELMOD2;LRP8;TRIM5;ERAP1;DHX58;FOXP1;FGR;APPL2;FCGR2B;CX3CL1;BIRC3;CD36;ZMPSTE24;IRF1;TKFC;SAMHD1
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.1517621389913242,-0.6434974678602128,0.9954954954954955,0.9532677677116257,1.0,46/46,85.42%,ADGRG1;CALCA;ADGRL1;GRK5;AKAP12;GABBR1;CALCRL;VIPR2;MC1R;CXCL9;AKAP5;ADGRL2;S1PR2;CCR3;GPR65;ADGRG3;ADRB2;RGS1;GNA14;PTGER4;ADRA2A;PTH1R;ABCA1;GPR3;ADGRE1;ADGRG5;GNAT1;TSHR;PF4;CALCB;GLP1R;RAMP2;RAMP1;ADCY6;LPAR3;ADM;PTGER2;GNA11;S1PR1;ADGRE5;RAMP3;CXCL10;S1PR4;TBXA2R;GNA15;ADORA2A
gsea,T cell differentiation (GO:0030217),0.2252337188854262,0.642696093867936,0.9461077844311377,0.9568030445585026,1.0,9/21,37.40%,ANXA1;ZFP36L1;FADD;RABL3;FCER1G;TCF7;RIPK3;DLL4;IL2
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.2364098416107579,0.6401649522300232,0.9058988764044944,0.9575258635601501,1.0,6/16,54.35%,IFNG;IL10;IL1B;TIMP1;ADRA2A;PTPN3
gsea,cellular response to calcium ion (GO:0071277),-0.1767727558351523,-0.6373849766831338,0.9642857142857143,0.9554302017990637,1.0,25/25,96.77%,ITPKB;PLCG2;SYT11;CAMK2D;SLC25A24;CPNE7;CPNE9;CLIC4;SMPD1;MEF2C;ECT2;LGMN;SYT7;RYR1;RASA4;PRKAA1;DMTN;SYT4;CPNE1;ALOX5AP;CPNE2;ADD1;CPNE3;RASGRP2;PPIF
gsea,regulation of chemotaxis (GO:0050920),0.21361773453068494,0.6364720818757781,0.8896551724137931,0.9589504440559379,1.0,15/15,91.73%,USP14;DUSP3;GPR183;THBS1;ADGRA2;EFNB2;P2RX4;ZSWIM4;F2RL1;PPM1F;CXCR4;PDGFB;AIF1;ZSWIM6;ZSWIM8
gsea,regulation of chemokine production (GO:0032642),0.235203497915234,0.632080852555655,0.9331476323119777,0.9607581920303179,1.0,11/21,45.10%,IFNG;TNFSF4;APP;TLR7;TLR4;CD74;AIRE;FOXP1;EGR1;HMOX1;TLR2
gsea,visual perception (GO:0007601),-0.16233685398357836,-0.6317491415194754,0.9830508474576272,0.956810850203404,1.0,28/28,91.73%,CEP250;CRYBG3;OPA1;EYA3;TYR;ATF6;MYO9A;OPA3;RDH12;ROM1;RPGR;CRYBA4;CACNA2D4;TULP2;COL1A1;GNAT1;COL11A1;CRYAA;TRPM1;REEP6;CRYZ;SIX3;DHRS3;GPR179;RABGGTB;RGS16;RP2;OAT
gsea,hematopoietic progenitor cell differentiation (GO:0002244),0.2230443760937334,0.6307425106141618,0.9302325581395349,0.9606003795565872,1.0,8/16,48.23%,MLF1;PLEK;UFL1;BATF;TNFRSF13B;INHBA;FLT3;HOXB4
gsea,sphingolipid biosynthetic process (GO:0030148),-0.17083665443768786,-0.6248460739110933,0.96398891966759,0.9588829680524731,1.0,27/27,95.35%,SMPD4;CERS6;PRKD2;HACD3;SAMD8;SGPL1;PRKD3;ELOVL4;SMPD1;PPM1L;SPHK2;ACER3;ELOVL6;ALDH3A2;SGMS1;FA2H;ELOVL2;ALDH3B1;PLPP1;HACD4;SPHK1;PLPP2;ST3GAL5;AGK;HACD1;ST8SIA1;HACD2
gsea,regulation of neuron differentiation (GO:0045664),0.19954999583858749,0.6201219470050137,0.95260663507109,0.965853424113288,1.0,28/28,91.52%,ID2;MMD;CDK5RAP1;TCF3;NRCAM;SIX3;CPNE1;LRRK2;BMP7;TCF4;NEPRO;REST;CALR;ECT2;KCTD11;MEF2C;DLL1;EIF2AK4;DTX1;TIAM1;ARHGEF2;ZEB1;SIN3A;IMPACT;MED1;YWHAG;ROCK1;CDK5RAP2
gsea,leukocyte cell-cell adhesion (GO:0007159),0.23465577292082263,0.6169472881000927,0.9369747899159664,0.966692155348542,1.0,7/15,40.12%,EZR;ICAM1;CD40LG;VCAM1;SYK;PECAM1;SELP
gsea,sodium ion transmembrane transport (GO:0035725),-0.17267765228651571,-0.6098344334301167,0.9858490566037735,0.9649530511563925,1.0,21/21,82.97%,ANO6;SLC12A2;SLC9A1;SLC4A8;SLC6A12;SLC12A3;ATP1A1;ATP1B1;SCN1B;SLC4A4;SLC8A1;SLC6A6;SCN4B;SLC9A2;SLC6A13;ATP1A2;ATP1A3;SLC6A11;SLC6A9;FXYD2;SLC9A9
gsea,positive regulation of lipid biosynthetic process (GO:0046889),0.2120191574986114,0.5936447095615836,0.9629629629629629,0.9771951469380223,1.0,8/15,39.67%,AKT1;MID1IP1;LPGAT1;SIRT4;MFSD2A;NR1H3;SCARB1;CTDNEP1
gsea,regulation of TORC1 signaling (GO:1903432),0.19684387008926563,0.587139517655398,0.9559633027522936,0.9789620753381213,1.0,17/17,93.61%,SEH1L;DYRK3;CASTOR1;PIH1D1;C9ORF72;ATM;SESN2;RNF152;GPR137B;SESN3;SESN1;ITFG2;RRAGB;KLHL22;SMCR8;TELO2;DEPDC5
gsea,actin filament bundle organization (GO:0061572),0.2143085490492339,0.5787687323913143,0.9561752988047809,0.9812988045261594,1.0,10/19,52.37%,EZR;USH1C;ADD1;EPS8;PLS1;PAWR;MYO1B;DMTN;MICAL1;FSCN1
gsea,response to amyloid-beta (GO:1904645),0.19897389023078987,0.5619806589591655,0.9738406658739596,0.9859754298451876,1.0,14/22,44.00%,ICAM1;APP;RAMP3;PRNP;TLR4;VCAM1;CD36;GRIN1;ATP1A3;FCGR2B;LRP1;MMP9;CACNA1B;CACNA2D1
gsea,positive regulation of histone acetylation (GO:0035066),0.1961453142664299,0.550865241802278,0.9686520376175548,0.9881156527421893,1.0,9/18,42.36%,SMARCB1;RUVBL2;PIH1D1;MUC1;IL1B;LIF;TADA2B;BRD7;TADA2A
gsea,sodium ion transport (GO:0006814),-0.15623092884169412,-0.534966151365986,0.9903225806451613,0.988939176459067,1.0,18/18,84.42%,ANO6;SLC12A2;SLC4A8;SLC6A12;SLC12A3;ATP1B1;SCN1B;FGF13;SLC4A4;SLC8A1;SLC6A6;SCN4B;SLC6A13;ATP1A2;SLC6A11;SLC6A9;SLC9B2;SGK1
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.14870896499713593,-0.5167735303547073,0.9957264957264957,0.9904802280390359,1.0,27/27,85.88%,PARP14;TRIM44;TXK;RIPK1;GAS6;CXCR4;ADAM17;HSPA1A;CSF1;HIF1A;C1QTNF4;TICAM2;HSPA1B;CASP4;MAVS;EDN1;CD300LF;CPNE1;AXL;CD74;GFI1;PARP9;AGPAT1;FADD;CASP1;AGPAT2;ZBP1
gsea,regulation of MAP kinase activity (GO:0043405),0.1476394383961737,0.5069667120041271,0.9974226804123711,0.996109100190014,1.0,21/48,50.09%,DUSP19;EZH2;DUSP1;PDGFA;RGS2;DUSP7;HRAS;HYAL2;IRAK3;IL1B;CD300A;TNFSF11;FGF2;CD40;SPRY4;VEGFA;SPRY1;PIK3R6;EDN1;FLT3;ADRA2A
gsea,glycosaminoglycan catabolic process (GO:0006027),0.16973591741326421,0.4991199346419995,0.9852459016393442,0.9961862197991112,1.0,12/19,56.98%,GUSB;HGSNAT;HYAL2;ARSB;FGF2;GPC1;HEXA;VCAN;NAGLU;SDC4;GALNS;HMMR
gsea,cellular response to amyloid-beta (GO:1904646),0.18557487023657904,0.49751624576881753,0.9866504854368932,0.9953763808866004,1.0,12/19,48.74%,ICAM1;APP;PRNP;TLR4;VCAM1;CD36;GRIN1;ATP1A3;FCGR2B;LRP1;CACNA2D1;IGF1
gsea,defense response to Gram-negative bacterium (GO:0050829),0.1897602197218318,0.4791074193439715,0.9937578027465668,0.9964763778070429,1.0,10/15,48.20%,HMGB2;TLR4;CHGA;CTSG;RNASE6;SLC11A1;SELP;IL23A;NOS2;MR1
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),0.16217851974415395,0.43617982559626667,0.9986595174262735,0.9983528801889259,1.0,8/16,43.49%,TESC;MUC1;RET;SYK;LIF;FOXC2;ADA;TGFB2
